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ABSTRACT  	  	  
Aneurysmal subarachnoid hemorrhage (SAH) carries a high morbidity and 
mortality. The current protocols used to treat the unruptured Intracranial 
Aneurysms (IAs) are inadequate underscoring the need of finding new 
descriptors. 	  
 
As demonstrated by the studies performed in this manuscript, 
haemodynamics plays an important role in the aetiopathogenesis of IAs. 
An evaluation of haemodynamic indices can provide a useful alternative to 
predict the behavior of an unruptured IA at an early stage. Studies 
performed by me demonstrate that Computational Fluid Dynamics (CFD) 
can be used successfully to predict haemodynamic indices where detailed 
in vivo measurement of haemodynamic flow variables is not possible 
owing to technical limitations. 
 
European Commission funded Project @neurIST was the first project of 
it’s kind that brought together a number of multidisciplinary professionals 
from 32 European institutions and made possible development of state-of-
the-art tools for personalised risk assessment and treatment IAs using 
CFD. These tools have been constantly improved and amended in the light 
of feedback gathered from their controlled exposures conducted world 
over, as described in the manuscript. However, need of a well-designed 
Randomized Controlled Trial in this context cannot be overemphasized, 
before these tools can be accepted by clinicians and patients. 
 
In my study on the validation of different concepts used in CFD, I 
demonstrated that there is no added advantage of complex Womersley-­‐flow-­‐profile	  over	  the	  much	  simpler	  plug-­‐flow	  profile.	   
 
One of my studies on initiation and rupture of IAs showed that the 
haemodynamic patterns of IAs during these two phases are significantly 
different with values of supra-physiological Wall Shear Stress (WSS) 
being higher in initiation while lower in rupture phase. I also investigated 
the effects of pharmacological agents on the aetiopathogenesis of IAs and 
found that heparin induces significant derangements in the 
haemodynamics of both, pre-aneurysmal as well as ruptured IA. I propose 
that heparin (and its derivatives) can, on the one hand may facilitate the 
rupture of existing IAs, on the other hand they may suppress the formation 
of new IAs.  
I have also found significant differences in the results using patient-
specific vs. Modeled Boundary Conditions and showed that the 1D 
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circulation model adopted by @neurIST performs better than other 
approaches found in the literature. 
 
I also proposed a novel mechanism of increase in Blood Viscosity leading 
to high WSS as one of the important underlying mechanisms responsible 
for the increased incidence of IA formation in smokers and hypertensive 
patients. 
 
In my study on patients with pre-existing Coarctation of Aorta (CoA) and 
Intracranial Aneurysms, I demonstrated that the cerebral flow-rates in 
CoA patients were significantly higher when compared to average flow-
rates in healthy population. It was also seen that the values and the area 
affected by supraphysiological WSS (>15Pa) were exponentially higher in 
patients with CoA indicating the possible role of increased haemodynamic 
WSS secondary to the increased flow-rates playing an important role in 
the pathogenesis and rupture of IAs in CoA patients.   
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1.2 Dilemmas with current management plans  
1.3 Importance of Haemodynamic Factors 
1.4 Limitations of current technology in measuring haemodynamic indices 
and role of CFD in this context 
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1.6 Application of CFD in the field of Intracranial Aneurysms 
1.7 Validation of common concepts used in CFD 
1.8 CFD as a tool to explore the aetiopathogenesis of Intracranial 
Aneurysms 
 
1.1 Background 
An aneurysm is an abnormal dilatation or ballooning of a part of a blood 
vessel due to weakness in its walls. Whereas, we can find aneurysms 
virtually anywhere in the body, one of the most fatal locations to have one 
is inside the cerebral vasculature, known as intracranial aneurysms (IAs). 
The work presented in this thesis is focussed on addressing different 
aspects of aetiopathogenesis and management of this particular variety 
using Computational Fluid Dynamics (CFD).  
 
The term aneurysm, derived from Greek word aneúrysma (ana; 
throughout + eurus; wide), meaning ‘to dilate’, was introduced by 
Claudius Aelius Galen, a philosopher of Greek origin in 200 AD. The 
earliest description of the intracranial or subarachnoid haemorrhage (SAH) 
as a cause of death in human beings, dates back to the ancient Biblical 
times. The first anecdotal evidence of an intracranial aneurysm as well as 
the earliest attempt to treat it come from Egypt. It is recorded in Ebers 
Papyrus, one of the oldest preserved medical documents that in 2725 BC, 
Imhotep, who was an Egyptian architect cum physician, tried to treat an 
aneurysm by using a fire glazed instrument [Lippi 1990].  
 
History as a whole plays a paramount role in motivating scientists as well 
as providing us a foundation for future work. The history of management 
of Intracranial Aneurysms, history of Computational Fluid Dynamics 
(CFD) and the current status of CFD in the field of Intracranial 
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Aneurysms, is therefore analyzed in detail by conducting a focused review 
of relevant literature in the section Review of Literature. 
 
1.2 Dilemmas with current management plans  
In spite of recent advancements in the management, aneurysmal 
subarachnoid hemorrhage (SAH) remains a major cause of morbidity and 
mortality in neurosurgical patients [Hop et al. 1997]. Whereas, the 
treatment protocols for a ruptured intracranial aneurysm (IA) have become 
clearer with time, the management of unruptured IAs remains one of the 
most controversial topics in neurosurgery. These uncertainties are multi-
factorial, owing mainly to incomplete and conflicting data about natural 
history of these lesions and the risks associated with the active 
management [ISUIA 1998, Raaymakers 1998, Rinkel 1998]. In order to 
offer the best possible treatment to the patient with the least side effects, 
formulation of a clear management protocols, directed by the natural 
history of unruptured IAs and, the risks associated with the active 
management, is required. Whereas, there are no strict guidelines, most of 
the studies [Juvela 2000, Komotar et al. 2008, Mayberg et al. 1994) 
including ISUIA trials [ISUIA 1998, Wiebers et al. 2003), almost 
unanimously recommend certain factors as indications of surgery or 
endovascular coiling in unruptured IAs: large aneurysmal size, 
symptomatic lesions, evidence of growth, multiple lesions, posterior 
circulation location, past history of SAH, history of smoking and 
hypertension, etc. All these criteria are found to have good correlation 
with increased risk of rupture and hence, active intervention is advocated 
in these situations to avoid the poor outcome. However, it is interesting to 
note that all of these factors also remain the underlying descriptors for 
poor surgical or endovascular outcome [Khanna et al. 1996, Solomon et al. 
1994, Wirth et al 1983]. In other words, by the time we take a decision to 
treat an IA based on the current guidelines, the patient has already become 
predestined for a poor outcome. 
 
1.3 Importance of Haemodynamic Factors 
Whereas, current evidence convincingly supports a multifactorial 
aetiology for IA formation, there is a growing body of literature 
underlining the importance of haemodynamic [Burleson et al. 1996, Byrne 
et al. 1998, Gao el al. 2008, Morimoto et al. 2002, Cebral et al. 2013, 
Sadasivan et al. 2013, Omodaka et al. 2012, Meng et al. 2013] and 
morphological [Lall et al. 2009, Sadatomo et al. 2008, Xu et al. 2013, 
Kashiwazaki et al. 2013] factors in this context. The haemodynamic 
variables often considered in these studies are wall shear stress (WSS), 
oscillatory shear index (OSI), blood pressure and other quantities used to 
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characterize blood flow, while important morphological indices are shape, 
aspect ratio, Zernike Moments, etc. An evaluation of these variables can 
provide a useful alternative to predict the behavior of an unruptured IA at 
an early stage before it changes in size, shape or becomes symptomatic. 
These factors therefore can guide us in selecting the IAs with greatest risk 
of rupture and thus warranting the active interventions before they join a 
cohort of IAs who are destined for a poor outcome if we take this decision 
based on current guidelines. At the same time, these factors can indicate 
the IAs with relatively low risk of rupture that can be safely monitored, 
thus avoiding the unnecessary interventions.  
 
I envision that, this prediction of risk of rupture in an Aneurysm-specific 
way will eventually revolutionize the treatment of Intracranial Aneurysms 
taking it to the next level. 
 
1.4 Limitations of current technology in measuring haemodynamic 
indices and role of CFD in this context 
Whereas, haemodynamic and morphological indices show great potential 
in guiding the correct management of IAs, limitations in current 
technology greatly restrict our ability to measure these factors in patients. 
In spite of some recent studies [Boussel et al. 2008, Isoda et al. 2009, Rayz 
et al. 2009] showing possibility of measuring some of the haemodynamic 
quantities in-vivo using magnetic resonance fluid dynamics (MRFD), 
inherent limitations in the technology impede its use in large cohort 
studies and aneurysms of <5 mm diameter. It is therefore fair to say that, 
the detailed in-vivo measurements of these relevant flow variables in the 
regions affected by the disease are currently very difficult and impractical 
[Shojima et al. 2004, Steinman et al. 2003].  
 
Computer modeling and simulation techniques are playing an increasingly 
important role in the way medicine is being practiced and has been 
successfully applied in a number of medical disciplines.  
 
1.5 CFD and its various applications in medicine 
Computational fluid dynamics (CFD) is one of the most important tools 
used for computer modeling and simulation that can represent a valuable 
alternative to extract additional non-observable information from patient-
specific data for IAs. 
 
CFD is the science of predicting fluid flow, heat and mass transfer, 
chemical reactions, and related phenomena by solving numerically the set 
of mathematical equations that govern a particular physical system 
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(conservation of mass, momentum, energy, species etc.). Since its early 
development in the 1960s and 1970s in the field of aerospace, where it 
was used mainly to improve the design and efficiency of aircrafts 
[Agarwal et al. 1999] CFD has been successfully used in many other 
clinical applications.  
 
One of the most important clinical areas where CFD is widely used is 
Circulatory System. It has been applied for assessing the blood flow 
through stenoses [Feng et al. 2011, Bark et al. 2010, Siouffi et al. 1998], 
analysis of physiology of blood flow through heart valves [Chan et al. 
2013] as well as the turbulence through prosthetic heart valves [Kaufmann 
et al. 2011], flow and patency of aortic grafts [Vardoulis et al. 2011, 
Prasad et al. 2011] and mechanics of arterial diseases [Tang et al. 2013]. It 
has also been used for assessing the flow through Arterio Venous Fistulas 
[Ene-Iordache et al. 2011, Kharboutly et al. 2010] and modelling of 
thrombosis of blood [Corbett et al. 2010]. CFD has also been applied to 
the Respiratory System for the simulation of airflow and evaluation of 
respiratory functions [Malvè et al. 2011] as well as characterization of 
respiratory aerosol drug delivery [Lou et al. 2004, Tian et al. 2011]. 
Investigators have also applied numerical modelling to the fluid dynamics 
inside the human Gastrointestinal System [Ferrua et al. 2010], the urinary 
flow-rates through the Genitourinary System [Frawley et al. 2009] and the 
flow dynamics of Cerebrospinal Fluid (CSF) and its correlation with the 
development of hydrocephalus [Linge et al. 2011, Penn et al 2011].  
 
1.6 Application of CFD in the field of Intracranial Aneurysms 
Success of CFD in other medical disciplines played an important role in 
inspiring biomedical scientists and paved a path for its further application 
in the field of cerebral vasculature and intracranial aneurysms [Boussel et 
al. 2008, Castro et al. 2006, Cebral et al. 2005, Shojima et al. 2004, Singh 
et al. 2009, Steinman et al. 2003, Morales et al. 2011, Lu et al. 2011, 
Wong et al. 2011, Hassan et al. 2011, Marzo et al. 2011, Doenitz et al. 
2010, Zeng et al. 2010, Sun et al. 2010, Sforza et al. 2010, Ford et al. 
2005, Ford et al. 2008, Sun et al. 2012, Alfano et al. 2013, Weichert et al. 
2013]. Apart form that; two other important factors behind the successful 
application of CFD in this field were; growing evidence emphasizing the 
important role played by haemodynamic indices in the aetiopathogenesis 
of Intracranial Aneurysms and difficulty of conducting detailed in-vivo 
measurement of these variables. 
 
The application of CFD in this relatively new field, however, was not 
without challenges. There were a number of prerequisites to be met and 
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hurdles to overcome, before the potential of CFD as a tool could be 
tapped, in predicting the risk of rupture in Intracranial Aneurysms. These 
challenges were met one by one in the project @neurIST.  
 
The initial step in computing these haemodynamic and morphological 
variables is building three-dimensional (3D) computer models of the 
Region of Interest (ROI) from patient specific medical images (e.g. 3D 
Rotational Angiograms, CT Angiograms, or MR Angiograms). This is 
achieved with the help of a software tool-chain (called herein tool-chain). 
First and foremost, prerequisite therefore was building a user-friendly 
robust tool-chain that is not observer dependent and can be used by a 
common user, consistently and repeatedly [Villa-Uriol et al. 2011]. This 
major breakthrough achieved by teams of dedicated biomedical scientists 
and computer engineers across a number of centers as a part of project 
@neurIST. This goal was accomplished in three main steps: a) 
development of software @aneuFuse or the tool-chain, b) continuing 
evaluation of the tool-chain by conducting its controlled exposures to the 
relevant audiences and users to collect useful feedback and, c) modifying 
the tool-chain by integrating this feedback as well as conducting a Multi-
centric Synchronization. The tool-chain is described in detail under 
materials and methods section along with an overview of its development 
process as undertaken by different teams. 
 
1.7 Validation of common concepts used in CFD 
After building a robust tool-chain, the next step was to establish the 
reliability of the common basic concepts applied while using CFD as a 
tool in the analysis of haemodynamic and morphological indices in the 
Cerebral Vasculature and Intracranial Aneurysms.  
 
Specification of Boundary Conditions is an important prerequisite for 
solving the governing equations in the extraction of these non-observable 
indices. As direct measurements of these flow-rate waveforms at the inlets 
and outlets of the domain are usually impracticable [Marzo et al. 2009], 
the Boundary Conditions are mostly derived using the available 1D 
Circulation models [Westerhof et al. 1969, Stergiopulos et al. 1992, 
Vignon-Clementel et al. 2006, Balossino et al. 2009, Bove et al. 2008]. A 
number of assumptions are made while applying these Boundary 
Conditions that can strongly perturb the numerical calculations. One such 
assumption is application of Womersley flow profile at inlet Boundary of 
the domain [Marzo et al. 2009]. The first study therefore was conducted to 
investigate the effects of different inlet velocity profiles on the 
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haemodynamics of IAs and compared them with the more important 
determinants of the haemodynamics like geometry of the domain.  
 
The study on the effects of Boundary Conditions on the haemodynamics    
of IAs further extended by taking phase contrast MR (pc-MR) 
measurements for flow-rates in 19 IAs from nine patients recruited in the 
study [Marzo et al. 2011]. The effects of the Boundary Conditions derived 
using these patient-specific pc-MR follow-rates and the traditional 1D-
model, on the haemodynamic characterization of IAs, were then compared 
and analyzed in order to quantify the agreements and differences in the 
values of derived haemodynamic indices. 
 
1.8 CFD as a tool to explore the aetiopathogenesis of Intracranial 
Aneurysms 
The final sections of this manuscript are devoted towards exploring the 
different factors that can influence the aetiopathogenesis of Intracranial 
Aneurysms by altering their haemodynamic environments. A number of 
studies were designed in this context and CFD was used to prove or refute 
the hypotheses.  
 
The first study in this section was conducted on the two well-known risk 
factors for Intracranial Aneurysm formation: smoking and hypertension. 
Whereas, smoking and hypertension are well-established risk factors in IA 
formation [Bonita 1986, de la Monte et al. 1985, Inci et al. 2000, Juvela 
2000, Kondo et al. 1997] their roles in the mechanisms that regulate 
aneurysm formation are poorly understood and are essentially limited to 
their statistical associations. In this study, I hypothesized that smoking and 
hypertension lead to intracranial aneurysm formation by changing the 
haemodynamic environment of the cerebral vasculature secondary to their 
effect on Blood Viscosity. There is good evidence in the literature that 
smoking and hypertension increase the Blood Viscosity in individuals [de 
Simone et al. 2005, Letcher et al. 1983]. CFD was used to compute the 
effects of these risk factors on wall shear stress (WSS) and oscillatory 
shear index (OSI) at the site of IA initiation, two most important factors 
for the development of Intracranial Aneurysms [Burleson et al. 1996, 
Byrne et al. 1998, Gao et al. 2008, Morimoto et al. 2002].  
 
In the next study, I analyze the differences in the haemodynamic 
environments of intracranial aneurysms during the stages of their initiation 
versus rupture. 3D Rotational Angiograms were used to build the three-
dimensional computer models of aneurysms included in the study 
followed by their qualitative and quantitative comparisons. The study 
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further extended by investigating the effects of heparin (and enoxaparin) 
on the haemodynamic characteristics of aneurysms. Heparin (and its 
derivative enoxaparin) is a widely used injectable anticoagulant for 
preventing venous thrombosis and pulmonary embolism. It inhibits the 
factors involved in blood clotting (factor Xa), causing instantaneous 
inactivation of thrombin, thereby reducing Blood Viscosity [Hitosugi et al. 
2001) and, in turn altering the haemodynamics of the blood circulation. 
Values of WSS and OSI were computed with the help of CFD in a 
ruptured Intracranial Aneurysm and compared with a tiny aneurysm in the 
stage of initiation. Possible link between the low Blood Viscosity, and 
alterations in values of WSS/ OSI, leading to the rupture of Intracranial 
Aneurysm was explored. Potential effects of other pharmacological agents 
on the aetiopathogenesis of intracranial aneurysms are also discussed. 
Another interesting study was conducted to analyze the haemodynamic 
changes in the cerebral circulation of patients with Coarctation of Aorta 
and its possible effects on the increased incidence and rupture of 
Intracranial Aneurysms in these patients. After a thorough search 
(PubMed®, Embase® and Google-Scholar™ searched from the year 1900 
up to 2009) I could retrieve only two relevant studies. Whereas, 
Hafkenschiel et al [Hafkenschiel et al. 1949) demonstrated a significant 
increase in cerebral arterial flow-rates in patients with Coarctation of 
Aorta in 1949, Rowe and colleagues [Rowe et al. 1964] found no 
significant differences in the flow-rates before and after the repair of 
Coarctation of Aorta in their study performed in 1964. I therefore 
preformed pc-MR measurements in the cerebral arteries of a Coarctation 
of Aorta patient with coexisting IA and five healthy volunteers to establish 
the flow-rates at different locations in the cerebral vasculature.  
 
Amongst other aetiologies proposed, Coarctation of Aorta has been 
highlighted as a major risk factor in the aetiopathogenesis of IAs [Abbott 
1928, Ahmetoğlu et al. 2003, Connolly et al. 2003, DuBoulay 1965, 
Eppinger 1871). Incidence of Intracranial Aneurysms among patients with 
CoA is approximately 5 times higher than that of the general population 
[Connolly et al. 2003]. The incidence of IA rupture in CoA patients 
(4.8%) [70,83 Mercado et al. 2002, Reifenstein et al. 1947] is also higher 
than the estimated rate of rupture in the general population, which is less 
than 1% [Weir et al. 1996]. In spite of CoA being a well-established risk 
factor for IA formation, [Abbott 1928, Ahmetoğlu et al. 2003, Connolly et 
al. 2003, DuBoulay 1965, Eppinger 1871] the exact underlying 
mechanisms for this association remain poorly understood. After 
measuring the flow-rates in the cerebral vasculature in patients with 
Coarctation of Aorta, an analysis of the different haemodynamic factors 
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inside Intracranial Aneurysms was performed. The possible role of 
haemodynamics is discussed in this context in a background of relevant 
literature.  
 
A better understanding of the aetiopathogenesis of the IA formation and 
rupture may help clinicians in preventing and treating the disease 
effectively. 
 
No study is perfect. It is therefore imperative to analyze the strengths and 
weaknesses of any work objectively. Towards the end of each section, 
limitations of the each study are discussed. This will provide readers and 
future workers a comprehensive insight in the methodology as well as 
enable them to reduplicate the studies, if required.  
 
Overall inferences and conclusions drawn from the work as a whole are 
given at the end of the manuscript along with scope for future work. 
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My contribution: I performed all literature reviews included in this 
chapter, independently.  
 
 
2.1 Introduction 
 
In the first section of this chapter I have reviewed the pertinent literature 
exploring the natural history of Intracranial Aneurysms (IAs) including 
incidence, anatomical locations, and different classifications. The 
phenomenon of ‘initiation’, ‘growth’ and ‘rupture’ are addressed 
separately with their possible mechanisms and different theories behind 
them with a focus on the possible role played by different haemodynamic 
factors in each stage. 
 
History as a whole plays a paramount role in motivating scientists as well 
as providing us a foundation for future work. The history of management 
of Intracranial Aneurysms, the history of Computational Fluid Dynamics 
(CFD) and the current status of CFD in the field of Intracranial 
Aneurysms, is therefore analysed in detail by conducting a focused review 
of relevant literature in the later sections of this chapter. 
 
2.2 Materials and Methods for Conducting Review of Literature 
A thorough search of different medical and non-medical databases was 
conducted. The databases searched were Pubmed®, Cochrane®, Medline®, 
Embase®, Experta Medica®, Cinahl®, Citation Index®, National Library for 
CHAPTER 2.0: REVIEW OF LITERATURE 	  
	   30	  
Health®. General-purpose search engines such as Google™, Google-
scholar™, and AltaVista™ were also used to generate search leads, which 
were further followed, by searching specific medical databases. I searched 
the different databases from the years 1910 to 2014. Strings from the 
bibliographies and references used by different authors of the published 
papers were also followed to retrieve the articles. The full text articles 
sourced through Sheffield Health Sciences Library, Northern General 
Hospital Library, The British Library, British Medical Association Library 
and British Museum. The full-text of the required articles was also 
obtained from the concerned journals. The authors of some papers were 
contacted directly if I was unsuccessful in retrieving the paper from any 
other source. Help of professional translators was taken to translate the 
articles obtained in languages other than English. Some unpublished work 
is also included in the data analysis after obtaining the relevant 
permissions from the concerned authors.  
 
The different key words used for searching were: "intracranial/ cerebral 
+ aneurysm + management", "intracranial/ cerebral + aneurysm + 
treatment", " intracranial/ cerebral + aneurysm + surgery", " intracranial/ 
cerebral + aneurysm + coiling", " intracranial/ cerebral + aneurysm + 
history", "intracranial/ cerebral + aneurysm + management + unruptured", 
"intracranial/ cerebral + aneurysm + aetiology", "intracranial/ cerebral + 
aneurysm + aetiopathogenesis" "intracranial/ cerebral + aneurysm + 
initiation" "intracranial/ cerebral + aneurysm + growth", "intracranial/ 
cerebral + aneurysm + rupture", "intracranial/ cerebral + aneurysm + 
natural + history", "computational + fluid + dynamics", “CFD”, “numeric 
simulations”, “CFD + validations”, “CFD + applications + medicine”, etc. 
2.3: Understanding the Natural History and aetiopathogenesis of 
Intracranial Aneurysms 
2.3.1: Incidence 
Depending upon the population sample, observers’ competence and the 
method used, the incidence of intracranial aneurysms varies in different 
autopsy series from 0.9% to 11% [Chason et al 1958, Cohen 1955, 
Jakubowski et al 1978]. The average annual prevalence of unruptured 
aneurysms in a population can be considered around 5% [ISUIA 1998, 
Kondo et al 1997]. The incidence is expectedly increasing with the advent 
of non-invasive techniques such as CTA, MRI and MRA. Intracranial 
aneurysms are rare in children, especially in first decade, with the 
incidence being highest during 4th, 5th and 6th decades [Kondo et al 1997]. 
The sex ratio changes with location. They are more common in women in 
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the internal carotid location (2:1) while the ratio is reversed in the middle 
cerebral artery (2:3). Multiple aneurysms can occur in 15 to 31% of the 
population [Kondo et al 1997]. The regional variations are reported with 
publications claiming higher incidence from Japan [Suzuki et al 1971]. 
2.3.2: Anatomic Location 
Most intracranial aneurysms arise in and around the circle of Willis, with 
peripheral aneurysms remaining a rarity. The frequency of IAs at different 
locations is given in Table-2.1. An aneurysm is usually formed at an 
arterial bifurcation or at the convexity of an arterial bend, the direction the 
axial blood stream would have taken if the curve were not there (Figure-
2.1) [Rhoton 1980]. 
2.3.3: Classification of Intracranial Arterial Aneurysms  
Intracranial aneurysms are typically classified on the basis of their location 
(on the artery, anterior or posterior circulation), morphology (saccular, 
fusiform, dissecting), aetiology (traumatic, inflammatory, neoplastic), size 
etc., as given in Table-2.2 and Table-2.3. In addition, the microaneurysms 
of Charcot and Bouchard can be found on the small perforating arteries in 
hypertensive individuals. 
Table	  2.1:	  The	  frequency	  of	  Intracranial	  Aneurysms	  as	  per	  different	  arterial	  locations	  (%)	  
Author/ Year Type of Study No. Of Cases MCA ACA ICA VA 
Kassell et al 
1990 
Cooperative 3521 22 39 30 4 
Sah et al  
1969 
Cooperative 2630 20 34 41 4 
Stebehns 
1972 
Case Series 5267 20 31 38 5 
Stebehns 
1972 
Autopsy 8000 33 30 24 12 
NB:	  MCA;	  middle	  cerebral,	  ACA;	  anterior	  cerebral,	  ICA;	  internal	  carotid,	  VA;	  vertebro-­‐basilar	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Figure 2.1: The common anatomical locations for IAs in cerebral vasculature. (Source: 
http://www.usmle-forums.com)   
 
2.3.4: Histopathological Considerations 
An understanding of the histological structure of a cerebral arterial wall is 
essential before the exact aetiopathogenesis of intracranial aneurysms can 
be discussed. A typical cerebral artery contains three layers: an outer 
adventia, a prominent muscular media and, the inner most intima lined by 
a layer of endothelial cells. The intima is separated from media by means 
of an internal elastic lamina. However, contrary to the systemic arteries 
the external elastic lamina is absent in cerebral arteries. Intimal fat pads 
are localised thickening of intima seen around bifurcations mostly at 
lateral angles, face, dorsum and apex. 
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‘Medial defects of Forbus’, encountered occasionally, are the places where 
the muscularis media is deficient leaving the remaining two layers with 
elastic lamina. The important histopathological differences between the 
walls of an artery and an aneurysm are summarized in Table-2.3. The wall 
of an aneurysm is usually deficient in media, which ceases abruptly at the 
neck. The aetiopathogenesis of an intracranial aneurysm can be divided in 
to three phases: initiation, growth and evolution and rupture. 
2.3.5: The Initiation-Growth-Rupture Continuum 
The natural history of an intracranial aneurysm can be divided into three 
phases: initiation, growth and rupture. It is quite intuitive to speculate that 
the factors, which are responsible for the formation of an intracranial 
aneurysm, will promote its growth as well, eventually leading to its 
rupture. Current evidence suggests, that some continue to work on all 
three phases, there are other factors superimposed on these background 
forces that act exclusively on each phase. The different aetiological factors 
playing roles in the pathogenesis of an intracranial aneurysm are shown in 
Table-2.3. The important theories for each phase are discussed in detail in 
the following sections. Whereas trauma, infection, tumours, radiation and 
other factors can play a role in 1-2% intracranial aneurysms, most develop 
spontaneously.  
 
Table	  2.2:	  Classifications	  for	  Intracranial	  Arterial	  Aneurysms	  Morphology	   Size	   Location	   Aetiology	  Saccular	  Fusiform	  Dissecting	   <3mm 3-6mm 
7-10mm 
11-25mm 
e>25mm	  
Anterior	  Circulation	  
Internal Carotid 
a.Carotid canal                                      
b. Intracavernous                         
c.Paraclinoid (Ophthalmic)          
d.Posterior Communicating Region 
e.Carotid Bifurcation 
Anterior Cerebral 
a.A1 (Main Branch)               
b.Anterior Communicating Region  
c.A2 (Distal Region) 
Middle Cerebral 
a.M1 (Main Branch)          
b.Bifurcation                        
c.Peripheral 
Posterior	  Circulation	  
Vertebral 
a.Main Trunk                                            	  	  
b.PICA Posterior Inferior Cerebeller Region 
Basilar 
a.Bifurcation                                             
b.Superior Cerebeller Region                           
c.AICA (Anterior Inferior Cerebeller Region)   
d.Basilar Trunk                             
e.Vertebrobasilar Junction Region 
Posterior Cerebral 
a.P1 (Proximal PCA)                                         
b.P2 (Distal PCA) 
Idiopathic 
Inflammatory 
Neoplastic  
Traumatic 
Source:	  Wilkins	  RH,	  Rengachary	  SS.	  Neurosurgery.	  pp.	  2198,	  2nd	  ed,	  1996,	  McGraw	  Hill,	  USA.	  
Table 2.3: Aetiologies of Intracranial Arterial Aneurysms 
Saccular Aneurysms 
A. Hemodynamic B. Structural C. Genetic D. Traumatic 
a)Uneven pulsatile pressure head distribution 
e.g. at bifurcations/ branching/ convex surface of 
curves, leading to change in different 
hemodynmic factors 
b)Increased Blood Flow 
i.AVM 
ii.Aplasia/Hypoplasia/Agenesis/ Contralateral 
vessel ligation 
iii.Persistent Foetal Circulation-  
a)Carotid Basilar- Trigeminal/Otic/ 
Hypoglossal/ Proatlantal 
b)Basilar Middle Meningeal 
iv.Increased Blood Pressure (+/-Vessel Wall 
Defects) 
*Essential Hypertension 
*Coarctation of aorta 
*APKD 
*Fibromuscular Dysplasias 
*Renal Artery Stenosis 
a)Combined Media/ 
Elastica defects 
 
b)Preaneurysmal    
lesions  
–Infundibula 
–Thin Areas 
-Microaneurysms  
a) Familial intracranial 
aneurysms 
a)Skull fracture 
b)Syndromes Associated 
with Aneurysms 
*Ehlers-Danlos syndrome 
*Marfans’s syndrome 
*Pseudoxanthoma      
elasticum 
*Rendu-Osler-Weber 
syndrome 
*Klipple-Trenaunay-
Weber syndrome 
*Type III collagen 
deficiency 
b)Penetrating 
Injuries 
c)Iatrogenic- in 
Surgery 
  
  
  
  
E. Infectious F. Neoplastic G. Disorders affecting 
blood Vessels 
G. Radiation 
i.Bacterial 
ii.Fungal 
i.Metastatic 
*Choriocarcinoma 
*Atrial Myxoma 
*Undifferentiated Ca 
ii.Primaary 
iii.Aneurysms associated 
with tumours – Pitutary 
adenomas 
i.Giant Cell Angiitis 
ii.SLE 
iv.Moyamoya disease 
v.Sickle cell anaemia 
Radian induced 
saccular 
aneurysms 
Fusiform Aneurysms 
A. Atherosclerosis B. Structural  C. Genetic D. Infectious 
Most common cause of Fusiform 
Aneurysm 
i.Loss of normal 
Elastica/ Media 
ii.Fibromuscular 
Dysplasias 
*Marfans’s 
syndrome 
*Pseudoxanthoma       
elasticum 
 
Syphilis  
E. Other disorders of Vs F. Hemodynamic  G. Radiation   
Giant cell arteritis Coarctation of aorta Radian induced 
saccular aneurysms 
 
Source: Wilkins RH, Rengachary SS. Neurosurgery. pp. 2198, 2nd ed, 1996, McGraw Hill, USA.  
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2.3.5.1: The Initiation 
Different workers over a period of 
time have tried to explain the 
formation of intracranial aneurysms 
based on various factors. These 
factors can broadly be divided into 
congenital and acquired, as detailed in 
Table-2.4. The important theories, 
their positive points and limitations are discussed below. 
 
Medial defect theory: The theory is also known as congenital theory. 
Eppinger [Eppinger 1887] in 1887 was the first person to draw attention 
that the congenital defects in the elastic properties of an arterial wall can 
lead to aneurysm formation. Forbus [Forbus 1930] published his 
observations in 1930 describing the medial defects in detail. In his study 
involving 33 subjects (14 children, 19 adults), he found that the medial 
defects were present in two third of each group. He stated that the 
aneurysms are the acquired lesions arising at the sites these congenital 
medial defects due to continuous overstretching of the elastic membrane 
caused by the haemodynamic stresses and facilitated by the degenerative 
process of the elastic lamina itself. 
 
Elastic Lamellar Theory: In a case control study Glynn [Glynn 1940] 
compared the arterial walls from the healthy persons and the patients 
diagnosed with aneurysms and noted that the medial defects were present 
in about 80% of the arteries in both groups. As the medial defects were far 
more common than the incidence of aneurysms, he raised strong suspicion 
about the validity of medial defect theory. In order to assess the strength of 
the different arterial layers he created artificial defects in the arterial walls 
and noted that defects were able to withstand an intraluminal pressure of 
up to 600 mmHg exerted by an external pump without bulging. He 
consequently proposed degeneration of internal elastic lamina rather than 
the medial defects as a cause of aneurysms.  
 
Degenerative Theory: In an autopsy study, Stehbens [Stehbens 1959] 
found that apical and lateral angle defects were more common after the 
age of 6 years, suggesting a possible acquired nature, at least for some of 
them. He also observed that these medial defects were more common at 
the lateral angles of a bifurcation, whereas the most common location for 
an intracranial aneurysm is carina. Moreover, these defects are present in 
all extra and intracranial arteries of humans and animals in equal 
proportions but the aneurysms occur preferably in intracranial arteries of 
humans and remain rare in extracranial arteries and animals. He turned 
Table	  2.4:	  The	  factors	  involved	  in	  the	  initiation	  
Congenital	  Factors	   Acquired	  Factors	  Medial	  defects	   Elastic	  degeneration	  Elastica	  defects	   Stehbens	  defects	  Origin	  of	  small	  vessels	   Inflammation	  Failure	  of	  branch	  involution	   Atherosclerosis	  	   Hypertension	  	   Haemodynamic	  stresses	  
Source:	  Wilkins	  RH,	  Rengachary	  SS.	  Neurosurgery,	  1996	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down Forbus theory on the basis of these observations. In an extensive 
histopathological study conducted on 454 cerebral arteries [Stehbens 
1963] he described three types of ‘preaneurysmal’ lesions: funnel shaped 
dilatations, areas of thinning and microscopic evaginations.  These funnel 
shaped dilatations described by him correspond to the infundibula seen in 
angiography mostly found at the origin of posterior communicating artery. 
Unlike Forbus’ medial defects, the media was not ending abruptly in these 
lesions and the adventia was not thickened. Later, by various angiographic 
studies it has been demonstrated that these infundibula can lead to the 
formation of aneurysm over time [Stuntz 1970, Waga 1979]. The areas of 
thinning were present at the apex of arterial bifurcations. These areas had 
relatively thin walls, with attenuated adventitia and, absent media and 
internal elastic lamina. He considered these areas as pre-aneurysmal 
lesions because of their occurrence in the areas where the aneurysms are 
most commonly formed. He also noticed that these lesions bulging when 
subjected to a pressure of 30-mmHg pressures contrary to the medial 
defects. Small evaginations, the third pre-aneurysmal lesions described by 
him were the herniation of intima through medial defects, visible 
microscopically.  
 
Congenital vestigial vessels theory: Some authors like Bremer proposed 
that when primitive capillary plexus fail to obliterate the aneurysms can be 
formed. However, as no vessels are seen originating from the apex of an 
aneurysm, this theory was not well accepted. Drennan thought that origin 
of small vestigial vessels from the apex of arterial bifurcations could 
provide a weak spot for the aneurysms to form. No such vestigial vessels 
originating from the arterial forks were found in the studies done by 
various pathologists [Carmichael 1950]. 
 
Anomalies and variations in the circle of Willis: Variations and 
anomalies of the circle of Willis have been long associated with increased 
risk of aneurysm formation. Among all variations, a definitive correlation 
between the increased aneurysm incidence and an anomaly has only been 
found in cases of anterior communicating-anterior cerebral artery complex 
variations [Stehbens 1963, Stehbens 1963b]. In spite of claims of having a 
congenital basis, the possible underlying factors in the genesis of an 
aneurysm in these cases may be the haemodynamic stresses originating 
from an imbalance in the circulation secondary to the anomalous 
vasculature [Kayembe 1984]. 
 
Inflammatory theory: The theory was postulated by Handler and 
Blumenthal who reported nine patients developing aneurysms after post-
arteritis destruction of internal elastic lamina [Handler 1954]. The 
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hypothesis however, could not get a widespread reorganization due to lack 
of confirmation of similar findings by other authors. 
 
Atherosclerotic theory: Atheromatous degeneration of the arterial wall in 
the genesis of an intracranial aneurysm was proposed by Kerpola and was 
supported by Walker and Allegre [Walker and Allegre 1954]. In spite of 
these reports, a definitive cause and effect relationship could not be 
established. 
 
Hypertensive theory: Hypertension has long been speculated as an 
underlying cause of cerebral aneurysms, working on the background of 
congenital medial defects. The Co-operative study of Intracranial 
Aneurysms showed that the incidence of hypertension was higher in the 
group with larger aneurysmal size. This however may reflect the high 
incidence of hypertension in elderly population where aneurysms are more 
common as well. Quite the contrary, the study demonstrated a negative 
correlation between the age at which ruptured aneurysms reached a critical 
size and hypertension, although the duration of hypertension in this group 
of patients was not known [Walker and Allegre 1954]. Similar findings 
were reproduced by McCormick and Schmlasteig [McCormick and 
Schmlasteig 1977] when they found no difference in the incidence of 
hypertension in a group of patients harbouring cerebral aneurysms at 
autopsy.  
 
In their study on 212 age-matched patients, Andrews and colleagues 
[Andrews and Spiegel 1979] found that the incidence of hypertension was 
significantly higher in the population with aneurysms. Both men and 
women with hypertension were twice as likely to develop aneurysm as 
compared to their non-hypertensive counterparts. They concluded that 
increasing age; high systolic and, diastolic pressure had good correlation 
with increased incidence of cerebral aneurysms in women, but not in men. 
Kwak and co-workers reported similar findings from Japan [Kwak et al 
1979]. The increased incidence of intracranial aneurysms in animal 
models with experimentally induced hypertension also testifies to the role 
of hypertension in the genesis of cerebral aneurysms. Therefore, on the 
basis of the available clinical and experimental data it can be concluded 
that the hypertension plays a crucial role in the initiation of the cerebral 
aneurysms. However, its role in growth and rupture remained 
controversial. 
 
2.3.5.1.1 Association of intracranial aneurysms with other diseases:  
Arteriovenous malformations (AVMs): The co-existence of intracranial 
arteriovenous malformations and related saccular aneurysms was initially 
described in 1925, and later further documented in 1930 and 1931. The 
incidence of a coexisting aneurysm in patients harbouring an AVM ranges 
from 2.7% to 16% (in the majority of studies diagnosed by means of 
cerebral angiography). Aneurysms associated with an AVM have also 
been reported in 5-7% of intracranial haemorrhage [Kim et al 2004]. 
Following the recent significant advancements in neuroradiology it has 
now been recognised the two lesions may co-exist more often than 
estimated before. Such association is mostly thought to be secondary to 
haemodynamic imbalance and is discussed in detail in haemodynamic 
section.  
Association with other diseases and genetic aspects: Genetic factors 
have also been implicated in the pathogenesis of intracranial aneurysms. 
Several epidemiological studies have demonstrated increased occurrence 
of these lesions in the first-degree relatives of the patients with cerebral 
aneurysms [Ronkainen et al 1998, Schievink et. al. 1995]. As it is evident 
from Table-2.3, the higher prevalence of cerebral aneurysms have been 
noted in various hereditary conditions like adult polycystic kidney disease 
(APKD), Ehlers-Danlos syndrome, Marfans’s syndrome, Pseudoxanthoma 
elasticum, Rendu-Osler-Weber syndrome, Klipple-Trenaunay-Weber 
syndrome, and Type III collagen deficiency. A number of studies have 
been done in order to establish the genetic link by analysing the encoding 
for protein synthesis in the genes [Kuivaniemi et al 1993, Peters et al 
1999]. Apart from the associations with some genetic mutations, a clear 
evidence for the genetic basis for the aetiopathogenesis an intracranial 
aneurysm is missing. Associations of cerebral aneurysms have also been 
suggested with pituitary tumours [Jakubowski and Kendall 1978] and 
moyamoya [Adams et al 1979] disease. Stebehns [Stehbens 1962] 
conducted an autopsy study to compare the incidence of congenital 
anomalies in the patients having intracranial aneurysms with the normal 
population. He found no difference in the occurrence of these anomalies in 
both the groups. However, the sample size taken was not statistically 
significant. After reviewing the relevant literature he later concluded that 
only coarctation of aorta and adult polycystic kidney disease (APKD) had 
a significant association with cerebral aneurysms. The increased incidence 
of hypertension in these two conditions can be a contributory factor. 
 
2.3.5.2: The Growth 
Most of the aneurysms don't grow in size is a general observation of 
Neurosurgeons and Neuroradiologists. However, sometimes it is difficult 
to imagine that an aneurysm will remain static in size forever. Recent 
evidence indicates that these are dynamic lesions with de-novo formation 
in the later life and growth in size of those already formed. In their recent 
publication (Aug 2008) in Journal of Neurosurgery Koffijberg and co- 
authors [Koffijberg et al 2008] conclude that the intracranial aneurysms 
don't follow a linear pattern of growth (Figure-2.2). They grow in spurts 
with periods of no growth in between and don't follow a strict growth 
pattern. Most of the aneurysms they grow initially to attain a particular 
size, stabilize there and then some rupture suddenly without changing their 
size. In a follow-up study Wermer et al [2005] over a period of 10 years 
13 out of 53 (24.5%; 95% CI-0.31-0.71%) aneurysms enlarged in size. 
Eleven aneurysms increased in size by 1-3 mm, one enlarged 3-5mm 
while one grew >5mm. The mean enlargement rate calculated by them 
was between 0.12 and 1.3 per year. The main risk factors for aneurysmal 
analysis were current smoking (HR 3.5, 95% CI-1.4-8.7), history of 
hypertension (HR 1.9, 95% CI 0.9-4.4) and multiple aneurysms. Other risk 
factors were positive family history and female sex. Smoking and female 
sex have also previously been shown as risk factors for aneurysmal growth 
by Juvela el al [Juvela el al 2001]. The growth of an intracranial aneurysm 
is mostly explained on the basis of pathological alterations in the 
mechanobiological properties of aneurysmal wall (e.g. stretching of 
collagen fibres and re-deposition of more collagen leading to fibrosis and 
thickening of aneurysmal wall), haemodynamic factors (WSS, OSI, Jet of 
blood stream, etc.) and as a passive yield to blood pressure. Tateshima et 
al in 2007 [Tateshima et al 2007] showed differences in the enlargement in 
their study as assessed by univariate Cox regression haemodynamic 
patterns of Intracranial Aneurysms that grew over a period of time 
(Figure-2.3). In an effort to analyse the mechanisms responsible for the 
Figure 2.2: Graphs showing the average size of aneurysms at the time of rupture during follow-up (left) 
and the average aneurysm size as function of patient age (right). For high mean growth rates almost all 
aneurysms rupture in the first 40 years of follow-up but small rupture rates indicate towards the 
nonlinear pattern of the growth. Source: Koffijberg et al J Neurosurg 2008 
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growth of an aneurysm Crompton [Crompton 1966] suggested that the 
cellular and fibrin proliferation of the wall of an unruptured aneurysm 
might result in it’s weakening. The weak point subsequently may give way 
leading to aneurysmal rupture or it may organise perhaps forming a ‘bleb’ 
 
(a small nipple shaped outpouching of the wall) with resultant growth in 
the size. Due to repeated organization and fibrosis the wall of a larger 
aneurysm may actually get thicker, however more friable with less tensile 
strength.  
 
Figure 2.3: Showing the intra-aneurysmal flow pattern inside an aneurysm before and after the growth. 
(Source: Tateshima et al) 
Table	  2.5:	  Activities	  or	  Events	  preceding	  Aneurysmal	  SAH	  Activity/Event	   Patients	  	   	  	   No.	   Percent	  %	  Chatting/Watching	  television/	  Staying	  home	   71	   13.8	  
Defecation/micturition	   65	   12.7	  Working	  at	  workplace	   63	   12.3	  Taking	  a	  bath/Shower	   44	   8.6	  Sleeping/resting	   41	   8.0	  Housework/Housekeeping	   39	   7.6	  Shopping/outing	   31	   6.0	  Brushing	  teeth/	  washing	  face	   25	   4.9	  
Eating/drinking	   24	   4.7	  Sport/exercise	   14	   2.7	  Driving/riding	  a	  bike	   12	   2.3	  Others	   27	   5.3	  Unknown	   57	   11.1	  
Total	   513	   100.0	  
Source:	  Matsuda	  et	  al	  2007	  	  
2.3.5.3: The Rupture 
Rupture of an intracranial aneurysm unfortunately remains the least well-
understood phenomenon. Rupture occurs typically when the stresses in the 
aneurysm wall exceed its strength. Different authors have suggested 
various risk factors for rupture. Hypertension has been found to be 
associated with rupture in up to 60% of the cases, as shown in both 
clinical [Inagawa 2005] as well as the necropsy series [Crompton 1964]. 
Most of the clinical series testify to this fact [Broderick et al 2003, Knekt 
et al 1991, Leppala et al 1999, Mhurchu et al 2001] whilst some contradict 
it [Juvela et al 1993, Longstreth et al 1992]. In his case control study on 
247 patients and equal number of healthy volunteers, Inagawa [Inagawa 
2005] found hypertension, cigarette smoking and hypercholesterolemia 
significantly more common in the patients with SAH.  
 
Diurnal and seasonal variations in the incidence of SAH have been 
reported in previous studies [Inagawa et al 2002, Inagawa 2000]. SAH 
exhibits two peaks during the day; between 6 am to 10 am and, between 
4pm to 8pm. Again, high incidence of SAH in winters has been noted as 
compared to summers [Inagawa et al 2002, Inagawa 2000]. The 
instantaneous peaks in the blood pressure have been suggested as possible 
factor responsible for these variations and likely to play an important role 
in affecting the rupture [Inagawa et al 2002, Inagawa 2000]. The 
relationship between cigarette smoking and increased SAH has widely 
been studied [Broderick et al 2003, Mhurchu et al 2001, Juvela et al 1993, 
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Longstreth et al 1992]. It has been suggested that smoking can increase the 
risk of rupture by accelerating the rate of formation of de-novo aneurysms 
as well as growth. Alpha -1 antitrypsin deficiency [Gaetani et al 1996] and 
degradation of internal elastic lamina in vessel walls [Qureshi et al 1998] 
have been asserted as a basic mechanism affected by smoking. Cigarette 
smoking causes acute rise in systolic blood pressure [Cellina et al 1975], 
these instantaneous spikes, in turn can be trigger the rupture [Longstreth et 
al 1992]. Increasing size and the presence of multi-loculations has also 
been implicated in the aneurysmal rupture. In Crompton’s [Crompton 
1966] series the majority of the ruptured aneurysms were more than 5mm 
in their maximum diameter. A size of 2 - 5mm was the critical size 
suggested by Crompton at which an aneurysm becomes suddenly unstable. 
Many studies including the recent ISUIA studies [Wiebers 2003, ISUIA 
1998] have reiterated the importance of the larger size making aneurysm 
more prone for rupture. The critical size however, suggested by more 
recent studies is 7mm. It is seldom possible in vivo to determine the exact 
site of rupture. However, in 271 of 289 cases where the site of rupture 
could be localised by Crompton [Crompton 1966], the ruptured had 
occurred from the apex in 227 cases. 57% of the ruptured aneurysms in the 
same series had multiple loculations or blebs or daughter nuclei as against 
16% of the unruptured aneurysms. Various activities have been proposed 
as risk factors for the aneurysmal rupture. Like Inagawa and colleagues 
[Inagawa et al 2002, Inagawa 2000], Matsude et al [Matsude et al 2007] 
also found a bimodal peak pattern for the aneurysmal SAH during a day. 
Peaks occurred during early morning (6-9 am) and late evening (6-9 pm), 
the period corresponding to the daily routine activities such as defecation, 
micturition, brushing teeth, washing face, dressing, drinking, and taking 
bath. 8% of all SAHs, however occurred during sleep or rest. Whereas 
they explained the morning peaks in the SAH on the basis of circadian 
spike of the blood pressure, no explanation could be found for the evening 
peaks. Some of the daily routine activities, like defecation and micturition, 
associated with a significant risk of bleed, have a predominant physiologic 
response essentially similar to Valsalva manoeuvre [Matsuda et al 2007]. 
The sudden changes in the arterial pressure during these activities can 
precipitate the aneurysmal rupture [Matsuda et al 2007].  Apart from the 
intramural factors, the peri-aneurysmal environment has also been 
proposed to influence the risk of rupture. In a retrospective analysis, Ruiz 
et al found that the existence of contact constraints between an intracranial 
saccular aneurysm and the surrounding structures had a significant 
influence on its shape and risk of rupture [San Millan Ruiz et al 2006]. 
The main activities at the time of rupture are given in the Table-2.5.  
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2.4: Importance of Haemodynamic Factors 
Haemodynamic factors are believed to play an important role in the 
initiation, growth and, rupture of an intracranial aneurysm. The initiation 
is usually attributed to the impingement of the axial blood stream on the 
carina of the arterial bifurcation and the arterial bends, explaining the 
common occurrence of aneurysms on these locations. Different type of 
haemodynamic forces working on the arterial wall or inside the aneurysm 
can influence the aetiopathogenesis of a cerebral aneurysm. The forces can 
broadly be divided into hydrostatic forces and dynamic forces. Whereas 
the hydrostatic forces work constantly in the background e.g. blood 
pressure; the dynamic forces exert their effect by momentary variations 
with time like impinging jet of blood. The different haemodynamic 
factors, their role in the aneurysmal aetiopathogenesis and the possible 
scientific explanations are provided below.  
 
Wall sear stress or shear stress is a tangential frictional force exerted by 
the flowing blood on the endothelial cells. WSS is typically expressed as a 
product of shear rate and viscosity  
 
    
 
Where τ = WSS, µ = viscosity, du/dx = shear rate  
 
Human blood, which is considered non-Newtonian fluid under normal 
circumstances, can behave as a Newtonian fluid at high shear stresses 
[Oka 1981]. u is constant in above equation for Newtonian fluid whereas 
is variable and, in fact is a function of shear rate in non-Newtonian fluids. 
 
	  
Figure 2.4: Showing the endothelial cells losing their normal alignment when exposed to abnormally 
low WSS. (Source: Malek et al JAMA) 
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The normal physiological range of WSS is crucial for endothelial cells to 
maintain their normal function and integrity. One of the important 
properties of WSS is to influence the behaviour of endothelial cells. In 
their study on the haemodynamics of the intracranial aneurysms Malek et 
al [Malek et. al. 1999] demonstrated a good correlation between the low 
WSS and aneurysmal growth. They found that the endothelial cells 
subjected to low WSS in a bovine artery lost their normal alignment 
(Figure-2.4). It was seen that whereas the normal endothelial cells 
produced high growth inhibitors and low growth promoters, the ratio was 
reversed in endothelial cells subjected to low WSS (Table-2.6).  
 
 
 
 
Table	   2.6:	   The	   ratio	   of	   normal	   growth	   mediators	   is	   reversed	   in	   endothelial	  cells	  exposed	  to	  abnormally	  low	  WSS	  in	  right	  column.	  Source:	  Malek	  et	  al	  JAMA,	  
1999	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WSS is directly proportional to the velocity and viscosity of blood flow 
inside the vessel or sac and will be highest in an end-on aneurysm while 
will be lowest in a side-on aneurysm, with bend-on aneurysm lying in 
between. Tateshima et al [Tateshima et al 2003] noted high WSS at the 
neck of the parent aneurysm and at the margin of the daughter bleb. The 
pre and post growth peak WSS were 5.61 n/m2 and 7.38 n/m2 respectively 
they attributed this high WSS to the flow separation and flow 
impingement at the margin of the bleb. Luscher et al 1993 [Luscher et al 
1993], found that the release of the endothelial derived growth and 
relaxation factors are WSS dependant, which in turn regulate the vascular 
remodelling endothelial cells and have a capacity to remodel the blood 
vessel in response to change in WSS. Increased WSS stimulates the 
endothelial cells to produce the matrixmetalloproteases, which are 
responsible for the degradation of the internal elastic lamina [Sho et al 
2002]. Tromp et al in 2004 [Tromp et al 2004], showed elevated 
expression of metalloprotienases-13 in abdominal aortic aneurysm and 
thought them to be responsible for destructive remodelling present in 
extracellular matrix of AAA. Focal high WSS is the predisposing factor in 
formation of aneurysm in healthy cerebral artery. Drexler in 1999 [Drexler 
and Hornig 1999] demonstrated that low WSS leads to endothelial 
dysfunction in coronary arteries. Pohl et al 1991 [Pohl et al 1991] proved 
that increased flow leading to increased WSS accelerates the release of 
endothelial derived relaxation factors (EDRF) from endothelium resulting 
in dilatation of an artery and demonstrated marked flow dependant 
dilatations in small arterioles in vivo and in vitro. The same authors also 
showed increased dilatation responses with an increasing viscosity 
indicating that the shear stress is the stimulus for the flow dependant 
dilatation. These flow-induced dilatations were abolished by inhibition of 
EDRF. Flow shear stress increases the production of N2O leading to 
increased EDRF release. It has been suggested by experimental studies 
that the shear stress may be directly or indirectly linked to the activation of 
Ca++ dependant endothelial N2O synthase [Busse et al 1990]. Elevated 
shear stress augments the release of ATP and substance-p from 
endothelium [Milner et al 1990], which in a paracrine manner may 
enhance EDRF production more directly [Pohl et al 1991]. Increased shear 
stress leads to the hyperpolarisation of the endothelial cells by mobilising 
the Ca++ from intracellular stores in the cultured endothelial cells [Ando et 
al 1988] probably via activation of phospholipase C [Bhagyalakshmi and 
Frangos 1989] and activation of K+ channels [Olesen et al 1988]. How 
shear stress transduces the signals to endothelial cells tom release EDRF 
production is not clear. It has been hypothesised that stress acts on the 
structures anchored in the endothelial membrane and mechanically 
enhances their interaction between regulatory proteins and their targets. 
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Neuraminidase inhibits the flow dependant dilatation by clearing the sialic 
acids, which are present in high concentration at the endothelial surface 
[Born and Palinski 1988] as an integral component of glycoproteins and 
lipoproteins, may act as mechanoreceptors. Fukuda et al [Fukuda et al 
2000] examined the role of N2O in the degenerative changes associated 
with and, preceding to the formation of a cerebral aneurysm in 
experimental models they found high localisation iNOS (Inducible N2O 
synthase) at the site of aneurysm formation in both rat and human arteries, 
as demonstrated by increased immunoreactivity. In contrast to its 
counterpart eNOS, iNOS is not commonly present in arterial walls it is 
usually synthesised or used within the endothelial cells and the smooth 
muscle cells by a number of different stimuli including high WSS. They 
showed that an NOS inhibitor, amino guanidine attenuated the early 
degenerative changes associated with new aneurysm formation. They also 
showed that a blood-thinning agent Batroxobin (a defibrinogenic agent) 
also prevented early iNOS induction and thus early aneurysm formation 
by lowering the WSS. This phenomenon was explained by virtue of 
primarily decreasing the blood viscosity. Blood viscosity is determined by 
the haematocrit, which in turn is dependent upon its fibrinogen 
concentration [Oka 1981]. Bx can reduce the blood viscosity by lowering 
its fibrinogen concentration [Ohba and Aoyama 1985], which in turn 
decreases the wall shear stress. Bx doesn’t have any effect on cerebral 
blood flow and MABP. They concluded that N2O especially one derived 
from iNOS is a prerequisite for a development for a new aneurysm in 
cerebral blood vessel. In their earlier studies they experimentally induced 
cerebral aneurysms in rat and monkeys. They found that the degenerative 
changes associated with aneurysm formation was almost exclusively 
localised at arterial bifurcation especially the intimal fat pad and 
neighbouring distal portion known juxta apical groove (JAG).  
 
The role of N2O in the vessel wall damaged was proven by Beckman et al 
[Beckman et al 1990] and Geng et al [Geng et al 1992] in 2 independent 
studies. Mattson et al [Mattson et al 1998] linked iNOS with high blood 
pressure. Burleson [Burleson and Turitto 1996] and Steiger [Steiger et al 
1988] were the other investigators who agreed with the association of site 
of high WSS and aneurysm formation. In their study on high WSS 
induced damage to endothelium and smooth muscle cells at JAG, Fukuda 
and colleagues [Fukuda et al 2000] classified the histopathological 
changes into 5 grades. Grade-1 changes are where no damage can be 
demonstrated, grade-2 is mild endothelial cell damage e.g. a wavy rippling 
of plasma membrane without smooth muscle cell damage, grade-3 
corresponds to moderate endothelial cell damage and grade-4 is severe 
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endothelial cell damage. The changes are called grade-5 when damage 
involved smooth muscle cell in addition to severe endothelial cell damage.  
 
 
Table 2.7: The literature-based evidence on the importance of haemodynamics in the aetiopathogenesis of IAs  
 
Haemodynamic 
factors 
Intracranial Aneurysm Proposed mechanism(s) References 
Initiation Growth Rupture 
Dynamic 
Wall Shear 
Stress (WSS) 
High Low Low Increased WSS increases the 
production  of MMP-13 which 
in turn leads to vessel wall 
damage 
Decreased WSS increases 
iNOS synthesis- NO induced 
damage to vessel wall 
Low WSS increases endothelial 
proliferation and apoptosis 
Boussel et al 2008, Fukuda 
et al 2000, Gao et al 2008, 
Jou et al 2008, Malek et al 
1999, Meng et al 2007, 
Shojima et al 2004, Ujie et 
al 1999 
 
Oscillatory 
Shear Index 
(OSI)  
High/Low High High Degenerative changes in 
endothelium 
Glor et al 2004, Goubergrits 
et al 2008, Mantha et al 
2006 
Jet of Blood 
Stream 
Impingement Impingement Impingement Localized endothelial cell 
injury 
Foutrakis et al 1999, Cebral 
et al 2005, Cebral et al 2009 
Flow Pattern - - Complex Statistical association Cebral et al 2005, Cebral et 
al 2009 
Hydrostatic 
Pressure High High High Passive yield/ water hammer 
effect 
Inci and Spetzler 2000, 
Morimoto et al 2002, 
Steiger et al 1989 
NB: WSS; wall shear stress, MMP-13; matrixmetalloproteneases-13, iNOS; inducible-nitric oxide synthase, NO; nitric oxide, OSI; 
oscillatory shear index 
 
In 1993 Resnick and co-workers [Resnick et al 1993a, Resnick et al 
1993b] identified a shear stress responsive element for iNOS on 
endothelial genes inducing the t-pa (tissue plasminogen activator), 
intracellular adhesions molecule- 1 and TGF- beta. Cooke et al in 1990 
[Cooke et al 1990] demonstrated the association between high NOS and 
atherosclerosis. Both magnitude of WSS and duration of exposure of 
endothelial cells to that high WSS, played an important role in the 
induction of iNOS in their experimental study. Wagner et al [Wagner et al 
1997] found that no iNOS was induced when the smooth muscle cells 
were exposed to the lower shear stresses in the order of 1.1 to 2.5 dynes 
per cm2 for a smaller period of time i.e. less than 24 hours. Table-2.7 
below summarizes literature-based evidence on the role of haemodynamic 
factors in the aetiopathogenesis of Intracranial Aneurysms. 
 
Analysis of the haemodynamic factors thus, may act as a crystal ball 
where we can see the future of an intracranial aneurysm and can take 
necessary interventions to modify it, as and when required. 
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2.5 Management of Intracranial Aneurysms: The History of a 
Paradigm Shift  
 
2.5.1: Background and Objectives 
With the advent of technology, management of intracranial aneurysms 
(IAs) have undergone a tremendous evolution. In order to appreciate the 
modern achievements, it is imperative to analyse the past.  
 
Apart from the masterly inactivity the initial treatment for IA was 
confined to the ligation of ipsilateral carotid artery mostly resulting in high 
morbidity and mortality. In 1927 Egas Moniz introduced cerebral 
angiography following which Dandy clipped the first aneurysm in 1937. 
This led to the surge in neurological surgeries to clip all ruptured 
aneurysms. Owing to the disastrous consequences originating from 
indiscriminate surgeries and poor surgical and neuroanaesthetic 
techniques, the euphoria however didn’t last long.  
 
Inherent limitations associated with surgical management inspired 
physicians to search for new and safer alternatives. Whilst the roots of 
some of these endovascular techniques can be traced back to the early 
nineteenth century, it’s only through the incredible progress in the 
technology over last couple of decades that made their safe and 
widespread clinical application possible. Since then, it has rapidly become 
a primary therapeutic option in most of centres worldwide.  
 
Present article summarises these diagnostic and therapeutic developments, 
in chronological order with an eye on the potential scope for research and 
future progress. 
 
2.5.2: Introduction 
With the advancements in modern microsurgical and endovascular 
techniques coupled with improved neuroanaesthetic approaches, the 
morbidity and mortality figures associated with aneurysmal subarachnoid 
haemorrhage (SAH), have improved significantly. Whereas most of the 
recent advancements in the neurological therapy of IAs are achieved in 
past 200 years, the journey of success began over 4000 years ago. The 
following sections discuss the temporal evolution of different diagnostic 
and treatment modalities along with an analysis of the important 
milestones achieved and their long-term implications. 
 
With all this recent technological progress, the protocols to treat the 
ruptured IAs became quite clear over time however, the management of 
unruptured IAs (UIAs) still remains controversial. These uncertainties are 
	   49	  
mainly due to an incomplete understanding of natural history of IAs and 
risks associated with active management [ISUIA-1998] The difficulties 
are further enhanced by the fact that the poor surgical outcome is dictated 
by the same factors [Komotar et al 2008] that currently form the basis of 
surgical decision making [Khanna et al 1996]. 
 
2.5.3: The Early Developments 
The earliest description of intracranial or subarachnoid haemorrhage 
(SAH) as a cause of death in human beings dates back to the ancient 
Biblical times. The first anecdotal evidence of an IA as 
well as the earliest attempt to treat it comes from Egypt. 
It is recorded in Ebers Papyrus, one of the oldest 
preserved medical documents that in 2725 BC Imhotep, 
who was an Egyptian architect cum physician, tried to 
treat an aneurysm by using a fire glazed instrument 
[Lippi 1990]. The term aneurysm, derived from Greek 
word aneúrysma (ana; throughout + eurus; wide), 
meaning ‘to dilate’, was introduced by Claudius Aelius 
Galen, a philosopher of Greek origin in 200 AD.  
 
In 1664, Thomas Willis [Willis 1664], (Figure-2.5) an 
Oxford-based physician provided the first scientific account of the 
cerebral vasculature later being honoured by the eponym ‘circle of Willis’. 
Almost a century later in 1761 [Morgagni 1761] an Italian anatomist from 
the city of Padua, published the first anatomical write-up describing the 
entity of an intracranial aneurysm. It however, took another four decades 
to recognize the definitive clinical importance of IAs until Blane in 1800 
published the clinical and autopsy findings of a patient with bilateral 
carotid cavernous aneurysms, described by John Hunter in 1792. The 
credit of first clinical diagnosis of an intracranial aneurysm goes to 
Hutchinson [Hutchinson 1875] in 1861. Based on the neurological signs 
he successfully diagnosed an intracranial aneurysm in a patient 11 years 
before his death. However, in spite of the handful of clinical diagnoses, 
the exact preoperative localization of an IA remained a challenge to 
clinicians until late.  
 
Figure	  2.5:	  Thomas	  Willis	  
(Source:http://www.accu-­‐chek.com)	  
2.5.4: The Surgical Era 
Understanding the deadly nature of these lesions, the 
earliest efforts of modern times to treat them by 
surgery were started in the form of carotid ligation. 
The concept presumably stems from an important 
observation made by Jean-Louis Petit in 1760s that 
there were no significant adverse effects on the 
human brain even after the complete occlusion of 
one carotid artery by thrombosis. The carotid 
ligation was initially popularised by John Hunter (Figure-2.6) in 1800s, 
and was known as ‘Hunterian ligation’ after him [Hutchinson 1875]. The 
first ever attempt to treat an aneurysm by ‘Hunterian ligation’ was 
endeavoured by Cooper in 1808 [Cooper 1852]. Carotid ligation remained 
popular and appeared a reasonably successful treatment except for the fact 
that in most of the cases it carried a significant risk of cerebral infarction 
and hemiplegia. Given the high mortality and morbidity produced by the 
acute occlusion of the carotids, the concept of gradual occlusion was 
introduced [Crutchfield 1959]. Numerous metallic clamps were designed 
that could be tightened over a period of several days. The 
clamp could be reopened should the patient become 
symptomatic. Because of unacceptably high complication 
rates, the ICA ligation was gradually replaced by common 
carotid artery ligation.  
Due to the lack of preoperative localization, most of the 
initial ‘direct surgical encounters’ of IAs were unplanned 
and were limited to their accidental surgical exposures. Sir 
Victor Horsley (Figure-2.7) [Drake 1985] was one of the 
first surgeons to witness an IA during a craniotomy in 
1885, when he was operating on a patient with a preoperative diagnosis of 
a middle fossa tumour, which turned out to be an IA. He treated the patient 
by ipsilateral carotid ligation. 
  
Two other important discoveries that altogether 
changed the ways of diagnosis and management of IAs 
can be considered as contributing to the dawn of 
modern neurovascular surgery. Quincke introduced the 
technique of lumber puncture in 1891 [Quincke 1891] 
while Egas Moniz discovered the cerebral angiography 
in 1927 [Moniz 1927]. The first direct planned surgical 
intervention to treat an intracranial aneurysm however, 
was endeavoured by Norman Dott on April 22 1931, 
when he stopped bleeding from an intraoperatively 
Figure	  2.8:	  Walter	  Dandy	  
(Source:	  Medscape)	  	  
Figure	  2.6:	  John	  Hunter	  
(Source:http://citizenscientistsleague.com)	  	  
Figure	  2.7:	  Sir	  
Victor	  Horsley	  
(Source:	  Medscape)	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ruptured carotid aneurysm by wrapping a muscle around it [Dott 1933]. 
The preoperative diagnosis of a carotid bifurcation IA was localised 
clinically and the procedure was tolerated well.  
 
The efforts were further matured by Walter Dandy (Figure-2.8) who gets 
the credit for the first successful clipping of a preoperatively diagnosed IA 
[Dandy 1938]. In March 1937 he treated a man of 43 by applying an 
ordinary flat silver clip to a pea sized IA of distal ICA. The operation was 
performed around six-years after Egas Moniz demonstrated the first IA by 
cerebral angiography in 1931. The diagnosis however, was localised 
solely on the basis of clinical signs. Dandy himself admits that such a 
precise clinical localization of an IA warranting a surgical attack is but a 
rare phenomenon [Dandy 1938]. Clipping became established as a new 
procedure to secure the ruptured IA, soon after Dandy published his 
monograph in 1938.  
 
Justification of Surgery: In absence of clear scientific evidence it was 
often difficult for earlier neurosurgeons to justify their surgical decisions 
against medical or conservative management. Strong doubts were raised 
about the effectiveness of surgery as most of the studies failed to show any 
advantage of surgery as compared with medical management (Figure-10).  
 
Continuing refinement in surgical techniques and instruments, coupled 
with the advancements in the neurocritical care, made the surgery 
progressively safer. Greenwood [Greenwood 1942] brought in the bipolar 
cautery in 1940, while the hypothermia was introduced by Lougheed, 
White and Sweet [Lougheed at al 1955] in 1953 for cerebral protection 
Figure	  2.9:	  Temporal	  Evolution	  of	  different	  surgical	  modalities	  Source:	  Neurosurg	  Focus,	  2006,	  ©	  AANS	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during cerebrovascular procedures. Almost a decade later Uihlein et al 
[Uihlein et al 1962] performed the first intracranial aneurysm clipping 
using induced hypothermia and total circulatory arrest. The entity of 
vasospasm was demonstrated by Ecker and Riemenscheidner in 1951 
[Ecker and Riemenscheidner 1951] The first operating microscope was 
introduced by Carl Zeiss Inc. in 1953 [Krampe 1984] a company 
established by the visionary German optician Carl Zeiss in 1846. 
Theodore Kurze from Los Angeles was the first neurosurgeon to use an 
operating microscope in neurosurgery in 1957 [Kurze 1964]. The twin 
benefits of illumination and magnification offered by the operating 
microscope, laid the pavement for microneurosurgery, led by Yaşargil and 
others.  
 
One of the earliest publications to attract the attention towards 
ineffectiveness of medical management of SAH came from Tappura in 
1962 [Tappura 1962]. He showed that rebleeding rates were as high as 
55% without any active intervention with 75% mortality. In the same year 
Norlén [Norlén 1963] published the results from his series of 134 patients 
of IAs managed surgically. He reported an astonishing success with a 
mortality of less than 2.5%. Over a period of time, the growing scientific 
evidence unequivocally established the superiority of intracranial surgery 
as compared to both, carotid ligation and bed rest. By the late 1970s direct 
clipping was accepted unanimously as a ‘gold-standard’ for the treatment 
of ruptured IAs.  
 
2.5.5: Neuroradiological Developments & Invent of Cerebral 
Angiography 
The radiological localization of an intracranial pathology remained a 
challenge to neurosurgeons until late. In this context the discovery of 
cerebral angiography by Egas Moniz in 1927 [Moniz 1927] a 
multitalented physician from Portugal, and the demonstration of an IA by 
this technique in 1931 was a breakthrough research. 
 
A group of researchers, including Sir Godfrey Hounsfield [Hounsfield 
1973] developed the first computed tomographic (CT) head scanner which 
became operational by 1971. The CT scan proved to be a crucial aid to the 
diagnosis of SAH due to its ability to pick subarachnoid and 
intraventricular blood. The early report about the first NMR image of a 
live human body was published by Damadian and colleagues [Damadian 
et al 1977] in 1977 and MRI came into clinical practice in 1982 after Sir 
Peter Mansfield [Mansfield et al 1979] and Paul Lauterbur [Lauterbur 
1989] developed mathematical techniques that allowed rapid acquisition 
of MR Images possible making it a practical tool. It surpassed every 
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available imaging modality in providing exquisite soft tissue 
differentiation. 
 
 
2.5.6: Endovascular Interventions 
 
The history of the evolution of endovascular treatment of the aneurysms is 
a fascinating story of ground-breaking work done by the early geniuses. 
Whereas roots for some of these endovascular techniques can be traced to 
the early nineteenth century it’s only through incredible progress in the 
technology over last couple of decades that made their safe and 
widespread clinical application possible.  
 
2.5.6.1: Extracranial Endovascular Interventions 
Medical measures: Apart from masterly inactivity, workers started trying 
various medical compounds to induce thrombosis in aneurysmal sacs. The 
most commonly used pharmacological compound was potassium iodide 
[Keen 1916] administered systemically. Various other medical measures 
tried were; vinegar, iron perchloride solutions, alcohol, gelatin, ergot salts, 
and even hypothermia by local ice packing [Keen 1916]. These procedures 
however, soon had to be discontinued due to inconsistent and 
unpredictable results.  
 
Insertion of foreign bodies/ wiring techniques: After abandonment of 
medical measures various investigators started attempting to treat 
aneurysms by inserting foreign bodies. The earliest description of such an 
endovascular procedure to treat an aneurysm is given by Ransohoff 
[Ransohoff 1886] reciting Sir E Herne who by the turn of eighteenth 
century induced thrombosis in an iliac artery aneurysm by inserting heated 
needles into it. The same concept was later applied to treat aortic 
aneurysms by many authors who replaced needles with metallic wires. In 
spite of initial enthusiasm among its advocates the overall results from 
these ‘wiring’ procedures remained poor. These procedures were 
ultimately abandoned during the first half of the twentieth century. 
 
Emergence of the concept of electrothrombosis: The limited success of 
these ‘wiring’ techniques stimulated investigators to search for more 
efficient alternatives. It was realised that one of the important reasons for 
failure was the lack of sufficient thrombus formation attributed mostly to 
inadequate aneurysmal packing. The idea of using galvanic current as an 
adjunct to enhance the thrombogenicity of these metallic coils presumably 
has taken its inspiration from the early experimental works done by 
Scudamore [Duncan and Fraser 1867] in 1824. It was however Phillips in 
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1832 [Phillips 1832] who gave birth to the concept of electrocoagulation 
in aneurysms. CH Moore introduced wiring for the treatment of aortic 
aneurysms in 1864. Another dimension to it was added when Corradi in 
1879 [Matas 1914] who passed the electric current through the wire. The 
technique was later called Moore-Corradi method after both the workers. 
The method remained in use for next 40 years and was adopted by many 
investigators.  
 
2.5.6.2: Transcranial Approaches 
Due to understandable limitations in the precise localization and 
difficulties in accessing  an IA, the early endovascular interventions were 
limited to the large and extracranial arteries. The initial attempts to treat an 
IA by iatrogenically induced thrombosis were therefore carried under 
direct vision during a craniotomy. In 1936 WJ Gardner [Gardner 1936] 
packed an accidentally opened giant IA with cotton sponges. The credit of 
the first successful ‘thermocoagulation’ of an IA however, goes to Werner 
[Werner et al 1941]. Working with Blakemore and King, in 1941 he 
treated a giant paraclinoid IA in a young girl. The aneurysm, resistant to 
multiple Hunterian ligations, was approached transorbitally. A ten-foot 
long silver wire was inserted through its fundus and heated for 40 sec, 
reportedly curing the aneurysm.  
 
Transition from transcranial to intravascular approach: The idea of 
using blood vessels as natural access to treat the cerebrovascular lesions 
may probably have taken motivation from the pioneering work done by 
Brooks [Brooks 1930]. He is credited with the first endovascular 
intervention to treat a cerebrovascular pathology. After exposing the ICA 
surgically, he embolised a traumatic carotid cavernous fistula in 1930 by 
placing a strip of muscle intravascularly. Switching from the transcranial 
to intravascular approach was nevertheless, not straightforward. 
Tortuosity, delicacy and narrowness of intracranial vasculature as well as 
the presence of the carotid siphon were the main obstacles for intracranial 
catheter navigation. This important shift could only be made possible 
through the development of sophisticated micro-catheter systems and 
intravascular delivery devices.  
 
Luessenhop and Spence [Luessenhop and Spence 1960] remained pioneers 
in cerebral endovascular navigation; they successfully cannulated an ICA 
to embolise an arteriovenous malformation (AVM) using flow-directed 
silastic spheres in 1960. They also set another important milestone in 
endovascular navigation in 1964; what is believed to be the first successful 
catheterization of intracranial vessels in a human being, finally shifting the 
focus from a transcranial to intravascular approach. With the help of a 
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glass chamber, surgically connected to the external carotid artery, they 
delivered a length of silastic tubing into intracranial arteries. The balloon 
at the tip of this flow-directed catheter was inflated temporarily to occlude 
the neck of a posterior communicating artery aneurysm.  
 
Superselective catheterization and magnetic navigation: Frei and 
colleagues [Frei 1966] from Rehvoth, Israel, added another dimension to 
endovascular navigation by introducing their novel microcatheter system 
in 1966. This high-tech system, also called POD (para-operational device) 
by its inventors, made superselective catheterization of intracranial vessels 
possible. The tip of the catheter was made of specialised soft silicone 
rubber to minimise vessel trauma. A micromagnet of 1 millimetre 
diameter, strategically placed inside the tip of the microcatheter was used 
to manipulate it with the help of external magnetic fields. In 1974 Hilal et 
al [Hilal et al 1974] published their experience with safe intracranial 
catheterization in 120 patients. Using a slightly modified version of 
magnetically directed POD catheter they catheterized many difficult to 
reach intracranial vessels and more importantly performed 
electrocoagulation of one basilar tip aneurysm, giving birth to the concept 
of neuroendovascular electrothrombosis.  
Following their initial success the magnetically directed catheters 
remained in use until the late 70s, however the lack of precise operator 
control and distortion of the fluoroscopic images by strong magnetic fields 
drove researchers to look for alternative methods of intracranial catheter 
navigation.  
 
Balloons: Convinced with the idea first given by Luessenhop and 
Rothenberg as early as in 1960s, [Luessenhop and Spence 1960] most of 
the investigators started realising with time that the best force to propel the 
endovascular catheter was the antegrade flow of blood itself. TJ Fogarty 
[Fogarty 1963] and co-workers introduced a novel balloon-tipped catheter 
system in 1963 to extract the arterial emboli. Fogarty catheter system 
proved as a milestone in the advancement of catheter technology and 
opened doors for the development of a range of endovascular catheters 
including the modern balloon-tipped catheters. The most important 
discovery in microcatheter technology however, was the invention of 
Tracker® microcatheter system in mid 1980s by Engelson [Engelson 
1986]. By virtue of its unique externally steerable tip it revolutionised the 
way intracranial arteries were negotiated.  
 
Montgomery et al from Massachusetts Institute of Technology (MIT), 
USA, designed the first detachable balloon catheter in 1970 using a 
modified POD catheter by mounting a balloon on its tip. However, it was 
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Fedor A. Serbinenko [Serbinenko 1974] from Burdenko Neurosurgery 
Institute, Moscow, who not only established endovascular interventions as 
a treatment modality for IAs but also gets the credit for founding 
Endovascular Neurosurgery as a new medical discipline. Inspired by a 
simple observation of helium-filled balloons at May Day celebrations in 
Moscow’s Red Square in 1959, he spent relentless hours in the laboratory 
to create prototype silicone and latex balloon catheters. Using these flow-
directed balloon-tipped catheters he mastered the art of balloon 
embolization of IAs and AVMs and performed 304 balloon endovascular 
procedures between 1969 and 1972 with just two mortalities [Kwan et al 
1991] laying the foundation stone for modern endovascular neurosurgery. 
The seminal works done by him changed the management of IAs forever 
and he is therefore rightfully called father of endovascular neurosurgery.  
 
From balloons to endovascular coiling: Due to wide spread application 
and growing experience, a number of shortcomings of the balloon 
embolization started to become apparent. Owing to the fixed and rigid 
shape (round or oval) of the balloons, it was difficult to achieve 100% 
occlusion of the IAs, frequently leaving an insecure aneurysm at the end 
of the procedure. Furthermore, this potential space and the balloon-
aneurysm complex together, when subjected to the continuous pulsations 
arising from the pulsating arterial blood column, were thought to produce 
a ‘water-hammer’ effect. This ‘water-hammer’ effect was reported to 
facilitate the IA recanalization, enlargement or delayed rupture [Kwan et 
al 1991]. Additionally, the balloons have also been reported to undergo 
slow-deflation, slowly loosening the packing further. All these drawbacks 
together formed the basis for the shift from balloons to coils for the 
endovascular treatment of the IAs.  
 
Transcatheter electrocoagulation: Therapeutic transcatheter vessel-
occlusion (TCVC), which was introduced in 1930s for the treatment of 
carotid-cavernous fistulae, [Greenfield 1980] slowly became a well-
established technique by the 70s. Thompson and colleagues provided a 
thorough and methodical description of the technique and uncovered its 
various merits and shortcomings. They also demonstrated that the clot size 
and the extent of thrombosis were directly related to the product of amount 
and duration of the current applied. Due to difficulties in precise 
placement of the anode in IA, TCEC was mostly used to occlude the 
vessels only. 
 
From ‘pushable’ coils to ‘detachable’ coils (GDC®): In the quest of 
selective and safe embolization of IAs Gianturco and colleagues invented 
a novel mechanical device in 1975, called ‘wool coils’ [Gianturco et al 
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1975]. It was one of the earliest ‘pushable’ coils where the ‘wool’ could be 
‘pushed’ into target using a guide wire. In 1989 Hilal et al reported 
another use of short ‘pushable’ coils for the treatment of IAs. Although 
being relatively stiff, it was almost impossible to achieve a dense packing 
of IAs with these coils. Moreover, these coils were inherently non-
retrievable and hence difficult to control. These ‘pushable’ coils later 
formed the basis of more advanced ‘detachable’ coils.  
The credit of inventing the modern detachable coils (commonly known as 
GDC®) can safely be attributed to Guido Guglielmi [Guglielmi 2009] 
Guido Guglielmi (Figure-2.10) was born in Rome, Italy and initially 
studied engineering for a while before opting for medicine as a career. 
Due to his great interest in engineering he studied the concept of 
electrothrombosis of IAs in detail and conducted a series of animal 
experiments in the 1980s. Guglielmi later moved to Los Angles where he 
came in contact with Ivan 
Sepetka, a research and 
development engineer at 
Target® Therapeutics. The 
genesis of this state-of-the- art 
coiling system has changed the 
way Neurovascular surgery is 
practiced and is a unique 
example of a creative 
interdisciplinary collaboration 
between these two 
masterminds.  
Working together they 
mounted soft platinum coils of 
different sizes to a stainless steel guide-wire. The thrombosis was 
achieved by passing an electric current to the coil once it is placed inside 
the IA. The coil would ‘detach’ from the delivery wire during the process 
of electrothrombosis due to the low melting point of the metal used to 
attach it to the guide wire. Another very important feature of these coils 
was their retrievability and softness, which at gave the operator added 
control over the procedure. The first GDC® was used in a human by Dr 
Viñuela on 6th March 1989 by treating a cavernous sinus fistula. The first 
IA was treated by GDC® in January 1991 at UCLA, Los Angeles. The 
techniques of endovascular interventions for the treatment of IAs have 
exploded in the past few decades. From a second line treatment in the 
early 1990s it has rapidly become a primary therapeutic option in most of 
the centres worldwide. 
A large, multicentric, prospective, randomised, controlled, clinical trial, 
the International Subarachnoid Aneurysm Trial (ISAT), was conducted 
Figure	  2.10:	  GDC® 	  Detachable	  coils	  Source:	  http://synapse.koreamed.org	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under the leadership of Neurovascular Research Unit, Oxford, UK. It has 
indicated that the outcome in terms of survival free of disability at 1 year 
is significantly better with endovascular coiling as compared to surgical 
clipping. It however, showed that the risk of re-bleed is slightly higher 
with coiling. 
 
2.5.7: Recent Advancement and Future of Neurovascular Surgery 
The easy availability and widespread use of non-invasive neurodiagnostic 
modalities, has brought to clinical attention a large and ever increasing 
group of patients harbouring unruptured and asymptomatic IAs. These 
UIAs are also diagnosed coincidentally at the time of catheter angiography 
done for a ruptured IA in a patient with multiple lesions. The increasing 
awareness of the relatively bleak prognosis related to aneurysmal rupture 
amongst the general public and clinicians, forces neurosurgeons to come 
up with a definitive answer for these asymptomatic lesions.  
 
Turjman et al [Turjman et al 1994] introduce a GDC into the sac of 
aneurysm with the help of micro catheter passing through the mesh of a 
stent. This technique provides tight packing without danger of the coil 
being herniating through arterial wall. Kinugasa et al [Kinugasa et al 
1992] used a polymerising plastic material, bismuth trioxide dissolved in 
dimethyl sulpoxide (DMSO) and cellulose acetate polymer (CAP), for 
endovascular packing of UIAs. However distal embolism and toxicity to 
DMSO are still cause of concern. Recently a few researchers used micro 
catheter to deposit viable migration capable fibroblasts as a promising 
endovascular technique to treat UIAs [Abruzzo et al 2007]. 
 
Though therapeutic management of IAs has evolved in past few decades 
but the issues, which still remain unresolved, is to identify patients at risk 
of developing IAs and take preventive measures. The flow of blood inside 
the intracranial vasculature, the shape of the IA and its structural 
properties, has long been thought to play a role in their aetiopathogenesis. 
Computational Fluid Dynamics (CFD) is providing a useful alternative to 
predict blood flows where detailed in vivo measurement of haemodynamic 
flow variables is not possible. Important haemodynamic factors to be 
considered are Wall Shear Stress (WSS) and Oscillatory shear index 
(OSI). In future these factors can be used as new descriptors to predict the 
risk of rupture for these lesions. 
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2.6: Computational fluid dynamics: the concept and need 
2.6.1: A Brief History 
Flow of fluid has always caught the attention of man since the beginning 
of civilisation, whether it is the water in river or ocean, air in the 
atmosphere or blood in human body. The first idea on 
this topic was introduced by Heraclitus (536-460), 
though it was in a philosophical sense rather than a 
scientific one. Archimedes (287-212 BC) gave a 
scientific meaning to the concept and worked on 
hydrostatics and static mechanics. During European 
Renaissance (15th century) Leonardo Da Vinci started 
depicting the natural world of fluid through his 
drawings. His findings on fluid mechanics are 
presented in a nine-part treatise (Del moto e misura 
dell'acqua- in Latin ‘Mensura motus et aqua’, in English- ‘Motion and 
measure water’). The pictorial representation of Leonardo was followed 
by quantification and prediction of the fluid flow phenomena by Newton 
in the late 17th century. Again, in the 17th century the foundations for 
experimental fluid dynamics were laid in England and France. In the 18th 
and 19th century, theoretical fluid dynamics gradually developed, again 
primarily in Europe.  As a result, throughout most of the 20th century the 
study and practice of fluid dynamics involved the use of pure theory on 
the one hand and pure experiment on the other hand. In 18th and 19th 
century Daniel Bernoulli (1700-1782) and Leonhard Euler (1707-1783) 
tried to mathematically describe the flow of fluid using for the first time 
the concept of infinitesimal calculus. 
 
Further, Claude Louis Marie Henry Navier (1785-1836) (Figure-2.11) and, 
George Gabriel Stokes (1819-1903) modified the Euler equation and gave 
birth to the now famous Navier-Stokes equation, which forms the basis of 
modern CFD. 
 
2.6.2: Navier-Stokes Equations  
The Navier-Stokes equations are set of nonlinear partial differential 
equations that describe the flow of fluids in terms of fluid velocity and 
pressure. The Navier-Stokes equations are: 
 !"!" + ∇ ∙  𝜌𝒖 = 0        .........................Continuity equation (1) 
 !!" 𝜌𝒖 + ∇ ∙ 𝜌𝒖 𝒖 + 𝝆𝑰 = ∇ ∙ 𝜏 + 𝜌𝑔...........Momentum equation (2) 
 
		Figure	2.11:	Claude	Navier	
				Source:	Medscape	
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Where ρ is density of the fluid, u its velocity, p its pressure, μ its viscosity 
and F represents body forces (e.g. gravitational forces). 
 
The Navier-Stokes equations are time-dependent and consist of a 
continuity equation for conservation of mass and conservation of 
momentum equations which is equivalent to Newton’s second law of 
motion (Force=Mass x Acceleration) but applied to a fluid. These 
equations can be used to describe and predict the fluid flow in any 
applications. 
 
When the fluid flow is simple these equations can be simplified and a 
solution can be computed. A typical example is the steady viscous flow of 
a fluid through a straight circular pipe, in which case the simplified 
version of the Navier-Stokes, leads to the well-known Poiseuille’s 
solution- 
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∂
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Which represent the famous Poiseuille’s parabolic velocity profile (see 
Figure-13), expressed in terms of viscosity μ,  radius r, and pressure drop 
dp/dx. 
 
 
Current knowledge in mathematics 
limits the analytical solution of the 
Navier-Stokes equations only to a 
restricted group of relatively simple 
applications (e.g. straight circular 
pipes and the likes). In most 
applications however, where fluid 
flows around or through more 
complex geometries, a solution of these 
equations is not readily available and it 
is necessary to recur to computational 
fluid dynamics, whose underlying concepts are further treated in the 
following chapters.  
 
 
 
 
 
Figure	  2.12:	  Equations	  for	  Poiseuille’s 
parabolic velocity profile  
Source:	  universe-­‐review.ca	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2.6.3: Why Computational Fluid Dynamics? The Concept And The 
Need 
Computational fluid dynamics constitutes a relatively new approach in the 
study and the development of the whole discipline of fluid dynamics. 
Around 1960, with the advent of high-speed digital computers and the 
development of accurate numerical algorithms a new third revolutionary 
approach developed that strongly affected the way we study and practice 
fluid dynamics today, the approach of computational fluid dynamics. This 
approach nicely and synergistically complements the other two approaches 
of pure theory and pure experiment, but it will never replace either of 
these. The interpretation and understanding of any fluid dynamics problem 
should rest upon a proper balance of all three approaches. 
 
Computational fluid dynamics is the science of predicting fluid-flow, heat 
& mass transfer, chemical reactions, and related phenomena by solving 
numerically the set of mathematical equations (conservation of mass, 
momentum, energy, species etc.) that govern a particular physical system. 
In the past decades it has been successfully used mainly in the engineering 
field for conceptual studies of new designs, troubleshooting redesign, or 
improving the physical understanding of a novel fluid mechanical 
phenomenon. Successful examples are found in the automotive sector, 
where it has helped to improve the aerodynamics of vehicles, civil 
engineering, where it has been used to design more efficient cooling 
systems, and nautical architecture, where it has been used in the design of 
more efficient keels. Accompanied to an in depth knowledge of the 
physical problem (theory) and supported by experimental data, CFD can 
be used as a powerful tool to reduce the total effort required in the 
experiment, design, and data acquisition.  
 
	  
Figure 2.13: Discretization and generation of polygonal mesh in a pipe flow fluid region 
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The behaviour of a particular physical problem is often represented by a 
set of partial differential equations (governing equations, i.e. conservation 
of continuity, momentum, energy, etc.) whose exact solution is sometimes 
tedious, if not impossible. In the case of fluid flows these equations are the 
Navier-Stokes equations. In complex physical problems the solution is 
often not available. In these contexts CFD offers the possibility to solve 
the governing equations by approximation. CFD solvers are based on the 
discretization of the fluid flow domain (i.e. the region traversed by flow). 
The domain is subdivided into a set of sub-volumes or cells called mesh or 
grid. The figure 2.13 shows the discretization and generation of polygonal 
mesh in a pipe flow fluid region. By using this discretization the 
governing differential equations of Navier-Stokes can be approximated 
and solved, but only at certain points (i.e. cell corners) of the domain, thus 
providing the solution in terms of pressure or velocity of the fluid at these 
points.  
 
While screening of patients (with high risk of cerebral aneurysm) through 
invasive techniques continues to play a paramount role in deciding the 
course of treatment, it has some disadvantages that explain the increasing 
emphasis many neurosurgeons are placing on computer simulation. 
 
2.7: How Long We Have Come So Far: A Focused Review of 
Literature of The Studies Published on the Application of 
Computational Fluid Dynamics in the Field of Intracranial 
Aneurysms 
 
2.7.1: Background and introduction 
A focused review of literature was conducted to assess the progression of 
Computational Fluid Dynamics research in the field of Intracranial 
Aneurysms. Twenty-six (26) full text publications were reviewed for past 
seventeen years (17 years) from 1998 to 2014. Table -2.8 shows the major 
journals publishing papers in the field. Efforts were made to cover the 
most important landmark studies of each year and at least one study was 
included in the review from each year except year 2000, as I could not 
find any relevant study conducted that year. A brief account of important 
studies reviewed is given below in Table-2.9.  
 
2.7.2: Initial work, current research groups involved and publication 
trends 
Initial studies: The initial studies were conducted using idealised rather 
than patient-specific models [Low et al 1993, Burleson et al 1995, Aenis et 
al 1997]. With the progression of time it was realised that the patient-
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specific models will be more appropriate to give a better approximation of 
the haemodynamic parameters in a given patient, and hence the 
researchers started using the patient specific models. The first simulations 
studies using the patient specific models were conducted in 2003 by 
Steinman and colleagues and Jou et al [Steinman et al 2003, Jou et al 
2003]. Apart form having other flaws, the earlier studies also had 
inconsistent methodology and less explicit in describing their materials 
and methods e.g. no clear description of software used for mesh 
generation and CFD analysis, imaging modality used, boundary conditions 
applied, type of analysis, assumptions made, etc. [Foutrakis et al 1999, 
Cebral et al 2001, Butty et al 2002]. Whereas, most of these shortcomings 
can definitely be attributed to the rudimentary technology available that 
time, there also seem to be a lack of appreciation among few author 
groups [Cebral et al 2001, Foutrakis et al 1999], on the importance of 
stating the material and methods clearly in their publications.   
 
Table 2.8: Showing the Journals publishing 2 and more papers in CFD in PubMed search 
No Journal Number of publications % of Total 
1 AJNR 37 20% 
2 J Biomech 19 10% 
3 Neurosurgery 11 5.6% 
4 Ann Biomed Eng 10 5% 
5 J Biomech Eng 9 4.6% 
6 Stroke 8 4% 
7 Int J Numer Method Biomed Eng 8 4% 
8 IEEE Trans Med Imaging 5 2.5% 
9 Acta Neurochir (Wein) 5 2.5% 
10 Med Phys 5 2.5% 
11 J Neurosurg 4 2% 
12 Med Biol Eng Comput 4 2% 
13 Conf Proc IEEE Eng Med Biol Soc 4 2% 
14 Neurol Res. 3 1.5% 
15 Neuroradiology 3 1.5% 
16 Academic Radiology 3 1.5% 
17 J Neurointerv Surg 3 1.5% 
18 Proc Soc Photo Opt Instrum Eng 2 1% 
19 Biorheology 2 1% 
20 Surg Neurol 2 1% 
21 Comput Math Methods Med 2 1% 
22 Med Eng Phys 2 1% 
23 NMR Biomed 2 1% 
24 Phys Med Biol 2 1% 
25 Physiol Meas 2 1% 
26 PLoS One 2 1% 
 
2.7.3: Salient Features of the Studies Reviewed 
Demography of the population in the publications reviewed: CFD 
analyses can be conducted either in human beings (patients or healthy 
subjects), animal models (e.g. experimental studies), in vitro models or 
virtual models (in silico). All of these methods have their own positives 
and negatives. Whereas, studies in human beings provide best chance to 
simulate the disease process of IAs in vivo and help in improving their 
ultimate management, they may be difficult to conduct and may limit 
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researchers’ ability to try new therapeutic options due to ethical and 
technical issues. In the publications reviewed here, most of the studies 
were conducted in human beings (19 out of 26, 73%), either in patient 
specific 3D geometries or healthy volunteers. Second method is in vitro 
experiments where 3D models are created (e.g. with the help of 3D 
printers) and experiments are conducted by simulating human tissues and 
blood by setting a rig. These in vitro studies are mainly used to simulate 
the human vasculature and IAs. These models serve excellent platform for 
validation of CFD results as used by many authors in my review (3, 11%) 
[Bordas et al. 2013, Acevedo-Bolton et al. 2006]. Animal models provide 
closest approximation to the human pathophysiology and give flexibility 
of experimentation to researchers, however, may lack specificity of the 
human disease process. In silico or computer generated virtual 3D models 
of idealized vessel/ IA geometries are popular among biomedical scientists 
who use them frequently to test mesh reliability and finite element 
solution methods (2, 8%). 
 
Cohort size: Most of the studies (>80%) were conducted on small number 
of subjects (cohorts of 10 or less). Less than 20% studies had a cohort size 
of more than 10 with biggest being analysing 114 IAs in 31 patients 
[Alfano et al, 2013] followed by 61 IAs in 57 patients [Cebral el al, 2005], 
29 IAs in 26 patients [Shojima et al, 2005] and 20 IAs in 19 patients 
[Shojima et al, 2004]. Location: Location-wise the studies can be divided 
into two categories; a) Analyses of haemodynamics of IA and b) Analyses 
of haemodynamics of cerebral arteries. Out of the 32 locations for IAs 
analysed 20 (60%) were in anterior circulation (ICA=7, MCA=7, ICA-
PComA Junction=2, ACA=2, AComA=2) while 10 (31%) were in 
Posterior circulation (BA=5, PComA=4, VA-BA=1). Locations for 2 (6%) 
IAs were not available (NA=2). These figures differ from the Juvela et al 
[Juvela et al 2000] who found in their study that 97% of IAs were located 
in anterior circulation while only 3% were in Posterior circulation.  
 
Type of IAs: Consistent with findings of other authors [Juvela et al 2000, 
Keedy 2006], the most common type of IAs in papers I reviewed was 
Saccular (81%) followed by Fusiform (2%) while for 11% type was either 
not available or not applicable (NA).  
 
Imaging modalities used in different studies for CFD analyses; 
Comparison of 3DRA/ CTA and MRA: Most common imaging modality 
used in most of the studies is 3DRA (3 Dimensional Rotational 
Angiography, also known as DSA= Digital Subtraction Angiogram) for 
creating 3D models and performing CFD analyses. Other imaging 
modalities used were CTA (CT Angiogram) and MRA (MR Angiogram). 
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In 3DRA the contrast is injected directly into the cerebral arteries leading 
to a high concentration of contrast material inside the arteries and 
Intracranial Aneurysm. This produces a very high-resolution image of the 
arterial ROI (Region of Interest) and the Intracranial Aneurysm making it 
the ‘Gold Standard’ modality for creating 3D Models and performing CFD 
Analyses. In rest two modalities (CTA and MRA) the contrast is injected 
systemically into a vein at a remote location (usually antecubital vein in 
the forearm of patient). The ‘bolus of the contrast’ material injected 
peripherally has to travel a long distance (via heart) before it reaches the 
cerebral arteries as well as is ‘diluted significantly’ by the time it reaches 
the cerebral arteries. Due to these two factors, the concentration of the 
contrast material inside the arterial (and aneurysmal) lumen remains 
significantly low in these two modalities resulting in lower resolution 
images compared to 3DRA.  
 
In spite of its ability to produce high quality better resolution images, 
3DRA remains a fairly invasive procedure carrying higher risks to patients 
when compared to CTA and MRA. The main risks of 3DRA [Dion et al. 
1987, Fifi et al. 2009] include Cerebral Ischemic Events (Stroke; including 
TIAs and Permanent Neurologic Deficits), intracranial bleed secondary to 
perforation of a vessel or the aneurysm itself, allergy to contrast media, 
acute kidney failure (Acute Tubular Necrosis), bleeding and hematoma 
formation at the puncture site, dissection of blood vessels, femoral 
abscess, femoral occlusion leading to distal ischemia, etc. CTA and MRA 
are relatively straightforward procedures carrying significantly lower risks 
that can be performed on outpatient basis and therefore used widely for 
monitoring unruptured aneurysms as well as post-procedural follow-ups. 
The risk of radiation exposure is common to both 3DRA as well as CTA 
while all three carry risk of developing allergy to contrast media. The 
MRA is least invasive of all three and supposed to be safest as well. 
However, as the effects of radiofrequency fields and the loud acoustic 
environment on a foetus remain unknown, further research is needed to 
establish the long-term safety of MRA on pregnant patients [Bulas 2013]. 
Furthermore, with advance in technology and introduction of sophisticated 
neuro-endovascular catheters, the risk profile of 3DRA is falling rapidly. 
Recent studies [Thiex et al. 2010] quote figures as low as approaching to 
zero in well-equipped centres, carefully selected cases and experienced 
operator. 
 
Software used for 3D Modelling and CFD Analyses: The process of 
analysing the haemodynamic variables and deducing other non-observable 
data can be divided into following steps: a) Importing the medical images 
into a suitable software interface and generation of 3D Models, b) Surface 
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extraction and mesh generation c) Application of appropriate boundary 
conditions on inlet and outlets of the geometry d) Simulation of blood-
flow into the geometrical models of arteries and IAs created in previous 
steps, d) Post-processing of the results obtained to display the 
haemodynamic variables. Different researchers used a number of software 
at each step.  
 
a) Generation of 3D Models: The medical data is ‘raw’ and need to be 
‘processed’ to create 3D Models that can be used for further processing. 
This is done by importing the medical images (e.g. 3DRA/ CTA/ MRA) 
into a suitable software-interface that generates Anatomical 3D Models of 
the ROI (Region of Interest), i.e. the IAs and surrounding vasculature. A 
number of software are available for generation of 3D models from 
medical images. The most common software used in my review of 26 
publications was In House Developed Software (7, 27%). Other software 
used were Rapidform™ (INUS Technology, Seoul, South Korea) (3, 12%), 
VMTK (Vascular Modelling Toolkit, an open source software containing 
C++ based algorithms, developed by VMTK Community, Bergamo, Italy; 
www.vmtk.org) (2, 8%), Alatoview™ (Toshiba, Japan), Altair 
HyperMesh™ (Altair Engineering, Inc., MI, USA), (X)-MedCon™ 
V0.5.10 (Open Source Software), AVS/Express Visual Development Tool 
V5.1 (Advanced Visual System Inc.), e.soft@LEONARDO™ (Siemens 
Medical Solutions USA, Inc.), VTK/ Paraview™ (Kitware Inc., NY, 
USA), Amira™ V 3.0 (Mercury Computer Systems, Berlin, Germany), 
ICEM™-CFD software (Ansys, Berkeley, CA), Matlab™ R2006b (The 
Mathworks, Natick, MA, USA), and CAD software RHINOCEROS™ V 
4.0 (McNeel &Associates, Indianapolis, IN, USA). For generating the 3D 
Models of Intracranial Aneurysms and surrounding vasculature in Project 
@neurIST, I used in house developed software @neuFuse. 
 
b) Mesh generation and Fluid flow simulation: Mesh or volume 
generation after surface extraction is the second step in the processing 
followed by application of Boundary Conditions and simulation of Fluid 
Flow by solving the equations iteratively, either as a steady-state or 
transient (also called as pulsatile) fluid flow. 
Two biggest giants building software in the field of CFD Simulation are 
Ansys® and Fluent® (bearing in mind that after acquisition in 2006, 
Fluent® has become a part of Ansys®). In my review of 26 publications, 
these two companies shared equal proportion of software used for mesh 
generation and blood flow simulation. Software provided by both Ansys® 
and Fluent® were used in 12 studies (46% each) totalling to 92% together. 
Main Ansys® software used for mesh generation is Ansys® ICEM™ used 
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in 7 studies (27%). Its counterpart from Fluent® is GAMBIT (Geometry 
and Mesh Building Intelligent Toolkit), which also used extensively in 
mesh generation and was used by equal number of authors (7, 27%) as 
ICEM™ from Ansys® in my review. Other popular software from Ansys 
are CFX™, CFD-Flo™, Ansys Fluent™, Ansys CFD Professional™.  
Ansys® has also integrated its all fluid dynamics solution products into 
the Ansys® Workbench™. Other software used for meshing and blood 
flow simulations by different authors are; FIDAP –CFD Software (Fluent 
Europe, Sheffield, UK), CFD-ACE+ package (CFD Research Corporation, 
Huntsville, AL, USA), STARCD, (CD Adapco, Melville, NY, USA), 
SC/Tetra V-5 (Software Cradle Co Ltd, Osaka, Japan), FeatFlow V1.3 
release candidate 3 (University of Dortmund, Germany), Gridgen V15.12 
(Pointwise Inc., TX), Nektar Spectral/ HP Element Framework  (Division 
of Applied Mathematics, Brown University, USA, Department of 
Aeronautics, Imperial College London, UK, and Scientific Computing and 
Imaging Institute, University of Utah, USA), etc. In the studies included in 
this thesis, whereas Ansys® ICEM™ software was used for mesh 
generation, Ansys® CFX™ was used for blood flow simulations in the 
ROI (Region of Interest), as a part of Project @neurIST.  
 
Boundary conditions applied: Boundary conditions (BCs) are required as 
due to limitation in current technology it is currently impossible to 
simulate the whole body vasculature at the same time. The region of 
interest (ROI) despite the fact being simulated in isolation is naturally 
affected by the region outside it. In order to perform a realistic simulation 
this information is passed to the solver by applying the Boundary 
Conditions. These boundary conditions can be either measured directly on 
the patient by using different techniques e.g. Transcranial Doppler (TCD) 
or MR Q Flow measurements or if not available has to be taken from the 
other sources. In my review total 35 Boundary Conditions were 
considered (including inlet and outlet Boundary Conditions in the same 
study). Out of these 35 BCs, 17 (approx. 49%) were measured in the 
patients. The most common method for measuring the BCs was 
Transcranial Doppler (TCD) Ultrasound (5, 30%), followed by Phase 
Contrast MRI (pcMRI) in 4 (24%), MR Velocimetery (2, 12%), Laser 
Doppler Velocimetery (LDV) (2, 12%). All of these methods, in spite of 
their advantages, have some inherent shortcomings. The most recent 
advancement in the field of measuring the BCs is taking the measurements 
of pressure and velocity by Intravascular Probe Sensors directly in the 
Intracranial Vessels and IAs as demonstrated by Levitt and colleagues in a 
ground breaking study done this year [Levitt et al. 2014]. However, it will 
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take some time before these methods can become a practical adjunct in 
routine clinical settings. 
 
Whenever this information is not available for a particular patient, we use 
the values observed in age sex matched other patients or the healthy 
volunteers or values from literature, also known as ‘modelled’ or 
‘phantom-boundary conditions’. In author’s review of 26 studies; 16 
(46%) were modelled BCs, out of which while 12 (34%) were literature 
based, rest 4 (11%) were measured in healthy age and sex matched 
volunteers. The variables often used as phantom-boundary conditions are 
heart rate, blood flow velocity, pressure, velocity profile, and usually 
applied at outlets in most of the studies, sometimes also called ‘Universal 
Boundary Conditions’ by some authors. Methods of obtaining BCs were 
not available in 2 studies. 
 
  
 
Table 2.9: CFD Analysis of Intracranial Aneurysms & Arteries: Some Main Studies, their Methodology and Results 
No Author/ 
  Year 
Journal/ 
Year 
Human/ 
Animal/ 
in- vitro 
Patients/ 
Animals/ 
Aneurysms 
Location Aneurysm 
type 
Imaging 
Modality 
Software used Haemodynamic  
Variables 
analyzed 
Results Boundary  
Condition 
Applied 
Type of 
Analysis 
Assumptions 
Made 
Salient 
features of 
study 
1 Ortega J Med Eng 
Technol 
1998 
Animal 3/3 CCA Saccular 3DRA *Surface Extraction 
and 3D Modeling:  
-In house developed 
software 
*CFD: 
- FIDAP –CFD 
Software, Fluent 
Europe, Sheffield, 
UK  
Flow patterns 
Jet stream 
impingement 
 
 
Flow patterns 
inside the IAs 
change with 
time during a 
cardiac cycle- 
this may lead to 
increased WSS 
in the IAs 
Measured 
with Doppler  
Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC 
One of the early 
study to show 
potential 
application of 
CFD in the 
prediction of 
haemodynamics 
of IAs 
2 Foutrakis 
et al 
 
AJNR 
1999 
 
In vitro 2/0 Cerebral 
artery 
Curves 
Bifurcations 
+/- 
Aneurysm -
-models 
Saccular NA *Surface Extraction 
and 3D Modeling:  
NA 
*CFD: 
NA 
Pressure 
Velocity 
Flow Pattern 
Impingement 
WSS 
High Pressure 
High Velocity, 
High WSS, 
Impingement –
Initiation 
Measured NA Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC 
One of the early 
study, used 2D 
Finite Element 
Models 
3 Cebral et 
al 
JBiomech 
2001 
Human 1/0 ICA and 
ECA of a 
healthy 
volunteer 
NA MRA *Surface Extraction 
and 3D Modeling:  
NA 
*CFD: 
NA 
NA 
 
Study describes 
a new method 
for mesh 
generation 
NA NA NA A new method 
for Mesh 
Generation 
described 
4 Butty et al Biorheology 
2002 
Human 1/2 ICA Saccular CTA *Surface Extraction 
and 3D Modeling:  
- Altair HyperMesh, 
Altair Engineering, 
Inc., MI, USA 
*CFD: 
- CFD-ACE+ 
package, by CFD 
Research 
Corporation, 
Huntsville, AL, USA 
Flow patterns 
Residence time 
Basins of 
attraction 
Complex flow 
patterns and 
mixing of blood 
seen inside the 
IAs 
NA NA Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC 
Early study, 
methodology 
not very clear 
esp. re: 
Boundary 
Conditions 
5  Steinman 
et al 
AJNR 
2003 
 
Human 1/1 ICA-
PcomA 
Saccular 3DRA *Surface Extraction 
and 3D Modeling:  
-NA 
*CFD: 
- In house developed 
finite element CFD 
Solver 
WSS 
Flow Pattern 
OSI 
Neck - High 
flow 
Aneurysmal sac 
– persistent & 
transient 
vortices 
Distal neck – 
high OCI & 
WSS 
 
 
Measured in 
Age/Sex 
matched 
volunteers 
Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC 
Validations 
done by 
comparing the 
CFD findings 
with the cine 
angiography 
showed good 
agreement 
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No Author/ 
  Year 
Journal/ 
Year 
Human/ 
Animal/ 
in- vitro 
Patients/ 
Animals/ 
Aneurysms 
Location Aneurysm 
type 
Imaging 
Modality 
Software used Haemodynamic  
Variables 
analyzed 
Results Boundary  
Condition 
Applied 
Type of 
Analysis 
Assumptions 
Made 
Salient 
features of 
study 
6 Shojima  
et al 
Stroke  
2004 
 
 
Humans  
19/20 MCA Saccular 3 D CTA *Surface Extraction 
and 3D Modeling:  
Alatoview, Toshiba, 
Japan 
*CFD: ICEM CFD, 
Ansys  
 
 
WSS High WSS – 
Initiation 
Low WSS – 
Growth & 
rupture 
Inlet: 
measured in 
One Pt. by 
TCD  
Outlet: 
Modeled 
Stationary Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC 
 
7 Hoi et al 
 
 
 
 
J Neurosurg 
2004 
 
In vitro 10 ICA 
Models 
Saccular 3D DSA *Surface Extraction 
and 3D Modeling:  
In House Software  
 
*CFD: -Gambit, 
Fluent, Lebanon, NH 
-STARCD, CD 
Adapco, Melville, 
NY 
 
 
Effects of 
arterial 
geometry and 
Neck Size 
WSS 
Velocity 
 
WSS increases 
with Curvature 
and Neck Size 
Measured Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC 
Effects of 
arterial 
geometry and 
Neck Size on 
WSS were 
investigated 
8 Hassan  
et al 
AJNR 
2004 
 
Human 1/1 Vertebro-
Basilar 
Saccular 3DRA *Surface Extraction 
and 3D Modeling:  
-(X) MedCon, 
V0.5.10, Open 
Source Software 
-AVS/Express visual 
development tool 
(V5.1, Advanced 
Visual System Inc.) 
 
*CFD:  
-ICEM CFD, Ansys  
-Gambit, Fluent, 
Lebanon, NH 
 
*Post Processing: 
Ensight, version 7.3.0 
(Computational 
Engineering 
International, Inc., 
Berkley, CA) 
 
 
 
 
 
Pressure, after 
therapeutic 
occlusion of 
VA- one by one 
Balloon 
occlusion of Rt 
VA better than 
the Lt VA 
Measured, 
TCD, 
Pt. Specific 
Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC 
CFD of a Giant 
IA showing 
growth 
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No Author/ 
  Year 
Journal/ 
Year 
Human/ 
Animal/ 
in- vitro 
Patients/ 
Animals/ 
Aneurysms 
Location Aneurysm 
type 
Imaging 
Modality 
Software used Haemodynamic  
Variables 
analyzed 
Results Boundary  
Condition 
Applied 
Type of 
Analysis 
Assumptions 
Made 
Salient 
features of 
study 
9 Jou  et al 
 
AJNR 
2005 
Humans 2/2 Basilar 
Artery 
Fusiform MRA *Surface Extraction 
and 3D Modeling:  
Rapidform (INUS 
Technology, Seoul, 
South Korea)  
*CFD:  
-Gambit (Fluent, 
Lebanon, NH) 
-Fluent 
(Fluent Inc., 
Lebanon, NH) 
WSS 
Flow Pattern 
Pressure 
Impingement 
Low WSS 
correlates with 
IA growth 
Pt. Specific- 
Inlet: pcMRA 
Outlet: MR 
Velicitometry 
Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC 
CFD on 
growing IAs  
10 Shojima  
et al 
Stroke  
2005 
 
Humans 26/29 ICA 
MCA  
ACA 
Saccular 3D DSA *Surface Extraction 
and 3D Modeling:  
ImageDesign (Quint 
Corporation) 
*CFD:  
SC/Tetra V-5 , 
Software Cradle Co 
Ltd, Osaka, Japan 
Pressure 
Velocity 
Flow Pattern 
Impingement 
WSS 
High Pressure- 
No correlation 
with Rupture, 
High Pressure- 
correlated with 
High WSS 
Inlet: 
Measured in 
one pt., used 
in all 
Outlet: 
modeled 
Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC 
Contrary to the 
common belief 
study shows 
Blood Stream 
Jet Impaction 
and Local 
Pressure 
Elevation less 
important 
factors in IA 
rupture 
11 Cebral el 
al  
AJNR 
2005 
Humans 57/62 ICA 
MCA 
PComA 
ACA 
NA 
Saccular 3DRA *Surface Extraction 
and 3D Modeling:  
In House Software  
 
*CFD: Ansys  
Peak Pressure 
OSI 
WSS 
Ruptured IAs: 
Complex, 
unstable flow, 
Small 
Impingement 
Area 
Small Jet Size 
Modeled 
Literature 
based 
Based on 
MRA 
Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC 
Cebral el al 
found 
correlations 
with Complex, 
Unstable flow, 
and ruptured 
IAs 
12 Karmonik 
et al 
IEEE 
Proceedings 
2006 
 
Human 3/3 Basilar 
Artery 
Saccular 3DRA *Surface Extraction 
and 3D Modeling:  
-
e.soft@LEONARDO, 
Siemens Medical 
Solutions USA, Inc.  
-VTK/ Paraview- 
Kitware Inc. 
*CFD: 
Meshing: Gambit  
CFD: Fluent, CFD 
Solver, Fluent, 
Lebanon, NH 
 
 
 
WSS- time 
dependent 
WSS varies 
with time 
Modeled, 
from 
literature 
Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC 
One of the early 
studies on CFD 
of IAs 
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No Author/ 
  Year 
Journal/ 
Year 
Human/ 
Animal/ 
in- vitro 
Patients/ 
Animals/ 
Aneurysms 
Location Aneurysm 
type 
Imaging 
Modality 
Software used Haemodynamic  
Variables 
analyzed 
Results Boundary  
Condition 
Applied 
Type of 
Analysis 
Assumptions 
Made 
Salient 
features of 
study 
13 Acevedo-
Bolton et 
al 
Neurosurgery 
2006 
Human/ 
in vitro 
1/1 Basilar 
Artery 
Fusiform MRI/ 
MRA 
Surface Extraction 
and 3D Modeling: 
Amira (version 3.0; 
Mercury Computer 
Systems, 
Berlin, Germany) and 
Rapidform 2004 
(INUS Technology, 
Seoul, South Korea) 
 
CFD: GAMBIT, 
Fluent 
Inflow Jet 
WSS 
 
*Low WSS- 
corresponds to 
Aneurysm 
growth 
*CFD can be 
used to model 
interventions  
Measured  
pcMRI 
Transient  Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC 
*in vitro and   
in vivo 
validations 
done 
*Increasing the 
WSS proposed 
as treatment  
14 Castro 
et al 
AJNR 
2006 
 
Humans 4/4 PComA 
Rt MCA 
Lt MCA 
AComA 
 
Saccular 3DRA 
 
*Surface Extraction 
and 3D Modeling:  
NA 
*CFD: 
NA 
WSS  
Flow Velocity 
Flow Pattern 
Significant 
effect of 
upstream parent 
vasculature on 
aneurysmal 
haemodynamics  
Modeled, 
based on the 
MR 
measurements 
in Normal 
Subjects 
Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC 
Effects of 
Geometry of 
the upstream 
parent artery on 
IA 
haemodynamics 
demonstrated 
15  Mantha et 
al 
AJNR 
2006 
 
Humans 3/3 ICA Saccular 3D DSA *Surface Extraction 
and 3D Modeling:  
In House Software  
 
*CFD: Gambit 
(Fluent, Lebanon, 
NH) 
WSS 
OSI 
Velocity 
Low WSS/  
Stagnant flow 
correlates IA 
Initiation 
Modeled 
Literature 
based 
Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC 
First one to use 
technique of 
removing the 
IA and 
computing 
WSS after 
reconstructing 
the parent wall 
16 Alnaes  
et al. 
Stroke 
2007 
 
Human 10/0 Complete 
Circle of 
Willis 
- CTA 
MRA 
3DRA 
*Surface Extraction 
and 3D Modeling:  
In House Software  
 
*CFD: FeatFlow 
(version 1.3, release 
candidate 3; Uni of 
Dortmund, Germany) 
 
*Post Processing: 
ParaView software 
(version 2.4; Kitware 
Inc., Los Alamos 
National Laboratory, 
Los Alamos, NM) 
 
 
WSS *WSS changes 
with Vessel 
radii and 
Branch Angles. 
*High WSS at 
the sites where 
Aneurysms are 
common 
*Modeled 
*Literature 
Based 
 
Stationary Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC 
Blood Density: 
1g/cm3 
Viscosity: 
0.0035 Pa.s 
Study provides 
CFD model of 
circle of Willis 
and values of 
WSS in it 
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No Author/ 
  Year 
Journal/ 
Year 
Human/ 
Animal/ 
in- vitro 
Patients/ 
Animals/ 
Aneurysms 
Location Aneurysm 
type 
Imaging 
Modality 
Software used Haemodynamic  
Variables 
analyzed 
Results Boundary  
Condition 
Applied 
Type of 
Analysis 
Assumptions 
Made 
Salient 
features of 
study 
17 Meng et al  Stroke 
2007 
 
Animals 6 CCA-
surgically 
created 
vessel 
branch 
Saccular/ 
Nascent 
aneurysm 
formation 
3DRA *Surface Extraction 
and 3D Modeling: 
ICEM-CFD software 
(Ansys, Berkeley, 
CA). 
*CFD: Star-CD (CD-
Adapco, 
Melville, NY) 
Impingement 
zones 
WSS 
WSS Gradients 
High WSS, 
Impingement- 
Initiation 
Measured Transient/ 
Stationary 
Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC 
Experimental 
study in 
animals 
showing 
histological 
changes in 
vessel walls of 
IA initiation 
18 Boussel et 
al 
 
Stroke  
2008 
 
Human 7/7 Basilar  
ICA 
MCA 
Saccular MRA *Surface Extraction 
and 3D Modeling:  
Rapidform (INUS 
Technology, Seoul, 
South Korea)  
 
*CFD: Fluent 
(Fluent Inc., 
Lebanon, NH) 
WSS TA 
(Time Averaged 
WSS) 
Low WSS 
correlates with 
Growth of IA 
Measured by 
pcMRI 
Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC,  
 
Correlation of 
Low WSS to 
Aneurysm 
Growth 
19 Cebral el 
al  
 
AJNR 
2009 
Human 1/1 Basilar Tip Saccular 3DRA *Surface Extraction 
and 3D Modeling:  
In House Software  
 
*CFD: Ansys  
WSS 
Velocity 
Flow Pattern 
Haemodynamic 
Characteristics 
of Ruptured 
IAs:  
*Concentrated 
inflow jet 
*Unstable Flow 
*Small 
Impaction zone 
*Low WSS 
Modeled  
Based on 
MRA 
Of Volunteers 
Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC, 
Haemodynamic 
and 
Morphology of 
IA remains 
same before 
and after 
rupture 
 
 
CFD analysis 
done just 2 
hours before the 
IA rupture 
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20 Baek et al Interface 
Focus 
2010 
Human 3/3 ICA 
PComA 
Saccular 3DRA 
CTA 
*Surface Extraction 
and 3D Modeling:  
Matlab R2006b (The 
Mathworks, Natick, 
MA, USA) 
*CFD:  
Mesh: Gridgen 
V15.12 (Pointwise 
Inc., TX) 
CFD: Nektar, 
Spectral/ HP Element 
Framework  
 
 
 
 
 
WSS 
OSI 
VFR 
 
Flow instability 
occurs in 
certain IAs -
esp. wide 
necked IAs that 
may be 
responsible for 
their growth or 
rupture 
Inlet: 
literature 
Based 
 
Outlet: 
Universal BC 
Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC,  
 
 
No Author/ 
  Year 
Journal Human/ 
Animal/ 
in- vitro 
Patients/ 
Aneurysms 
Location Aneurysm 
type 
Imaging 
Modality 
Software used Haemodynamic  
Variables 
analyzed 
Results Boundary  
Condition 
Applied 
Type of 
Analysis 
Assumptions 
Made 
Salient 
features of 
study 
21 Bernardini 
et al 
Interface 
Focus 
2011 
Virtual  0/1 NA Saccular Idealized 
vessel 
and IA 
geometry 
*Surface Extraction 
and 3D Modeling:  
CAD software 
RHINOCEROS v. 
4.0 (McNeel 
&Associates, 
Indianapolis, IN, 
USA) *CFD:  
Meshing: Ansys 
ICEM 
CFD: Ansys CFX,  
(ANSYS, 
Canonsburg, 
Pennsylvania)  
 
 
Position and 
deployment of 
stent 
WSS 
Impact zone 
Position of 
stent influences 
the WSS and 
impact zone in 
the IAs 
Inlet: 
literature 
Based 
 
Outlet: 
Universal BC 
Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC,  
 
Position of 
stent influences 
the WSS and 
impact zone in 
the IAs 
22 Kono et al Neurosurgery 
2012 
Human 1/1 ACA Saccular 3DRA 
CTA 
*Surface Extraction 
and 3D Modeling:  
NA 
 
*CFD:  
Meshing: Ansys 
ICEM 
CFD: Ansys CFX,  
(ANSYS, 
Canonsburg, 
Pennsylvania) 
 
WSS 
OSI 
Velocity 
Static pressure 
Site of rupture 
corresponds 
with Low End-
Diastolic WSS 
and High Peak-
Systolic 
Pressure 
Inlet: 
Measured by 
Doppler 
 
Outlet: 
Universal BC 
Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC,  
 
Rare study that 
computed 
Haemodynamic 
variables during 
IA rupture 
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23 Li et al JNeurosurg 
2012 
Human 17/17 ICA 
AComA 
PComA 
 
Saccular 3DRA *Surface Extraction 
and 3D Modeling:  
In house software 
 
*CFD:  
Meshing: Ansys 
ICEM 
CFD: Ansys CFX,  
(ANSYS, 
Canonsburg, 
Pennsylvania)  
 
 
Max WSS 
Spatially Ave 
WSS  
Values of Max 
WSS and 
Spatially Ave 
WSS at peak 
systole were 
significantly 
higher at the 
neck in 
recanalized IAs 
after coiling 
Inlet: 
Measured by 
Doppler in 
healthy 
volunteers 
 
Outlet: 
Universal BC 
Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC,  
 
Study addresses 
a common 
problem of 
recanalization 
in IAs 
24 Alfano et 
al 
Neurosurgery 
2013 
Human 31/114- 
10 common 
locations 
Vessel 
bifurcations 
- 3DRA 
CTA 
*Surface Extraction 
and 3D Modeling:  
Vascular Modeling 
Toolkit 
*CFD: ICEM Ansys  
WSS 
WSS Gradient 
Av WSS 
Max WSS 
Impact zones 
 
 
 
 
 
 
 
High WSS 
correlates with 
the site of IA 
formation 
Literature 
based 
Stationary Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC,  
 
- 
No Author/ 
  Year 
Journal Human/ 
Animal/ 
in- vitro 
Patients/ 
Aneurysms 
Location Aneurysm 
type 
Imaging 
Modality 
Software used Haemodynamic  
Variables 
analyzed 
Results Boundary  
Condition 
Applied 
Type of 
Analysis 
Assumptions 
Made 
Salient 
features of 
study 
25 Bordas et 
al 
Interventional 
Med Applied 
Sci 
2013 
 
In vitro  1 PComA 
MCA 
AComA 
Saccular MRA 
 
*Surface Extraction 
and 3D Modeling:  
NA 
 
*CFD:  
Meshing: Ansys 
ICEM 
CFD: Fluent,  
(ANSYS, 
Canonsburg, 
Pennsylvania)  
 
 
 
 
 
 
 
 
 
WSS 
Velocity 
 
Good 
agreement was 
found between 
experimental 
and CFD results 
MRA 
LDV  
=Laser 
Doppler 
Velocimetery 
Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC,  
 
Validates CFD 
for analysis of 
Haemodynamic 
indices in IAs 
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26 Levitt et 
al 
AJNR 
2014 
Human 4/4 ICA Saccular 3DRA *Surface Extraction 
and 3D Modeling:  
Vascular Modeling 
Toolkit (Bergamo, 
Italy; www.vmtk.org) 
 
*CFD:  
Meshing: Gambit  
CFD: Fluent,  
(ANSYS, 
Canonsburg, 
Pennsylvania)  
Blood Flow 
Pressure 
WSS 
 
 
Flow diverter 
stents lead to 
significant 
intra-IA 
reduction in 
WSS and WSS 
Gradient and a 
trend in reduced 
blood flow- that 
may induce 
thrombosis in 
IA 
 
 
 
 
 
 
 
 
 
 
Pressure and 
velocity was 
measured by 
Intravascular 
Probe Sensors 
directly in the 
Intracranial 
Vessels and 
IA 
Transient Newtonian 
Fluid, Rigid 
Vessel Wall, 
Non Slip BC,  
 
CFD 
simulations of 
Flow Diverter 
Stents, Use of 
Intravascular 
Probe Sensors 
to measure the 
Pressure and 
Velocity 
directly in the 
Intracranial 
Vessels and IA 
Transient vs. stationary analyses: Whereas, the blood-flow entering into 
the domain is pulsatile (varying according to the stage of cardiac cycle), 
for the sake of simplicity, sometimes authors perform analyses considering 
blood-flow as stationary or steady state. Most of the analyses in my review 
(19, 73%) however, were performed using pulsatile blood-flow shown, as 
transient analyses in the Table-9. 12% (3) analyses were stationary while 
the information was not available in another 12% (3) studies. One analysis 
was performed using both methods, transient as well as stationary.  
Assumptions made: As stated above, it is often difficult and impractical to 
measure all Boundary Conditions in a given patient, most of the authors 
tend to make some assumptions while performing CFD Analyses of 
Intracranial Aneurysms. In this review author found that 24 (92%) studies 
made assumptions that blood is a Newtonian fluid, vessel walls are rigid, 
and boundaries of domain are non-slip. In addition to these assumptions, 
one study also made assumption that shape and size of the intracranial 
aneurysm does not change before and after rupture. Information was not 
available in one study. 
 
Haemodynamic variables analysed: Wall shear stress (WSS) is the most 
important haemodynamic variable receiving attention of maximum 
number if researchers worldwide. In this review I found the same pattern 
with 22 (85%) studies computing WSS. Different types of WSS computed 
were; WSS gradient, time-dependent WSS, time-averaged WSS, max and 
min WSS, spatially-averaged WSS, etc. Next two haemodynamic 
variables analysed were Flow Patterns and Jet Stream Impingement (8, 
31% each) followed by Pressure and Velocity (7, 27% each), Flow-rates, 
Residence Time, Basins of Attraction, Effects of Geometry of Parent 
Vessel and Neck Size on the haemodynamics, Position of deployment of 
Stent, etc.  
 
Results and Salient Features: This short review draws attention towards a 
number of important factors. Most common unanimous conclusion from 
the studies reviewed was that High WSS favours Initiation of Aneurysm 
as well as Low WSS promoting the Aneurysmal Growth and Rupture (12, 
46% studies). Good correlations were also demonstrated between Rupture 
of IAs and Complex Blood Flow, Unstable Blood Flow, Mixing of Blood, 
and Small Impingement Zone by 9 (35%) authors. Other parameters 
analysed were; High Pressure and High Velocity correlates with Initiation, 
Flow patterns inside IAs change with cardiac cycle, High flow seen at 
neck, WSS increases with curvature of vessel and Neck size of IAs, CFD 
can be used to model interventions, Significant effects of Upstream Parent 
Vessel on the IA Haemodynamics, WSS changes with Tine and Radii of 
Vessels, Position of Stent Affects WSS and Impact Zones, High WSS 
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associated with Re-canalization of coiled IAs, Experimental Validations of 
CFD show Good Correlation, etc.  
 
2.8: Conclusions 
Intracranial Aneurysms share a multifactorial aetiology with 
haemodynamics playing an important role. Though therapeutic 
management of IAs has evolved in past few decades but the issues that 
still remain unresolved are to identify patients at risk of developing IAs 
and take preventive measures. The flow of blood inside the intracranial 
vasculature, the shape of the IA and its structural properties, has long been 
thought to play a role in their aetiopathogenesis. Computational Fluid 
Dynamics (CFD) is providing a useful alternative to predict blood flows 
where detailed in vivo measurement of haemodynamic flow variables is 
not possible. Important haemodynamic factors to be considered by a 
number of authors are Wall Shear Stress (WSS), Oscillatory Shear Index 
(OSI), Pressure, Jet Impingement, Flow Patterns and Stability over time 
and space, Complexity of Flow, etc. In future these factors can be used as 
new descriptors to predict the risk of rupture for these lesions. 
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*My contribution: The tool-chain (e.g. @neuFuse) were primarily 
developed by computer scientists (including Dr Alberto Marzo, Dr Mari-
Cruz Villa-Uriol, etc., as detailed in acknowledgement section) working in 
project @neurIST, however, I played major role in the clinical evaluation 
to gather users’ feedback that was used in the improvement of these tools. 
I was also responsible for recruitment of the patients/ volunteer form 
Sheffield Centre including consenting and facilitating Scans, etc. 
 
 
3.1. Introduction 
One of the most important parameters that can be used to assess the 
quality of a good study is the ease with which it can be replicated and, 
ability to reproduce similar results by other researchers independently. 
Results of any study can only be replicated consistently and reliably if 
materials and methods are constant across the researchers who are trying 
to replicate the research. A clear and detailed description of materials and 
methods used in any research is thus of paramount importance. The 
materials and methods used in different studies while conducting the work 
presented in this thesis are described here in detail.  
 
3.2. Project @neurIST 
 
Overview 
@neurIST [@neurIST Project 2007, Project 
Identifier: IST-2004-027703, www.aneurist.org], 
was a major multidisciplinary European initiative 
funded by the European Commission with a budget 
€17 million. The main co-ordination of the project 
CHAPTER 3.0: MATERIALS AND METHODS 
	  	  	  
Figure 3.1- Project @neuriST 
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is done from Center for Computational Imaging & Simulation 
Technologies in Biomedicine, Universitat Pompeu Fabra, Barcelona, 
Spain.  
 
The total duration of the project @neurIST was 4 years- from January 
2006 to December 2009. The period was extended further for another 
three months until March 2010. The studies included in this thesis were 
conducted as a part of project from March 2008 to March 2010. Studies 
were mainly done jointly in the Departments of Neurosurgery and 
Neuroradiology, Royal Hallamshire Hospital, and the Academic Unit of 
Medical Physics, Department of Cardiovascular Science, University of 
Sheffield, Sheffield, UK, with collaborations and support from other 
project partners.  
 
The project brings together neurosurgeons, neuroradiologists, 
epidemiologists, engineers, biologists and computer scientists from 32 
European institutions, both public and private, in 12 countries (Figure-3.1) 
to develop a usable interface for personalised risk assessment and 
treatment of patients with IAs and SAH. The University of Sheffield and 
the Sheffield Teaching Hospitals NHS Trust played a major role in the 
development of image-processing and computational tools to provide new, 
non-observational measures for the characterisation of the disease. 
Activities in the project are executed through different suites, as outlined 
below briefly: 
 
1. @neuLink: The suite is aimed at exploring the genetic aspects of IAs 
and linking them to their initiation, growth and rupture. It also 
facilitates successful application of data-mining, text-mining or micro 
array analysis leading to the development a model of the molecular 
mechanisms involved in the disease forming a platform for the future 
genetic epidemiological studies thus facilitating the process of 
molecular genetics. 
2. @neuFuse: @neuFuse is the state of art software developed in the 
project that fuses diagnostic, modelling and simulation data into a 
coherent representation of the patient's condition. 3 dimensional 
models of the intracranial vasculature and intracranial aneurysms can 
be created starting from the patient medical image @neuFuse can solve 
these models to provide a prediction of haemodynamic, morphological 
and structural indices inside an IA. More details of @neuFuse are 
given below in the relevant section. 
3. @neuRisk: @neuRisk provides clinicians a tool to facilitate the 
personalised risk assessment and guidelines establishment to treat 
patients by integrating the various sources of information (molecular to 
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clinical level). The management of unruptured intracranial aneurysms 
will be improved by optimizing the decision-making process. The goal 
of @neuRisk is to reduce the number of unnecessary treatments by 
50%, leading to reduction of risks to the patient and economic savings. 
4. @neuEndo: @neuEndo is developing computational tools to optimise 
and customise the design of endovascular devices. These tools simulate 
the structural, haemodynamic and biological responses of the body to 
the deployment of stents and coils before the procedure. This will serve 
not only the manufacturers in the design of these implants, but also the 
medical end-user in the planning of an intervention. Additionally, with 
the help of advanced numerical-simulation tools it can predict the 
occurrence of device-induced thrombosis and drug elution processes. 
5. @neuInfo: @neuInfo enables accessing clinical and epidemiological 
data distributed in different databases. Different data sources can be 
searched using a query user interface linked to the actual physical data 
sources. It allows direct navigation through different specific 
knowledge domains. 
6. @neuCompute: @neuCompute provides distributed (remote) 
computing capabilities to @neurIST ensuring secure data transport. 
This integration of computing resources supports computationally 
demanding tasks such as complex modelling and simulation demanded 
by the integrative suites @neuRisk, @neuLink, @neuEndo and 
@neuFuse. A focus is placed on interoperability and integration, 
leveraging on existing technologies. 
7. @neuQuest: This data entry software was used to enter the clinical, 
social, radiological etc. data about the recruited patients across the 
project. 
8. @neuBrowser: The data entered through @neuQuest at different 
locations is integrated through this suite. With the help of this unique 
software categorization and basic analysis of the data can be done 
along with its graphical representation. 
 
3.3. Ethical Approvals 
The project has appropriate ethical approvals for the required research. All 
partners involved in the project took separate ethical approvals from their 
local ethical committees after satisfying their requirements. The ethical 
matters for UK are managed by Project Ethical Committee, Oxford, UK 
(Oxfordshire Research Ethics Committee-A Study Number: 
07/Q1604/53). 
 
3.4. Recruitment of patients 
The patients involved in different studies were recruited through seven 
clinical centres across Europe after taking informed consents. The clinical 
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centres responsible for the patient recruitment and data collection are: 
Royal Hallamshire Hospital and Sheffield Teaching Hospitals NHS Trust, 
Sheffield, UK; John Radcliffe Hospital, Oxford, UK; Université de 
Genève, Geneva, Switzerland; Medical University of Pecs, Hungary; 
Erasmus Medical Centre, Rotterdam, The Netherlands; Hospital General 
de Catalunya, Barcelona, Spain; and Hospital Clinical i Provincial de 
Barcelona. More recently, Dr. A. Asenjo Institute of Neurosurgery & 
Neuroradiology, Santiago, Chile, and Beaumont Hospital, Dublin, Ireland 
have also started the process of joining the project. Total number of cases 
was 1591, recruited through all clinical centres. 
 
3.4.1: Demography of Recruited Cases 
A total number of 1591 cases were recruited to @neurIST through all 7 
clinical centres. A brief overview of different demographic characteristics 
of the recruited population is given in Tables-3.1 and Table-3.2. 
 
The patients were recruited randomly either in a retrospective or 
prospective manner through Neurosurgical Clinics and Wards. However, 
due to low risk of rupture majority of the population was recruited 
retrospectively. Depending upon the type of consent patients gave, blood 
samples were also collected and analysed for exploring the genetic aspects 
of the disease. In order to compare the characteristics of the case cohort, 
population matched controls were also recruited through the same sources.
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Table: 3.1. Demographic details for all recruited cases in project @neurIST 
 
 
 
  
Location No. Aneurysmal aspect No. Side of the IA  
Total recruited 1591 Total recruited 1591 Total recruited 1591 
Info about IA location 
available 
1264 Info about IA aspect 
available 
1036 Info about IA side available 893 
No-info about IA location 
available 
327 No info about IA aspect 
available 
555 No info about IA side available 698 
Intracavernous internal carotid  61 Smooth 812 Left 347 
Ophthalmic segment carotid  111 Rough 224 Midline 183 
Medial wall carotid  31 Presence of blebs on IA  Right 363 
Posterior Communicating  200 Total recruited 1591 Endovascular treatment  
Ant Choroidal segment carotid  25 Info about IA blebs available 1102 Total recruited 1591 
Anterior and superior wall 
carotid  
6 No info about IA blebs 
available 
489 Info about IA endovascular treatment 
available 
750 
Carotid bifurcation  56 No bleb present 841 No info about IA endovascular 
treatment available 
841 
A1 segment ant  26 One bleb present 190 Parent vessel occlusion  6 
Ant communicating artery  231 Two blebs present 44 Coil - Balloon remodelling  23 
A2 segment ant  10 Multiple blebs present 27 Coil - 3D Bare 142 
Pericallosal cerebral artery  24 Presence of lobules in IA  Coil - 3D Coated 98 
Distal ant cerebral artery  4 Total recruited 1591 Coil – Random Shape -Bare 428 
M1 segment middle cerebral 
artery  
130 Info about IA lobules 
available 
1117 Coil – Random Shape –Coated 53 
Sylvian bifurcation  175 No info about IA lobules 
available 
474 Stent - Covered stent - self expanding 5 
Distal to sylvian bifurcation  10 No lobule present 835 Stent - Leo - self expanding  4 
V4 segment vertebral artery  5 One lobule present 160 Stent - Neuroform - balloon 
expandable  
10 
PICA  32 Two lobule present 107 Stent - open entry - balloon 
expandable  
9 
AICA  7 Multiple lobule present 15 Other endovascular procedures  15 
Superior cerebellar artery  24 Total recruited 1591 Stimulant abuse  
Basilar trunk  10 Ruptured vs. Unruptured 
IAs 
 Total recruited 1591 
Basilar Tip  74 Total recruited 1591 Info about stimulant abuse available 822 
P1 Posterior cerebral artery  4 Info about IA rupture 
available 
1260 No info about IA stimulant abuse 
available 
709 
P1-P2 junction posterior 
cerebral artery  
5 No info about IA rupture 
available 
331 Cocaine 12 
P2 posterior cerebral artery  1 Unruptured 693 Amphetamine 2 
Distal posterior cerebral artery  0 Ruptured 567 Diet pills 2 
Ophthalmic artery  2 Total recruited 1591 Nasal spray 28 
Type No. Genetic tissue samples 
collected 
 Oral decongestants 7 
Total recruited 1591 Total recruited 1591 None 771 
Info about IA Type available 1263 Total samples collected 2658   
No info about IA Type 
available 
328 Blood 928   
Saccular side wall 377 Tissue from IA dome 14   
Saccular bifurcation 869 Leucocytes 271   
Fusiform dissecting 12 Plasma 315   
Fusiform non-dissecting 3 DNA 299   
Fusiform segmental ectasia 1 PAXgene 792   
Fusiform transitional 1 No info about sample 
available 
39   
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Table: 3.2. Main known risk factors for IA development and SAH in the recruited population 
Risk factor No. Moyamoya  
Total recruited 1591 Info about moyamoya available 1132 
Sex  No-info about APKD available 459 
Info about sex available 1327 Moyamoya absent 1129 
No info about sex available 264 Moyamoya present 3 
Males 455 Associated AVM  
Females 872 Info about AVM available 1133 
Ethnicity  No-info about AVM available 458 
Info about ethnicity available 1075 Associated AVM absent 1125 
No-info about ethnicity available 516 Associated AVM present 8 
Arab 5 ED syndrome  
Japanese  1 Info about EDS available 1132 
Eurasian, Albanian 2 No-info about EDS available 459 
Eurasian, Anglo-Celt  298 EDS absent 1131 
Eurasian, Baltic 1 EDS present 1 
Eurasian, Basque  4 Aortic coarctation (CoA)  
Eurasian, Caucasian 42 Info about CoA available 1130 
Eurasian, French  77 No-info about CoA available 461 
Eurasian, German 10 CoA absent 1125 
Eurasian, Hungarian 161 CoA present 5 
Eurasian, Italian  21 Family history (FH) of SAH  
Eurasian, Other  152 Info about FH available 1141 
Eurasian, Portuguese 10 No-info about FH available 450 
Eurasian, Romanian  2 FH of SAH absent 965 
Eurasian, Slav  6 FH of SAH present 176 
Eurasian, Spanish  175 Smoking  
Iranian-Median, Kurd 1 Info about smoking available 1090 
Latin-Caribbean Americans 14 No-info about smoking available 501 
Malay, Filipino, Java  2 Never smoked 482 
North American 1 Active smokers 341 
South Asian, Indian, Nepali 2 Ex-smokers 267 
Undefined 87 Hypertension (HTN)  
Coagulopathy  Info about HTN available 1198 
Info about coagulopathy available 775 No-info about HTN available 393 
No-info about coagulopathy available 816 No HTN 794 
No coagulopathy  766 HTN – not treated 73 
Coagulopathy present 9 HTN - treated and controlled 301 
Abdominal aneurysm (AAA)  HTN - treated and poorly controlled 30 
Info about AAA available 1130 Multiple IAs  
No-info about AAA available 461 Info about multiplicity available 1119 
AAA absent 1125 No-info about multiplicity available 472 
AAA present 5 Solitary lesions 200 
APKD  Multiple IAs 919 
Info about APKD available 1129 Past SAH  
No-info about APKD available 462 Info about past SAH available 1151 
APKD absent 1118 No-info about past SAH available 440 
APKD present 11 No past SAH 1105 
Alpha-1 antitrypsin deficiency (A-1AD)  Past SAH present 46 
Info about A-1AD available 1132 Marfan’s syndrome  
No-info about A-1AD available 459 Info about Marfan’s Synd. available 1133 
A-1AD absent 1131 No-info about Marfan’s Synd. available 458 
A-1AD present 1 No Marfan’s Synd. 1131 
Oral contraceptives (OCP) use   Marfan’s Synd. Present 2 
Info about OCP use available 1142 Heart disease  
No-info about OCP use available 449 Info about heart disease available 1131 
No OCP  1090 No-info about heart disease available 460 
OCP users 52 No heart disease 1120 
  Heart disease Present 11 
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3.5. Data collection and organization  
3.5.1: @neuQuest & CRIM (Clinically Relevant Information Model) 
The relevant clinical, demographic, 
social and radiological information of the 
participants was collected using the data 
entry software @neuQuest (Figures 3.2 
and 3.3) @neuQuest is a GUI (Graphical 
User Interface) based software developed 
in Sheffield initially to collect local data 
but finally used by most of the clinical 
centres in @neurIST.   
 
 
3.5.2: Data collection using @neuQuest: An editable definition file lists 
the data fields to be collected both in 
terms of data type (date, text, number, 
etc.) and description of the item. All 
data entered into @neuQuest is 
recorded with audit information. 
Whereas, as much as possible 
information was collected, a minimum 
number of dataset also defined to 
prioritize the entry of information at 
the fastest possible pace without 
missing the most vital bits through CRIM (clinically relevant information 
model). Collected data is made available outside the clinical environment 
after a rigorous anonymization process. The medical DICOM images 
selected in @neuQuest are also anonymized prior to export. Files 
anonymized for export are uploaded to an @neurIST DataNode where the 
data is imported into a database ready for users to query. @neuQuest also 
includes the functionality to scan patient DICOM imaging studies and 
automatically completes data sets. 
 
3.5.3: Testing of the software and processing events: The @neuQuest 
suite and the routines for collecting data, anonymizing data and 
distributing data have constantly been tested by the clinical sites. 
Feedback has allowed new functionality to be added and issues to be 
fixed. The ultimate goal is @neuQuest to be adapted by many centres 
world over once the @neurIST and its products are taken over by 
ESMINT (European Society for Minimally Invasive Neurological 
Therapy).  
 
 
Figure 3.2: @neuQuest GUI (Graphical 
User Interface) 
Figure 3.3: @neuQuest GUI –Data Collection 
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3.5.4: @neuBrowser 
The anonymized data in @neuQuest 
software from all clinical centres were 
finally uploaded to a common server. This 
data was then passed to a central server 
called @neuBrowser (Figure-3.4) 
@neuBrowser is another state of the art 
tool developed with project @neurIST. 
Apart from organizing and categorizing the 
data it can also present the information in nice and easy to understand 
graphs.  
 
3.5.5: Image Acquisition and Processing 
The medical images used in different studies were obtained using 
rotational acquisition in a Philips® Integris™ Allura™ machine (Philips® 
Medical Systems, Best, The Netherlands), producing 100 images in 6 
seconds, with 5 milliseconds exposure per image. Voxel size (Voxel is a 
‘blend word’ derived form ‘volume’ and ‘pixel’ whereas ‘pixel’ itself is a 
combination of ‘picture’ and ‘element’. A Voxel therefore represents the 
smallest distinguishable boxed shaped part of a 3D image) in the 
reconstructed 3D images was either 121 microns or 234 microns 
(depending on the study, as specified in the beginning of each study) with 
reconstruction matrix of either 512x512x512 or 256x256x256 (depending 
on the study, as specified in the beginning of each study). All images were 
anonymized, respecting the @neurIST ethical approval for use of patient 
data.  
 
The current version of the @neuFuse software (prototype 4), based on the 
Multimod Application Framework [Viceconti et al 2004] and developed 
within the @neurIST project, was used to reconstruct the vessel surfaces, 
create the model and set up the haemodynamic analysis. The solvers used 
within @neuFuse to solve the fundamental equations describing the blood 
flow behavior within the region of interest were ANSYS®-ICEM™ and 
ANSYS®-CFX™ (Ansys®, Inc., Canonsburg, PA, USA).  
 
All analyses performed were pulsatile except for the workshops conducted 
for the evaluation of @neuFuse software, where simple stationary 
analyses (non-pulsatile but constant flow rate and pressure at the openings 
of the region of interest) were performed by the participants using Intel® 
core duo 2.4 GHz machines, with 2 GB RAM and 512 MB of dedicated 
graphic memory. 
 
Figure-3.4 @neuBrowser- showing 
graphical representation of data 
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3.6. Software @neuFuse 
By definition, @neuFuse is a computer-aided medicine-application 
(CAM-application) software that integrates the visualization, modelling 
and simulation of multimodal biomedical data with specific respect to 
Intracranial Aneurysms. In the broad context of an integrated IT system 
for IA management, the role of such a suite is to gather clinical structured 
information from electronic medical records, and the unstructured 
functional imaging, to provide a state-of-the-art environment for medical 
imaging processing and modeling aimed at producing a structure of three 
distinguished complex derived indicators: morphological, haemodynamic, 
and structural. The derived data is then used by epidemiologists to find the 
definitive correlations to assess the risk of rupture. Innovative key 
elements are the capability of combining medical imaging data, simulation 
results and morphological indicators into a coherent set of patient-specific 
data, properly fused and interactively accessible from within an easy-to-
use application and the development of a fat client that exploits the client 
hardware capabilities in advanced visualization while being fully 
integrated with the backend Grid infrastructure [Rajasekaran 2008].   
 
3.6.1 Development of @neuFuse: Contributions and Process 
@neuFuse is a result of joint collaboration received from several project 
partners that contributed at different layers by providing specific 
algorithmic plug-ins, or by providing application’s modules for a specific 
task, or by providing software libraries to connect to a specific service. In 
brief, Universitat Pompeu Fabra (UPF), Barcelona (Spain) provided the 
advanced medical imaging functionalities such as the segmentation and 
the skeletonization plug-ins. NEC Europe Ltd (Germany) contributed to 
Figure-3.5: @neuFuse Software architecture 
	   88	  
the data model design and provided routines for preprocessing the 
geometric models of vessel in an appropriate format for CFD solvers. 
Erasmus Medical Centre (The Netherlands) contributed in enhanced 
imaging filtering plug-in. The University of Sheffield (UK) and Ecole 
Polytechnique Federale de Lausanne (Switzerland) provided and 
integrated the 1D circulatory model. GridSystems S.A. (Spain), NEC 
Europe Ltd (Germany) and University of Vienna, Institute of Scientific 
Computing (Austria), provided the Grid-connectors libraries. University 
of Bedfordshire (former University of Luton) (UK) contributed to 
develop advanced graphics interface to visualize and manipulate vessel 
geometries. Super Computing Solution (s.r.l. B3C), Bologna, (Italy) was 
responsible for most of the development of the software, the integration 
and the maintenance. Major versions of @neuFuse applications have been 
released routinely every six months and it is being used by six clinical 
pilot centers (UPF, UNIGE, USFD, EMC, OXF, PEC).  
 
All these software components were integrated on an existing backbone, 
provided by the Multimod Application Framework. MAF is an open 
source freely available framework (MAF, http://www.openmaf.org) for 
the rapid development of applications based on the Visualisation Toolkit 
(www.vtk.org) and other specialized libraries. It provides high-level 
components that can be easily combined to develop a vertical application 
in different areas of scientific visualization (Figure-3.5). OpenMAF is 
further extended by an additional software layer, called MafMedical that 
contains all MAF components specific to the biomedical application 
domain. A generic MafMedical application, such as @neuFuse, is defined 
by choosing from the framework the necessary components, and 
eventually specialising them. It is also possible to develop ad hoc 
components that are necessary only to the application itself, and plug 
additional third party libraries. 
 
There are four types of components that form any MAF application: 
Virtual Medical Entities (VME); that are the data objects, Views; that 
provide interactive visualisation of the VMEs, Operations; that create new 
VMEs or modify existing ones, and interface elements; generic graphic 
user interface (GUI) components that define the user interface of the 
application.   
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3.6.2 @neuFuse: Work Flow at a Glance 
Haemodynamic modeling of cerebral aneurysms involves several steps 
(Figure-3.6). It starts with the retrieval of medical images in DICOM or  
 
V3D format; creation of a geometric model of the vasculature; topological 
reconstruction of the vasculature, assignment of boundary conditions to 
the domain from the 1D flow model and, solution of the flow equations 
that are actually demanded for a specific off-the-shelf software. The main 
steps involved in the process are given below. 
  
Figure-3.6: @neuFuse CFD processing toolchain. Form top right clockwise: DICOM images ate 
loaded and the vessel geometry segmented. Then a topologically correct geometric model is processed 
to extract vessel Centre line (axis). This information is then used to map 3D vessels with a 1D 
circulatory model. This mapping allows deriving flow boundary conditions for haemodynamic model. 
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Figure	   3.7:	   Operation	   workflow	   from	   medical	   image	   to	   haemodynamic	   results.	   A)	   Orthoslice	  visualization	   of	   the	   3DRA	  medical	   image	   in	  @neuFuse.	   B)	   Visualisation	   of	   the	   extracted	   vessel	  surface.	  C)	  Visualisation	  of	  reduced	  region	  of	  interest	  with	  location	  of	  inlet	  and	  outlet	  openings.	  D)	  1D	  circulation	  model.	  E)	  Visualisation	  of	  predicted	  streamlines.	  F)	  Visualisation	  of	  predicted	  wall	  shear	  stress.	  	  
Segmentation: The very first step to build CFD models of an IA is 
extraction of geometrical representation of the cerebral arteries from a 
medical image. Segmentation is a process where every pixel (or voxel in 
case of a medical images stack) of the image is labeled in order to form a 
small set of pixel clusters known as segments, to obtain a representation 
that is easier to analyze. The first product obtained here as a result of 
segmentation is the set of voxels that have been labeled as interior surface 
of the vasculature corresponding. In the literature, many different 
approaches are documented, but whereas some of these methods give 
acceptable results with a particular imaging modality; other methods are 
too operator-dependent. To combat the issue an automatic, multi-modal 
algorithm [Hernandez and Frangi 2007] has been developed and integrated 
in @neuFuse. Automatic segmentation could compute an accurate model 
of the arteries in few minutes.  
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Figure-3.8: A snapshot of 3D volume generation, segmentation and clipping of the ROI 
 	  
Geometric Healing: Lack of resolution or other contrast medium artifacts 
could generate errors in the automatic segmentation process that should be 
resolved by the operator. A typical example is the “kissing vessels” 
problem due to a lack of the image resolution. Two close vessels are glued 
together by the reconstruction algorithm, but in reality they are separate. If 
this problem is not solved before modeling, it may result in a gross error. 
To address this kind of problem, the @neuFuse operator should check that 
the resulting geometry is a topologically correct representation of the 
cerebral arteries and eventually fixes with a set of general-purpose tools, 
in a way which is similar to photo editing software.  
 
 
	  
Figure-3.9: A typical example of geometric healing where an artifact (a) and (b)“kissing vessels” can 
cause distortion of real geometry due to lack of the image resolution. Two close vessels are glued 
together by the reconstruction algorithm, but in reality they are separate 
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Vasculature Topology- Skeletonization: Once the geometric model is 
topologically correct, the next step is to extract the vasculature network. 
This process is called skeletonization because the result is a kind of graph 
that represents the vessels [Mellado et al 2007]. This representation is 
fundamental for many purposes; with this information it is possible to 
navigate the vessels, to check vessel diameters along a specific artery and, 
to plan an endovascular treatment choosing the position for deploying a 
stent.  
	  
Figure-3.10: Process of defining the centre line and Skeletonization 
  
	   94	  
Boundary Conditions assignment: In this step the operator defines the 
domain of the flow simulation by localizing the inlets and outlets in 
relation to the vessel skeleton. Followed by this each vessel in the patient 
specific geometry is literally matched with the corresponding vessel in the 
1D circulatory system model. The Boundary Conditions were derived 
from two main sources as described below in section 3.6. 
 
	  
Figure-3.11- Application of BCs at the inlets and outlets using 1D Model dictionary 
 
 
Solving flow equations: Once the model is completely defined, flow 
equations are solved. @neuFuse could launch the simulation software 
locally, or it can connect to the Grid infrastructure and request a remote 
simulation. To do so, data should be stored in a neutral format, as the 
simulation software could have several implementations. Then, data are 
processed and stored in the particular file format depending upon the 
solver used. The solver used in @neuFuse is ANSYS® ICEM-CFX™, 
which is then launched and finally results are loaded in @neuFuse.  
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Presenting results: The CFD solution is a very complex collection of data 
and it is a challenge to present them in an environment, which is coherent 
with the medical images and the clinical context (Figure-7). Results are 
composed by multi-scalar and multi-vector time-variant fields sampled on 
a tridimensional unstructured mesh, where each element represents an 
infinitesimal solid cell (typically tetrahedral).  
 
 
Figure-3.12: Visualization of haemodynamic simulation in @neuFuse. On top right, flow particle 
tracing erythrocytes are animated according to the velocity field. On top left picture, streamlines 
represented with pressure-coded colouring. In the bottom left picture, WSS drawn on the vessel wall. On 
bottom right, complex visualization showing streamlines crossing an arbitrary plane coloured according 
a colour-code where red regions represent inward flow whilst represent outward flow regions. 
 
Typical representations for flow (velocity) fields are streamlines that 
represent the tangent of the velocity fields. Streamlines then are usually 
colored according the pressure gradients. To give an idea of the flow 
pattern, I introduced a particle tracer. It enables the visualization of flow 
particles’ position and to follow their trajectories in the boundaries for 
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each time-stamp of the simulation, by integrating the velocity field. The 
operator can also visualize 3D representation of the scalar fields. Vessel 
walls can be colored according to WSS values. Furthermore, it is also 
possible to superimpose scalar values on 2D original medical images. 
More complex, representations can also be obtained by combining those 
already presented. 
 
3.7. Boundary conditions used in different studies: Measured and 1D 
model  
 
Application of appropriate Boundary Conditions at the inlets and outlets of 
the ROI (Region of Interest or domain) remains an essential prerequisite 
for any accurate CFD analysis. Accuracy of our predictions obviously 
depends upon the accuracy of the Boundary Conditions applied. The 
Boundary Conditions applied here in the studies done are derived from 
following sources: 
 
1) Phase Contrast MRI (pc-MR) Scan: pcMR was used to measure the 
flow-rates in arteries at different locations to get the boundary conditions. 
All MR imaging and measurements were performed at high field strength 
(Achieva™ 3.0T, Philips® Medical Systems, Best, The Netherlands) 
using a standard 8-channel, radiofrequency receive-only head coil. The 
same radiographer imaged all patients to maximize the reproducibility of 
the overall acquisition technique. A pre-designed protocol guided the 
radiographer through the desired measurement locations for subsequent 
application of CFD BCs. As afferent vasculature has an important 
influence on intra-aneurysmal haemodynamics [Cebral et al 2005, Castro 
et al 2006, Moyle et al 2006, Oshima et al 2005], proximal measurements 
were taken at a distance of approximately 12 parent vessel diameters from 
the aneurysm. Measurements in distal arteries were taken four diameters 
away from the IAs. To minimize patient discomfort, table-occupancy time 
was no greater than 1 hour. Within this period, it was difficult to ensure 
that all measurements were obtained for all patients. The tortuous nature 
of the vasculature also made slice selection perpendicular to the artery 
difficult to achieve. To maintain integrity in the final measurement dataset, 
data was rejected if there was doubt about the placement of the 
measurement plane. Locations of pc-MR measurements are reported in 
Table-3.3. The manufacturer’s proprietary postdata-acquisition software 
(Q-Flow™, Philips® Medical Systems, Best, The Netherlands) was used 
to estimate volumetric flow rate (VFR) waveforms at each location. 
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Table-3.3: Radiological characteristics of IAs included in the study along with the location, type and 
method of BC application 
Pt.	   IA	  
No	  
IA	  Location	   Size*	  
(mm)	  
Neck	  
(mm)	  
BC	  location	   BC	  type†	   BC	  
Metho
d	  	  
A	   1	   Lt	  ICA	  Cavernous	   5.0/3.5	   4.3	   1.Lt	  ICA	  Proximal	  2.Lt	  ICA	  Distal	  3.Lt	  OphthA	   Inlet/	  velocity	  Outlet/	  velocity	  Outlet/	  pressure	  
pc-­‐MR	  pc-­‐MR	  1-­‐D	  
B	   2	   Lt	  MCA	  	   11.1/7.3	   4.3	   1.Lt	  MCA	  Proximal	  2.Lt	  MCA	  Supr-­‐Div	  M-­‐2	  3.	  Lt	  MCA	  Infr-­‐Div	  M-­‐2	   Inlet/	  velocity	  Outlet/	  pressure	  Outlet/	  pressure	  
pc-­‐MR	  1-­‐D	  1-­‐D	  
C	   3	   Lt	  ICA	  Cavernous	   3.4/3.3	   3.1	   1.Lt	  ICA	  Proximal	  2.Lt	  ICA	  Distal	  3.Lt	  OphthA	   Inlet/	  velocity	  Outlet/	  pressure	  Outlet/	  pressure	  
pc-­‐MR	  1-­‐D	  1-­‐D	  
D	   4	   Rt	  MCA	  Bifurcation	   4.4/7.3	   3.0	   1.Rt	  MCA	  Proximal	  2.Antr	  Temp	  branch	  of	  Rt	  MCA	  3.Rt	  MCA	  Supr	  Div	  M-­‐2	  4.Rt	  MCA	  Infr	  Div	  M-­‐2	  
Inlet/	  velocity	  Outlet/	  pressure	  Outlet/	  pressure	  Outlet/	  pressure	  
pc-­‐MR	  1-­‐D	  1-­‐D	  1-­‐D	  
E	   5	   Lt	  ICA	  Subclinoid	   2.9/2.5	   3.1	   1.Lt	  ICA	  Proximal	  2.Lt	  ICA	  Distal	  3.Lt	  OphthA	   Inlet/	  velocity	  Outlet/	  velocity	  Outlet/	  pressure	  
pc-­‐MR	  pc-­‐MR	  1-­‐D	  
6	   Lt	  MCA	  	  Bifurcation	   2.5/2.0	   2.2	   1.Lt	  MCA	  Proximal	  2.Lt	  MCA	  Supr-­‐Div	  M-­‐2	  3.Lt	  MCA	  Infr-­‐Div	  M-­‐2	   Inlet/	  velocity	  Outlet/	  pressure	  Outlet/	  pressure	  
pc-­‐MR	  1-­‐D	  1-­‐D	  
NB:	  Lt;	  left,	  Rt;	  right,	  ICA;	  internal	  carotid	  artery,	  MCA;	  middle	  cerebral	  artery,	  OphthA;	  ophthalmic	  artery,	  Supr;	  superior,	  Infr;	   inferior,	   Div;	   division,	   Antr;	   anterior,	   Temp;	   temporal.	   *size	   is	   reported	   as	  max	   diameter/max	   length.	   †BC	  method	  refers	  to	  the	  analyses	  based	  on	  patient-­‐specific	  BC. 
 
2) 1D Model: In studies where patient-specific boundaries were not 
available (this is specified in the beginning of each study in their 
respective Materials and Methods sections), the Boundary Conditions 
were derived from the flow-rate and pressure waveforms computed by 
using the 1D circulation model developed by Reymond et al [Reymond et 
al 2009]. Development of this 1D Model was also a part of the @neurIST 
Project. This is a distributed model of the systemic arterial tree, including 
a detailed description of the cerebral arteries, and coupled to a heart 
model. Authors, Reymond and colleagues, have extensively validated the 
1D Model given by them by measuring the flow and pressure in a number 
of arterial locations in healthy volunteers and found good agreement 
between these measurements with the corresponding values computed 
using the 1D Model [Reymond et al 2009]. The distal vessels and vascular 
beds of the model are terminated with three-elements Windkessel models 
to account for proximal and distal resistance and compliance of the 
peripheral vasculature. Flow-rate waveforms were used for all primary 
inlets and pressure waveforms for all primary outlets. 	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3.8. Statistical analysis:  
 
Robust and appropriate statistical tools were applied to analyze the results 
from different studies. Significance was calculated using Student’s t-test 
wherever required. Quantitative comparisons of the data obtained from 
different methodologies were made using boxplot diagrams. SPSS™ and 
Excel software were used to perform advanced statistical analyses as and 
where required.  
 
 
3.9. Designing and Performing Different CFD Studies  
 
A number of studies were designed and performed as a part of this thesis. 
Next three sections of this manuscript are devoted to cover these studies as 
summarized below:  
First section: Validations of few common concepts used often in 
Computational Fluid Dynamics are covered in this section. Studies were 
designed by applying these concepts to CFD and their validity tested. 
Main concepts tested are; assessing effects of two common velocity 
profiles and effects of measured vs. modeled Boundary Conditions are 
also assessed on haemodynamics of Intracranial Aneurysms. 
 
Second section: This section covers Development and Controlled 
Exposures of Tool-chain.  
 
Third section: In this section, Computational Fluid Dynamics is used as a 
Tool to Explore the Aetipathogenesis of Intracranial Aneurysms. The main 
studies conducted were: Analysis of different haemodynamic factors 
during initiation and rupture of intracranial aneurysms, assessing the 
influence of various drugs, smoking, and hypertension on the 
haemodynamic characteristics of intracranial aneurysms, and effects of 
Aortic Coarctation on cerebral haemodynamics and aetiopathogenesis of 
intracranial Aneurysms.  
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Overview 
 
4.1: Introduction 
4.2: Effects of Different Velocity Profiles on the Haemodynamics of 
Intracranial Aneurysms 
4.3: Effects of Measured vs. Modeled Boundary Conditions on the 
Haemodynamics of Intracranial Aneurysms 
4.4: Discussion and conclusions 
 
*My contribution: In both studies described in this chapter, I played 
major role in concept, study design, conducting review of literature, 
performing analyses, performing statistical calculations, writing and 
submission of manuscripts to journals for publications. Dr Alberto Marzo 
(and other biomedical scientists, as detailed in acknowledgement section) 
gave important support and contribution in retrieval of medical images, 
performing CFD analyses, and post-processing of the results. 
 	  
4.1. Introduction Once	   a	   robust	   tool-­‐chain	   is	   build	   by	   the	   software	   engineers	   and	  biomedical	   scientists	   as	   described	   earlier,	   the	   next	   step	   was	   to	  establish	   the	   reliability	   of	   the	   common	  basic	   concepts	   applied	  while	  using	   CFD	   as	   a	   tool	   in	   the	   analysis	   of	   haemodynamic	   and	  morphological	  indices	  in	  the	  cerebral	  vasculature	  and	  IAs.	  	  	  Specification	  of	  boundary	  conditions	  is	  an	  important	  prerequisite	  for	  solving	   the	   governing	   equations	   in	   the	   extraction	   of	   these	   non-­‐observable	   indices.	   As	   direct	   measurements	   of	   these	   flow-­‐rate	  waveforms	   at	   the	   inlets	   and	   outlets	   of	   the	   domain	   are	   usually	  impracticable	  [Marzo	  et	  al.	  2009],	  the	  boundary	  conditions	  are	  mostly	  derived	   using	   the	   available	   1D	   Circulation	   models	   [Westerhof	   et	   al.	  1969,	  Stergiopulos	  et	  al.	  1992,	  Vignon-­‐Clementel	  et	  al.	  2006,	  Balossino	  et	   al.	   2009,	   Bove	   et	   al.	   2008].	   A	   number	   of	   assumptions	   are	   made	  while	   applying	   these	   boundary	   conditions	   that	   can	   strongly	   perturb	  the	   numerical	   calculations.	   One	   such	   assumption	   is	   application	   of	  Womersley	  flow	  profile	  at	  inlet	  boundary	  of	  the	  domain	  [Marzo	  et	  al.	  2009].	   The	   first	   study	   therefore	   was	   conducted	   to	   investigate	   the	  
CHAPTER 4.0: VALIDATIONS OF THE COMMON CONCEPTS 
USED IN COMPUTATIONAL FLUID DYNAMICS 
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  effects	  of	  different	  inlet	  velocity	  profiles	  on	  the	  haemodynamics	  of	  IAs	  and	   compared	   them	   with	   the	   more	   important	   determinants	   of	   the	  haemodynamics	  like	  geometry	  of	  the	  domain.	  	  	  The	   study	   on	   the	   effects	   of	   boundary	   conditions	   on	   the	  haemodynamics	  of	  IAs	  further	  extended	  by	  taking	  phase	  contrast	  MR	  (pc-­‐MR)	   measurements	   for	   flow-­‐rates	   in	   19	   IAs	   from	   nine	   patients	  recruited	  in	  the	  study	  [Marzo	  et	  al.	  2011].	  The	  effects	  of	  the	  boundary	  conditions	   derived	   using	   these	   patient-­‐specific	   pc-­‐MR	   follow-­‐rates	  and	  the	  traditional	  1D-­‐model,	  on	  the	  haemodynamic	  characterization	  of	   IAs,	   were	   then	   compared	   and	   analyzed	   in	   order	   to	   quantify	   the	  agreements	   and	   differences	   in	   the	   values	   of	   derived	   haemodynamic	  indices.	  
 
4.2. Effects of Different Velocity Profiles on the Haemodynamics of 
Intracranial Aneurysms	  
 
4.2.1 Background and Objectives 
 
Pressure or flow rate waveforms are often available, from say magnetic 
resonance or 1D circulation models, as 1D values averaged over the cross 
sectional area of the vessel, and at specific instants along the cardiac cycle. 
The solution of the 3D Navier-Stoke equations, on the other hand, requires 
these quantities to be specified as point wise values at each node of the 3D 
boundary mesh. Assumptions made while completing such deficient data 
at boundaries is not trivial and can strongly perturb the numerical results. 
 
Many authors rely on the theory of Womersley (Womersley 1955) for the 
specification of the velocity profile of flow rate-based boundary 
conditions, assuming that flow is fully and axially developed and behave 
similarly to flow in a circular pipe. This is certainly the most realistic 
guess but it is known that geometry remains the most important factor 
(Cebral et al. 2005, Moyle et al. 2006, Oshima et al. 2005) that ultimately 
determines the flow development in cardiovascular vessels. The over-
complication of applying a Womersley velocity profiles might be 
unnecessary and in some circumstances unrealistic in the determination of 
the haemodynamics within the aneurismal sac. 
 
Studies done so far (Myers et al. 2001) to assess the effect of these 
assumptions on systemic vessel haemodynamics have shown that 
geometry takes over within a relatively short distance from the location of 
the inlet boundaries, thus nullifying the effects of these assumptions. 
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However, the effects have only marginally been studied in the context of 
saccular cerebral aneurysms [Oshima et al. 2005], which often presents 
more complex haemodynamic patterns [Cebral et al. 2005a)] when 
compared to the simpler geometries of the studies reported so far [Myers 
et al. 2001; Moyle et al. 2006]. 
 
The current study investigates the effects of using different velocity 
profiles on the haemodynamics of intracranial aneurysms, and their 
secondary role when compared to anatomical geometry and extension of 
afferent vasculature, in three typical anatomical locations.  
 
 
 
 
 
 
 
 
Figure-­‐4.1:	   Representation	   in	   one	   of	   @neurIST	   application	   suites	   of	   a	   typical	  cerebral	   arterial	   tree,	   with	   locations	   of	   geom.1,	   geom.1b,	   geom.2,	   and	   geom.3	  indicated	  by	  white	  spheres	  and	  black	  arrows.	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4.2.2 Materials and Methods 
Three typical intracranial aneurysms found in the circle of Willis were 
considered in this study: an aneurysm at the tip of the basilar artery (herein 
called geom.1), an aneurysm of the right ophthalmic segment of the 
internal carotid artery (geom.2), and an aneurysm of the terminal 
bifurcation of the right middle cerebral artery (geom.3). Locations are 
shown in Figure-4.1. In order to study the flow development at the 
confluence of the vertebral arteries an additional geometry for the basilar 
artery aneurysm was reconstructed (geom.1b), which contains the junction 
of the two vertebral arteries. Essentially speaking geom.1 and geom.1b are 
same except for the presence of some extra proximal segment of vertebral 
arteries in geom.1b. 
 
Some images, in addition to the aneurysm of interest, contain additional 
minor aneurysms. These are highlighted by black arrows in Figure-2, and 
were excluded from the study. The aneurysm in each of geom.1 and 
geom.3 was saccular bilobular. The aneurysm in geom.2 was saccular with 
a single lobe. These geometries present a progressively higher level of 
tortuosity of the aneurysmal afferent loop from geom.1, where the basilar 
artery is only slightly curved, to geom.3, where the feeding vasculature 
presents several bends, changes in the lumen diameter and bifurcations, 
before reaching the aneurysm of interest. Properties of these geometries 
are given in Table-4.1. 
  
 
 
 
 
 
Rotational acquisitions were obtained using a Philips® Integris™ BV 
5000 machine (Philips® Medical Systems, Best, The Nederland), 
producing 100 images in 4 seconds, with 5ms exposure per image. A built-
in x-ray image intensifier was used, with a close-circuit-digital camera and 
software to correct for geometrical deformation. Voxel size in the 
reconstructed 3D images was 303 microns with reconstruction matrix 
512x512x512. Images were anonymized, respecting the ethical approval 
for @neurIST’s for use of patient data. 
 
Figure-­‐4.2.	  Reconstructed	  geometries:	  geom.1,	  basilar	  artery	  aneurysm,	  geom.1b,	  basilar	  artery	  aneurysm	   including	  vertebral	  arteries,	  geom.2,	   internal	  carotid	  artery	  aneurysm,	  geom3,	   middle	   cerebral	   artery	   aneurysm.	   Black	   arrows	   show	   secondary	   smaller	  aneurysms,	   excluded	   from	   the	   study.	   Labels	   indicate	   the	   openings	   where	   boundary	  conditions	  were	  applied.	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Table-4.1: Geometrical properties of geom.1-3. 
	   Aneurysm	  size	  [mm]	   	   	  
	  
Depth	   Max	  diameter	  
Neck	  
(max	  
width)	  
Length	  of	  afferent	  vessel	  
(normalized	  with	  inlet	  
diameter)	  
Complexity	  
of	  afferent	  
loop	  
geom.1	   5.5-­‐6.5*	   4.6-­‐5.8*	   5.5	   10D	   low	  
geom.1b	   5.5-­‐6.5*	   4.6-­‐5.8*	   5.5	   	  	  	  	  12D**	   low	  
geom.2	   5.5	   4.6	   4.3	   	  8.2D	   medium	  
geom.3	   4.4-­‐3.8*	   3.3-­‐2.3*	   3.1	   12D	   high	  
*Values for the two lobes, **values for both inlet afferent vessels, i.e. vertebral arteries, D= inlet diameter. 	  
The @neurIST computational tool chain was used to segment, extract and 
repair the vessel surfaces. In particular, vessel triangular surfaces were 
created using a threshold isosurface extraction tool, based on the marching 
cubes algorithm developed by Lorensen et al. (1987) Artifacts and 
unnecessary vasculature were removed and surface repaired using tools 
based on the Visualization Toolkit (VTK) (www.vtk.org), further 
developed within the Multimod Application Framework (Viceconti et al. 
2004) in @neurIST. All inlet openings were extruded and morphed into 
circular edges for the appropriate application of Womersley-based 
boundary conditions. Extrusion of some outlets was necessary to ensure 
that spatially constant pressure represented an appropriate boundary 
condition at the termination of the 3D domain. The results of the geometry 
reconstruction process are shown in Figure-4.2. 
 
During vessel reconstruction the neck of the aneurysms was manually 
identified and marked to define the aneurysmal sac that was used for the 
haemodynamic characterization of each aneurysm. 
 
Volumetric meshes were generated using ANSYS® ICEM CFD 11.0™ 
and based on the octree approach. Grids were made finer at the walls and 
progressively coarser towards the vessel axis. Tetrahedral elements were 
used for the discretization of the domain core, with three layers of 
prismatic elements adjacent to the wall, thus ensuring accurate 
computation of wall shear stresses (WSS) and oscillatory shear indices 
(OSI). Element size and number were set accordingly to the outcome of a 
mesh dependency study performed on similar aneurysmal geometries 
(Radaelli et al. 2008, private communications). In this study, results were 
found to be grid independent for meshes greater than 1700 el/mm3. In 
order to maintain consistency across the meshes used for all geometries, 
similar element density and the same wall element size and maximum core 
element size were used in the discretization of the domains. Mesh details 
are reported in Table-4.2 below. 
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Table-4.2: Grid properties for geom.1-3 
	   volume	  
[mm3]	  
elements	   nodes	   average	  
density	  
[el./mm3]	  
max	  el.	  size	  
[mm]	  
max	  wall	  el.	  
size	  [mm]	  
geom.1	   433.9	   1321449	   411331	   3046	   0.4	   0.12	  
geom.1b	   540.4	   1678606	   527615	   3106	   0.4	   0.12	  
geom.2	   1375.5	   3173174	   912842	   2307	   0.4	   0.12	  
geom.3	   848.2	   2292777	   694172	   2703	   0.4	   0.12	  
 
The 3D unsteady Navier-Stokes equations were solved by using the finite-
control-volume software, ANSYS®-CFX™. The default second order 
high-resolution advection-differencing scheme was used. The solution 
algorithm is an implicit coupled solution scheme, based on an algebraic 
multigrid method for the coupled linear equations. Blood was assumed to 
be incompressible, with density ρ=1050 kg/m3, and Newtonian, with 
viscosity μ=0.0035 Pa s. All analyses were run in parallel, using the 
communication mode MPICH on two Itanium2 900MHz 64-bit processors 
of a Tiger-2 Linux cluster node with 4GB of registered DDR-SDRAM 
PC1600. 
 
4.2.3 Boundary conditions 
Patient-specific flow measurements at boundaries were not available for 
the data sets under consideration, thus boundary conditions were derived 
from the flow-rate and pressure waveforms computed by using the 1D 
circulation model developed by Reymond et al. (2008), which is part of 
the @neurIST computational tool chain. This is a distributed model of the 
entire systemic arterial tree, coupled to a heart model and including a 
detailed description of the cerebral arteries. The 1D form of the fluid 
equations are applied over each arterial segment and intimal wall shear 
stress is modeled using the Womersley theory. A non-linear viscoelastic 
constitutive law for the arterial wall is considered. The systemic arterial 
tree dimensions and properties were taken from literature and extended to 
include a description of the cerebral arterial tree obtained from real patient 
scans. 
 
Flow-rate waveforms were used for all primary inlets and pressure 
waveforms for all primary outlets. All pressure and flow rate waveforms 
used for the analyses are reported in Figure-3 to Figure-6. Flow-rate 
waveforms were used to specify, in turn, plug-flow (i.e. flat velocity 
profile) and Womersley velocity profiles at the inlet boundaries.  
  
	   106	  
	  	  	  	  
	  
Figure 4.3 Flow-rate (top) and pressure waveforms (bottom) applied in geom.1 	  
0.0E+00
2.0E-06
4.0E-06
6.0E-06
0 0.2 0.4 0.6 0.8
time [s]
flo
w
 
ra
te
 
[m
^
3/
s]
in1
8.0E+03
1.3E+04
1.8E+04
0 0.2 0.4 0.6 0.8
time [s]
pr
es
su
re
 
[P
a]
out1-out2
out3-out4
out5-out6
	   107	  
	  
Figure 4.4 Flow-rate (top) and pressure waveforms (bottom) applied in geom.1b  
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Figure 4.5 Flow-rate (top) and pressure waveforms (bottom) applied in geom.2 	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Figure 4.6 Flow-rate (top) and pressure waveforms (bottom) applied in geom.3 
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The waveforms were decomposed into Fourier series as indicated in 
equation (1) 
   					…………….(1) 
where N is the number of harmonics , and ω is the angular frequency 
derived from the period of the cardiac cycle T=0.8 s. The Womersley 
velocity profile was expressed in terms of the Fourier representation of the 
flow rate waveforms as indicated in equation (2) 
 
 …..……..(2) 
 
where R is the radius of the inlet boundary, Q0 is the first harmonic 
coefficient responsible for the parabolic profile of a steady flow (i.e. 
Poiseuille’s flow), J0 and J1 are Bessel functions of order zero and one, 
respectively, and 
 
 …………….(3) 		 ……………(4) 
 
where αn is the Womersley number of the n-th harmonic. A Fortran 
subroutine was created and interfaced to the ANSYS®-CFX™ solver for 
the computation of the velocity inlet profiles within each time loop. 
 
Analyses were run for four cardiac cycles to nullify the transient artifacts 
generated by the initial conditions, and only data from the 4-th cycle were 
used in the post-processing phase. 
 
4.2.4 Results 
Relevant haemodynamic variables were compared qualitatively and 
quantitatively for the two velocity profile assumptions both at two time-
points along the cardiac cycle (corresponding to the lowest and highest 
Reynolds numbers achieved during diastole and systole, respectively), and 
as time-averaged quantities across the cardiac cycle. The haemodynamic 
variables chosen for these comparisons have been associated to 
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aneurysmal initiation, growth, and rupture in the literature (Shojima et al. 
2004, Cebral et al. 2005) 
 
4.2.4.1: Qualitative comparison using instantaneous velocity contours 
Figure-4.7 shows the comparison between Womersley and plug-flow 
boundary conditions during diastole and systole, using velocity contours at 
specific cross sections. The cross-sections were selected as those, which 
subjectively, best illustrated the complexity of the flow within the three 
domains. Results for geom.1 show that for both flow regimes; the 
Womersley and plug-flow flow patterns are essentially the same with 
some minor discrepancy in the magnitude of the velocity field, as shown 
by the arrows in Figure-4.7.  	  
 
 
 
 
 
 
 
Figure-­‐4.7:	  Velocity	  contours	  across	  the	  aneurysmal	  sac	   for	  a)	  Womersley	  BC	  at	   lowest	  Re	   during	   diastole,	   b)	   plug-­‐flow	   BC	   at	   lowest	   Re	   during	   diastole,	   c)	   Womersley	   BC	   at	  highest	   Re	   during	   systole,	   d)	   plug-­‐flow	   BC	   at	   highest	   Re	   during	   systole.	   From	   top	   to	  bottom:	  geom.1,	  geom.2,	  and	  geom.3.	  Grey	  arrows	  indicate	  areas	  of	  discrepancies.	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Results for geom.2 are consistent with geom.1 except that discrepancies in 
velocity magnitudes are more pronounced in the lower part of the cross 
section, representing the velocity patterns within the parent vessel. Finally, 
results for geom.3 show good agreement in the patterns as well as the 
magnitude of the velocity field. Contours in geom.2 and geom.3 show the 
presence of a jet of fluid entering the aneurysm and impinging onto the 
distal side of the aneurysmal wall. Moreover, results for all geometries 
show that flow is rather stable (according to the definition of Cebral et al. 
2005), exhibiting the same characteristics during diastole and systole. 
 
4.2.4.2: Qualitative comparison using instantaneous WSS contours 
Figure-4.8 shows the comparison between Womersley and plug-flow 
boundary conditions during diastole and systole, using contours of WSS 
on the wall of the aneurysmal sac. Results for geom.1 show that 
Womersley and plug-flow boundary conditions at inlet develop essentially 
the same WSS distribution in the aneurysm in both flow regimes. It was 
noticed that the bigger lobule of geom.1 is one, which is subjected to 
comparatively low WSS at both reported time-points in the cardiac cycle, 
whereas in the smaller lobule WSS values reach their highest values. 
Results for geom.2 and geom.3 show essentially the same WSS patterns 
for both inflow assumptions and for both flow regimes, with some minor 
variations for geom.2 during diastole near the aneurysmal neck, and for 
geom.3 during systole as shown by the arrows in Figure 4.8. 
 
As for velocity distributions, WSS present similar patterns during diastole 
and systole, showing stability of the flow. 	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4.2.4.3: Qualitative comparison using time-averaged WSS and OSI 
contours 
Time-averaged haemodynamic quantities can be used to assess the 
agreement between results over the whole cardiac cycle, and not solely at 
specific snap-shots in time. Time-averaged WSS are reported, together 
with Oscillatory Shear Index (OSI) for further comparison. OSI is defined 
in equations 5, 6 and 7, and was used to quantify the oscillatory shears 
experienced by the cells of the inner part of the arterial vessel and 
aneurysm (endothelial layer). …………(5) 
 ……………(6) 
 
where ts represents the surface traction vector. Figure 4.9 and Figure 4.10 
show the time-averaged WSS and OSI contours, respectively, on the 
aneurysmal wall of all three geometries and for both inlet boundary 
conditions.  
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Figure-­‐4.8:	  WSS	  contours	  for	  a)	  Womersley	  BC	  at	  lowest	  Re	  during	  diastole,	  b)	  plug-­‐flow	  BC	  at	  lowest	  Re	  during	  diastole,	  c)	  Womersley	  BC	  at	  highest	  Re	  during	  systole,	  d)	  plug-­‐flow	  BC	  at	  highest	  Re	  during	  systole.	  From	  top	  to	  bottom:	  geom.1,	  geom.2,	  and	  geom.3	  
A	   B	   C	   D	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Figure-­‐4.9:	   Time-­‐averaged	   WSS	   contours	   for	   a)	  Womersley	   boundary	   conditions,	   b)	   plug-­‐flow	   BC.	  From	  top	  to	  bottom:	  geom.1,	  geom.2,	  and	  geom.3. 
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The results are consistent with those of the instantaneous measures, i.e. 
very little differences are observed between WSS and OSI patterns, and 
only minor differences in magnitudes, from Womersley and plug-flow 
boundary conditions. For these aneurysms, exhibiting stable flow patterns 
over the cardiac cycle, it is noted that the time-averaged WSS stress 
pattern is qualitatively very similar to that of its instantaneous 
counterparts. 
  
Figure-­‐4.10:	  OSI	  contours	  for	  a)	  Womersley	  BC,	  b)	  plug-­‐flow	  BC.	  From	  top	   to	  bottom:	  geom.1,	  geom.2,	  and	  geom.3.	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4.2.4.4: Qualitative comparison on flow development 
Figure 4.11a and Figure 4.11b show the development of the flow for 
Womersley and plug-flow boundary conditions for geom.1. Although the 
two flows start from different assumptions at the inlet opening, both 
develop into a very similar velocity pattern before reaching the 
aneurysmal sac. Figure 4.11c, illustrating the results for the extended 
domain of geom.1b, shows that the two converging vessels produce a ring-
like velocity profile that is significantly different from both the 
Womersley and flat profiles, but in fact closer to the latter.  
 
 
 
This indicates clearly that there are geometries (of course those that are 
least like a straight tube) for which the Womersley profile is actually a 
worse choice than the flat profile. Nevertheless, once again the flow close 
to the aneurysm is relatively similar for all boundary conditions 
considered. 
 
4.2.4.5: Quantitative comparison 
For a more accurate and direct evaluation of the effects that different 
boundary conditions may have on local haemodynamics, several 
haemodynamic indices were extracted from the flow field of the three 
aneurysmal sacs, for both inflow boundary conditions. These are reported 
in Table-3 with the percentage discrepancy between Womersley and plug-
flow results. In geom.1, the maximum discrepancy was observed in the 
spatial-average speed in the aneurysmal sac (4.3%) and in the area of 
elevated pressure in the aneurysmal wall (also 4.3%). Relatively high 
discrepancies were also observed in the values predicted for the maximum 
speed within the aneurysm at systole (2.3%) and the location of maximum 
OSI (2.8%). In geom.2, the maximum discrepancy was observed in the 
Figure-4.11: Velocity vectors on cross-sections along the afferent vessel at peak systole for geom.1 
(a,b) and geom.1b (c). The distance between the cross-sections is 1.5D, where D is the diameter of 
the inlet boundary in geom.1. 
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predictions of area of elevated pressure (4.1%) and for geom.3 in the 
values of max OSI (3.7%) and its location (4.1%). 
 
Table 4.3. Haemodynamic indices extracted for geom.1-3 and percentage error between Womersley and plug-flow 
results. 1) Elevation defined as 50% of peak pressure minus average pressure in the aneurysm at systole. 2) 
Elevation defined as 50% of maximum time-averag 
	   Geom.1	   Geom.2	   Geom.3	  
	   Wom	   Plug	   Err%	  	   Wom	   Plug	   Err%	   Wom	   Plug	   Err%	  
Max	  speed	  within	  
aneurysm	  at	  systole	  	  
[m/s]	  
1.774	   1.733	   -­‐2.3	   1.154	   1.155	   0.1	   1.555	   1.544	   -­‐0.7	  
Spatial	  mean	  speed	  	  
in	  aneurysm	  at	  
systole	  	  [m/s]	  
0.331	   0.317	   -­‐4.3	   0.557	   0.557	   0.0	   0.619	   0.619	   0.0	  
Peak	  static	  wall	  
pressure	  at	  systole	  
[Pa]	  
16131	   15950	   -­‐1.1	   15770	   15750	   -­‐0.1	   14560	   14550	   -­‐0.1	  
Location	  X	  of	  max	  
pressure	  [m]	   3.51E-­‐02	   3.51E-­‐02	   0.0	   4.20E-­‐02	   4.20E-­‐02	   0.0	   1.73E-­‐02	   1.73E-­‐02	   0.0	  
Location	  Y	  of	  max	  
pressure	  [m]	   1.64E-­‐02	   1.64E-­‐02	   0.0	   2.33E-­‐02	   2.33E-­‐02	   0.0	   3.11E-­‐02	   3.11E-­‐02	   0.0	  
Location	  Z	  of	  max	  
pressure	  [m]	   -­‐3.67E-­‐02	   -­‐3.67E-­‐02	   0.0	   -­‐3.48E-­‐02	   -­‐3.48E-­‐02	   0.0	   -­‐3.65E-­‐02	   -­‐3.65E-­‐02	   0.0	  
Spatial	  mean	  static	  
pressure	  in	  
aneurysm	  at	  systole	  
[Pa]	  
15260	   15130	   -­‐0.9	   15140	   15120	   -­‐0.1	   13770	   13770	   0.0	  
Area	  of	  elevated	  
pressure1	  [m2]	   0.123E-­‐06	   0.118E-­‐05	   -­‐4.3	   4.18E-­‐06	   4.01E-­‐06	   -­‐4.1	   7.06E-­‐06	   7.13E-­‐06	   1.1	  
Max	  time-­‐averaged	  
WSS	  [Pa]	   25.79	   25.52	   -­‐1.1	   16.44	   16.87	   2.6	   49.07	   50.52	   2.95	  
Location	  X	  of	  max	  
time-­‐averaged	  WSS	  
[m]	  
3.604E-­‐2	   3.604E-­‐2	   0.0	   4.18E-­‐02	   4.18E-­‐02	   0.0	   1.79E-­‐02	   1.79E-­‐02	   0.0	  
Location	  Y	  of	  max	  
time-­‐averaged	  WSS	  
[m]	  
0.196E-­‐03	   0.196E-­‐03	   0.0	   0.232E-­‐03	   0.232E-­‐03	   0.0	   0.291E-­‐03	   0.291E-­‐03	   0.0	  
Location	  Z	  of	  max	  
time-­‐averaged	  WSS	  
[m]	  
-­‐3.48E-­‐02	   -­‐3.48E-­‐02	   0.0	   -­‐3.49E-­‐02	   -­‐3.49E-­‐02	   0.0	   -­‐3.36E-­‐02	   -­‐3.36E-­‐02	   0.0	  
Area	  of	  elevated	  
time-­‐averaged	  WSS2	  
[m2]	  
1.83E-­‐06	   1.82E-­‐06	   -­‐0.9	   6.39E-­‐07	   6.39E-­‐07	   0.0	   2.60E-­‐07	   2.56E-­‐07	   -­‐1.4	  
Max	  OSI	  in	  
aneurysmal	  wall	  [	  ]	   0.491	   0.487	   -­‐0.8	   0.471	   0.472	   0.2	   0.494	   0.475	   -­‐3.7	  
Location	  X	  of	  max	  
OSI	  [m]	   3.21E-­‐02	   3.12E-­‐02	   -­‐2.8	   4.13E-­‐02	   4.13E-­‐02	   0.0	   1.95E-­‐02	   1.97E-­‐02	   1.2	  
Location	  Y	  of	  max	  
OSI	  [m]	   1.80E-­‐02	   1.79E-­‐02	   -­‐0.9	   2.34E-­‐02	   2.34E-­‐02	   0.0	   3.12E-­‐02	   2.99E-­‐02	   -­‐4.1	  
Location	  Z	  of	  max	  
OSI	  [m]	   -­‐3.20E-­‐02	   -­‐3.12E-­‐02	   -­‐2.7	   -­‐3.75E-­‐02	   -­‐3.75E-­‐02	   0.0	   -­‐3.67E-­‐02	   -­‐3.68E-­‐02	   0.3	  
Area	  of	  elevated	  OSI	  
[m2]	   6.44E-­‐05	   6.37E-­‐05	   -­‐1.0	   3.39E-­‐07	   3.35E-­‐07	   -­‐1.2	   7.30E-­‐07	   7.70E-­‐07	   5.4	  
RMS	  error	  %	   	   	   1.9	   	   	   1.2	   	   	   1.98	  
 
The root mean square of the errors of the different indices was also 
computed and is reported in the last row of Table-4.3. 
 
Overall, the maximum discrepancy between Womersley and plug-flow 
results was observed in geom.3, where the RMS is 2%. Lower RMS 
values were calculated for geom.1, RMS = 1.9%, and geom.2, RMS = 
1.2% 
 
4.2.5 Discussion 
The purpose of this section is to compare the results from two common 
methods of application of proximal velocity boundary conditions for 
haemodynamic analysis of cerebral aneurysms. The context is that of 
	   118	  
specification of a robust protocol for routine haemodynamic analysis as 
part of a clinical workflow. 
 
The isolation of the vessel of interest from the rest of the cardiovascular 
tree and its surroundings (e.g. tissues, bones) implies that wall and flow 
conditions will have to be specified at the boundaries of the vessel. 
Patient-specific assessment of the properties of the vessel walls and its 
surroundings are difficult. There is some evidence that pulsatility of the 
vessel wall might have negligible effect on haemodynamics even when the 
wall motion is of the order of the radius of a vessel (Jeays et al. 2007) and 
even less so in the context of cerebral aneurysms in the confined 
compartment of the skull (Dempere-Marco et al. 2006). For the purposes 
of the current study, (and probably for a routine clinical analysis protocol) 
the walls of the vessel are considered fixed. 
 
Patient-specific flow measurements are in principle attainable from MRI 
or Doppler ultrasound but the intricacy of the cerebral vasculature, the 
small size of its vessels, and the fact that these are not part of the clinical 
procedure make them rarely available. Even when they are, it is unusual to 
rely on the spatial distribution of velocity (due to resolution of MRI and 
difficulties of location of Doppler ultrasound measures). To overcome 
these difficulties several authors use lumped-parameters or 1D models for 
the description of the remaining vascular systems (Formaggia et al. 1999, 
Quarteroni et al. 2001). Flow boundary conditions, whether from patient-
specific ultrasound MRI measures or computed using simple models of the 
cardiovascular system, are available as cross-sectional average values of 
velocity or pressure along the cardiac cycle. Thus assumptions on their 3D 
development across the same boundaries are to be made to match the level 
of details required by 3D modeling. While imposing inflow boundary 
conditions from the flow-rate waveforms computed by a 1D distributed 
model, for instance, one assumption often imposed at the inlet boundary is 
that of axisymmetric flow with a velocity distribution determined by the 
Womersley theory.  
 
The results of the comparative analyses with Womersley and flat velocity 
profiles indicate that there is no change in qualitative flow patterns, and 
detailed examination of the flow fields yields maximum differences of less 
than 5%, and RMS differences between 1 and 2%. It is suggested that 
these differences are unimportant in the context of interpretability against 
known thresholds, and particularly in the context of other uncertainties in 
the analysis (patient blood pressure, beat-to-beat variations, alternative 
physiological states including exercise, patient haematocrit and viscosity 
models). Certainly, the errors are small compared with those that might 
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arise from inaccurate segmentation of the patient specific geometry, when 
variability up to 48% has been reported (Moyle et al. 2006). Whilst the 
true significance and relevance of discrepancies between Womersley and 
plug-flow results can only be assessed once associations are found 
between haemodynamic indices and aneurysmal evolution, it is probably 
safe to assume that the uncertainties of any thresholds and the safety 
factors that will be built into any clinical interpretation and 
recommendations will always remain greater than that associated with 
analysis errors from the inlet velocity profile provided the inlet 
development domain is of adequate length.  
 
The computational savings associated with a recommendation of the 
simplest inlet-velocity-boundary-condition that of a flat profile, are not 
significant. More important is that the simpler the analysis protocol 
adopted, the more likely it is that other centers will contribute to the 
growth of an established database of haemodynamic characterizations, 
ultimately reflecting on its power to provide meaningful, peer-reviewed 
and clinically implementable associations of the characteristic 
haemodynamic measures with observed clinical outcome. Until such 
associations are established, the impact of CFD on the management of 
cerebral aneurysms will be minimal. 
 
A limitation of the current study is that results are reported for only three 
aneurysms, with one further variation. Nevertheless, these aneurysms have 
been selected as typical of those that arise most commonly in the cerebral 
vasculature and, given the consistency of the results and their resonance 
with expectations based on the physics of the problem, it is suggested that 
it provides strong evidence that haemodynamic characterizations are 
indeed likely to be insensitive to details of the inlet velocity distribution.  
 
Although specific analysis and comment on the haemodynamic results for 
any one aneurysm is not the focus of the current study, the analysis of 
geom.1 revealed some interesting haemodynamic characteristics that are 
worthy of mention. Primary haemodynamic activity is clearly confined to 
one of the lobules, whilst the other is subject to very low wall shear 
stresses. In fact it is the smaller lobule that exhibits strong haemodynamic 
activity and the larger that is relatively stagnant. It is noted that the larger 
lobe has a more irregular shape. No follow-up data is available and so it is 
impossible to determine which, if either, lobe is growing or which might 
rupture. Nevertheless, it is noteworthy that the haemodynamic 
environment in the smaller lobes is more similar to that in the parent 
vasculature rather than that in the larger lobe, and that the mean shear 
stress in the larger lobe is below that threshold that has been associated 
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with negative outcome and the onset of disease in other vascular 
applications [Malek et al. 1999].  
 
4.2.6.  Conclusions 
The following conclusions can be drawn from this study: 
 
1. The haemodynamic characterization of a cerebral aneurysm, under 
given proximal flow conditions is relatively insensitive to the details of the 
velocity profile on inlet boundaries that are sufficiently far from the 
aneurysm. 
 
2. Wider adoption of a given analysis protocol is more likely if it is simple 
to implement, and the specification of a flat velocity profile at the inlet to 
a 3D domain provides an adequate and justifiable description for the 
purposes of haemodynamic characterization. 
 
4.3. Computational Haemodynamics in Intracranial Aneurysms: the 
Effects of Modeled versus Patient-Specific Boundary Conditions 
 
4.3.1 Background and Objectives 
 
There is growing consensus that haemodynamics plays an important role 
in the growth, rupture and initiation of IAs [Cebral et al 2005, Sekhar and 
Heros 1981, Shojima 2004]. Two haemodynamic indices, WSS (wall 
shear index) and OSI (oscillatory shear index), have received particular 
attention due to their influence on endothelial cell behavior [Cebral et al 
2005, Shojima 2004].  
 
Although the studies from Rayz et al [Rayz et al 2008], Boussel et al 
[Boussel et al 2008], and Isoda et al [Isoda et al 2010], showed that in-
vivo measurements of these quantities are possible using magnetic 
resonance fluid dynamics (MRFD), inherent limitations in the technology 
impede its use in large cohort studies where detailed haemodynamics is 
needed also for smaller aneurysms (max diameter < 5 mm). 
 
In this context, numerical modeling can provide detailed predictions for 
WSS and OSI using input parameters derived from medical imaging, 
blood sampling, and other patient information. In fact, CFD has been used 
by many authors in the context of IAs to find correlations between 
haemodynamics and risk of rupture or growth. For convenience, in these 
works the extension of the computational domain is often limited to a 
restricted area around the aneurysm. The specification of boundary 
conditions at the interfaces with the rest of the cardiovascular network 
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thus remains a pre-requisite for the solution of the governing equations. 
Different authors approach this particular aspect differently. 
 
Some studies use patient-specific Boundary Conditions (BCs) based on 
measurements obtained using phase contrast – magnetic resonance (pc-
MR) or transcranial Doppler (TCD) ultrasound, to record blood velocity; 
and applanation tonometry, to infer pressure. However, because of the 
inherent difficulty in obtaining these measures in the small and intricate 
vessels of the cerebral vasculature, and the fact that these measurements 
are to date rarely justifiable as part of the clinical routine, such studies are 
often based on small cohort sizes and lack statistical significance [Jou et al 
2008, Hassan et al 2004, Jou et al 2005, Boussel at al 2008, Rayz et al 
2008, Rayz et al 2008b]. Furthermore when patient-specific-BC data is 
available, these are often limited to the inflows of the fluid domains 
[Hassan et al 2004, Jou et al 2005, Boussel at al 2008, Rayz et al 2008, 
Rayz et al 2008b] where vessels are larger and easily accessible by the 
available measurement techniques. 
 
Larger cohort studies, in contrast, rely on inflow BCs based on 
measurements taken from typical healthy individuals, in some cases [Jou 
et al 2008, Radaelli et al 2008, Venugopal et al 2007, Cebral et al 2009, 
Mantha et al 2006] scaled to achieve a supposedly more realistic mean 
WSS of 1.5 Pa, and outflow BCs that assume the same peripheral 
resistance at all openings (traction free or zero pressure BCs). The 
assumptions associated with this type of BCs may also lead to unrealistic 
results. 
 
As detailed comparison with in-vivo measurements is currently difficult, 
the validity of CFD tools in the context of IAs rupture risk assessment and 
management relies upon the extent to which the correlations between 
haemodynamic predictions and rupture are statistically matched for a large 
cohort study. One of the important aims of @neurIST (www.aneurist.org), 
a multidisciplinary EU project of which this study forms a part, is to 
establish these correlations by processing a large number of cases. The 
lack of patient-specific data for use at computational boundaries remains 
an important limiting factor in the project. This issue has been addressed 
by deriving a complete set of BCs for 3D CFD analysis from a 1D-model 
of the circulatory system, including the cerebral vasculature [Reymond et 
al 2009]. 
 
This study explores and analyzes the effects that BCs derived using in turn 
the 1D-model, patient-specific pc-MR measurements, and other 
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approaches found in the literature, have on the haemodynamics within 
typical intracranial aneurysms. 
 
4.3.2 Materials and Methods 
 
Study design, demographics and clinical details: The study was 
conducted in cooperation between the Departments of Neurosurgery and 
Neuroradiology, Royal Hallamshire Hospital, and the Academic Units of 
Medical Physics and Radiology, University of Sheffield, Sheffield, UK. A 
total of 5 patients diagnosed with IAs between Dec 2006 and Jan 2009, 
were identified retrospectively and followed prospectively according to 
the data collection protocol of the @neurIST project upon appropriate 
ethical approval and patient consent. Table-4.4 gives the demographic 
constitution of the population along with the relevant aneurysm details. 
All IAs were sidewall saccular aneurysms and their location is shown in 
Figure-4.12. 
 
Figure: 4.12. Locations of aneurysms 1-5 in a typical cerebral vasculature (illustration generated using 
the @neurIST software)	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Table 4.4 Patient demographics and aneurysm radiological features 
Patient	   	   Aneurysm	  
#	   Sex	   Age	   	   #	   Side	   Location	   Rupture	   Size(diam/neck)[mm]	  1	   M	   44	   	   1	   Left	   ICA	   No	   5/4.3	  2	   M	   52	   	   2	   Left	   MCA	   No	   11.1/4.3	  3	   F	   50	   	   3	   Left	   ICA	   No	   3.4/3.1	  4	   F	   41	   	   4	   Right	   MCA	   Yes	   4.4/3	  5	   F	   51	   	   5	   Left	   ICA	   No	   2.9/3.1	  ICA	  =	  Internal	  Carotid	  Artery;	  MCA	  =	  Middle	  Cerebral	  Artery	  bifurcation	  
 
Image acquisition: The medical images used for surface reconstruction 
were obtained using 3D rotational acquisition (3DRA) in a Philips® 
Integris™ Allura machine (Philips® Medical Systems, Best, The 
Netherlands), producing 100 images in 6 seconds, with 5ms exposure per 
image. Voxel size in the reconstructed 3D images was 121 microns with 
reconstruction matrix of 512x512x512. 
 
pc-MR protocol: All MR imaging was performed at high field strength 
(Achieva™ 3.0T, Philips®  Medical Systems, Best, The Netherlands) 
using a standard 8-channel, radiofrequency receiver-only head coil. The 
same radiographer imaged all patients to maximize reproducibility of 
overall acquisition technique. Macroscopic vascular flow and IA location 
were visualized using a qualitative Time-Of-Flight (TOF) MR 
angiography sequence. Maximum intensity projections (MIP) from this 
3D dataset were used to define the placement of each quantitative phase 
contrast measurement plane perpendicular to the vessel under 
investigation. A 2D acquisition sequence (TR=7.7ms, TE=3.7ms, flip 
angle=10˚; field of view=270x179mm, acquisition matrix=1.7x1.60mm, 
slice thickness=5mm) was used to acquire 40 velocity-encoded ‘time-
point’ over the cardiac cycle at each vascular location. Vector Electro 
Cardiography (ECG) triggering was used to standardize each quantitative 
acquisition. Appropriate maximum velocity-encoding (VENC) values 
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Figure-4.13: Mesh particulars and BC types used. QMRI is the velocity-based boundary condition from 
MRI patient-specific measurements, Q1D is the velocity-based boundary condition from 1D model, 
Q1D-S is the WSS-scaled velocity-based boundary condition 
 
condition from 1D model, and P1D is the pressure boundary condition 
from 1D Model was chosen (150 cm/sec for ICA and 120 cm/sec for 
MCA regions) to ensure that appropriate dynamic ranges were sampled in 
all cases. A pre-designed protocol guided the radiographer through the 
desired measurement locations for subsequent application of CFD BCs. As 
afferent vasculature has an important influence on intra-aneurysmal 
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haemodynamics [Cebral et al 2005, Castro et al 2006, Marzo et al 2009, 
Moyle et al 2006, Oshima et al 2005] proximal measurements were taken 
at a distance of approximately 10 parent vessel diameters from the 
aneurysm. Measurements in distal arteries were taken 3 diameters apart 
from the IAs. Patient table-occupancy time was no greater than 1 hour. 
Within this period it was difficult to ensure that all measurements were 
obtained for all volunteers. The tortuous nature of the vasculature also 
made slice selection perpendicular to the artery difficult to achieve. To 
maintain integrity in the final measurement dataset, data was rejected if 
there was doubt about the placement of the measurement plane. 
 
Table-4.5: Boundary conditions location, type and method 
Aneurysm	   BC	  Location	   type	   Method	  I	   Method	  II	   Method	  III	  1	   ICA	  proximal	   inlet	   pc-­‐MR/velocity	   1D/velocity	   1D/velocity	  scaled	  	   ICA	  distal	   outlet	   pc-­‐MR/velocity	   1D/pressure	   1D/pressure	  	   OphthA	   outlet	   1D/pressure	   1D/pressure	   1D/pressure	  2	   MCA	  M1	   inlet	   pc-­‐MR/velocity	   1D/velocity	   1D/velocity	  scaled	  	   MCA	  M2	  supr	   outlet	   1D/pressure	   1D/pressure	   1D/pressure	  	   MCA	  M2	  infr	   outlet	   1D/pressure	   1D/pressure	   1D/pressure	  3	   ICA	  proximal	   inlet	   pc-­‐MR/velocity	   1D/velocity	   1D/velocity	  scaled	  	   ICA	  distal	   outlet	   1D/pressure	   1D/pressure	   1D/pressure	  	   OphthA	   outlet	   1D/pressure	   1D/pressure	   1D/pressure	  4	   MCA	  M1	   inlet	   pc-­‐MR/velocity	   1D/velocity	   1D/velocity	  scaled	  	   TempA	   outlet	   1D/pressure	   1D/pressure	   1D/pressure	  	   MCA	  M2	  supr	   outlet	   1D/pressure	   1D/pressure	   1D/pressure	  	   MCA	  M2	  infr	   outlet	   1D/pressure	   1D/pressure	   1D/pressure	  5	   ICA	  proximal	   inlet	   pc-­‐MR/velocity	   1D/velocity	   1D/velocity	  scaled	  	   ICA	  distal	   outlet	   pc-­‐MR/velocity	   1D/pressure	   1D/pressure	  	   OphthA	   outlet	   1D/pressure	   1D/pressure	   1D/pressure	  ICA=internal	   carotid	   artery,	   OphthA=ophthalmic	   artery,	   MCA	   M1=middle	   cerebral	   artery,	   MCA	   M2	  supr/infr=superior/inferior	  division	  of	  the	  middle	  cerebral	  artery,	  TempA=temporal	  artery 
 
Locations of pc-MR measurements are reported in Table-4.5 (column “BC 
Location”). The manufacturer’s proprietary post-data-acquisition software 
(Q-Flow™, Philips® Medical Systems, Best, The Netherlands) was used 
to estimate volumetric flow rate (VFR) waveforms at each spatial location. 
 
1D circulation model: The finite-difference model developed by 
Reymond et al [Reymond et al 2009], was used to compute pressure and 
VFR waveforms at the desired boundaries of the 3D domain. The model 
solves the 1D form of the Navier-Stokes equation in a distributed model of 
the main human systemic arteries including the main arteries of the circle 
of Willis. It accounts for ventricular-vascular interaction and wall 
viscoelasticity, and it was recently validated through a comparison with 
in-vivo measurements taken using applanation tonometry, B-mode, and 
colour-coded duplex flow imaging, and pc-MRI. Although the model 
could be personalized tuning input parameters such as heart rate (HR), 
cardiac contractility, age (vessel elasticity), height (vessel geometry), and 
blood properties, in this study the model was used with the properties of a 
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typical young individual as patient-specific data was not available for all 
patients. A typical analysis is solved in approximately 8 min. 
 
CFD models: The @neurIST computational tool-chain was used to 
reconstruct vessel and aneurysmal geometries, following the workflow 
described in Marzo et al [Marzo et al 2009]. The 3D transient Navier–
Stokes equations were solved by using the finite-control-volume software, 
ANSYS®-CFX™. Blood was assumed to be incompressible, with density 
ρ=1060 kg/m3, and Newtonian, with viscosity µ=0.0035 Pa·s. Boundary 
conditions were applied following three different approaches, as reported 
in Table-4.5. Method I used pc-MR VFR measurements at the openings 
for which these could be measured, and 1D model pressure waveforms at 
every remaining interface. For aneurysm-1 and 5 measurements were 
available at all vessel openings but one. Method II used VFR and pressure 
waveforms from the 1D circulation model. Method III used the typical 
waveforms derived using the 1D model, where VFR curves where scaled 
to obtain a mean WSS of 1.5 Pa at inlets. For all velocity-based BCs a flat 
velocity profile was applied, in line with the recent findings of Marzo et al 
[Marzo et al 2009]. Arterial walls were assumed to be rigid. The validity 
of this assumption has been extensively tested in the context of 
intracranial aneurysms by other authors [Dempere-Marco et al 2006]. 
Tetrahedral elements were used to discretize the core of the computational 
domain, with 3 layers of prismatic elements at the wall to ensure accurate 
computation of the velocity gradients. Grid sizes with an average density 
of 2000 el/mm3 were used as a result of a mesh dependency study in 
which WSS, pressure and velocity values, were monitored at several 
points within aneurysm and parent vessel. Figure-4.13 shows the meshes 
and BC types used in the analyses. Three cardiac cycles were computed 
for each analysis and haemodynamic data were extracted from the last 
cardiac cycle, herein assumed to be independent from the initial numerical 
conditions. Analyses were run in parallel using 30 cluster nodes Xeon® 
2.8 GHz 2GB RAM. The average time required to solve a complete 3-
cycle analysis was approximately 5 hrs. 
 
Statistical analysis: Quantitative agreement between data obtained with 
the different BC methodologies was analyzed using boxplot diagrams. 
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4.3.3 Results 
 
Relevant haemodynamic variables were compared qualitatively and 
quantitatively for the BC methods analyzed. For the qualitative 
comparison I considered values of WSS time-averaged along the cardiac 
cycle (tavWSS) and OSI. The qualitative analysis of the results also 
included a comparison of the normalized values of tavWSS (ntavWSS), 
where normalization was done by dividing the absolute values of tavWSS 
to the spatial average of tavWSS at the aneurismal wall. 
 
4.3.3.1 Qualitative comparison 
Figure-4.14 shows contour distributions of tavWSS at the wall of the IAs 
considered. 
 
For all methods, areas of relatively high WSS concentrate around the 
aneurysmal neck and apex, for aneurysms 1, 2, whilst for aneurysms 5 an 
area of relatively higher WSS is also present at the body. In aneurysms 3 
and 4 only the neck is affected by high WSS, leaving the remaining part of 
the aneurysmal wall exposed to lower values of WSS. For all aneurysms, 
areas of relatively low WSS concentrated around their bodies.  
 
From a visual comparison of the contour plots, the most pronounced 
differences between method I (pc-MR) and method II (1D-model) are in 
the distribution of tavWSS for aneurysms 1, 3, and 5 whereas aneurysms 2 
and 4 showed closer agreement. As an effect of the quantitative 
differences between patient-specific and 1D model waveforms, for all IAs 
except 2, tavWSS values were underestimated when 1D-model BCs were 
applied.
  
Figure- 4.14: Contour plots of tavWSS for method I (pc-MR), method II (1D-model), and method III 
(WSS-scaled). 
 
  
Method I
1
2
3
4
5
Method II Method III
6
	   129	  
 
Figure-4.15: Contour plots of normalized values of tavWSS (ntavWSS) for method I (pc-MR), method 
II (1D-model), and method III (WSS-scaled). 
 
The qualitative comparison between method I (pc-MR) and method III 
(WSS-scaled) showed larger discrepancies than those observed when 
comparing method I and II, except from aneurysm 1 where contour values 
of tavWSS are closer to the method I predictions. Values of tavWSS 
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obtained with method III are for all IAs smaller than those observed in 
method I. Figure-4.15 shows contours of normalized values of tavWSS 
(ntavWSS). Interestingly, the overall distribution of areas of 
proportionally higher, or lower, WSS is quantitatively similar for all 
methods.  
 
Figure-4.16: Contour plots of OSI for method I (pc-MR), method II (1D-model), and method III (WSS-
scaled). 
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Figure-4.16 shows contour distributions of OSI on the surface of the 
aneurysms. Although some small differences can be observed, the OSI 
patterns are very similar, with areas of higher values occupying the same 
locations for all methods employed. As expected, areas of elevated OSI 
tend to concentrate where tavWSS is low. OSI values obtained with 
method II look closer to the pc-MR-based values, than those obtained 
using method III. 
 
4.3.3.2 Quantitative comparison 
For some selected indices computed within the aneurismal sac, namely 
maximum OSI (mOSI), normalized maximum value of time-average WSS 
(nmtavWSS), maximum time-average WSS (mtavWSS), maximum time-
average velocity (mtavU) and spatial and time-average velocity (stavU), 
Figure-4.17 reports the boxplots diagrams of the percentage differences 
between method I and method II (top boxplot) and method I and method 
III (bottom boxplot). Percentage error was calculated as equal to  
 
(index_valuemethodI-index_valuemethodX) 100/index_ valuemethodI.  
 
As previously observed in the qualitative comparison, both quantitative 
comparisons show that the smallest discrepancies are observed in the 
values of mOSI and nmtavWSS (median value 17.5-23.5% for mOSI and 
11-20.5% for nmtavWSS). On the other hand, the haemodynamic index 
showing highest discrepancies is mtavWSS with median values of 46% for 
method I vs. II and 69% for method I vs. III. 
 
When considering the cross-comparison of the methods II (1D-model) and 
III (WSS-scaled) with method I (pc-MR), herein assumed as gold 
standard, the larger discrepancies are observed for the comparison 
between methods III and I. If I consider only the median values of each 
index we observe that all indexes in method I perform better than their 
counterpart in method III. 
  
 
   
Figure-4.17: Boxplots showing the distribution percentage differences between methods I and II (top) 
and method I and III (bottom). Asterisks denote outliers above or below 1.5 times the inter quartile 
range. 
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4.3.4 Discussion 
 
The creation of a computational model for the prediction of 
haemodynamics in IAs requires assumptions that can adversely affect the 
numerical results. One of the most important areas where assumptions are 
frequently required is the application of BCs. Several authors have 
demonstrated the major influence of BCs on computed haemodynamic 
indices [Hassan et al 2004, Chatziprodromou et al 2003, Rayz et al 2008, 
Venugopal et al 200]. 
 
Depending on their method of derivation, BCs can be broadly divided into 
two categories: patient-specific and non-patient-specific BCs. 
 
4.3.4.1 Patient-specific BC:  
Patient-specific-BCs are deservedly considered as ‘gold-standard’ [Hassan 
et al 2004, Chatziprodromou et al 2003, Venugopal et al 2007]. 
Unfortunately, these are rarely available. Of the 24 articles on CFD in IAs 
reviewed for this study (Table-4.7), only six (25%) used patient-specific 
BCs [Jou et al 2003, Hassan et al 2004, Jou et al 2005, Boussel et al 2008, 
Rayz et al 2008, Rayz et al 2008b]. In these studies, pc-MR remained the 
most common modality (5 out of 6) for obtaining patient-specific 
measurements, while TCD was used by one author [Hassan 2004]. Most 
authors (5 out of 6) applied these measurements only at inlets. Jou and 
colleagues [Jou et al 2005] was the only group to use patient-specific pc-
MR measurements both at inlets and outlet for analyzing a basilar artery 
fusiform aneurysm. Thus, even when patient-specific measurements can 
be justified in a busy clinical setting, technical difficulties may 
compromise their application at all openings, further limiting their use in 
establishing statistical correlations with rupture. In fact, a major constraint 
when adopting patient-specific BCs is that due to current restrictions in 
obtaining these measurements, they have not been applied in large cohort 
studies, thus compromising the possibility of using CFD to find significant 
statistical correlations between haemodynamics and aneurysmal evolution 
(initiation, growth and rupture). In the current review, the mean cohort 
size in the patient-specific group was significantly smaller, i.e. 3 (range 1-
7) [Boussel et al 2008, Castro et al 2006, Castro et al 2006b, Castro et al 
2006c, Cebral et al 2005, Cebral et al 2009, Chatziprodromou et al 2003, 
Dempere-Marco et al. 2006, Hassan et al 2004, Jou et al 2003, Jou et al 
2003, Karmonik et al, Mantha et al 2006, Marzo et al 2009, Mitsos et al 
2008, Radaelii et al 2008, Rayz et al 2008, Rayz et al 2008b, Shimogonya 
et al 2009, Steinman et al 2003, Venugopal et al 2007] as compared to 9.5 
(range 1-62) where non-patient-specific BCs were used [Shojima et al 
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2004, Cebral et al 2005, Shojima et al 2005, Jou et al 2008]. There is 
another important aspect one has to consider. There may be significant 
diurnal variations in a person’s day-to-day life associated with stress or 
anxiety [Ford et al 2008, Kulikov et al 2005] physical exertion [Gonzalez-
Alonso 2004, Ide and Secher 2000] and other day-to-day activities [Hajjar 
et al 2007]. It can be argued that patient-specific BCs, invariably measured 
with a patient lying quietly in a scanner surrounded by an artificial 
environment or stressed by the overall clinical experience (e.g. white-coat 
hypertension), might not represent the normal day-to-day physiology for 
that individual, and therefore might not represent exactly the type of BCs I 
need for our statistical associations. Gonzalez-Alonso et al [Gonzalez-
Alonso 2004] recorded population-average flow rate variation as high as 1 
ml/s at middle cerebral artery level between a rest and exercise status. 
  
	   135	  
Table-4.6: Time-average volumetric flow-rates and inlet radii for the 6 aneurysms in study 
 Qav-MR(ml/s) Qav-1D(ml/s) Qav-wss (ml/s) rpt(mm) r1D(mm)* 
Aneu-1 7.53 3.95 4.31 2.3 2.1-2.6 
Aneu-2 1.46 1.90 0.74 1.3 1.4-1.5 
Aneu-3 6.36 3.94 3.11 2.1 2.1-2.6 
Aneu-4 2.00 1.91 0.42 1.1 1.4-1.5 
Aneu-5 5.44 3.95 2.21 1.9 2.1-2.6 
NB: Aneu; aneurysm, Pt.; patient, Qav-MR; average flow measured using pc-MR, Qav-1D; average flow predicted by 1D-model, Qav-WSS; average 
flow predicted by 1D-model scaled to obtain WSS=1.5 Pa at boundary, rpt; radius of the vessel as measured in the patient, r1D; average radius of the 
vessel used in 1D-model, * min and max radii in 1D model vessel where BCs was originated 
 
4.3.4.2 Non patient-specific BC: 
In absence of patient-specific-BCs many investigators use typical or 
modeled BCs. Out of 24 authors in the current review 18 (75%) [Steinman 
et al 2003, Boussel et al 2008, Castro et al 2006b, Castro et al 2006c, 
Castro et al 2006d, Cebral 2005a, Cebral 2009, Chatziprodromou et al 
2003, Hassan et al 2004, Jou et al 2003, Jou et al 2005, Karmonik et al 
2006, Mantha et al 2006, Marzo et al 2009, Mitsos et al 2008, Radaelli et 
al 2008, Rayz et al 2008, Rayz et al 2008b, Shimogonya 2009, Venugopal 
et al 2007] used this approach, reflecting their common usage. Non-
patient-specific waveforms are usually obtained from population-averaged 
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Figure-4.18: VFR waveforms for a typical healthy individual and aneurysm patients included in this 
study, measured using pc-MR at internal carotid level. Typical waveform was taken from Radaelli et al 
2008. 
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measurements taken on healthy volunteers [Ford et al 2008, 
Chatziprodromou et al 2003]. While the use of such waveforms remains 
the most popular method of BC application (17 out of 18 non-patient-
specific BCs in my review) [Shojima et al. 2004, Cebral et al 2005, 
Steinman et al 2003, Shojima et al. 2003, Jou et al 2008, Radaelli et al 
2008, Chatziprodromou et al 2003, Cebral et al 2005, Karmonik et al 
2006, Castro et al 2006, Castro et al 2006b, Castro et al 2006c, Cebral et al 
2009, Mantha et al 2006, Mitsos et al 2008, Shimogonya 2009] they carry 
important limitations. First, as these measurements are taken in a healthy 
population, they may well differ from patient waveforms. This difference 
is apparent in Figure-4.18, where waveforms from a healthy volunteer 
show differences both in shape and values, when compared with those for 
patients 1,3, and 5. 
 
Second, these waveforms represent average values of pressure and 
velocity across the population, and lack adaptability in terms of location 
and vessel geometrical properties. In an attempt to address these issues 
and make these typical waveforms more patient-specific, Cebral and 
colleagues in 2008 [Cebral et al 2008] suggested ‘scaling’ the inflow rates 
to the inflow boundary area to keep the WSS within a ‘physiological’ 
range (around 1.5 Pa). The same approach has been adopted by other 
scientists [Jou et al 2008, Radaelli et al 2008, Mitsos et al 2008]. Although 
Cebral and co-workers [Cebral et al 2008] found an important flow-area 
correlation based on experimental evidence at some specific vessel 
locations, their approach is very sensitive to the boundary location along 
the vessel, due to diameter variations along the vessel, and to 
segmentation error and image modality. More importantly, Cebral’s work 
is based on an important assumption derived from Murray’s law, which 
states that WSS should be constant across the branches of the vascular tree 
in order to minimize the energy used to drive blood flow. This hypothesis 
may be true for a typical healthy individual but, as reported by many 
authors in the field, it is mostly atypical variations in haemodynamics (e.g. 
WSS) that are believed to influence the aetiopathogenesis of IAs [Sekhar 
and Heros 1981, Shojima et al. 2004, Cebral et al 2005, Cheng et al 2007] 
challenged this hypothesis in their recent review, which showed large 
variations of average WSS (variation range: 0.2-1.6 Pa). Atypical values 
of WSS have been associated with other conditions such as maladaptive 
growth, congenital malformations, patent ductus arteriosus, and 
atherosclerosis [Cheng et al 2007]. 
 
Quarteroni and collaborators [Quarteroni et al 2004] pioneered the concept 
of using lumped and 1D-circulation-models in a quest to provide realistic 
BCs to 3D circulation models [Formaggia et al 2001, Lagana et al 2002]. 
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More recently in 2009, Marzo and colleagues [Marzo et al 2009] 
introduced the use of a 1D-circulation-model to derive BCs while studying 
haemodynamics within IAs. This is the same model used in the current 
study. The parameters of the 1D model used in the current study are 
relative to a healthy typical individual, an approach exposed to the 
limitations mentioned above for typical “healthy” waveforms. Indeed, this 
might explain in part the discrepancies observed in the quantitative 
comparisons.  
 
The use of a 1D model, however, as opposed to other methods allows 
flexibility in the locations of the model boundaries and, more importantly, 
has the potential of being adaptable to the patient specific parameters, 
when available, to obtain more representative values at the boundaries. 
The comparison in Figure-4.17 (top) shows important differences between 
1D-model and pc-MR data ranging from a minimum median value of 11% 
(OSI) to a maximum of 46% (mtavWSS). 
 
These discrepancies, however, are determined by differences in flow rates 
between the 1D model and patient specific waveforms, which are of the 
same order of magnitude of the physiological variations reported by 
Gonzalez-Alonso et al [Gonzalez-Alonso et al 2004], see Table-4.6. 
 
As reported in the results session, differences among the different methods 
analyzed are only quantitative, while the distribution of WSS remains the 
same as shown by the comparison on the normalized data. This confirms 
once again the major role played by geometry in determining the 
haemodynamic development within the aneurysm [Cebral et al 2005, 
Marzo et al 2009].  
 
For all methods scrutinized, the comparisons performed on the OSI values 
showed good agreement. This is in line with the fact the OSI in its 
definition uses the normalization of local WSS. 
 
Table-4.7: A comprehensive review of the methods adapted by different authors while applying BCs 
No	   Author/	  Year	   Cohort	  
size	  (IAs)	  
IA	  location	  (s)	   BC	  type/	  location	  	   BC	  source	  (method)	  
1	   Steinman	  et	  al	  2003	   1	   Terminal	  ICA	   Inlet/	  ICA	   Healthy	  Subjects	  (pc-­‐MR)	  Outlets/	  MCA,	  ACA	   Traction-­‐free	  	  
2	   Chatziprodromou	  et	  al,	  2003	   2	   Supraclinoid	  ICA	   Inlets/	  ICA	   Healthy	  Subjects	  	  Outlets/	  ICA	   Traction-­‐free	  	  
3	   Jou	  et	  al,	  2003	   1	   BA	  –	  Fusiform	   Inlets/	  VA	   Patient-­‐Specific	  (pc-­‐MR)	  Outlet/	  BA	   Patient-­‐Specific	  (pc-­‐MR)	  
4	   Hassan	  et	  al,	  2004	   1	   Vertebro-­‐Basilar	   Inlet/	  VA	   Patient-­‐Specific	  (TCD)	  Outlet/	  BA	   Traction-­‐free	  
5	   Shojima	  et	  al,	  2004	   20	   MCA	   Inlets/	  MCA-­‐M1	   Healthy	  Subjects	  (TCD)	  Outlets/	  MCA-­‐M2	   Traction-­‐free	  	  
6	   Cebral	  et	  al,	  2005	   62	   ICA(22),	  MCA(14),	  Pcom(13),	  ACA(1),	  Post(9),	  (3	  NA)	   Inlets/	  ICA,	  MCA,	  ACA,	  BA	   Healthy	  Subjects	  (pc-­‐MR)	  Outlets/	  NA	   NA	  
7	   Jou	  et	  al,	  2005	   2	   BA	  (fusiform)	   Inlets/	  VA	   Patient-­‐Specific	  (pc-­‐MR)	  Outlets/	  PCA	   NA	  
8	   Shojima	  et	  al,	  2005	   29	   ICA	  (14),	  MCA	  (14),	  MCA	  (1)	   Inlets/	  ICA	   Healthy	  Subjects	  (TCD)	  Outlets/	  ICA,	  MCA	   Traction-­‐free	  	  
9	   Cebral	  et	  al,	  2005	   4	   ICA	  (1),	  SCA	  (1),	  ICA	  (1),	  Pcom	  (1)	  	   Inlets/	  NA	   Healthy	  Subjects	  (pc-­‐MR)	  Outlets/	  NA	   Traction-­‐free	  	  
10	   Karmonik	  et	  al,	  2006	   3	   BA	  top	   Inlets/	  BA,	  VA	   Healthy	  Subjects,	  (pc-­‐MR/	  TCD)	  	  Outlet	   NA	  
11	   Castro	  et	  al,	  2006	   4	   Pcom	  (1),	  Acom	  (1),	  MCA	  (2)	   Inlets	   Healthy	  Subjects	  (pc-­‐MR)	  Outlets/	  NA	   Traction-­‐free	  	  
12	   Castro	  et	  al,	  2006	   7	   Acom	  (1),	  BA	  (1),	  ICA	  (2),	  MCA	  (1),	  SCA	  (1),	  PCA	  (1)	   Inlets/	  NA	   Healthy	  Subjects	  (pc-­‐MR)	  Outlets/	  NA	   Traction-­‐free	  
13	   Castro	  et	  al,	  2006	   2	   Acom	   Inlets/	  ICA	   Healthy	  Subjects	  (pc-­‐MR)	  Outlets/	  NA	   Traction-­‐free	  
14	   Mantha	  et	  al,	  2006	   3	   ICA	   Inlets/	  NA	   Healthy	  Subjects	  (Scaled)	  Outlets/	  NA	   NA	  
15	   Venugopal	  et	  al,	  2007	   1	   Acom	   Inlet/	  A1	   Healthy	  Subjects	  (Scaled)	  	  Outlet/	  A2	   Traction-­‐free	  
16	   Boussel	  et	  al,	  2008	   7	   BA(3),	  ICA(3),	  MCA(3)	   Inlets/	  NA	   Patient-­‐Specific	  (pc-­‐MR)	  	  Outlets/	  NA	   NA	  
17	   Mitosos	  et	  al,	  2008	   1	   Acom	  	  	   Inlet/	  NA	   Healthy	  Subjects	  (LDV)	  Outlet/	  NA	   Traction-­‐free	  
18	   Rayz	  et	  al,	  2008	   4	   BA	   Inlets/	  VA	   Patient	  Specific	  (pc-­‐MR)	  Outlets/	  PCA	   Traction-­‐free	  
19	   Radaelli	  et	  al,	  2008	   1	   ICA	   Inlet/	  ICA-­‐proximal	   Healthy	  Subjects	  (Scaled)	  Outlet/	  ICA-­‐distal	   Traction-­‐free	  
20	   Rayz	  et	  al,	  2008	   3	   BA	   Inlet/	  VA	   Patient-­‐Specific	  (pc-­‐MR)	  Outlet/	  PCA	   Likely	  traction	  free	  
21	   Shimogonya	  et	  al,	  2008	   1	   ICA	   Inlet/	  ICA-­‐proximal	   Healthy	  Subjects	  waveforms	  Outlet/	  ICA-­‐distal	   Traction-­‐free	  
22	   Jou	  et	  al,	  2008	   26	   ICA-­‐clinoidal	   Inlets/	  ICA	   Healthy	  Subjects	  (Scaled)	  Outlet/	  NA	   NA	  
23	   Marzo	  et	  al,	  2009	   3	   BA,	  ICA	   Inlet/	  BA,	  ICA-­‐proximal	   Computed	  (1-­‐D	  Model)	  Outlet/	  BA,	  ICA-­‐distal	   Traction	  free	  
24	   Cebral	  et	  al,	  2009	   1	   BA	  top	   Inlet/	  Mid	  BA	   Healthy	  Subjects	  (Scaled)	  Outlets/	  PCA	   Traction-­‐free	  
NB:	   BCs;	   boundary	   conditions,	   PC-­‐MR;	   phase	   contrast	   magnetic	   resonance	   angiography,	   TCD;	   trans-­‐cranial	   Doppler’s	  ultrasound,	   LDV;	   laser	  Doppler	  Velocimetery,	   ICA;	   internal	   carotid	   artery,	  ACA;	   anterior	   cerebral	   artery,	  Acom;	   anterior	  communicating	   artery,	   MCA;	   middle	   cerebral	   artery,	   Pcom;	   posterior	   communicating	   artery,	   SCA;	   superior	   cerebellar	  artery,	  BA;	  basilar	  artery;	  VA;	  vertebral	  artery,	  Post;	  posterior	  circulation	  
 
The current study will benefit from a larger cohort size (5 aneurysm only 
in current study), although this is bound to the difficulties experienced 
while performing pc-MR measurements in a clinical environment, and 
from a wider range of aneurysm locations, for example aneurysm of the 
anterior communicating artery (AComA) or basilar artery, which were not 
available for this study. 
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4.3.5 Conclusions 
Significant differences were found between results obtained with patient-
specific and modeled BCs. These are largely attributable to the underlying 
differences in the waveforms (similar peak but higher mean flow was 
observed in the measured values). It is most likely that in future patient-
specific BCs will be provided as a part of the routine clinical procedure. 
Before that, CFD has to affirm itself in finding statistical correlations 
using non-patient-specific-BCs. The results of this study show that the 1D 
circulation model adopted by @neurIST performs better than other 
approaches found in the literature and offers a viable means to find 
correlation with rupture in large cohort size studies. 
 
4.4: Overall Conclusions form this Section 
In the study on the validation of different concepts used in CFD, I 
demonstrated that there is no added advantage of complex Womersley-­‐flow-­‐profile	  over	  the	  much	  simpler	  plug-­‐flow	  profile.	   	  
The second study in this section on Modeled vs. Patient-Specific 
Boundary Conditions it I found that there are significant differences in the 
results obtained with these two methods. These are largely attributable to 
the underlying differences in the waveforms (similar peak but higher mean 
flow was observed in the measured values). It is most likely that in future 
patient-specific BCs will be provided as a part of the routine clinical 
procedure. The results of this study show that the 1D circulation model 
adopted by @neurIST performs better than other approaches found in the 
literature and offers a viable means to find correlation with rupture in large 
cohort size studies. 
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*My contribution: In the study described in this chapter, I played a major 
role in concept, study design, conducting review of literature, conducting 
workshops for exposure of the tools, collecting feedback, performing 
analyses, performing statistical calculations, writing and submission of 
manuscripts to journals for publications. Dr Alberto Marzo, Dr 
Alessandro Chiarini and Dr Keith McCormack gave important support 
and contribution in conducting workshops at different venues. 
 
*Declarations: Whereas, as mentioned below, a total of six evaluations of 
the software @neuFuse were performed at different international locations 
by conducting the workshops, due to unavailability of the data only the 
first workshop conducted during the meeting of ESMINT (European 
Society of Minimally invasive Neurological Therapy), in Lisbon, Portugal, 
is included in this chapter.  	  
5.1. Introduction 
The tool-chain @neuFuse was developed under Project @neurIST by 
teams of computer and biomedical scientists working across a number of 
centers as described in Chapter 3 - Materials and Methods. The 
development of the tool-chain was a process of trial and error where the 
perfect final product could only be achieved due to continuous 
improvements made hand in hand while it was still under development.  
 
CHAPTER 5.0: EVALUATIONS AND CONTROLLED 
EXPOSURES OF @NEUFUSE TOOL-CHAIN	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Due to the importance of haemodynamics in the aetiopathogenesis of 
intracranial aneurysms (IAs), mathematicians and engineers are 
increasingly using computational fluid dynamics (CFD) for 
haemodynamic predictions. However, whilst engineers and computer 
scientists devote their efforts towards the development and validation of 
these computational tools, it is imperative to collect the opinion of the 
clinical and other scientific community and evaluate their experience with 
the software. 
 
5.1.1 Methods in general: The evaluation of these tools was done by 
conducing six hands-on workshops on CFD analysis. The workshops are 
designed by keeping in mind a wide range of audience including clinicians 
(Neurosurgeons/ Neuroradiologists/ Neurologists/ Nursing etc.), 
Biomedical Engineers, Computer Scientists, Software Programmers, 
Epidemiologists, CFD scientists and Residents still in training. The 
workshops were typically of 75 minutes consisting of an initial overview 
of the IAs and their current management followed by explanation of basic 
concept of CFD and role of haemodynamic and morphological indices in 
the aetiopathogenesis of these lesions. The participants were then 
presented with a clinical vignette treated using the current management 
protocols. They were then asked to perform the CFD analysis on the IA of 
the same patient using a printed ‘Ready Reckoner’ and see the results at 
Figure-­‐5.1:	  Snapshot	  of	  a	  Questionnaire	  used	  to	  gather	  Feedback	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the end. The case was reappraised again in the light of available CFD 
results at the end of CFD analysis. The management was then discussed 
with participants in the form of an open question that if they had offered a 
different treatment to the patient if they would have these results 
beforehand? A Preformed Questionnaire (Figure-5.1, also given as an 
Appendix at the end of this chapter) was used to gather feedback on all 
these issues as well as about the different aspects of software @neuFuse. 
The data was analysed later and which was used to improve the on-going 
development of the software.  
 
A total of six evaluations of this type were performed at different 
international locations. The first planned exposure of this series, 
conducted during the meeting of ESMINT (European Society of 
Minimally invasive Neurological Therapy), in Lisbon, Portugal, is 
described below in detail in this chapter. The findings of this exposure 
have been published in the form of a peer-reviewed paper the journal 
Computational Intelligence and Neuroscience: [Singh et al 2009]  
 
5.2 The role of computational fluid dynamics in the management of 
unruptured intracranial aneurysms: a clinicians’ view 
 
5.2.1 Background and Objectives 
The management of unruptured cerebral aneurysms remains one of the 
most controversial topics in neurosurgery. These uncertainties are multi-
factorial owing mainly to incomplete natural history of these lesions and 
risks associated with active management [Juvela et al 2004, Raaymakers 
et al 1998, ISUIA 1998, Wiebers et al 2003]. Recent evidence, however, 
suggests a good correlation between different haemodynamic factors and 
aetiopathogenesis of intracranial aneurysms [Burleson et al 1996, Gao et 
al 2008, Morimoto et al 2002, Byrne et al 1998]. This, together with the 
fact that current technologies do not allow detailed in-vivo measurements 
of blood flow [Shojima et al 2004, Steinman et al 2003] in cerebral 
arteries have given computational fluid dynamics (CFD) new strength and 
a chance to affirm itself as a technology that can help in the management 
of unruptured intracranial aneurysms. Many studies have been published 
where patient-specific medical images and CFD are used to predict 
relevant haemodynamic variables that correlate well with initiation, 
growth, and rupture of an IA [Boussel et al 2008, Cebral et al 2005, Cebral 
et al 2005, Castro et al 2006, Steinman et al 2003, Shojima et al 2004, 
Mantha et al 2006]. Until recently, engineers, physicists or mathematicians 
performed these works in collaboration with select clinicians. However, in 
order to make an impact on clinical practice and to enhance trust among 
clinicians, a controlled and extensive exposure of the software and its 
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concepts to the broader clinical community is crucial along with its 
continuing validations. 
 
The current study is the first effort of its kind where the concept and 
application of CFD software was exposed to the clinical community, 
followed by analysis of their views, understanding and performance. 
 
5.2.2 Materials and Methods 
The first gathering of the ESMINT (European Society of Minimally 
Invasive Neurological Therapy) Teaching Course on intracranial 
aneurysms was chosen as an ideal opportunity to expose the computational 
tools being developed within the European project @neurIST (@neurIST), 
to the attention of its audience. The workshop was held near the birthplace 
of angiography at the “Edificio Egas Moniz” of the Hospital Santa Maria 
in Lisbon, Portugal between 6th and 12th September 2008. 
 
5.2.2.1 Participants’ Demography and Overview 
The workshop was attended mainly by neurosurgeons and 
neuroradiologists. Out of all participants 86% had a clinical, 8% and 
engineering, and 6% a scientific background. Participants broadly fell into 
four age groups: 20-30 yrs. old (3 participants, 8%), 31-40 (22, 61%), 41-
50 (9, 25%), 50+ (2, 6%). Participants were prevalently male with a ratio 
M: F = 8:1. These data are summarized in Figure-5.2.  
 
Figure	  -­‐5.2:	  Participants’	  demographic	  constitution	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Participants were subdivided into groups of about 8 individuals per session 
to maximize teacher-to-attendee ratio. Two tutors were available during 
each session, one with a clinical background, (neurosurgeon= Pankaj 
Singh, the author) and one with an engineering background (biomedical 
engineer= Alberto Marzo). Teaching was delivered via a lecture of 75 
minutes, which included a discussion of the clinical background and 
relevance of haemodynamic factors in aetiopathogenesis of IAs, a brief 
introduction on the use of CFD in haemodynamic predictions, and 
explanation of key fluid dynamics concepts in this context e.g. wall shear 
stress (WSS), boundary conditions etc. This was followed by a supervised 
hands-on experience with the software.  
 
 
 
The exercise was presented to the audience via a clinical vignette of a 
typical difficult scenario encountered in the clinic, represented in Figure-
5.3.  
 
The vignette illustrates a typical case of an incidentally discovered IA in 
an anxious young patient. Due to its size (5 mm maximum diameter) and 
absence of any other major known risk factors, the aneurysm should be 
managed conservatively as per ISUIA (International Studies for 
Unruptured Intracranial Aneurysms) guidelines [ISUIA-1998, Wiebers et 
al 2003]. However due to patient’s concerns and insistence for active 
intervention the management plan becomes controversial. 
 
Figure	  5.3:	  Clinical	  Vignette:	  typical	  challenging	  case	  scenario	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The participants were then asked to use the software @neuFuse to extract 
additional and non-observable haemodynamic data from the 3 dimensional 
rotational angiographic (3DRA) image of this case. Attendees performed 
the tasks independently with the help of a ready-reckoner containing the 
complete guided procedure with illustrations to facilitate the exercise. 
One-to-one support and supervision was provided during each session, as 
required. 
 
5.2.2.2 Image Acquisition and Processing 
The medical image used in the workshop was obtained using rotational 
acquisition in a Philips® Integris™ Allura™ machine (Philips® Medical 
Systems, Best, The Netherlands), producing 100 images in 6 seconds, with 
5ms exposure per image. Voxel size in the reconstructed 3D images was 
234 microns with reconstruction matrix 256x256x256. Images were 
anonymized, respecting the @neurIST 
ethical approval for use of patient data. 
The characteristics of the aneurysm 
considered in this study are reported in 
Table-5.1. 
 
The current version of the @neuFuse 
software (prototype 4), based on the 
Multimod Application Framework [Viceconti et al. 2004] and developed 
within the @neurIST project, was used to reconstruct the vessel surfaces, 
create the model and set up the haemodynamic analysis. The solvers used 
within @neuFuse to solve the fundamental equations describing the blood 
flow behavior within the region of interest were ANSYS®-ICEM™ and 
ANSYS®-CFX™ (Ansys®, Inc., Canonsburg, PA, USA).  
 
For the purpose of the workshop a simple stationary analysis (non-
pulsatile but constant flow rate and pressure at the openings of the region 
of interest) was performed by the participants using Intel® core duo 2.4 
GHz machines, with 2 GB RAM and 512 MB of dedicated graphic 
memory. 
 
5.2.2.3 CFD Analysis 
Figure 5.4 shows the overall workflow of the operations performed from 
uploading the raw medical image to the software through the visualization 
of relevant haemodynamic data in @neuFuse. 
Table-­‐5.1:	  Aneurysm	  Radiological	  Characteristics	  Localisation:	   Carotid	  artery/	  ophthalmic	  segment/	  medial	  wall	  Side:	   Left	  Dome	  status:	   Unruptured	  Depth:	   4.2	  mm	  Max	  diameter:	   5	  mm	  Max	  neck	  width:	   3.7	  mm	  Type:	   Side-­‐wall,	  saccular	  Aspect:	   Smooth	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Any CFD analysis requires knowledge of the volumetric region traversed 
by the fluid (i.e. aneurysm including connected surrounding vasculature) 
plus information about velocity and pressure of the fluid at the boundaries 
of the chosen region of interest (boundary conditions). Participants were 
asked to reconstruct the region of interest starting from the medical image, 
and specify the boundary conditions using the software @neuFuse. The 
first step was to launch @neuFuse and import the medical image (Figure 
5.4A). The geometry of the vessel, including the IA, was then extracted 
from the imported image (Figure-5.4B). As only a sub-region of the 
extracted vasculature around the aneurysm has influence on the 
haemodynamic computation, all vessels entering or leaving the IA were 
identified and cropped at desired locations to define the region of interest 
(ROI). The ascending carotid artery, which was an inlet (blood enters the 
domain through it), was cropped at ten vessel diameters proximal to the IA 
as shown in Figure-5.4C. The distal carotid artery in the region of 
cavernous sinus and the ophthalmic artery were identified as the two 
outlets of ROI (blood exits the domain through these two vessels). These 
are shown in Figure-5.4C. For the sake of simplicity and time constrains 
the mesh used in the analysis was coarse and was constructed using simple 
tetrahedral elements. As is often the case in real-life clinical situations, 
Figure	   5.4:	   Operation	   workflow	   from	   medical	   image	   to	   haemodynamic	   results.	   A)	   Orthoslice	  visualization	   of	   the	   3DRA	   medical	   image	   in	   @neuFuse.	   B)	   Visualization	   of	   the	   extracted	   vessel	  surface.	  C)	  Visualization	  of	  reduced	  region	  of	  interest	  with	  location	  of	  inlet	  and	  outlet	  openings.	  D)	  1D	  circulation	  model.	  E)	  Visualization	  of	  predicted	   streamlines.	   F)	  Visualization	  of	  predicted	  wall	  shear	  stress.	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information on pressure or velocity of the blood at these locations for the 
patient under examination was not available. Boundary conditions were 
therefore provided by using a 1D mathematical model of the systemic tree, 
which has been developed within @neurIST [Reymond et al 2008]. A 
representation of the @neurIST 1D circulation model is depicted in Figure 
3D. This model provides values of pressure and flow of blood at several 
locations along the systemic arterial tree, including locations in the circle 
of Willis for a typical individual. Plug-flow BCs were applied at inlet and 
pressure BC at outlet, using average values from the waveforms provided 
by the 1D circulation model. Typical values of blood viscosity (μ=0.004 
Pa.s) and density (ρ=1066 kg/m3) were applied to define the blood 
properties. Although the blood is a non-Newtonian fluid for the sake of 
simplicity and time-constraints, and also in view of recent findings from 
Cebral et al [Cebral et al 2005], I decided to assume constant blood 
viscosity. 
 
Whilst arterial walls move under the effect of the propagating pressure 
waves, it has been shown that the effects of this movement on 
haemodynamic predictions are negligible [Jeays et al 2007]. Fixed walls 
were thus considered in this analysis. The computation was automatically 
performed by the software and participants were asked to display different 
predicted haemodynamic variables like flow streamlines (Figure-5.4E), 
pressure distribution within the aneurysm or arterial wall, and WSS 
(Figure-5.4F). Participants were then asked to compare the WSS values 
computed within the aneurysm with the critical values found in the 
experimental studies of Malek et al [Malek et al 1996] below which the 
endothelium is affected by cell loss, desquamation and deranged activity 
of wall-growth regulators. 
 
5.2.2.4 Evaluation 
Finally, the feedback was collected via a questionnaire consisting of 48 
questions. These were broadly divided into 6 categories (Table-5.2); 
general feedback, course design and conduct, experience with the 
software, haemodynamics understanding, impact of CFD in neurosurgery, 
and bringing this software into routine use. Each section of the 
questionnaire was carefully designed to collect information on different 
aspects of the participant experience as described in Table-5.2. The 
questionnaire with the complete list of questions is reported in Appendix-1 
at the end of this chapter. 
 
Performance of participants was measured by analyzing the file containing 
an audit trail of the operations performed during the analysis. The 
performance criteria were based on the analysis settings that have major 
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influence on the outcome of the numerical predictions: The quality of the 
reconstructed geometry, its extension, the locations in the 1D circulation 
model from which boundary conditions were extracted, and the 
correctness of the applied boundary condition type (i.e. whether it was 
correctly set to inlet or outlet). Each correct operation was assigned one 
point, leading to a maximum score of four. Expert performance was 
considered as gold standard (4 out of 4) and participants’ performance rate 
was compared against this, 
 
5.2.3 Results 
For each section of the questionnaire only data gathered for the most 
representative questions were reported in this manuscript. Results were 
represented using tables with percentage distribution for a ready 
appreciation of feedback across the participants. These are reported 
section by section below.  
 
 
 
  
Table-­‐5.2:	  Questionnaire	  sections	  and	  objectives	  
Section	   Category	   Objectives	  1	   General	  feedback	   To	  gather	  impressions	  on	  the	  overall	  experience	  2	   Course	  design	  and	  conduct	   To	  gather	  suggestions	  on	  possible	  improvements	  and	  identify	  any	  shortcomings	  in	  the	  design	  of	  the	  workshop	  3	   Experience	  with	  the	  software	   To	  identify	  weak	  points	  as	  perceived	  by	  clinicians	  in	  the	  graphical	  user	  interface	  of	  the	  current	  version	  of	  the	  software	  4	   Haemodynamics	  understanding	   To	  assess	  their	  current	  knowledge	  and	  understanding	  in	  the	  role	  of	  haemodynamics	  in	  the	  aetiopathogenesis	  of	  intracranial	  aneurysms	  5	   Impact	  of	  CFD	  in	  neurosurgery	   To	  assess	  their	  faith	  in	  the	  principles	  of	  CFD	  and	  its	  use	  in	  the	  clinical	  environment,	  along	  with	  the	  need	  of	  validation	  through	  a	  multicentre	  trial	  6	   Bringing	  this	  software	  into	  routine	  use	   To	  explore	  the	  participants	  view	  on	  cost	  related	  issues	  and	  gather	  information	  on	  future	  marketing	  potentials	  of	  this	  kind	  of	  software	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Section 1:  General feedback: As shown in Table-5.3, the overall 
feedback about the workshop was positive. The 86 % of participants 
would recommend the software to a colleague, 75 % found the workshop 
useful and 78% rated their overall experience between good and very 
good. Negative feedback was confined averagely within less than 5%. 
Most participants recognized the need to improve management of IAs and 
for 47% this was the main reason for attending the workshop. 
 
 
 
 
 
 
 
 
 
 
 
  
Table-­‐5.3:	  General	  feedback	  
Question/Answer	  options	  
	  
No	  of	  participants	  (%)	  
Would	  you	  recommend	  the	  software	  to	  
a	  colleague?	  
	  Yes	   31	   (86)	  No	   3	   (8)	  n.a.	   2	   (6)	  
Why	  did	  you	  decide	  to	  participate	  to	  
this	  workshop?	  
	   	  
Working	  in	  the	  field	   16	   (45)	  Interested	  in	  CFD	   2	   (6)	  Improve	  management	  of	  aneurysms	   17	   (47)	  Other	   1	   (2)	  
How	  useful	  did	  you	  find	  this	  workshop?	   	   	  Not	  useful	   1	   (3)	  Not	  sure	   8	   (22)	  Useful	   16	   (45)	  Very	  useful	   11	   (30)	  
Rate	  your	  overall	  experience	   	   	  Poor	   1	   (3)	  Average	   7	   (19)	  Good	   15	   (42)	  Very	  good	   13	   (36)	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Section 2: Course design and conduct: 80% of candidates found the 
workshop to be of the right duration, 14% found it to be too short while 
for 6% it was too long (Table 5.4). Participants-to-instructor ratio was 
right for 91% while 6% thought that there were too many participants. 
Most of the participants did not have any difficulty in understanding the 
instructions. On a scale of 1 to 5, where 1 is not clear and 5 is very clear, 
86% rated it 4-5, while 14% were not sure. 94% of the participants 
thought that the course content was scientifically appropriate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table-­‐5.4:	  Course	  design	  and	  conduct	  
Question/Answers	   No	  of	  participants	  (%)	  
Was	  the	  duration	  of	  the	  workshop	  …	   	  Right	   29	   (80)	  Short	   5	   (14)	  Long	   2	   (6)	  
Was	  the	  participant-­‐to-­‐instructor	  ratio…	   	   	  Right	   33	   (91)	  Too-­‐many	   2	   (6)	  n.a.	   1	   (3)	  
Were	  the	  instructions	  given	  in	  a	  clear	  
way?	  
	   	  Not	  sure	   5	   (14)	  Clear	   18	   (50)	  Very	  clear	   13	   (36)	  
	  Was	  the	  content	  of	  the	  course	  
scientifically	  appropriate?	  
	   	  
Yes	   34	   (94)	  No	   2	   (6)	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Section 3: Experience with the Software: 34% of the candidates found 
the current version of the software user friendly, 11% think it needs some 
improvement, while 6% found it was not user-friendly (Table-5.5). The 
remaining 46% were unsure. 48% of the participants think that clinicians 
with limited IT skills will find using the software challenging, 11% 
disagree with this assumption and 33% were not sure. 86% of all attendees 
were able to complete all the steps of the haemodynamic analysis within 
the time allocated (approx. 50 minutes). 11% missed one or more steps. 
Application of boundary conditions and clipping the region of interest 
were amongst the most difficult steps reported by majority of participants.  
These were equally distributed among participants with scientific and 
clinical background.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table-­‐5.5:	  Experience	  with	  the	  software	  
Question/Answers	   No	  of	  participants	  (%)	  
Do	  you	  find	  the	  software	  user	  friendly?	   	  No	   2	   (6)	  Needs	  improvement	   4	   (11)	  Not	  sure	   17	   (46)	  User	  friendly	   11	   (31)	  Very	  user	  friendly	   1	   (3)	  n.a.	   1	   (3)	  
Will	  clinicians	  without	  tech/IT	  experience	  have	  
trouble?	  
	   	  
Yes	   17	   (48)	  Not	  sure	   12	   (33)	  No	   4	   (11)	  n.a.	   3	   (8)	  
Were	  you	  able	  to	  complete	  all	  the	  steps	  of	  the	  
haemodynamic	  analysis?	  
	   	  
Yes	   30	   (86)	  No	   4	   (11)	  n.a.	   1	   (3)	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Section 4: Haemodynamics understanding: Whereas for 78% of the 
participants it was easy to understand the technical concepts used 
throughout the course (Table-5.6), 19% faced some difficulties in 
understanding the terminology, mostly related to concepts such as 
boundary conditions and WSS.  
 
36% of the participants showed trust in the results predicted by the 
software and think they are realistic. However, 58% were unsure. 48% 
believe that there is good scientific evidence to justify the role of 
haemodynamics in the aetiopathogenesis of IAs, 3% did not agree with 
this. 43% of the candidates were not sure. Whereas 50% of the participants 
were aware of the use of CFD as a tool in the prediction of rupture in IAs, 
42% were hearing the concept for the first time. 
 
Interestingly, 84% of all participants were willing to read further peer-
reviewed articles published on CFD and role of haemodynamics in IAs.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table-­‐5.6:	  Haemodynamics	  understanding	  
Question/Answers	   No	  of	  participants	  (%)	  
Did	  you	  have	  difficulty	  with	  the	  technical	  concepts	  
(boundary	  conditions,	  wall	  shear	  stress,	  etc.)?	  
	  Yes	   7	   (19)	  No	   28	   (78)	  n.a.	   1	   (3)	  
Are	  the	  results	  from	  this	  software	  realistic?	   	   	  Yes	   13	   (36)	  Not	  sure	   21	   (58)	  No	   0	   (0)	  n.a.	   2	   (6)	  
Is	  current	  evidence	  sufficient	  to	  justify	  a	  role	  for	  
haemodynamics	  in	  the	  pathogenesis	  of	  aneurysms?	  
	   	  
No	   1	   (3)	  Not	  sure	   15	   (43)	  Yes	   17	   (48)	  n.a.	   2	   6	  
Were	  you	  previously	  aware	  of	  the	  use	  of	  CFD	  to	  predict	  the	  
risk	  of	  rupture	  in	  intracranial	  aneurysms?	  
	   	  
No	   15	   (42)	  Yes	   18	   (50)	  n.a.	   3	   (8)	  
If	  you	  see	  a	  publication	  on	  computational	  predictions	  for	  
IA	  in	  a	  peer-­‐reviewed	  journal,	  will	  you	  read	  it?	  
	   	  
No	   3	   (8)	  Yes	   30	   (84)	  n.a.	   3	   (8)	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Section 5: Impact of CFD in neurosurgery: Responding to the question 
“Who should perform the CFD analysis for your patient”, 19% answered a 
consultant, 6% thought it should be done by a registrar or a junior member 
of the team (Table 5.7). 25% 
believed that analysis should be 
performed by a dedicated 
clinical scientist/engineer, while 
another 25% think that it can be 
done by anyone provided that 
they have adequate training. 
 
84% of the participants were of 
the view that the software can 
be used as a diagnostic tool on 
outpatient basis, 8% did not 
agree with them. 84% of the 
participants were aware of 
similar software, whereas for 
8% of them it was the first 
exposure to this kind of 
software. When asked about 
automated versus user-
controlled software, 
interestingly 35% expressed a 
wish to retain user control. 26% 
preferred a fully automated tool, 
while another 26% were unsure. 
 
Although the majority of 
participants (88%) were 
convinced that there is a future 
for CFD as a risk prediction 
tool, and that there is a 
significant, or emerging clinical 
need for these kinds of 
innovative tools (84%), most of 
them (75%) thought that the 
current version of the software 
was not yet ready and would 
require refinement before it 
could be introduced into clinical 
practice. 
 
Table-­‐5.7:	  Impact	  of	  CFD	  in	  neurosurgery	  
Question/Answers	   No	  of	  participants	  (%)	  
Ideally,	  who	  should	  perform	  this	  type	  of	  computational	  
analysis	  for	  patients?	  
	  Consultant	   7	   (19)	  Dedicated	  clinical	  scientist	   9	   (25)	  Registrar	   2	   (6)	  Anyone	  with	  training	   14	   (38)	  Office	  member	   1	   (3)	  All	   1	   (3)	  n.a.	   2	   (6)	  
When	  ready	  could	  this	  software	  be	  used	  diagnostically	  in	  
an	  outpatient	  clinic?	  
	   	  Yes	   30	   (84)	  No	   3	   (8)	  n.a.	   3	   (8)	  
Are	  you	  aware	  of	  any	  similar	  software?	   	   	  Yes	   30	   (84)	  No	   3	   (8)	  n.a.	   3	   (8)	  
Should	  this	  type	  of	  analysis	  be	  fully	  automated,	  or	  is	  it	  
better	  that	  the	  user	  has	  control?	  
	   	  Automated	   10	   (26)	  User	  control	  	   14	   (35)	  Not	  sure	   10	   (26)	  n.a.	   5	   (13)	  
Is	  there	  a	  future	  for	  computational	  tools	  for	  risk	  
prediction	  of	  intracranial	  aneurysm	  rupture?	  
	   	  
Yes	   29	   (80)	  No	   2	   (6)	  Not	  sure	   2	   (6)	  n.a.	   3	   (8)	  
How	  great	  a	  clinical	  need	  is	  there	  for	  this	  software?	   	   	  Significant	   17	   (48)	  Emerging	   13	   (36)	  Low	   3	   (8)	  n.a.	  	   3	   (8)	  
Do	  you	  think	  that	  this	  type	  of	  analytical	  software	  is	  
ready	  for	  introduction	  into	  the	  clinical	  environment?	  
	   	  
Ready	   4	   (11)	  Needs	  work	   26	   (75)	  n.a.	   5	   (14)	  
In	  which	  cases	  might	  this	  software	  influence	  your	  
decision-­‐making	  about	  patient	  management?	   	   	  All	   7	   (19)	  Small	  unruptured	  asymptomatic	   14	   (39)	  Other	   2	   (6)	  Not	  sure	   1	   (3)	  None	   3	   (8)	  n.a.	   9	   (25)	  
Would	  you	  be	  interested	  in	  participating	  in	  a	  multi-­‐
centre	  trial	  on	  the	  evaluation	  of	  this	  software?	  
	   	  
Yes	   25	   (69)	  No	   5	   (14)	  n.a.	   6	   (17)	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64% of the candidates believed that an early prediction of the risk of 
rupture computed with the help of this software could influence their 
decision making in the management of an IA. Out of the 64% over half 
(39%) think that small asymptomatic unruptured cases specially falling in 
the border-line category based on current evidence, are the best cases 
where such software can provide definitive help. Interestingly, 19% 
thought that it could be useful in all cases. 69% of the participants were 
convinced of the need for a multi-centric trial for the evaluation of the 
software and expressed their willingness to participate in it. 
 
Section 6: Bringing this software into routine use: Once the software is 
in routine use, 30% of the participants believed that it should be an 
integral part of the scanner (Table-5.8). 27% thought that it should be 
supplied as a standalone product, while 32% say it could be provided in 
either way. 
Cost will be an important deciding factor for 72% and another 81% prefer 
it to be a freeware or shareware. However, cost is a low priority for 17% 
and another 11% won’t mind paying for it. 
 
 
 
 
 
  
Table-­‐5.8:	  Bringing	  this	  software	  into	  routine	  use	  
Question/Answers	   No	  of	  participants	  (%)	  
Would	  you	  expect	  this	  software	  to	  be	  provided	  as	  
part	  of	  a	  scanner,	  or	  as	  a	  stand-­‐alone	  	  product?	  
	  Scanner	   11	   (30)	  Standalone	   10	   (27)	  Both	   12	   (32)	  n.a.	   4	   (11)	  
Would	  the	  price	  of	  this	  software	  be	  an	  important	  
factor	  in	  your	  deciding	  to	  obtain/use	  it?	  
	   	  Important	   26	   (72)	  Low	  priority	   6	   (17)	  n.a.	   4	   (11)	  
Would	  you	  expect	  to	  pay	  for	  this	  software,	  or	  
would	  you	  prefer	  a	  freeware/shareware	  
arrangement?	  
	   	  
Pay	   4	   (11)	  Shareware	   14	   (37)	  Freeware	   17	   (44)	  n.a.	   3	   (8)	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Performance: Attendees totalized an average score of 63% of experts’ 
performance (Table-5.9). When age is taken into consideration youngest 
delegates in the group 20-30 yrs. scored highest (65%) with score figures 
reducing progressively with age. Age group 50+ obtained the lowest 
scores (56%). Performance was slightly higher in scientific community 
(2.7), as compared to the clinicians (2.5) 
 
5.2.4 Discussion 
5.2.4.1 The current challenges posed by unruptured IAs 
The easy availability and widespread use of relatively non-invasive and 
sophisticated neurodiagnostic modalities such as high resolution CT, MRI 
and MRA, have brought to clinical attention a large and ever increasing 
group of patients harboring unruptured and asymptomatic cerebral 
aneurysms. These unruptured lesions are also diagnosed coincidentally at 
the time of catheter angiography done for a ruptured aneurysm in patients 
having multiple aneurysms. The increasing awareness of relatively bleak 
prognosis related to aneurysmal rupture in general public and clinicians, 
forces neurosurgeons to come up with a definitive answer for these 
unruptured lesions.  
 
With the advancements in the microsurgical techniques and improved 
neuroanaesthetic and interventional neuroradiological approaches, the 
morbidity and mortality figures associated with the active management of 
the ruptured aneurysms has improved significantly when compared to 
their conservative management. In other words, the indications for the 
active interventions in ruptured intracranial aneurysms are now well 
established. The situation unfortunately is not as straightforward in cases 
of unruptured aneurysms and, the management of these lesions remains 
one of the most controversial topics in Neurosurgery [Juvela et al 2004, 
Raaymakers at al 1998, ISUIA 1998, Wiebers at al 2003]. Most of the 
large series including ISUIA studies agree on the low risk or rupture for 
unruptured intracranial aneurysms. The cumulative rupture rates in ISUIA 
studies were between 0.05 to <1 percent per annum [ISUIA-1998, Wiebers 
Table-­‐5.9:	  Attendees’	  performance	  
	   Score	  	  	  	  	  	  	  	  	  	  	  	  	  	  %	  
Average	   2.52	   (63)	  
Performance	  with	  
age	  
	   	  20-­‐30	  yrs	   2.58	   (65)	  31-­‐40	  yrs	   2.50	   (63)	  41-­‐50	  yrs	   2.36	   (59)	  50+	  yrs	   2.22	   (56)	  
Performance	  with	  
background	  
	   	  Clinicians	   2.5	   (63)	  Scientists	   2.7	   (68)	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et al 2003]. The fact that the prevalence of unruptured aneurysms in 
general population outnumbers the incidence of subarachnoid hemorrhage 
shows that not all unruptured intracranial aneurysms share a common 
natural history. The annual prevalence of unruptured aneurysms in a 
population is around 5% [ISUIA-1998] while the incidence of 
subarachnoid hemorrhage in the corresponding population is observed up 
to a maximum of 10 cases per 100, 000 persons per year [ISUIA-1998]. It 
is clear from the above-mentioned figures that 80 to 85% of all intracranial 
aneurysms will never rupture.  
 
The current uncertainties in the management of unruptured intracranial 
aneurysms are well accepted by the clinical community, and were amongst 
the most important motivating factors for majority of the participants 
(47%) to attend this workshop.  
 
In order to offer the best possible treatment to the patient with least side 
effects, the formulation of a clear management protocol, directed by the 
natural history of the unruptured intracranial aneurysms and the risks 
associated with the active management, is required. Whereas the 
endovascular coiling is increasingly being accepted as a preferred 
treatment modality for ruptured intracranial aneurysms, surgery has been 
advocated as a first line treatment for unruptured lesions [Juvela et al 
2004, Wiebers at al 2003]. Although there are no strict guidelines, most of 
the studies [Juvela at al 2000, Komotar et al 2008, Mayberg et al 1994] 
including ISUIA trials (ISUIA-1998, Wiebers et al 2003], almost 
unanimously recommend certain factors as indications of surgery in 
unruptured aneurysms: large aneurysmal size, symptomatic lesions, 
evidence of growth, multiple lesions, posterior circulation location, and 
past history of SAH.  All these criteria been established to have good 
correlation with increased risk of rupture and hence, surgery is advocated 
in these situations to avoid the poor outcome. It is interesting to note that 
whereas on the one hand the above-mentioned criteria are used to decide 
the need and suitability for surgery in an unruptured intracranial 
aneurysm, all of these factors also remain the underlying descriptors for 
poor surgical outcome [Solomon et al 1994, Khanna at al 1996, Wirth et al 
1983].  
 
In the light of current evidence it is clear that the group which will stand 
best chances of an excellent outcome after surgery will be one with 
solitary, very small (<5 mm), truly asymptomatic aneurysms located in the 
anterior circulation, without any evidence of growth. Quite the contrary, 
current protocols dictate clinicians not to operate upon this group [ISUIA-
1998, Wiebers et al 2003, Komotar et al 2008]; and in fact contraindicate 
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any active management option in such patients [ISUIA-1998, Wiebers et 
al 2003, Komotar et al 2008). Moreover, the small aneurysms of <5 mm 
size which are traditionally thought to be ‘safe’, are not ‘rupture-proof’. In 
a study Yasui et al [Yasui et al 1996] found that in a group of 25-ruptured 
aneurysms, 16 (64%) were <5 mm in size. Similarly, Juvela and 
colleagues [Juvela et al 1993] who followed 142 patients with 181 
aneurysms for a mean period of 13.9 years with an aneurysmal size of <4 
mm, demonstrated a 19% rupture rate i.e. 27 out of 142 patients had a 
rupture.  
 
In order to improve the surgical outcome if we choose to operate on these 
smaller and ‘safe’ lesions, we have to operate on every single patient. The 
ideal situation, however, would be if we could identify the aneurysms at 
greater risk of rupture while they are still small in size and operate upon 
them, leaving others to be monitored expectantly.  
 
5.2.4.2 The emerging need for new alternatives 
It is evident that due to limitations associated with conventional risk 
factors used to assess the risk of growth and rupture, it is currently 
impossible to identify those patients who are at an increased risk in this 
subset having a real need of an early surgery from those who can be 
monitored safely without any active intervention. The situation 
consequently leaves us with no options other than searching some new 
descriptors that can predict the risk of rupture independently in small 
cerebral aneurysms before they join the cohort destined for a poor surgical 
outcome. This is in part reflected by the large number of participants 
(84%, Table-5.7) who believe that there is a significant or emerging need 
of new alternatives. 
 
There is a rapidly growing body of literature affirming the importance of 
haemodynamics in the aetiopathogenesis of cerebral aneurysms [Burleson 
et al 1996, Gao et al 2008, Morimoto et al 2002, Byrne et al 1998]. The 
haemodynamic variables often considered in these studies are wall shear 
stress (WSS), oscillatory shear index (OSI), blood pressure and other 
quantities used to characterize blood flow. Proportional to blood viscosity 
and its velocity, WSS is the tangential frictional force exerted by the 
flowing blood on the walls of each vessel. High supraphysiological and 
low infraphysiological values of WSS have been associated with initiation, 
growth and rupture of aneurysms [Gao et al 2008, Fukuda et al 2000, 
Meng et al 2007, Shojima et al 2004, Jou et al 2008, Malek et al 1996, 
Ujie et al 1999, Boussel et al 2008]. A measure of the oscillatory nature of 
these viscous forces is given by the oscillatory shear index (OSI), often 
associated with endothelial cells degeneration [Mantha et al, 2006, Glor et 
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al 2004, Goubergrits et al 2008]. Table 10 below gives a comprehensive 
list of haemodynamic variables from the literature and their association 
with intracranial aneurysm evolution. 
 
An evaluation of these variables can provide a useful alternative to predict 
the behavior of an unruptured IA at an early stage before it changes in 
size, shape or becomes symptomatic. Unfortunately, the detailed in-vivo 
measurements of all relevant flow variables in the regions affected by the 
disease are currently impossible [Shojima et al 2004, Steinman et al 2003]. 
 
5.2.4.3 Computational Fluid Dynamics: a brief overview 
Motivated by the important role played by haemodynamics and the 
difficulty of conducting detailed in-vivo observations of relevant 
haemodynamic variables, engineers and computer scientists have started 
using Computational Fluid Dynamics (CFD) to predict blood flows in 
intracranial aneurysms [Boussel et al 2008, Cebral et al 2005, Cebral et al 
2005, Castro et al 2006, Steinman et al 2003, Shojima et al 2004, Mantha 
et al 2006].	  
	  
Computational fluid dynamics is the science of predicting fluid flow, heat 
and mass transfer, chemical reactions, and related phenomena by solving 
numerically the set of mathematical equations that govern a particular 
physical system (conservation of mass, momentum, energy, species etc.) 
Since its early development in the 1960s and 1970s in the aerospace field, 
where it was mainly used to improve the design and efficiency of aircrafts 
[Anderson 1995], CFD has been successfully used in many other 
applications. In the past decades, engineers used CFD in the automotive, 
nautical, and civil engineering industries for conceptual studies of new 
designs, troubleshooting redesign, or improving the physical 
understanding of a novel fluid mechanical phenomenon. Supported by 
experimental studies and a profound theoretical knowledge of the 
application at hand, CFD can be applied anywhere the flow of a fluid is 
important. Validation, through comparisons with experimental data, has 
always been a key aspect in successful applications of CFD. In the context 
of its use in intracranial aneurysms, although some early validation work 
has shown promising results [Ford et al 2008, Ford et al 2005, Radaelli et 
al 2008, Karmonik et al 2008], a more systematic validation remains a pre-
requisite before CFD can be adopted as a routine tool in clinical practice. 
Whereas the majority of participants (78%) did not find any difficulty in 
understanding the technical concepts used in CFD, only 36% of them 
believed that the results produced by its application were realistic. The 
mistrust in the results indicates the need for validation. This is further 
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supported by the fact that most of the participants (84%) readily wanted to 
participate in a multi-centric clinical trial.  
  
Although participants showed a manifest interest in computational 
predictions (Table 5.6), there is a clear lack of awareness concerning the 
role of haemodynamics in the aetiopathogenesis of IAs and the use of 
CFD in this context (42%, Table 5.6). More efforts therefore are required 
by the scientific community to enhance understanding of the role of 
haemodynamics and awareness of the use of CFD in this field. 	  
	  
Table	  5.10:	  The	  literature-­‐based	  evidence	  on	  the	  importance	  of	  haemodynamics	  in	  the	  aetiopathogenesis	  of	  IAs	  	  
Haemodynamic 
factors 
Intracranial Aneurysm Proposed 
mechanism(s) 
References 
Initiation Growth Rupture 
Dynamic 
Wall Shear 
Stress (WSS) 
High Low Low Increased WSS 
increases the production 
of MMP-13 which in 
turn leads to vessel wall 
damage 
Decreased WSS 
increases iNOS 
synthesis- NO induced 
damage to vessel wall 
Low WSS increases 
endothelial proliferation 
and apoptosis 
Boussel et al 2008, 
Fukuda et al 2000, 
Gao et al 2008, Jou 
et al 2008, Malek et 
al 1999, Meng et al 
2007, Shojima et al 
2004, Ujie et al 1999 
 
Oscillatory 
Shear Index 
(OSI)  
High/Low High High Degenerative changes in 
endothelium 
Glor et al 2004, 
Goubergrits et al 
2008, Mantha et al 
2006 
Jet of Blood 
Stream 
Impingement Impingement Impingement Localized endothelial 
cell injury 
Foutrakis et al 1999, 
Cebral et al 2005, 
Cebral et al 2009 
Flow Pattern - - Complex Statistical association Cebral et al 2005, 
Cebral et al 2009 
Hydrostatic 
Pressure High High High Passive yield/ water 
hammer effect 
Inci and Spetzler 
2000, Morimoto et al 
2002, Steiger et al 
1989 
NB:	  WSS;	  wall	  shear	  stress,	  MMP-­‐13;	  matrixmetalloproteneases-­‐13,	  iNOS;	  inducible-­‐nitric	  oxide	  synthase,	  NO;	  nitric	  oxide,	  OSI;	  oscillatory	  shear	  index	  	  
5.2.4.4 The concept of controlled exposure 
The use of CFD in this context represents a significant change in the 
clinical workflow and a successful transfer of knowledge will only happen 
via carefully planned, controlled exposure. Clinical sites must be 
supported locally, underpinning the training for clinicians with the 
involvement of clinical scientists. The effectiveness of interdisciplinary 
transfer of knowledge is largely dependent on the course design and the 
methodology used. As reflected by the results (Table-5.9), a hands-on 
workshop using multimedia PowerPoint presentation, one-to-one 
supervision, and low participants-to-instructor ratio with a carefully 
designed course based on sound scientific principles, can lead to good 
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results. The correct duration of such a course is also an important factor 
(Table 5.4). A close collaboration between engineers and the clinical 
community is also a pre-requisite for successful transfer of knowledge. 
Supervision during this workshop was hence, jointly provided by a 
biomedical engineer and a clinician. Given a short training period of only 
75 minute, the first ever exposure of the software and its concepts to most 
of the participants (Table 5.6), together with the fact that the software is 
still in its prototype stage, the overall response and average performance 
of 63% was remarkable. It is anticipated that performance can be 
enhanced to the level of the expert-user by means of a user-friendlier 
version of the software and more intensive training. The results also show 
a decline in performance with age. It may be associated with the IT skills 
necessary to use this type of software efficiently. This fact should be kept 
in mind when interpreting the results and formulating future training and 
translational requirements.  
 
5.2.4.5 Software design improvement 
Many valuable suggestions were collected from participants on the 
possible improvements in the software design and its functionalities. 
Among the important suggestions included automating the steps for which 
user intervention is not strictly necessary, improving user friendliness 
through a more intuitive graphical user interface (GUI) where the user is 
guided through the number of operations required, or use of the icons in 
place of the more cumbersome operation from the menu bar and, finally 
graphical representation of the 1D circulation model for easier application 
of boundary conditions. After discussing the feasibility with developers, 
most of these suggestions were implemented in the latest version of the 
software @neuFuse.  
 
5.2.4.6 The expected place of CFD in Neurosurgery 
It is interesting to note that the majority of the participants (63%, Table 
5.7) want these analyses to be performed either by an expert clinical 
scientist/engineer or a person with the same level of expertise, rather than 
a clinician. The fact may reflect clinicians’ reluctance to conduct the 
analyses themselves due to their understandable concern over time-
constraints and may indicate the requirement of a dedicated team with 
sufficient infrastructure for the purpose. In spite of this, most of the 
clinicians (84%, Table 5.7) see the software as a handy tool, which can be 
used on an outpatient basis (e.g. ophthalmoscope, otoscope, etc.) rather 
than a specialist department-based facility (e.g. 3DRA, MRA etc.). On 
comparing the software in terms of the different properties of a diagnostic 
modality, which makes it an ideal outpatient tool versus those requiring a 
dedicated set-up, I found that this software has some important features of 
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an ideal outpatient tool. It is non-invasive and is not directly performed on 
the patient (patients do not have to come prepared, e.g. empty stomach). 
As it is totally non-invasive, there is no risk of cross-infection or 
contamination. Due to no associated side effects, no admission or post-
operative care is necessary. Although only time will decide, in my view 
only a dedicated department with sufficient IT facilities and dedicated 
biomedical engineers can take the burden of the extensive computational 
time required by more realistic transient analyses and, effort to visualize 
and extract the haemodynamic characteristics required for clinical decision 
making. 
 
Whereas the current study indicates a positive response among the clinical 
community for CFD and its use in IAs, it will be necessary to expose the 
software to a larger number of clinicians before definitive conclusions can 
be drawn.  
 
5.2.5 Conclusions 
 
Although participants showed a manifest interest in computational 
predictions, there is a clear lack of awareness concerning the role of 
haemodynamics in the aetiopathogenesis of IAs and the use of CFD in this 
context. More efforts therefore are required by the scientific community to 
enhance awareness and understanding of the clinicians in the subject. 
There is a clear willingness to use such software as an outpatient tool. The 
mistrust in the results indicates the need for validations, and most of the 
participants supported with the need of a multi-centric trial, when software 
is ready. Keeping in mind the very first exposure to CFD for most of the 
participants and the inherent difficulties associated with a developing-
software, the average performance of 2.5 (63% of an expert) was 
remarkable. Adequate training, controlled exposure, and further 
development of these tools is necessary before these can be efficiently 
used by a common clinician. 
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5.3 Appendix-1: Questionnaire used for feedback 
	  
Edificio “Egas Moniz”, Hospital de Santa Maria Faculdate de Medicina da Universidade de Av. Professor Egas Moniz 1649-028 Lisboa, Portugal 
http://www.fm.ul.pt/ 
Workshop	  Evaluation	  -­‐	  @neuFuse	  	  
Personal Details Title:	   First	  Name:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Surname:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Age:	  	  	  	  	  	  Degree:	   	  Job	  Title:	   	  Institution/Department:	   	  Background:	   	  	  Clinical	  	  	  	  	  	  	  Engineering	  	  	  	  	  	  	  Scientific	  	  	  	  	  	  Other:	  Address:	  	  	   	  Email:	   	  Telephone:	   	  
Section 1: General Feedback 
Q1. Why	  did	  you	  decide	  to	  participate	  to	  this	  workshop?	   	  	  Working	  in	  the	  field	  	  	  Suggestion	  by	  colleague	  	  	  Interested	  in	  computational	  haemodynamics	  	  	  	  Improve	  management	  of	  aneurysms	  	  	  Other:	  please	  specify	  	  …………………………………………….	  
Q2. How	  useful	  did	  you	  find	  this	  workshop?	   Not	  	  1	  	  	  2	  	  	  3	  	  	  4	  	  	  5	  Very	  
Q3. Would	  you	  recommend	  a	  friend	  to	  attend?	   	  	  No	  	  	  	  	  	  	  Yes	  
Q4. Would	  you	  recommend	  the	  software	  to	  a	  friend	   	  	  No	  	  	  	  	  	  	  Yes	  
Q5. Any	  specific	  shortcomings,	  surprises?	   1.	  2.	  3.	  
Q6. Any	  suggestions	  for	  course	  improvements?	   	  	  No	  	  	  	  	  	  	  Yes,	  I’ve	  described	  them	  below	  	  …………………………………………….	  
Q7. Rate	  your	  overall	  experience…	   Bad	  	  1	  	  	  2	  	  	  3	  	  	  4	  	  	  5Good	  
Section 2: Course Design and Conduct 
Q8. Was	  the	  participant-­‐to-­‐instructor	  ratio…	   	  	  OK	  	  	  	  	  	  Too	  many	  students	  
Q9. Were	  the	  instructions	  given	  in	  a	  clear	  way?	   No	  	  1	  	  	  2	  	  	  3	  	  	  4	  	  	  5	  Very	  
Q10. Was	  the	  content	  of	  the	  course	  scientifically	  appropriate?	   	  	  No	  	  	  	  	  	  	  Yes	  
Q11. Do	  you	  think	  the	  instructors	  were	  helpful?	   No	  	  1	  	  	  2	  	  	  3	  	  	  4	  	  	  5Very	  
Q12. How	  useful	  was	  the	  presentation	  and	  notes?	   Not	  	  1	  	  	  2	  	  	  3	  	  	  4	  	  	  5Very	  
Q13. Did	  you	  have	  any	  difficulty	  with	  terminology?	  	   	  	  No	  	  	  	  	  	  	  Yes,	  I’ve	  described	  it	  below	  	  …………………………………………….	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Q14. Were	  the	  IT	  facilities	  satisfactory?	   No	  	  1	  	  	  2	  	  	  3	  	  	  4	  	  	  5Very	  
Q15. Was	  the	  duration	  of	  the	  workshop…	   	  Too	  short	  	  	  	  	  Just	  right	  	  	  	  	  Too	  long	  
Section 3: Experience with the Software 
Q16. Do	  you	  find	  the	  software	  user-­‐friendly?	  	   No	  	  1	  	  	  2	  	  	  3	  	  	  4	  	  	  5	  Very	  
Q17. Will	  clinicians	  without	  tech/IT	  experience	  have	  trouble?	   	  	  No	  	  	  	  	  	  	  Not	  Sure	  	  	  	  	  	  	  Yes	  
Q18. Were	  you	  able	  to	  complete	  all	  the	  steps	  of	  the	  haemodynamic	  analysis?	  	   	  	  No,	  I	  missed	  those	  below	  	  	  	  	  	  	  Yes	  	  ……………………………..………….	  
Q19. Is	  there	  any	  obvious	  limitation	  which	  may	  prevent	  the	  use	  of	  this	  software	  in	  future?	  	   	  	  No	  	  	  	  	  	  	  Yes,	  I’ve	  described	  it	  below	  	  …………………………………………….	  
Q20. Please,	  identify	  the	  easiest	  and	  most	  difficult	  steps	  in	  the	  use	  of	  @neuFuse	   Easiest:	   ……………..………..	  Most	  Difficult:	   ……………………….	  
Q21. What	  would	  you	  change/improve	  in	  the	  software?	   1.	  2.	  3.	  
Q22. In	  particular,	  do	  you	  think	  that	  the	  Graphical	  User	  Interface	  (GUI)	  can	  be	  improved	  in	  any	  way?	   	  	  No	  	  	  	  	  	  	  Yes,	  I’ve	  described	  it	  below	  	  ………………………………………….	  
Q23. Do	  you	  now	  feel	  confident	  in	  the	  use	  of	  this	  software?	   No	  	  1	  	  	  2	  	  	  3	  	  	  4	  	  	  5	  Very	  
Q24. Would	  you	  like	  to	  be	  kept	  informed	  about	  developments	  of	  this	  software?	   	  	  No	  	  	  	  	  	  	  Yes	  
Section 4: Haemodynamic Understanding 
Q25. Did	  you	  have	  difficulty	  with	  the	  technical	  concepts	  (boundary	  conditions,	  wall	  shear	  stress,	  etc.)?	  	   	  	  No	  	  	  	  	  	  	  Yes,	  I’ve	  named	  them	  below	  	  …………………………………………….	  
Q26. Are	  the	  results	  from	  this	  software	  realistic?	   	  	  No	  	  	  	  	  	  	  Yes	  	  	  	  	  	  	  Not	  sure	  
Q27. Is	  current	  evidence	  sufficient	  to	  justify	  a	  role	  for	  haemodynamics	  in	  the	  pathogenesis	  of	  aneurysms?	   	  	  No	  	  	  	  	  	  	  Yes	  	  	  	  	  	  	  Not	  sure	  
Q28. Were	  you	  previously	  aware	  of	  the	  use	  of	  CFD	  to	  predict	  the	  risk	  of	  rupture	  in	  intracranial	  aneurysms?	   	  	  No	  	  	  	  	  	  	  Yes	  
Q29. If	  you	  see	  a	  publication	  on	  computational	  predictions	  for	  IA	  in	  a	  peer-­‐reviewed	  journal,	  will	  you	  read	  it?	   	  	  No	  	  	  	  	  	  	  Yes	  
Q30. Would	  you	  be	  interested	  in	  receiving	  high-­‐quality	  peer-­‐reviewed	  publications	  on	  haemodynamics	  in	  IA?	  	   	  	  No	  	  	  	  	  	  	  Yes	  
Section 5: Impact of CFD in Neurosurgery 
Q31. Ideally,	  who	  should	  perform	  this	  type	  of	  computational	  analysis	  for	  patients?	   	  	  Consultant	  	  	  A	  dedicated	  clinical	  scientist/	  engineer	  	  	  Registrar/	  junior	  member	  of	  team	  	  	  Anyone	  provided	  with	  adequate	  training	  	  	  It	  should	  be	  simplified	  so	  it’s	  an	  office	  job	  	  	  Other,	  please	  specify:	  	  …………………………………………….	  
Q32. Could	  this	  software	  be	  used	  diagnostically	  in	  an	  outpatient	  clinic?	   	  	  No	  	  	  	  	  	  	  Yes	  
Q33. Are	  you	  aware	  of	  any	  similar	  software?	  	   	  	  No	  	  	  	  	  	  	  Yes,	  I’ve	  named	  it	  below	  	  …………………………………………….	  
Q34. Should	  this	  type	  of	  analysis	  be	  fully	  automated,	  or	  is	  it	  better	  that	  the	  user	  has	  control?	   	  	  Automate	  	  	  	  	  Not	  Sure	  	  	  User	  control	  
Q35. Is	  there	  a	  future	  for	  computational	  tools	  for	  risk	  prediction	  of	  intracranial	  aneurysm	  rupture?	   	  	  No	  	  	  	  	  	  	  Yes	  	  	  	  	  	  	  Not	  sure	  
Q36. How	  great	  a	  clinical	  need	  is	  there	  for	  this	  software?	   	  	  Significant	  	  	  	  	  	  Low	  	  	  	  	  	  Emerging	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Q37. Do	  you	  think	  that	  this	  type	  of	  analytical	  software	  is	  ready	  for	  introduction	  into	  the	  clinical	  environment?	   	  	  Ready	  	  	  	  	  	  Not	  required	  	  	  	  	  	  Needs	  work	  
Q38. In	  which	  cases	  might	  this	  software	  influence	  your	  decision-­‐making	  about	  patient	  management?	  	   	  	  None	  	  	  	  	  	  	  All	  	  	  	  	  	  	  Those	  below…	  	  …………………………………………….	  
Q39. Would	  you	  be	  interested	  in	  participating	  in	  a	  multi-­‐center	  trial	  on	  the	  evaluation	  of	  this	  software?	   	  	  No	  	  	  	  	  	  	  Yes	  
Q40. Can	  you	  see	  any	  legal	  or	  ethical	  implications	  in	  the	  use	  of	  this	  software?	  	   	  	  No	  	  	  	  	  	  	  Yes,	  I’ve	  described	  them	  below	  	  …………………………………………….	  
Q41. The	  principles	  employed	  in	  @neurIST	  are	  applicable	  to	  other	  diseases;	  is	  this	  important?	   	  	  Important	  	  	  	  Only	  care	  about	  IA	  
Q42. More	  complex	  and	  informative	  analyses	  take	  longer	  to	  calculate;	  are	  quick	  results	  better?	   	  	  Quick	  	  	  	  	  	  	  Complex	  	  	  	  	  	  	  Let	  me	  choose	  
Q43. @neurIST	  IA	  rupture	  risk	  assessment	  can	  use	  more	  that	  haemodynamic	  data;	  is	  this	  important?	   	  	  Important	  	  	  	  Only	  need	  haemodynamics	  
Q44. @neurIST	  offers	  tools	  for	  researchers	  as	  well	  as	  clinicians;	  are	  these	  important?	   	  	  Important	  	  	  	  Only	  need	  clinical	  
Section 6: Bringing this Software into Routine Use 
Q45. Would	  you	  expect	  this	  software	  to	  be	  provided	  as	  part	  of	  a	  scanner,	  or	  as	  a	  stand-­‐alone	  product?	   	  	  Scanner	  	  	  	  	  	  	  Standalone	  	  	  	  	  	  	  Both	  
Q46. Would	  you	  expect	  such	  software	  to	  be	  provided	  by	  a	  scanner	  company	  or	  an	  independent	  specialist?	   	  	  Scanner	  Co	  	  	  	  	  	  	  Independent	  
Q47. Would	  you	  expect	  to	  pay	  for	  this	  software,	  or	  would	  you	  prefer	  a	  freeware/shareware	  arrangement?	   	  	  Pay	  	  	  	  	  	  	  Freeware	  	  	  	  	  	  	  Shareware	  
Q48. Would	  the	  price	  of	  this	  software	  be	  an	  important	  factor	  in	  your	  decision	  to	  obtain/use	  it?	   	  	  Important	  	  	  	  Cost	  is	  a	  lower	  priority	  
Any other comments? 	  
Thank-­‐you	  for	  completing	  this	  Questionnaire!	  	  	  .......................................................................................................................................................................................................................................................................	  	  	  OFFICE	  USE	  ONLY	  	  
Instructor’s evaluation of individual’s performance 	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OVERVIEW 
 
6.1: Introduction 
6.2: Effects of Smoking and Hypertension on the Formation of IAs 
6.3: Analysis of Different Haemodynamic Factors During Initiation and 
Rupture of an Intracranial Aneurysm and Possible Influence of Low 
Molecular Weight Heparin Mediated Change in the Blood Viscosity on 
Computed Values of These Haemodynamic Factors  
6.4: The Effects of Aortic Coarctation on Cerebral Haemodynamics and 
its Possible Role in the Aetiopathogenesis of Intracranial Aneurysms 
6.5: Conclusions 
 
*My contribution: In the studies described in this chapter, I played a 
major role in concept, study design, recruitment of patients, consenting 
them, conducting review of literature, performing analyses, performing 
statistical calculations, writing and submission of manuscripts to journals 
for publications. Dr Alberto Marzo (and other biomedical scientists, as 
detailed in acknowledgement section) gave important support and 
contribution in retrieval of medical images, performing CFD analyses, 
and post-processing of the results. 
 
**Declaration: In my study on The Effects of The Effects of Aortic 
Coarctation on Cerebral Haemodynamics and its Possible Role in the 
Aetiopathogenesis of Intracranial Aneurysms, apart form CoA patient, the 
measurements were also taken in five healthy volunteers to establish the 
flow-rates at different locations in the cerebral vasculature. The data form 
these volunteers however, could not be included in the study as 
unfortunately this data is not currently available. 
 	  
6.1. Introduction 
CFD is used as a tool for exploring the different factors that can influence 
the aetiopathogenesis of Intracranial Aneurysms by altering their 
haemodynamic environments. A number of studies are conducted in this 
context and CFD was used to prove or refute the hypotheses.  
 
CHAPTER 6.0: COMPUTATIONAL FLUID DYNAMICS AS A 
TOOL TO EXPLORE THE AETIPATHOGENESIS OF 
INTRACRANIAL ANEURYSMS 
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The first study in this section was conducted on the two well-known risk 
factors for Intracranial Aneurysm formation: smoking and hypertension. 
Whereas, smoking and hypertension are well-established risk factors in IA 
formation [Bonita 1986, de la Monte et al. 1985, Inci et al. 2000, Juvela 
2000, Kondo et al. 1997] their roles in the mechanisms that regulate 
aneurysm formation are poorly understood and are essentially limited to 
their statistical associations. In this study, I hypothesized that smoking and 
hypertension lead to intracranial aneurysm formation by changing the 
haemodynamic environment of the cerebral vasculature secondary to their 
effect on Blood Viscosity. There is good evidence in the literature that 
smoking and hypertension increase the Blood Viscosity in individuals [de 
Simone et al. 2005, Letcher et al. 1983]. CFD was used to compute the 
effects of these risk factors on wall shear stress (WSS) and oscillatory 
shear index (OSI) at the site of IA initiation, two most important factors 
for the development of Intracranial Aneurysms [Burleson et al. 1996, 
Byrne et al. 1998, Gao et al. 2008, Morimoto et al. 2002].  
 
In the next study, I analyze the differences in the haemodynamic 
environments of intracranial aneurysms during the stages of their initiation 
versus rupture. 3D Rotational Angiograms were used to build the three-
dimensional computer models of aneurysms included in the study 
followed by their qualitative and quantitative comparisons. The study 
further extended by investigating the effects of heparin (and enoxaparin) 
on the haemodynamic characteristics of aneurysms. Heparin (and its 
derivative enoxaparin) is a widely used injectable anticoagulant for 
preventing venous thrombosis and pulmonary embolism. It inhibits the 
factors involved in blood clotting (factor Xa), causing instantaneous 
inactivation of thrombin, thereby reducing Blood Viscosity [Hitosugi et al. 
2001) and, in turn altering the haemodynamics of the blood circulation. 
Values of WSS and OSI were computed with the help of CFD in a 
ruptured Intracranial Aneurysm and compared with a tiny aneurysm in the 
stage of initiation. Possible link, between the low blood viscosity, and 
alterations in values of WSS/ OSI, leading to the rupture of IAs was 
explored. Potential effects of other pharmacological agents on the 
aetiopathogenesis of intracranial aneurysms are also discussed. 
 
Another interesting study was conducted to analyze the haemodynamic 
changes in the cerebral circulation of patients with Coarctation of Aorta 
and its possible effects on the increased incidence and rupture of 
Intracranial Aneurysms in these patients. After a thorough search 
(PubMed®, Embase® and Google-Scholar™ searched from the year 1900 
up to 2009) I could retrieve only two relevant studies. Whereas, 
Hafkenschiel et al [Hafkenschiel et al. 1949) demonstrated a significant 
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increase in cerebral arterial flow-rates in patients with Coarctation of 
Aorta in 1949, Rowe and colleagues [Rowe et al. 1964] found no 
significant differences in the flow-rates before and after the repair of 
Coarctation of Aorta in their study performed in 1964. We therefore 
preformed pc-MR measurements in the cerebral arteries of a Coarctation 
of Aorta patient with coexisting IA and five healthy volunteers to establish 
the flow-rates at different locations in the cerebral vasculature.  
 
Amongst other aetiologies proposed, Coarctation of Aorta has been 
highlighted as a major risk factor in the aetiopathogenesis of IAs [Abbott 
1928, Ahmetoğlu et al. 2003, Connolly et al. 2003, DuBoulay 1965, 
Eppinger 1871). Incidence of Intracranial Aneurysms among patients with 
CoA is approximately 5 times higher than that of the general population 
[Connolly et al. 2003]. The incidence of IA rupture in CoA patients 
(4.8%) [Shimogonya et al 2009, Mercado et al. 2002, Reifenstein et al. 
1947] is also higher than the estimated rate of rupture in the general 
population, which is less than 1% [Weir et al. 1996]. In spite of CoA being 
a well-established risk factor for IA formation, [Abbott 1928, Ahmetoğlu 
et al. 2003, Connolly et al. 2003, DuBoulay 1965, Eppinger 1871] the 
exact underlying mechanisms for this association remain poorly 
understood. After measuring the flow-rates in the cerebral vasculature in 
patients with CoA, an analysis of the different haemodynamic factors 
inside Intracranial Aneurysms was performed. The possible role of 
haemodynamics is discussed in this context in a background of relevant 
literature.  
 
A better understanding of the aetiopathogenesis of the IA formation and 
rupture may help clinicians in preventing and treating the disease 
effectively. 
 
6.2. Effects of changing blood viscosity on computed wall shear stress 
and oscillatory shear index at the site of intracranial aneurysm 
formation 
 
6.2.1 Introduction 
Aneurysmal subarachnoid hemorrhage (SAH) remains a major cause of 
morbidity and mortality in neurosurgical patients [Inagawa et al 2001, 
Numminen et al 1996]. Smoking and hypertension are well-established 
risk factors in IA formation [Bonita 1986, de la Monte 1985 et al, Inci and 
Spetzler 2000, Juvela 2000, Kondo et al 1997]. However, their roles in the 
mechanisms that regulate aneurysm formation are poorly understood and 
are essentially limited to their statistical associations. 
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Recent evidence indicates WSS and OSI as important underlying 
haemodynamic factors in IA formation [Burleson and Turitto 1996, Gao et 
al 2008, Morimoto et al 2002]. One of the important parameters 
influencing WSS is blood viscosity, which in turn is influenced by 
smoking and hypertension [de Simone et al 1990, Letcher et al 1983]. The 
current study employs CFD to predict the effect of smoking and 
hypertension on the WSS patterns at the site of IA initiation with aim to 
explore the possible underlying mechanisms leading to their formation. 
 
6.2.2 Materials and Methods 
6.2.2.1 Study design and patient recruitment: The study was conducted 
jointly in the Departments of Neurosurgery and Neuroradiology, Royal 
Hallamshire Hospital, and the Department of Cardiovascular Science, 
University of Sheffield, Sheffield, UK. A total of two (n=2) patients 
diagnosed with IAs between Jan 2004 and March 2009, were identified 
retrospectively and recruited with appropriate consent and ethical 
approval. In order to avoid age and sex bias both patients were selected 
from the same age group (45 years) with one male and one female. Their 
relevant demographic and clinical data are reported in Table-6.1. 
 
Table-6.1: Patients’ demography, clinical presentations of IAs included in the study, their 
management, and the known risk factors 
Pt
. 
Age
/Sex 
Clinical 
presentation  
Ruptured/  
Unruptured 
Management Location of 
IA 
Smoking Hypertension Other risk 
factors 
1 45/
M 
Asymptomatic Unruptured Observed Lt terminal 
ICA  
>60 cigarettes/ 
day/ 25 years 
Poorly 
controlled 
None 
2 45/ 
F 
Asymptomatic Unruptured GDC 
embolization 
Rt terminal 
ICA  
>40 cigarettes/ 
day/ 22 years 
Controlled on 
medication 
None 
NB: Pt.; patient, GDC; Guglielmi detachable coils, Lt; left, Rt; right, ICA; internal carotid artery 
 
3DRA acquisitions: Medical images were obtained using rotational 
acquisition in a Philips® Integris™ Allura machine (Philips® Medical 
Systems, Best, The Netherlands), producing 100 images in 6 seconds, with 
5ms exposure per image. Voxel size in the reconstructed 3D images was 
121 microns with reconstruction matrix 512x512x512. 
 
6.2.2.1 Numerical 3D model: @neuFuse, the computational tool-chain 
developed within the EU project @neurIST was used to reconstruct vessel 
and aneurysmal geometries. Vessel triangular surfaces were reconstructed 
using a threshold isosurface extraction tool, based on the marching cubes 
algorithm developed by Lorensen and Cline [Lorensen and Cline 1987]. 
The removal of IAs was performed with the help of software @neuFuse. 
In order to mark the location of the IA in the parent artery after its 
removal, the image with IA in situ was superimposed over the image 
where the IA was removed. This step was done during the post-processing 
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of data with the help of software ANSYS®-CFX Postprocess™. A virtual 
marker (a sphere) was placed at the location of IA in the parent vessel 
from where the IA was removed. Now the first image (image with IA 
intact) was taken out and the location of IA (as localized by the virtual 
marker) was displayed by the arrows. Understanding the importance of the 
issue I have used exactly the same views for comparing the 
haemodynamic indices with and without intracranial aneurysms, so that 
the readers can make out the location of IAs easily in the view where there 
no IAs are present. 
 
Volumetric meshes were generated using ANSYS® ICEM™ CFD 11.0 
(Ansys®, Inc., Canonsburg, PA, USA) based on the octree approach. The 
mesh was refined at the wall (using prismatic elements) for more accurate 
computation of WSS and OSI. For computational efficiency a 
progressively coarser mesh was used towards the vessel axis. Tetrahedral 
elements were used for the discretization of the domain core, with three 
layers of prismatic elements adjacent to the wall, thus ensuring accurate 
computation of WSS and OSI. Element size and number were set 
according to the outcome of a mesh dependency study performed on 
similar aneurysmal geometries [Radaelli et al 2008]. In this study results 
were found to be grid independent for meshes greater than 1700 el/mm3. 
In order to maintain consistency across the meshes used for all geometries, 
similar element density and the same wall element size and maximum core 
element size were used in the discretization of the domains. 
 
The 3D transient Navier-Stokes equations were solved using the finite-
control-volume software, ANSYS®-CFX™. In view of the recent findings 
of [Marzo et al 2009] I used the ‘plug-flow’ or ‘flat’ velocity profile at 
inlet instead of Womersley flow profile. The default second-order high-
resolution advection-differencing scheme was used. Blood was assumed to 
be incompressible, with density ρ=1060 kg/m3 and Newtonian, with 
viscosity µtypical=3.5 mPa·s. The effects of hypertension and smoking 
were modeled by increasing BV values by 8.1% (µatypical=3.78 mPa·s) 
according to the findings of De Simone et al [de Simone et al 1990] and 
Price et al [Price et al 1999]. Boundary conditions (BCs) for the 3D 
models were provided in form of typical volumetric flow rate waveforms 
at inlet and pressure waveforms at outlet. These were computed using the 
1-D circulation model developed by Reymond et al [Reymond et al 2009]. 
The authors validated their model and found that the predictions of this 1-
D model have good agreement with the measurements performed in the 
real patient/ healthy volunteers. 
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6.2.3 Results 
Values of WSS and OSI were time-averaged for one cardiac cycle and a 
qualitative and quantitative comparison made for the two BVs. WSS 
contours reported in Figures-6.1 and 6.2, and the data reported in Table-
6.2, show that, in the case of  
 
Table-6.2: Quantitative comparison of areas and values of WSS the effects for µtypical and µatypical  
 Patient 1 Patient 2 
 µtypical µatypical % µtypical µatypical % 
Area of WSS > 15 Pa at aneurysm location [mm2] 1.24 1.42 +14.5 0.67 0.68 +1.5 
Area of WSS > 15 Pa in parent vessel [mm2] 7.01 8.24 +17.5 148.8 160.0 +7.5 
Maximum WSS at aneurysm location [Pa] 21.3 22.2 +4.2 56.54 58.73 +3.9 
Average WSS in parent vessel [Pa] 4.5 Pa 4.7 Pa +4.4 12.12 12.68 +4.6 
NB: µtypical; typical blood viscosity, µatypical; blood viscosity in smokers and hypertensive patients 
 
both patients, the aneurysm formed at a location where WSS was higher 
than the mean value in the parent vessel. At physiological BV, the 
maximum WSS at the site of IA initiation for patient-1 (21.3Pa) was 
approximately 5 times higher than the mean value in the parent vessel 
(4.5Pa).
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  
Similarly, for patient-2, the maximum WSS at the initiation site (56.5Pa) 
was approximately 5 times higher than in the parent vessel (12.1Pa). OSI 
also followed the same trend with relatively higher values at the sites of 
aneurysmal development for both patients, compared to that in the 
respective parent vessel (Figures 6.1 and 6.2, Table-6.2). However, it must 
Figure-6.1: Reconstructed geometry of the IA and surrounding vasculature for patient-1 (A). Contours of WSS 
(B,C) and OSI (D,E) for µtypical (B,D) and µatypical (C,E) are displayed. Arrows indicate the site of IA along the 
parent vessel before removal. 
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be noted that areas of relatively high WSS and OSI were not exclusively 
limited to the sites of IA formation.  
 
 
 
 
The threshold value of 15Pa for WSS used in the study was chosen as an 
arbitrary limit to highlight the areas of relatively higher WSS where the 
IAs were initiated and to appreciate/ quantify the effects of changes in BV 
in smokers and hypertensives on WSS. Whereas it was possible to identify 
Figure-­‐6.2:	  Reconstructed	   geometry	   of	   the	   IA	   and	   surrounding	   vasculature	   for	   patient-­‐2	   (A).	   Contours	   of	  WSS	  (B,C)	  and	  OSI	  (D,E)	  for	  µtypical	  (B,D)	  and	  µatypical	  (C,E)	  are	  displayed.	  Arrows	  indicate	  the	  site	  of	  IA	  along	  the	  parent	  vessel	  before	  removal.	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a threshold for infra-physiological WSS (<0.4Pa) [Malek et al 1996], no 
such values could be found in the literature for supra-physiological WSS. 
An increase in BV, to represent the effects of smoking and hypertension, 
is reflected in the values of WSS and OSI, reported in Table-6.2. For 
patient-1 the area of high WSS (>15Pa) increased by 17.5%, whereas for 
patient-2 the increment was 7.5%. The maximum values of WSS at 
initiation sites followed a similar trend, but the increment was around 4% 
for both patients. Interestingly, the increase in the value of WSS does not 
correlate linearly with the increment in BV. Furthermore, from the data in 
Table-2, it can be seen that changes in BV do not have a significant or 
consistent effect on the value of OSI at the site of aneurysmal 
development. 
 
Table 6.3: The literature-based evidence on the importance of WSS and OSI in the aetiopathogenesis of IAs  
Haemodynamic 
factors 
Intracranial Aneurysm Proposed mechanism(s) References 
Initiation Growth Rupture 
Dynamic 
Wall Shear Stress 
(WSS) 
High Low Low Increased WSS increases the 
production of MMP-13 which in 
turn leads to vessel wall damage 
Decreased WSS increases iNOS 
synthesis- NO induced damage to 
vessel wall 
Low WSS increases endothelial 
proliferation and apoptosis 
Boussel et al 2008, Fukuda et 
al 2000, Gao et al 2008, Jou et 
al 2008, Malek et al 1999, 
Meng et al 2007, Shojima et al 
2004, Ujie et al 1999 
 
Oscillatory Shear 
Index (OSI)  
High/Low High High Degenerative changes in 
endothelium 
Glor et al 2004, Goubergrits et 
al 2008, Mantha et al 2006 
NB: WSS; wall shear stress, MMP-13; matrixmetalloproteneases-13, iNOS; inducible-nitric oxide synthase, NO; nitric oxide, OSI; 
oscillatory shear index 
 
6.2.4 Discussion 
The exact aetiopathogenesis of IA formation is poorly understood [Sekhar 
and Heros 1981]. Whilst there is some indication of a congenital link 
[Forbus 1930], IAs are believed primarily to be acquired lesions 
[Crawford 1959, Stehbens 1975]. Recent evidence suggests a strong 
correlation between different haemodynamic factors and the 
aetiopathogenesis of IAs [Burleson and Turitto 1996, Byrne 1998, Gao et 
al 2008, Morimoto et al 2002]. In particular, a number of studies suggest a 
link between aneurysmal initiation, growth and rupture and the magnitude 
and distribution of WSS and OSI (Table-6.3).  
 
6.2.4.1 Wall Shear Stress (WSS) 
WSS is a tangential frictional force exerted by flowing blood on the 
arterial endothelium, and is proportional to the blood viscosity and the 
velocity gradients. Mean arterial WSS has been suggested by Malek et al 
to lie within the range of 1.5-2.0Pa [Malek et al 1996]. There is an 
increasing body of literature suggesting that high WSS plays a role in the 
initiation of IAs [Burleson and Turitto 1996, Byrne 1998, Gao et al 2008, 
Gonzalez et al 1992, Morimoto et al 2002, Sacco et al 1984]. This is 
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further supported by the observation that IAs most frequently occur at 
bifurcations and arterial bends. These are regions, which are exposed to 
constantly high WSS [Foutrakis et al 1997, Rossitti 1998]. 
 
A number of different mechanisms have been proposed to explain how 
WSS influences the natural history of an IA. It has been established that 
the normal behavior of arterial endothelial cells (ECs) is regulated by 
haemodynamic shear stress. Sho et al [Sho et al. 2002] observed that 
increased WSS stimulates ECs to produce matrix metalloproteinase 
(MMP-13), which, in turn, leads to degeneration of the internal elastic 
lamina. In 1993 Luscher and Tanner [Luscher and Tanner 1993] found 
that the release of EC-derived growth and relaxation factor (EDRF – later 
recognized as nitric oxide) is shear stress dependent and is responsible for 
vascular remodeling. It has been demonstrated by a number of workers 
[Cooke et al 1990, Fukuda et al 2000, Pohl et al 1991] that WSS increases 
the production of NO by the ECs by inducing an enzyme responsible for 
its synthesis (iNOS; inducible nitric oxide synthase). Fukuda et al [Fukuda 
et al 2000] found a high localization of iNOS at the site of IA formation, 
in both rat and human arteries. They also demonstrated that iNOS 
inhibitors such as Aminoguanidine and Batroxobin (DF-521) attenuate the 
early degenerative changes associated with IA formation. The preventive 
effects of these drugs are thought to be mediated by lowering BV and 
hence WSS [Fukuda et al 2000]. They concluded that iNOS is a 
prerequisite for de novo development of IAs in cerebral vessels. In 1995, 
Wang et al [Wang et al 1995] showed that smooth muscle cells (SMCs) in 
arterial wall can also respond to WSS in intact arteries by virtue of 
interstitial flow generated by transmural flow gradients, further 
accentuating the vessel wall damage. 
 
A number of authors have attempted to explain the mechanisms linking 
WSS with EDRF/NO production. Experimental studies conducted by 
Busse et al [Busse et al 1990] revealed that WSS activates calcium ion-
dependent endothelial iNOS leading to its increased production. 
Furthermore, WSS augments the release of adenosine tri-phosphate (ATP) 
and substance-P from EC [Milner et al 1990]. Increased concentrations of 
these two mediators are believed to enhance NO production in a paracrine 
manner [Pohl et al 1991]. More directly, increased WSS leads to 
hyperpolarization of the ECs by mobilizing the calcium ions from 
intracellular stores in cultured ECs [Ando 1988] probably via activation of 
phospholipase-C [Bhagyalakshmi and Frangos 1989] and/ or K+ channels 
[Olesen et al 1988]. Several authors have attempted to explain the 
mechanism of WSS transduction by the endothelium [Born and Palinski 
1985, Pohl et al 1991, Radaelli et al 2008]. Born and Palinski [Born and 
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Palinski 1985] identified 3D mechanoreceptors anchored to the endothelial 
membrane. They hypothesized that WSS acts on these mechanoreceptors, 
mechanically enhancing the interaction between regulatory proteins and 
their targets [Born and Palinski 1985]. Resnick and colleagues [Resnick et 
al 1993] located a WSS-responsive element for iNOS on endothelial genes 
in 1993.  
 
Table-6.4 gives an overview of the important mechanisms proposed on the 
role of WSS in vascular remodeling.  
Table-6.4: WSS-induced vascular remodeling: an overview of some important mechanisms proposed	  
Author/ Journal/ Year	   Proposed mechanism(s)/ Observations	   Implications	  
Rossitti et al (Acta Radiol, 
1998); Foutrakis et al 
(Neurol Res, 1997) 
IAs mostly occur at arterial bends and bifurcations	  
exposed constantly to high WSS	   High WSS can be a possible culprit in the development of 
IAs	  
Sho et al (Exp Mol Pathol, 
2002) 
Increased WSS stimulates endothelial cells to 
produce matrix metallo-proteinases (MMP-13) 
Degeneration of the arterial 
internal elastic lamina by 
MMP-13 
Luscher et al (Am J 
Hypertens, 1993 
Release  of  endothelium  derived  EDRF  is  
shear stress dependent  
Vascular remodeling by 
WSS 
Cooke et al (Am J Physiol, 
1990), Pohl et al (Am J 
Physiol, 1991) Fukuda et al 
(Circulation, 2000) 
 
 WSS induces iNOS, an enzyme responsible for 
NO synthesis
 
Increased production of 
NO in the endothelium, 
EC injury 
Fukuda et al (Circulation, 
2000) 
Found high concentrations of iNOS at the site of IA 
formation, both in rat and human arteries 
Levels of iNOS correlate 
with IA initiation 
Fukuda et al (Circulation, 
2000) 
iNOS inhibitors; Aminoguanidine and Batroxobin 
(DF-521) attenuate the early degenerative changes 
associated with IA formation 
Aminoguanidine and 
Batroxobin (DF-521) have 
preventive effects on IA 
formation by lowering WSS 
Wang et al (J Biomech 
Eng, 1995) 
SMCs in arterial walls also respond to shear stress WSS induced vessel wall 
damage can extend to SMCs 
Busse et al (FEBS Lett, 
1990) 
WSS activate the calcium ion dependent 
endothelial iNOS 
WSS increases the synthesis 
of iNOS 
Milner et al (Proc Biol Sci, 
1990), Pohl et al (Am J 
Physiol, 1991) 
WSS also augments the release of adenosine 
triphosphate (ATP) and substance-P from ECs 
These two mediators 
increase EDRF production 
in a paracrine manner 
Ando et al (In Vitro Cell 
Dev Biol, 1988) 
High WSS leads to the hyperpolarization of the 
ECs by mobilizing the calcium ions from 
intracellular stores 
EC damage 
Bhagyalakshmi et al 
(Biochem Biophys Res 
Commun, 1989) 
Hyperpolarization of ECs and mobilization of 
intracellular calcium is via activation of 
phospholipase-C 
EC damage 
Olesen et al (Nature, 1988) Hyperpolarization of the ECs and mobilization of 
intracellular calcium is via activation of K+ 
channels 
EC damage 
Born et al (Br J Exp 
Pathol, 1985) 
Identified presence of 3D mechanoreceptors 
anchored to the EC membrane, WSS acts on these 
mechanoreceptors, mechanically enhancing the 
interaction between regulatory proteins and their 
targets 
Link is established on how 
WSS transduces signals to 
ECs 
Resnick (Proc Natl Acad 
Sci USA, 1993) 
Located a WSS responsive element for iNOS on 
EC genes 
Role of WSS in EC damage 
Fukuda et al (Circulation, 
2000) 
Both, the magnitude of WSS as well as the duration 
of exposure for the endothelium remain important 
determinants for the induction of iNOS 
Duration and magnitude of 
WSS play important role in 
IA formation 
Wagner et al (J Clin 
Invest, 1997) 
Demonstrated that no iNOS was induced when the 
SMCs were exposed lower WSS (1.1-2.5 Pa) for 
shorter durations (<24 Hrs.) 
Chronic and significant 
exposure of WSS are 
required for the initiation of 
IAs 
NB: MMP-13; matrixmetalloproteneases-13, NO; nitric oxide, iNOS; inducible-NO synthase, EC; endothelial cells 
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The findings of the current study support the correlation between high 
WSS and initiation of IA. Maximum values of WSS at the site of 
aneurysm formation were approximately 5 times higher than the mean 
values observed in the parent vessels, in both patients (Table-6.2). 
 
6.2.4.2 Oscillatory shear index (OSI) 
The OSI is measure of the oscillatory nature of shear forces [Glor et al 
2004, Glor et al 2003, Goubergrits et al 2008, Marzo et al 2009]. This 
index, which has a range of between 0 and 0.5, represents the fraction of 
the cardiac cycle over which the instantaneous shear force vector forms an 
angle greater than 90 degrees to the time-average direction of the same 
force. Consistently high values of OSI have been associated with EC 
dysfunction [He et al 1996] and changes in cell structure secondary to 
cyclic mechanical stress have been demonstrated by Wang et al. [Wang et 
al 1995] reporting disruption of the actin cytoskeleton of ECs.  
 
Glor and colleagues propose that an OSI of 0.2 represents a threshold 
value above which endothelial damage is initiated [Glor et al 2004, Glor et 
al 2003]. Damage to ECs produced by high OSI may contribute in IA 
formation. Areas of relatively high OSI predicted at the site of aneurysm 
formation for patient-2 in my CFD simulations support such theories; the 
maximum values observed approached the threshold value of OSI (0.2) 
identified in the literature. In contrast, for patient-1, the OSI at the site of 
IA initiation fell well below the threshold. This may indicate a less 
significant role for OSI in IA formation, at least in the case of this 
particular patient. 
 
Whilst, for both patients, areas of high WSS and OSI were located 
primarily at the bifurcations where the two IAs were observed, areas of 
high value for these indices were also predicted at other sites in the parent 
vessels. This raises a further question; why are these other critical areas 
unaffected? One explanation is that, in addition to the key haemodynamic 
triggers, IA initiation is governed by many other factors including 
amongst others; smoking, hypertension, genetics, polycystic kidney 
disease, Ehlers-Danlos syndrome, Marfans’s syndrome, etc. In addition, 
the possibility of de novo IA formation in these patients in other locations 
in the future cannot be excluded without a long-term follow-up. 
 
6.2.4.3 Role of smoking and hypertension in the IA formation 
Smoking and hypertension are two well-established risk factors for IA 
formation. A number of clinical studies have highlighted the strong 
association between smoking [Anderson et al 2004, Bonita 1986, Qureshi 
et al 1998, Sacco et al 1984, Sauerbeck et al 2008] and hypertension [Inci 
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and Spetzler 2000, Sakaki et al 1993, Solenski et al 1995, Taylor et al 
1995, Teunissen et al 1996] and de novo IA formation. Indeed, both risk 
factors also correlate with the presence of multiple IAs [Erbengi et al 
1997, Juvela 2000, Ostergaard et al 1985, Qureshi et al 1998, Rinne et al 
1994]. Experimental studies, where IA has been induced by hypertension, 
confirm these findings [Handa et al 1993, Hashimoto et al 1987, Kim et al 
1992, Kondo et al 1997, Nagata et al 1980, Strother et al 1992]. 
Furthermore, autopsy studies conducted to assess the relationship between 
the IA formation and hypertension demonstrate even stronger correlations 
[Chason and Hindman 1958, Crompton 1964, de la Monte et al 1985, 
Sarner et al 1965, Toftdahl et al 1995]. 
 
Whilst being well-established risk factors for IA formation, the exact 
mechanisms by which smoking and hypertension lead to increased IA 
formation remain controversial [Inci and Spetzler 2000]. A number of 
explanations have been offered including; endothelial cell injury, 
occlusion of vasa vasorum and disturbances in the synthesis of elastin and 
collagen [Inci and Spetzler 2000]. It has been proposed that 
protease/protease-inhibitor factor imbalance is a factor in smokers and a 
quantitative deficiency of alpha-1-antitrypsin has been reported both in 
patients with SAH and in smokers [Gaetani et al 1996, Schievink et al 
1995, St Jean et al 1996]. Alpha-1-antitrypsin is an inhibitor of elastase, a 
proteolytic enzyme that enhances collagen catabolism. This link is not 
supported universally; Sakai et al [Sakai et al 1999] attribute the increased 
plasma protease levels found in patients with IAs to leukocytosis after 
SAH thus disputing the significance of plasma protease/protease-inhibitor 
imbalance as a marker for IA formation. Another hypothesis suggests that 
IA formation is a part of a vascular degenerative process similar to 
atherosclerosis and that smoking leads to IA initiation by facilitating this 
process [Adamson et al 1994, Greenhalgh et al 1980]. 
  
One widely recognized effect of smoking and hypertension is an increase 
in BV [de Simone et al 1990, Price et al 1999]. I propose that the missing 
link between these risk factors and increased IA formation is via high 
WSS secondary to an increase in BV. This hypothesis is supported by my 
findings, which show an increase in the area of vessel wall subject to high 
WSS and elevated maximum values of WSS coincident with the IA 
initiation site for the two patients studied. For patient-1 both qualitative 
(Figure-6.3) and quantitative (Table-6.2) comparisons show that increased 
BV results in a substantial increase in the maximum WSS of 4.2%. The 
area of wall affected by very high WSS (>15Pa), up by 14.5% and 17.5% 
for the site of the IA and parent vessel respectively. Similar trends were 
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observed for patient-2 but the relative differences were lower (Figure-6.4, 
Table-6.2).  
 
There is strong evidence to indicate that induction of iNOS in ECs is 
dependent on both the magnitude and duration of exposure to WSS 
[Fukuda et al 2000]. In an experimental study, Wagner et al [Wagner et 
al], found that iNOS was not induced when the vessel walls were exposed 
to low WSS (1.1-2.5 Pa) for short durations (<24 Hrs.). The study suggests 
that the chances of IA development are increased if an artery is exposed to 
high WSS on chronic basis. Both patients included in my study were 
exposed to these two risk factors chronically for an extended period (20-
25 years). Long-term exposure to high WSS, and the increase in the area 
of vessel wall affected, may have led to EC damage in these patients and 
contributed to an increased risk of IA development.  
 
Changes in OSI at the sites of IAs were less marked than changes in WSS, 
and had no consistent trend. Whilst OSI is not directly dependent on BV, 
changes in haemodynamics resulting from altered rheology may be 
reflected in the OSI. However, the results indicate its less significant 
dependency from the haemodynamic changes secondary to altered BV. 
 
It is important to note that my findings differ in some respects from those 
reported for previous studies, based on similar methodology [Marzo et al 
2009, Shimogonya et al 2009]. These sought to develop novel indices in 
an attempt to link initiation with a haemodynamic trigger whilst indicating 
that WSS was relatively low at the site of IA initiation. Shimogonya et al 
[Shimogonya et al 2009] reported a significant correlation between IA 
formation and a self-proposed haemodynamic index which they termed 
the ‘gradient oscillatory number’ (GON) and Mantha et al [Mantha et al 
2006] showed a correlation between IA initiation and their newly-
proposed haemodynamic index; aneurysm formation indicator (AFI). In 
considering these results in the light of the current work, it is important to 
note that Shimogonya et al used a simplified geometry that may have 
influenced their results. Furthermore, as there are bodies of literature 
associating low [Boussel et al 2008, Byrne 1998, Jou et al 2005, Malek et 
al 1996] and high [Burleson and Turitto 1996, Byrne 1998, Fukuda et al 
2000, Gao et al 2008, Gonzalez et al 1992, Morimoto et al 2002, Rossitti 
1998] WSS with endothelial dysfunction and the aetiopathogenesis of IA, 
it could be argued that both supra-physiological and infra-physiological 
WSS lead to perturbance of normal EC behavior. My findings agree with 
the majority of studies [Burleson and Turitto 1996, Byrne 1998, Fukuda et 
al 2000, Gao et al 2008, Gonzalez et al 1992, Morimoto et al 2002, 
Rossitti 1998] that support the role of high WSS in IA formation. 
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It is evident that the IA formation is likely to have a multi-factorial 
aetiology with haemodynamic factors acting as an important cog in this 
process. Many factors are likely to act in parallel rendering the vessel wall 
more susceptible to the effects of increased pressure and WSS. 
 
6.2.5 Limitations of the study 
Before drawing any conclusions it is important to emphasize that my 
study, in common with other CFD analyses, carries inherent limitations 
associated with the assumptions necessary to create the models. First, 
whilst very high quality images (3DRA) were used to reconstruct the 
vessel geometries, these represent the volume of the vessel occupied by 
contrast agent. If vessel filling with contrast is incomplete, this may 
generate errors in surface prediction. Unfortunately, due to the limitations 
of current technology this remains an unresolved problem. Second, the 
BCs used in the analyses were obtained from a generic 1D circulation 
model and were not patient-specific [Reymond et al 2009]. Here it is 
important to note that recent validation of this model against flow 
waveforms measured for young volunteers justify its use [Reymond et al 
2009]. Third, despite being non-Newtonian, blood was considered as a 
Newtonian fluid for the purposes of these analyses. This assumption was 
based on the observations that, blood behaves as a Newtonian fluid at the 
high shear-rates which apply at most sites in the cerebral circulation 
(>100s-1) [Bonert et al 2002], in particular in areas coinciding with sites 
of IA formation. Fourth, the arterial wall was considered rigid, neglecting 
wall motion, as this has been shown to have a negligible effect on CFD 
predictions [Ford et al 2008, Jeays 2007]. Finally, the study was 
performed on a small cohort of two IAs. The work must be considered as a 
preliminary study; analyses will be required for a significantly larger 
number of IAs before firm conclusions can be drawn. 
 
6.2.6 Conclusions 
The current study suggests that if the smoking and hypertension affect the 
blood viscosity as per the values given in the literature, the high values of 
blood viscosity can change the haemodynamic environment of the IAs. 
Furthermore, when I substituted these high blood viscosity values in CFD 
simulation I found that the values of computed WSS and OSI for patient 
were significantly higher.  
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6.3 Analysis of Different Haemodynamic Factors During Initiation 
and Rupture of an Intracranial Aneurysm and Possible Influence of 
Low Molecular Weight Heparin Mediated Change in the Blood 
Viscosity on Computed Values of These Haemodynamic Factors  
 
6.3.1 Introduction 
Aneurysmal subarachnoid haemorrhage (SAH), despite improvement in 
surgical and medical management, remains a major cause of morbidity 
and mortality [Inagawa 1998]. Whereas the exact aetiopathogenesis of IA 
formation and rupture is poorly understood, recent evidence indicates 
haemodynamics as an important underlying factor [Baskurt 2003, Danesh 
et al 2000, Sekhar and Heros 1981, Shojima et al 2004]. Most of the IAs 
are formed at arterial bends and bifurcations corresponding to the areas 
exposed to highest WSS. [Danesh et al 2000] Contrary to the initiation, 
aneurysmal growth has been demonstrated to coincide with regions where 
endothelial cell lining is exposed to abnormally low WSS. [Baskurt 2003] 
The rupture typically occurs when the stresses and strains in the 
aneurysmal wall exceed its strength and have been correlated to the 
complex intra-aneurysmal flow patterns, jet impingement, and areas of 
low WSS [Cebral et al 2005, Cebral et al 2008]. 
 
As confirmed by many authors [Baskurt 2003, Danesh et al 2000] 
haemodynamics of intracranial vasculature is dependent upon the 
rheological properties of blood, including BV. It is intuitive to speculate 
that the factors, which affect BV, may influence the haemodynamic 
environment of an IA, affecting in turn its initiation, growth, and rupture. 
Various workers have demonstrated the influence of commonly used 
drugs on BV including heparin, [Hosoda and Iri 1966] amlodipine, [Linde 
et al 1996], metoprolol [Hosoda and Iri 1966], pentoxiphilline 
[Schmetterer 1996], nitrates [Brugger et al 1985], oral contraceptives 
[Coata et al 1995], statins [Rosenson and Tangney 1998], various 
chemotherapeutic agents [Mark et al 2001], etc.  
 
As correctly feared by Sekhar and Heros [Sekhar and Heros 1981] in their 
classical review; with ever increasing use of more and more 
pharmacological agents there is a pragmatic possibility that a certain 
medical or surgical treatment modality may alter the delicate balance, 
leading to increased aneurysm formation or rupture. In the current study I 
analyzed and compared the important haemodynamic factors in two IAs, 
one in the stage of initiation (a preaneurysmal lesion, Aneu-1) and other a 
ruptured aneurysm (Aneu-2). Followed by this, the study investigates the 
effects of heparin on the haemodynamics of these IAs, and discusses its 
possible long-term implications on their natural history. 
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6.3.2 Material And Methods 
The study was conducted jointly in the departments of Neurosurgery and 
Neuroradiology, Royal Hallamshire Hospital, and the Academic Unit of 
Medical Physics, School of Medicine and Biomedical Sciences, University 
of Sheffield, Sheffield, UK. After obtaining appropriate consent and 
ethical approval the patient was recruited to the project @neurIST 
(www.aneurist.org). 
 
6.3.2.1 Clinical Details 
The patient included in the study was a 58-years-old woman presented in 
March 2008 with a history of sudden onset of severe headache, nausea 
vomiting, photophobia and loss of consciousness. She had a past medical 
history of deep vein thrombosis (DVT) and was on long-term warfarin for 
that. The Glasgow Coma Score (GCS) at the time of admission was 13/15 
(E3V4M6) with bilateral normally reacting pupils and no signs of 
meningism. An urgent CT scan of the head revealed presence of 
subarachnoid blood with normal ventricles.  
 
6.3.2.2 Endovascular Intervention and Postoperative Period 
 
A CT angiogram 
performed later 
demonstrated the 
presence of two 
IAs, further 
confirmed by a 
four-vessel 3DRA 
(Figure-6.3). First 
aneurysm (Aneu-1) 
was a tiny ‘bleb’ 
type IA in the 
ophthalmic segment 
of right internal 
carotid artery (ICA) 
and is considered as 
preaneurysmal 
lesion here. The 
second IA (Aneu-2) 
considered as 
source of bleed here 
was present in right 
Figure-6.3: Reconstructed geometries showing the IAs and 
connecting vessels reconstructed with software @neuFUSE. Labels 
indicate the openings where boundary conditions were applied. 	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ICA at the level of right posterior communicating artery (PComA). The 
radiological characteristics of the IAs are given in Table-6.5. It was 
decided to coil the tubular right ICA-PComA aneurysm in the same sitting 
using GDC® (Guglielmi Detachable Coils) embolization. A 6-French 
guide-wire catheter was positioned distally within the right extracranial 
ICA. The aneurysm was catheterized with an Excelsior® microcatheter 
using a Transend® 14 guide wire (Boston Scientific®, USA). The IA was 
packed satisfactorily using four Micrus® endovascular bare platinum 
coils. Patient’s hospital stay was unfortunately complicated by bouts of 
chest infections necessitating prolonged hospitalization. Throughout the 
hospital stay, she received low molecular weight (LMW) heparin 
(enoxaparin, Clexane®) for her DVT prophylaxis. The tiny ‘bleb’ IA was 
found unsuitable for coiling and therefore decided to be followed by 
MRAs. 
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Table-6.5: Radiological characteristics of IAs  
 Aneu-1 Aneu-2 
Location Rt. ICA –Ophthalmic  
segment 
Rt. ICA at the origin  
of PComA 
Size 1.4x2mm 9x3 mm 
Neck size 2.3mm 3.6mm 
Dome status Unruptured Ruptured 
Type Bleb/ preaneurysmal/  
side wall 
Saccular/ side wall 
Aspect Smooth Smooth 
Connected vessels   
Inlets Rt. ICA, Rt. PComA Rt. ICA, Rt. PComA 
Outlets Rt. Ophthalmic, Rt. MCA,  
Rt. ACA 
Rt. Ophthalmic, Rt. MCA,  
Rt. ACA 
NB:  Rt; Right, PComA; posterior communicating artery, ICA; internal carotid artery, MCA; middle cerebral artery, 
ACA; anterior cerebral artery. Connected vessels are used as outlets or inlets in the flow simulation, as indicated. 
  
6.3.2.3 Image acquisition protocol 
The medical images used in the study to reconstruct the aneurysm 
geometries were obtained using rotational acquisition in a Philips® 
Integris™ Allura™ machine (Philips® Medical Systems, Best, The 
Netherlands), producing 100 images in 6 seconds, with 5ms exposure per 
image. Voxel size in the reconstructed 3D images was 121 microns with a 
reconstruction matrix of 512x512x512. 
 
6.3.2.4 Numerical 3D model 
The @neurIST computational tool-chain was used to reconstruct the 
vessel surfaces as described by Singh and colleagues (Figure-3). 
Volumetric meshes were generated using ANSYS®-ICEM™ CFD-11.0, 
based on the octree approach. Grids were made finer at the walls and 
progressively coarser towards the vessel axis. Tetrahedral elements were 
used for the discretization of the domain core, with three layers of 
prismatic elements adjacent to the wall thus ensuring accurate 
computation of haemodynamic indices. In order to maintain consistency 
across the meshes used for all geometries, similar element density, same 
wall element size and maximum core element size were used in the 
discretization of the domains.  
 
6.3.2.5 CFD Analysis 
The 3D transient Navier–Stokes equations were solved by using the finite-
control-volume software, ANSYS®-CFX™. The default second-order 
high-resolution advection-differencing scheme was used. Blood was 
assumed to be incompressible, with density ρ=1060 kg/m3 and 
Newtonian, with viscosity μuntreated=0.0045 Pa.s; for untreated blood, and 
μheparin=0.0025 Pa·s; 22 for heparinized blood. This simulates the effect of 
heparin at an average therapeutic concentration of 0.0075 mg/ml. All 
analyses were run in parallel on two Itanium2 900MHz 64-bit processors 
of a Tiger-2 Linux cluster. The average time required to solve one cardiac 
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cycle was approximately 8.6 Hrs. The relevant haemodynamic variables 
were computed for both the viscosity values. Qualitative and quantitative 
comparisons of all the computed haemodynamic variables were 
performed. 
 
6.3.3 Results 
6.3.3.1 Comparison of the haemodynamics in initiation (Aneu-1) and 
rupture (Aneu-2) phase 
Table-6.6 gives the details of all haemodynamic indices computed using 
typical BV (μuntreated=0.0045 Pa.s) and their quantitative comparison 
between Aneu-1 and Aneu-2. The WSS, OSI and blood velocity values 
used in the present study are time-averaged along the cardiac cycle while 
the area of elevated pressure was considered at peak systole. Whereas, the 
flow was stable throughout the cardiac cycle in both the IAs and was 
momentum driven, it was more vortical in the ruptured lesion (Aneu-2) 
with higher flow velocities.  
Table-6.6: Inter-aneurysmal comparison of haemodynamic indices in Aneu-1 and Aneu-2 for typical BV (μuntreated) 
Haemodynamic variable Aneu-1 Aneu-2 Difference (%) 
Max-t-av-velocity in IA (m/s) 0.049 1.024       +95.2 
Space t-av-velocity in IA (m/s) 0.085 0.085 0 
t-av-WSSmin (Pa) 1.066 0.055 -1838.18 
t-av-WSS max (Pa) 35.9 67.75 +47 
Area of infra-physiological WSS (<0.4 Pa) 00% 0.8% +100 
Area of supra-physiological WSS (>1.5 Pa) 99.9% 91.2% -9.6 
OSI max 0.21 0.43 +51 
Area of elevated OSI (>0.2) 0.1% 2.6% +96 
Area of elevated pressure (%) 2.1% 3.5% +40 
No. Of Vortices 1 2-3  
NB: Aneu-1; preaneurysmal lesion, Aneu-2; ruptured aneurysm, μuntreated; untreated viscosity values used = 0.0045 
Pa.s, WSS; wall shear stress, OSI; oscillatory shear index, Max-t-av-velocity; maximum time-averaged velocity 
over the cardiac cycle; Space t-av-velocity; space and time-averaged velocity, t-av-WSSmin; minimum time-
averaged WSS, t-av-WSSmax; maximum time-averaged WSS. The values of WSS between 0.4 and 1.5 Pa are 
considered as physiological range after Malek et al. (1996) and the values of OSI above 0.2 were considered as a 
threshold value above which endothelial damage is initiated after Glor and colleagues. [Glor et al 2003 and 2004, 
Goubergrits 2008]. 
 
The most striking differences however were observed in the values of 
WSS, OSI and pressure. Whereas the values for minimum time-averaged 
WSS (t-av-WSSmin) were substantially lower (by 1838.18%) in the 
ruptured lesion the values for maximum time-averaged WSS (t-av-
WSSmax) showed an opposite trend. The area affected by infra-
physiological WSS (<0.4Pa) was larger in the ruptured lesion (0.8%) as 
compared to the preaneurysmal stage (0%). Quite the contrary, the area 
affected by supra-physiological WSS (>1.5 Pa) was larger in 
preaneurysmal stage. Both, the maximum values of OSI (OSImax) as well 
as the areas affected by the elevated OSI (>0.2) were higher in the 
ruptured lesion. Ruptured aneurysm also exhibited approximately 40% 
rise in the pressure on it wall as compared to its preaneurysmal 
counterpart. 
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6.3.3.2 Comparison of the effects of heparin on aneurysmal 
haemodynamics 
6.3.3.2.1 Qualitative comparison 
The comparisons of qualitative contour plots of WSS and OSI with and 
without effects of heparin show (Figure-6.4) that whereas the distributions 
of both the indices follow similar patterns for both values of BV, the areas 
affected by their high or low values have changed significantly. It is 
evident from Figure-6.4 that heparin as a rule increasing the areas affected 
by relatively low WSS while decreasing the areas affected by relatively 
high WSS. This pattern of change in the distribution is observed 
consistently across both the geometries. Whilst for both BV values, areas 
of low WSS remain confined within the dome and body of the aneurysms, 
zones of comparatively higher WSS were concentrated around the distal 
part of the neck and in areas within the aneurysmal body, where the jet 
generated at the base of the aneurysm impinges against its wall. Figure-6.4 
shows the increasing ‘low-WSS’ (black arrows) and decreasing ‘high-
WSS’ patterns for Aneu-1 and Aneu-2 (red arrows).  
 
Contrary to the t-av-WSS, it is observed that heparin treatment has 
peculiar effect on OSI. Whereas in some of the areas the areas of low OSI 
(black arrows) are increasing with heparin treatment, in other areas it is 
increasing the areas affected high OSI (red arrows). 
 
6.3.3.2.2 Quantitative comparison 
Table-6.7 shows a quantitative comparison between minimum and 
maximum values of WSS and OSI,  
Table-6.7: The Quantitative comparison of effects of heparin on haemodynamic indices  
 Aneu-1  Aneu-2  
 µuntreated µheparin Change % µuntreated µheparin Change % 
t-av-WSSmin (Pa) 1.066 1.086 +1.8 0.055 0.048 -12.7 
t-av-WSSmax (Pa) 35.9 28.08 -21.8 67.75 45.11 -33.4 
Area of infra-physiological WSS (<0.4 Pa) 0.009% 0.07% +677.8 0.8% 1.2% +50.0 
Area of supra-physiological WSS (>1.5 Pa) 99.9% 99.6% -0.3 91.2% 88.7% -2.7 
OSImax 0.21 0.17 -19.0 0.43 0.46 +7.0 
Area of elevated OSI (>0.2) 0.1% 00% -100.0 2.6% 4.1% +57.7 
Area of elevated pressure (%) 2.1% 2.5% -19.0 3.5% 4.0% +14.3 
NB: Aneu-1; preaneurysmal lesion, Aneu-2; ruptured aneurysm, μuntreated; untreated viscosity values used = 0.0045 
Pa.s, WSS; wall shear stress, OSI; oscillatory shear index, Max-t-av-velocity; maximum time-averaged velocity 
over the cardiac cycle; Space t-av-velocity; space and time-averaged velocity, t-av-WSSmin; minimum time-
averaged WSS, t-av-WSSmax; maximum time-averaged WSS. The values of WSS between 0.4 and 1.5 Pa are 
considered as physiological range after Malek et al. (1996) and the values of OSI above 0.2 were considered as a 
threshold value above which endothelial damage is initiated after Glor and colleagues. [Glor et al 2003, 2004, 
Goubergrits 2008] 
areas where values for these indices are outside their normal physiological 
range, [Glor et al 2003, 2004, Goubergrits 2008] and areas of elevated 
pressure for both the geometries. The change in values of these indices 
	   186	  
before and after heparin treatment is represented in percentage, in the last 
columns. 
 
Qualitative and quantitative comparisons for only three most relevant 
haemodynamic indices i.e. WSS, OSI and pressure were performed.  
 
 
Figure-6.4: The qualitative differences in the patterns of t-av-WSS and OSI in pre (a,b) and post heparinized (c,d) 
blood. Top two rows are contour plots for t-av-WSS. Bottom two rows are contour plots for OSI. a&b; front views, 
c&d; back views. Row 1&3; Aneu-1, row 2&4; Aneu-2.  
 
Whereas t-av-WSSmin was decreased in Aneu-2 after heparin 
administration by 12.7%, the values were minimally (1.8%) increased in 
Aneu-1. t-av-WSSmax was decreased in both IAs. An increase in the areas 
affected by infra-physiological WSS (<0.4Pa) was observed in both the 
lesions. The increments however were substantially higher (+677.8%) in 
the preaneurysmal lesion (Aneu-1) as compared to the ruptured IA (50%). 
The areas affected by supra-physiological WSS (>1.5 Pa) were decreased 
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in both the lesions when BV values specific to heparin were used. 
Whereas, the values for OSImax and the areas of elevated OSI (>0.2) were 
decreased in Aneu-1, the corresponding values were increased in Aneu-2 
after treatment with heparin. The distribution of elevated pressure areas 
followed the similar trend to that of OSI. 
 
6.3.4 Discussion 
There is a rapidly growing body of literature affirming the importance of 
haemodynamics in the aetiopathogenesis of IAs [Baskurt 2003, Burleson 
et al 1996, Castro et al 2006, Cebral et al 2005, Cebral et al 2008, Danesh 
et al 2000, Fukuda et al 2000, Gao et al 2008, Glor et al 2003, 2004, 
Goubergrits 2008, Inci and Spetzler 2000, Malek et al 1999, Mantha el at 
2006, Morimoto et al 2002, Shojima et al 2004, Steinman et al 2003]. The 
haemodynamic variables often considered in these studies are WSS, 
oscillatory shear index (OSI), blood pressure, and other quantities used to 
characterize blood flow. Proportional to blood viscosity and its velocity, 
WSS is the tangential frictional force exerted by the flowing blood on the 
walls of each vessel. High supra-physiological and low infra-physiological 
values of WSS have been associated with initiation, growth and rupture of 
aneurysms [Baskurt 2003, Fukuda et al 2000, Gao et al 2008, Glor et al 
2003, Shojima et al 2004]. A measure of the oscillatory nature of these 
viscous forces is given by the OSI, often associated with endothelial cells 
degeneration. [Glor et al 2003, 2004, Goubergrits 2008] Table-8 below 
gives a comprehensive list of haemodynamic variables from the literature 
and their association with IA evolution. 
 
An evaluation of these variables can provide a useful alternative to predict 
the behavior of an unruptured IA at an early stage before it changes in 
size, shape or becomes symptomatic. Unfortunately, the detailed in-vivo 
measurements of these relevant flow variables in the regions affected by 
the disease are currently impossible [Shojima et al 2004, Steinman et al 
2003]. Motivated by the important role played by haemodynamics and the 
difficulty of conducting detailed in-vivo observations of relevant 
haemodynamic variables, engineers and computer scientists have started 
using CFD to predict blood flows in IAs [Baskurt 2003, Castro et al 2006, 
Cebral et al 2005, Cebral et al 2008]. 
 
In this study, I observed that both aneurysms, representing the two 
extreme stages in the natural history of an IA, were peculiar in their 
haemodynamic characteristics (Table-6.6). Max-t-av-velocity was 
approximately 95% higher in Aneu-2 than the preaneurysmal lesion IA 
(Aneu-1). This might represent a correlation of high max-t-av-velocity and 
aneurysmal rupture. On the other hand the space and t-av velocity was 
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identical in both IAs making it difficult to draw any conclusions on its 
effect IA pathogenesis.  
 
Table 6.8: The literature-based evidence on the importance of haemodynamics in the aetiopathogenesis of IAs  
Haemodynamic 
factors 
Intracranial Aneurysm Proposed mechanism(s) References 
Initiation Growth Rupture 
Dynamic 
Wall Shear 
Stress (WSS) 
High Low Low Increased WSS increases the 
production of MMP-13 which 
in turn leads to vessel wall 
damage 
Decreased WSS increases 
iNOS synthesis- NO induced 
damage to vessel wall 
Low WSS increases endothelial 
proliferation and apoptosis 
Boussel et al 2008, Fukuda 
et al 2000, Gao et al 2008, 
Jou et al 2008, Malek et al 
1999, Meng et al 2007, 
Shojima et al 2004, Ujie et 
al 1999 
 
Oscillatory 
Shear Index 
(OSI)  
High/Low High High Degenerative changes in 
endothelium 
Glor et al 2004, Goubergrits 
et al 2008, Mantha et al 
2006 
Jet of Blood 
Stream 
Impingement Impingement Impingement Localized endothelial cell 
injury 
Foutrakis et al 1999, Cebral 
et al 2005, Cebral et al 2009 
Flow Pattern - - Complex Statistical association Cebral et al 2005, Cebral et 
al 2009 
Hydrostatic 
Pressure High High High Passive yield/ water hammer 
effect 
Inci and Spetzler 2000, 
Morimoto et al 2002, 
Steiger et al 1989 
NB: WSS; wall shear stress, MMP-13; matrixmetalloproteneases-13, iNOS; inducible-nitric oxide synthase, NO; nitric oxide, OSI; 
oscillatory shear index 
 
WSS is one of the most extensively studied haemodynamic indices. 
Whereas high supra-physiological values have been associated with 
initiation, the low values are thought to be responsible for growth and 
rupture. Cebral et al 2005, Cebral et al 2008 Values of t-av-WSSmin in the 
preaneurysmal lesion (Aneu-1) were significantly (1838.18%) higher as 
compared to the ruptured IA where it was significantly lower. t-av-
WSSmax also showed the similar patterns being higher in the Aneu-1 as 
compared to Aneu-2. As suggested by Malek et al [Malek et al 1999] the 
values of WSS between 0.4 Pa and 1.5 Pa were considered physiological 
range in the study. Whereas, the area affected by infra-physiological WSS 
(<0.4Pa) was larger in ruptured IA, the area affected by supra-
physiological WSS (>1.5 Pa) was bigger in initiation stage. It has been 
suggested that supra-physiological WSS increases the production of 
MMP-13, which in turn leads to vessel wall damage [Boussel et al 2008] 
leading to IA formation, especially at arterial bends and bifurcations. 
Infra-physiological WSS on the other hand increases iNOS (inducible 
Nitric Oxide) synthesis. [Fukuda et al 2000] NO induced damage to vessel 
wall increases endothelial proliferation and apoptosis.  
 
The increased values of OSI (>0.2) are found to be associated with 
aneurysmal pathogenesis by producing degenerative changes in 
endothelium. [Glor et al 2003, 2004, Goubergrits 2008]. In my study, both 
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OSImax and the area of elevated OSI (>0.2) were higher in ruptured IA as 
compared to one in the stage of initiation (Aneu-1). This observation may 
indicate that possibly the high values of OSI play more important role 
during the rupture of an IA than its initiation.  
 
High pressure has long been implicated in aneurysmal rupture [Inci and 
Spetzler 2000]. The rupture is thought to be an effect of passive yield to 
pressure leading to tissue failure and the water hammer effect [Inci and 
Spetzler 2000]. Keeping in consistent with the previous authors’ findings, 
the area affected by high pressure in the current study was greater in the 
ruptured IA (Aneu-2). The number of vortices inside an IA represents 
complexity of its flow, which in turn correlates with aneurysmal rupture 
[Cebral et al 2005, Cebral et al 2008]. Whereas, only one vortex was 
observed in Aneu-1 (preaneurysmal lesion) the flow was relatively 
complex in Aneu-2 (ruptured) with 2-3 vortices.  
 
Various pharmacological agents including Beta aminoproprionitrile 
fumarate (BAPN), a lathyrogen, have been successfully used in the 
induction of IAs in experimental animal models [Hosoda et al 1966, Inci 
and Spetzler 2000, Kim et al 1989]. BAPN irreversibly inhibits lysyl 
oxidase enzyme preventing the cross-linkage between elastin and collagen 
fibers, critical for the maintenance of normal structure and strength of 
vessel wall. The net effect is disruption or loss of internal elastic lamina, 
possibly facilitating the IA formation. Apart from the experimental animal 
models, there are reports describing the bilateral IA formation in human 
beings after the anticoagulation therapy [Turowski et al 2007]. The 
dissecting aneurysms regressed when aspirin replaced warfarin. It has 
been suggested that a combination of increased pressure (hypertension) 
and anticoagulation can play a role in the development of IAs in these 
situations thus contraindicating the use of anticoagulants in these patients 
[Pezzini et al 2006]. In their novel experimental studies Akoi and 
colleagues [Aoki et al 2007, Aoki et al 2007, Aoki et al 2008, Aoki et al 
2008, Aoki et al 2009] showed various inflammatory mediators playing a 
crucial role in the initiation and progression of IAs. More recently, the 
same group also demonstrated preventive effects of different drugs on the 
formation or progression of IAs including simvastatin [Aoki et al 2008], 
pitavastatin [Aoki et al 2009], and nifedipine [Aoki et al 2008]. It has been 
suggested that protective effects of these drugs are mediated through their 
property of inhibiting the inflammatory reactions in the IA wall. 
 
The effects of various pharmacological agents on the rheological 
properties of blood have extensively been studied by many authors. It has 
been shown that drugs like heparin [Hosoda and Iri 1966] 
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antihypertensives [Hosoda and Iri 1966], pentoxiphilline [Schmetterer 
1996] nitrates [Brugger et al 1985] oral contraceptives [Coata et al 1995] 
statins [Rosenson et al 1998], various chemotherapeutic agents [Mark et al 
2001], etc., can influence the BV. Heparin, a highly sulfated 
glycosaminoglycan, is a widely used injectable anticoagulant. Heparin and 
its newer derivatives like enoxaparin are very effective in preventing deep 
vein thrombosis and pulmonary embolism in the patients at risk. By 
binding with plasma-protease inhibitor antithrombin III, heparin 
accelerates its action, which in turn inhibits factors involved in blood 
clotting most notably factor Xa. Heparin increases the rate of this 
inactivation complex formation 1000-fold, thus causes instantaneous 
inactivation of thrombin, lowering the BV [Hosoda and Iri 1966]. This 
reduction in the BV then alters the haemodynamics of blood circulation 
[Baskurt 2003, Danesh et al 2000, Hitosugi and co-workers [Hitosugi et al 
2001] demonstrated that there was a decrease in the BV by 55.6% by 
heparin at a therapeutic concentration of 0.75 IU/lit. These values are used 
in the current study to simulate the BV in the patient when she was 
receiving this drug for DVT prophylaxis.  
 
As noted above the high values of t-av-WSSmin favor initiation and low 
values favor the rupture. Whereas the values of t-av-WSSmin in Aneu-2 
were decreased by heparin by 12.7%, the same values were affected 
minimally in Aneu-1, an observation that may promote rupture of an IA 
without much affecting the initiation. Quite the contrary, the heparin 
administration decreased t-av-WSSmax in both Aneu-1 and Aneu-2 by 
21.8% and 33.4%, respectively. Whereas, the situation favors rupture of 
the existing IAs, it may actually provide protection against formation of 
new ones. A dramatic increase of 677.8% was seen in the area affected by 
infra-physiological WSS (<0.4Pa) in preaneurysmal lesion (Aneu-1) after 
heparin administration. The same values were also increased by 50% in 
ruptured IA. Again, the deranged values are expected to facilitate the 
rupture of the existing IAs; but can be protective against formation of new 
lesions. The area affected by supra-physiological WSS was minimally 
affected by heparin. The values of OSImax are associated with both 
initiation as well as rupture of IAs. [Glor et al 2003 and 2004, Goubergrits 
2008]. Whereas, heparin decreased both OSImax as well as area of 
elevated OSI in preaneurysmal lesion (Aneu-1) the effect was opposite in 
the ruptured IA (Aneu-2) where both the values were increased. The 
findings further indicate that whereas heparin administration may 
accelerate the rate of rupture in the existing aneurysms it may suppress the 
formation of new IAs. 
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6.3.5 Conclusions 
Haemodynamics plays important role in the aetiopathogenesis of IAs. 
CFD can offer valuable alternative to extract this non-observable data 
from IAs that can be used to improve the prognosis and management of 
disease. The current study demonstrates that the haemodynamic patterns 
of IAs during initiation and rupture are significantly different. Whereas, 
values of t-av-WSSmin and areas affected by supra-physiological WSS 
were higher in preaneurysmal lesion the corresponding values were lower 
in ruptured IA. The area affected by infra-physiological WSS (<0.4Pa) 
was significantly higher in ruptured lesion as compared to preaneurysmal 
IA. Furthermore, by changing the blood viscosity, heparin can induce 
significant derangements in the haemodynamics of both, preaneurysmal as 
well as ruptured IA. In the light of evidence form this study, it is expected 
that whereas on the one hand such alterations in haemodynamics may 
facilitate the rupture of existing IAs, on the other hand they may suppress 
the formation of new IAs. Similar effects may be associated with other 
pharmacological agents, warranting further investigations.  
 
6.3.6 Limitations of the Study 
Before drawing any conclusions it is important to emphasize that my 
study, in common with other CFD analyses, carries inherent limitations 
associated with the assumptions necessary to create the models. First, 
whilst very high quality images (3DRA) were used to reconstruct the 
vessel geometries, these represent the volume of the vessel occupied by 
contrast agent. If vessel filling with contrast is incomplete, this may 
generate errors in surface prediction. Unfortunately, due to the limitations 
of current technology this remains an unresolved problem. Second, the 
BCs used in the analyses were obtained from a generic 1D circulation 
model and were not patient-specific. Here it is important to note that 
recent validation of this model against flow waveforms measured for 
young volunteers justify its use [Reymond et al 2009]. Third, despite 
being non-Newtonian, blood was considered as a Newtonian fluid for the 
purposes of these analyses. This assumption was based on the 
observations that, blood behaves as a Newtonian fluid at the high shear-
rates which apply at most sites in the cerebral circulation (>100s-1), 7 in 
particular in areas coinciding with sites of IA formation. Fourth, the 
arterial wall was considered rigid, neglecting wall motion, as this has been 
shown to have a negligible effect on CFD predictions [Ford et al 2008, 
Jeays et al 2007]. Finally, the study was performed on a small cohort of 
two IAs. The work must be considered as a preliminary study; analyses 
will be required for a significantly larger number of IAs before firm 
conclusions can be drawn. 
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6.4 The Effects of Aortic Coarctation on Cerebral Haemodynamics 
and its Possible Role in the Aetiopathogenesis of Intracranial 
Aneurysms 
 
6.4.1 Introduction 
Estimated annual incidence of IAs in most western countries is 1 to 2% 
[Atkinson et al 1989, Inagawa et al 1990]. Aneurysmal subarachnoid 
haemorrhage (SAH) is feared with unacceptably high overall mortality 
rates of 45% (32-67%) [Hop et al 1997]. About 30% of survivors have 
moderate to severe disabilities and 66% of those who have ‘successful’ 
clipping, never return to same quality of life as before SAH [Hop et al 
1997, Drake et al 1981]. The current evidence convincingly supports a 
multi-factorial basis for the initiation and rupture of IAs [Sekhar and 
Heros 1981, Yong-Zhong et al 1990, Stehbens 1989].  
 
Amongst other aetiologies proposed, Coarctation of Aorta (CoA) has been 
highlighted as a major risk factor in the aetiopathogenesis of IAs 
[Eppinger at al 1871, Abbott et al 1928, Walton et al 1956, Laitinen et al 
1960, DuBoulay 1965, Patel 1971, Orsi 1993, Schievink 1996, Ishii 2001, 
Mercado 2002, Ahmetoğlu 2003, Connolly 2003, Cowan 2004, Hudaoglu 
2006, Kan 2007]. A wide range for the incidence of IAs in patients with 
CoA has been reported starting from 2.5% [Abbott 1928] to as high as 
50% [Shearer 1970]. All quoted figures nevertheless are above the 
estimated incidence of 1-2% of IAs in general population. It is however 
found by Connolly and colleagues in their recent study that the frequency 
of IAs among patients with CoA is approximately 5 times higher that of 
the general population [Connolly2003]. Apart from that the incidence of 
IA rupture in CoA patients (4.8%) [Reifenstein1947] also outnumbers the 
estimated rate of rupture in the general population, which is less than 1% 
[Weir1996]. In spite of CoA being a well-established risk factor for IA 
formation [Eppinger1871, Abbott1928, Walton1956, Laitinen1960, 
DuBoulay1965, Patel1971, Orsi1993, Schievink1996, Ishii2001, 
Mercado2002, Ahmetoğlu2003, Connolly2003, Cowan2004, 
Hudaoglu2006, Kan2007], the exact underlying mechanisms for this 
association remain poorly understood. Hypertension [Orsi1993, 
Walton1956, Stehbens1962, Stehbens1989, DuBoulay1965, Patel1971, 
Banna1973, Orsi1993, Ishii2001, Ahmetoğlu2003] and developmental 
errors of neural crest resulting in abnormal vessel wall collagen 
[Laitinen1960, Schievink1996, Mercado2002, Connolly2003, 
Cowan2004, Hudaoglu2006, Kan2007] are two main factors thought to 
facilitate the formation of IAs in presence of CoA. It is surprising to note 
that in spite of well-established role of WSS in the genesis of IAs 
[Burleson1996, Gao2008, Morimoto2002, Handa1983, Hashimoto1987, 
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Hashimoto1980, Mantha2006, Meng2007, Wang2009], none of the 
workers explored this important link in this context. 
 
Owing to their direct origin from the pre-coarctation segment of aorta 
cerebrocephalic arteries are most likely to be affected by the 
haemodynamic changes occurring in this part of aorta. Secondary to the 
increased resistance to outflow increased aorto-cranial pressure gradients 
have been demonstrated by a number of authors correlating to the severity 
of stenosis [Gupta1951, Abbott1928, Hom2008, Varaprasathan2002, 
Mohiaddin1993]. Dilatation of cervicocephalic arteries in CoA secondary 
to this increased pressure gradient is has also been reported [Rowe et al 
1964, Abbot1928]. 
 
An increase in the radius (r) of cerebral arteries and increased arorto-
cranial pressure gradient (ΔP) in CoA are expected to result in an 
exponential rise in flow-rates (Q) as per the Hagen-Poiseuille’s law 
(Equation-1), given the viscosity (µ) and length (L) remain constant.  
 
 
 𝑄 = ∆!!!" 𝜋𝑟!............. (Eq-1) 
 
Furthermore, bradicardia coupled with increased stroke volume and 
cardiac output is a known feature of CoA [Gupta1951]. These increments 
will further increase the cerebral blood-flow (CBF).  
 
An increased flow-rate (Q) on the other hand remains one of the major 
factors responsible for increased wall shear stress (WSS) in the 
intracranial arteries (Equation-2).  
 
 𝜏 = 4𝜂 !!!!................. (Eq-2) 
 
Where 𝜏 is WSS and 𝜂 is average blood viscosity. 
 
Literature seems to be particularly deficient and controversial on the 
effects of CoA on cerebral flow-rates. After a thorough search (Pubmed®, 
Embase® and Google-Scholar™ searched from the year 1800 up to 2009) I 
could retrieve only two studies done in this field. Whereas, in 1949 
Hafkenschiel et al [Hafkenschiel1949] demonstrated a significant increase 
in cerebral flow-rates in patients with CoA, Rowe and colleagues [Rowe 
1964] found no significant differences in the flow-rates before and after 
the repair of CoA in their study done in 1964. No apparent efforts were 
done since then to measure the cerebral flow-rates in patients with CoA. 
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Paucity of information about the flow patterns inside the cerebral 
circulation in presence of CoA provided us a rationale to measure the 
cerebral flow-rates in the present patient. Furthermore, given the widely 
accepted importance of haemodynamics in the aetiopathogenesis of IAs 
[Burleson1996, Gao2008, Morimoto2002, Handa1983, Hashimoto1987, 
Hashimoto1980, Mantha2006, Meng2007, Wang2009] it is logical to 
analyse the haemodynamic factors in the coexisting IA of our patient. A 
better understanding of the aetiopathogenesis of the IA formation and 
rupture may help clinicians in preventing and treating the disease 
effectively.  
In the current study I preformed pc-MR (phase contrast magnetic 
resonance) measurements in the cerebral arteries of an IA patient with 
coexisting CoA and five healthy volunteers followed by an analysis of the 
different haemodynamic factors inside IA. The possible role of 
haemodynamics is discussed in this context in a background of relevant 
literature. 
6.4.2 Materials and Methods 
The study was conducted jointly in the departments of Neurosurgery and 
Neuroradiology, Royal Hallamshire Hospital, and the Academic Units of 
Medical Physics, and Radiology, School of Medicine and Biomedical 
Sciences, University of Sheffield, Sheffield, UK. After obtaining 
appropriate consent and ethical approval the patient was recruited to the 
@neurIST project (www.aneurist.org). 
6.4.2.1 Clinical details: This 51-years old lady, presented for the first 
time to cardiovascular surgeons in 1989 at the age of 31 years through 
obstetric unit. She had hypertension in both her pregnancies but was 
otherwise asymptomatic. She was a smoker, smoking 10-15 cigarettes per 
day. On clinical examination, she was generally fit and well with a BP of 
160/90. No femoral pulses were palpable and there was an ejection 
systolic murmur in the aortic area coupled with a continuous machinery 
murmur at left scapula. She was taking oral antihypertensives (Atenolol 
and Nifedipine) to control her hypertension. Subsequent investigations 
including DVI (digital vascular scan) done that time revealed a severe 
(>80% reduction in diameter) post-ductal aortic coarctation distal to origin 
of left subclavian artery. X-ray chest showed typical inferior notching of 
3rd and 8th ribs, bilaterally. No other congenital anomalies were detected 
apart from a pseudo-bicuspid aortic valve, without any evidence of 
regurgitation or stenosis. One year later, the patient was treated with 
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Dacron onlay patch graft (DOPG) repair for her coarctation with an 
uneventful postoperative recovery.  
A follow-up MRI of the heart and great vessels done in July 2004 after 15 
years of primary procedure demonstrated evidence of re-coarctation with 
significant (60-70%) loss of luminal diameter. The stenosis occurred just 
distal to the origin of left subclavian artery coinciding with the site of 
repair. Presence of significant collaterals was also noted along with 
marginal concentric hypertrophy of left ventricle but satisfactory ejection 
fraction. A BRUCE treadmill stress test done to evaluate cardiac fitness 
demonstrated an appropriate exercise tolerance without any chest pain or 
ECG changes. 24-hour BP monitoring further confirmed a satisfactory BP 
control (Figure-6.5). Being completely asymptomatic and no signs of 
cardiac failure whatsoever it was decided to manage her conservatively.  
Figure-6.5: 24 hours ambulatory Non-invasive BP (NIBP) monitoring showing satisfactory 
BP control for both systolic and diastolic values. 
	   196	  
The patient was referred to the neurosurgeons in May 2007 with 
complaints of tingling and numbness affecting right side of her face. On 
further interrogation she gave history of a similar episode three years back 
resulting in spontaneous resolution, but no other neurological symptoms. 
On clinical examination she had an unremarkable neurology. An MRI 
done to investigate it further demonstrated presence of two incidental IAs. 
First aneurysm was located in the pericallosal artery and was 4.2 mm in 
maximum diameter. A second small broad necked 1 mm aneurysm was 
also present at the origin of left anterior temporal artery arising from the 
proximal left middle cerebral artery (MCA). The findings were further 
confirmed by a 3D rotational angiogram (3DRA), which apart from two 
previous IAs, also revealed an approximately 1.8 mm aneurysm in the 
subclinoid segment of left internal carotid artery (ICA), pointing medially 
(Figure-6.6). The case was discussed in a multidisciplinary meeting with 
neuroradiologists and it was found that due to its small neck the 
pericallosal IA was suitable for coil embolization.  
 
6.4.2.2 3DRA acquisition: All medical images were obtained using 
rotational acquisition in a Philips® Integris™ Allura machine (Philips® 
Medical Systems, Best, The Netherlands), producing 100 images in 6 
seconds, with 5 ms exposure per image. Voxel size in the reconstructed 
3D images was 121 microns with reconstruction matrix of 512x512x512. 
 
Figure-­‐6.6:	   Intracranial	   aneurysm	   included	   in	   the	   study	   shown	   in	   (a)	   circle	  of	  Willis	   (yellow	  sphere)	  and	  (b)	  in	  subclinoid	  part	  of	  ICA	  (arrow)	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6.4.2.3 Endovascular Interventions: The pericallosal artery aneurysm 
was coiled under general anaesthetic in May 2008 with GDC® (Guglielmi 
Detachable Coils) embolization. A 6-French guided catheter was gently 
placed within the distal right ICA. The aneurysm was catheterized with an 
Excelsior® SL-10 microcatheter using a Transend® 14 guide-wire (Boston 
Scientific, USA). The IA was packed satisfactorily using four Micrus® 
Cerecyte® endovascular bare platinum coils. She made an uneventful 
recovery from the procedure. Owing to their small size and unsuitability 
for endovascular coiling (broad neck) remaining two aneurysms were 
decided to be observed by follow-up MRAs.  
 
6.4.2.4 Flow Measurements & pc-MR protocol: MR imaging was 
performed at high field strength (Achieva™ 3.0T, Philips® Medical 
Systems, Best, The Netherlands) using a standard 8-channel, 
radiofrequency receive-only head coil. The same radiographer imaged the 
patient and all volunteers to maximize reproducibility of overall 
acquisition technique. Macroscopic vascular flow and IA location were 
visualized using a qualitative Time-Of-Flight (TOF) MR angiography 
sequence (TR=25ms; TE=3.5ms; α=20˚; visualization voxel 
size=0.39x0.39x1.00mm3). Maximum intensity projections from this 3D 
dataset were used to define the placement of each quantitative phase-
contrast measurement plane perpendicular to the vessel under 
investigation. A 2D acquisition sequence (TR=8ms; TE=4.4ms; α=10˚; 
field of view=220x179mm2; in-plane acquisition matrix=128x112; slice 
thickness=5mm) was used to acquire 40 velocity-encoded ‘time points’ 
over the cardiac cycle at each vascular location. Vector ECG triggering 
was used to standardize each quantitative acquisition. 
 
The measurements were performed at three locations, both in healthy 
volunteers and in patient: left proximal ICA, left distal ICA, and left ACA 
A-1 segment. An appropriate maximum velocity-encoding (VENC) value 
was chosen (100 cm/sec) for ICA to ensure that appropriate dynamic 
ranges were sampled in all cases and no phase-aliasing occurred. As 
proximal vessels geometry has an important influence on intra-aneurysmal 
haemodynamics [Castro 2006], measurements were taken at a distance of 
approximately 10 vessel diameters from the aneurysm location. 
Measurement location in distal vessels was approximately 3 diameters 
from the IA.  
 
Measurements are reported in Table-6.9, and are consistent with boundary 
conditions (BCs) in the 3D models. The manufacturer’s proprietary post-
data-acquisition processing software (Q-Flow™, Philips® Medical Systems, 
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Best, The Netherlands) was used to estimate VFR waveforms at each 
spatial location.  
 
Table-6.9: Radiological characteristics of the IA included in the study, the pc-MR measurements in CoA patient 
and healthy volunteers along with the locations, types and methods of BC application 
IA Location, 
Size* and 
Neck Size* 
Q-flow measurements using pc-MR and BC application 
 
Lt ICA 
Subclinoid, 
1.8mm, 3.1mm 
Location of Q-Flow 
measurements 
Q-av-Typical 
Healthy 
Volunteers (ml/s) 
Q-av-CoA 
patient 
(ml/s) 
Change 
(%) 
BC location BC type BC Method†  
1. Lt ICA Proximal 3.95 5.44 +27.4 1. Lt ICA 
Proximal 
Inlet/ 
velocity 
pc-MR 
 2. Lt ICA Distal 3.7 5.07 +27.1 2. Lt ICA 
Distal 
Outlet/ 
velocity 
pc-MR 
 4. Lt ACA 1.2 2.66 +54.9 3. Lt 
OphthA 
Outlet/ 
pressure 
Typical/ population 
average 
NB: Q-av; average blood flow, BC; boundary condition, Lt; left, Rt; right, ICA; internal carotid artery, MCA; middle cerebral artery, OphthA; 
ophthalmic artery, *size is reported as max diameter. †BC method refers to the analyses based on patient-specific BC from CoA patient. 
 
6.4.2.5 Transthoracic Doppler echocardiography: Flow and pressure 
measurements were performed using transthoracic Doppler 
echocardiography (Philips® Sonos™ 5500). The results are reported in 
Figure-6.9. 
 
6.4.2.6 Numerical 3D models and computational fluid dynamics 
(CFD) analysis: The @neurIST computational tool-chain was used to 
reconstruct vessel and aneurysmal geometries, as described by Marzo et al 
[Marzo 2009]. The 3D transient Navier–Stokes equations were solved by 
using the finite-control-volume software ANSYS®-CFX™. Blood was 
assumed to be incompressible, with density ρ=1060 kg/m3 and Newtonian, 
with viscosity µ=0.0035 Pa·s. The relevant haemodynamic indices were 
computed (Table-6.10) in the IA located in subclinoid part of left ICA 
(Figure-6.6) of the patient using the VFR values measured in the patient as 
BCs. A second analysis was performed with BCs derived from the average 
VFR values measured in healthy volunteers. Location, type and method of 
BC applied in the study are indicated in Table-6.9. All analyses were run 
on two Itanium2® 900MHz 64-bit processors. The average time required 
to solve one cardiac cycle was approximately 8.6 Hr. 
 
6.4.3 Results 
On comparing the patient-specific waveforms (Figure-6.7) from CoA 
patient (red) with that of typical normal individual (blue) it becomes 
apparent that the VFR waveform in the proximal ICA of CoA patient is 
higher then the one for the healthy volunteers. This also reflected by the 
average values reported in Table-6.9 where the flow-rates for the CoA 
patient are 1.5 times higher (5.44 ml/sec) as compared to the normal 
healthy individuals (3.62 ml/sec). 
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The flow waveforms further illustrate that the cerebral flow in CoA rises 
and falls slowly than that of a typical individual but the overall volume 
over one cardiac cycle is increased from 3.48 ml to 4.54 ml. A new broad 
hump (arrow-a) is seen just after the original peak (arrow-b). The systolic 
upstroke is delayed and slow; the peak is broader (between arrows a & b), 
slightly lower and rounded. The flow during diastole is almost a smooth 
decline curve (arrow-c) and the notch indicating the beginning of diastole 
is absent (arrow-d).  
  
0.0
5.0
10.0
0.00 0.20 0.40 0.60 0.80
Q 
[m
l/s
]
time [s]
coarctation patient
typical average (n=5)
mean coarctation patient
mean typical avaerage
a
c
d
b
Figure-6.7: A comparison of VFR waveforms from CoA patient (marked-red) measured in 
proximal ICA and average VFR waveforms from healthy volunteers (marked-blue) in the same 
location. The flow-rates in presence of CoA are 1.5 times higher (5.44 ml/sec) as compared to the 
normal healthy individuals (3.62 ml/sec). Solid horizontal lines represent average values of VFR for 
CoA (red) and typical (blue). 	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The contour plots for haemodynamic indices and their absolute values 
 
 
 	  	  
 
 
 
 
 
 
 
 
 
 
Figure-­‐6.8:	  Time-­‐averaged	  WSS	  (top)	  and	  OSI	   (Oscillatory	  shear	  index)	   (bottom)	  contour	  plots	  in	  the	  left	  subclinoid	  intracranial	  aneurysm	  of	  CoA	  patient.	  Whereas,	  the	   areas	   affected	   by	   high	   WSS	   are	   increased	   in	   CoA	   patient	   (top,	   right)	   as	  compared	  to	  healthy	  volunteers	  (top,	  left)	  the	  OSI	  values	  are	  minimally	  changed	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Table-6.10 below shows the absolute values of WSS, OSI, velocity and 
pressure for IA, obtained using BCs derived from healthy volunteers and 
measurements taken in CoA patient by pc-MR. 
 
 
 
 
Table-6.10: Absolute values of WSS, OSI, velocity and pressure for IA, obtained using BCs derived from healthy 
volunteers and measurements taken in CoA patient by pc-MR 
Haemodynamic Indices 
BCs derived from  
healthy volunteers (without CoA) 
BCs derived from  
patient (with CoA) % difference 
Max t-ave velocity (m/s) 0.5 0.72 +44 
Space and t-ave velocity (m/s) 0.072 0.097 +35 
Max OSI 0.3 0.3 0 
Area of WSS below 0.4 Pa (mm2) 0.05 (0.3%) 0.03 (0.2%) -34 
Area of WSS above 15 Pa (mm2) 0.4 (0.4%) 3.0 (17.2%) +650 
Space and t-ave WSS in aneurysm (Pa) 5.7 9.4 +65 
Max pressure on aneurysm wall (mmHg)* 122.4 140.8 +15 
Area of elevated pressure (mm2)* 3.0 (17.1%) 1.5 (8.5%) -50% 
NB: WSS; wall shear stress, OSI; oscillatory shear index, Max; maximum, ave; average, t; time, BC; boundary 
condition, * indicates the values at peak systole	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Figure-6.9: Transthoracic Doppler echocardiogram showing aortic coarctation with a 
diastolic tail. A coarctation gradient of 30-40mmHg was seen (arrowhead) while the average 
aortic pressure was 16mmHg. The peak velocity in aorta was 276cm/sec. 
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6.4.4 Discussion 
The CoA is a connective tissue disorder accounting for 10% cases of 
congenital heart disease [Verheugt 2008]. The most common site of 
narrowing is distal to the left subclavian artery. Due to the mechanical 
outflow obstruction and extensive collateral formation a number of 
haemodynamic changes are seen in CoA. The most notable is a differential 
hypertension produced in the segment of aorta above the site of narrowing 
leading to increased aorto-cranial pressure gradients [Gupta1951, 
Abbott1928, Hom2008, Varaprasathan2002, Mohiaddin1993] and 
dilatation of cervicocephalic arteries [Rowe et al 1964, Abbot 1928]. The 
similar changes were seen in our patient (Figure-6.9). A pressure gradient 
of 30-40 mmHg was present at the site of coarctation. The peak velocity in 
aorta was also increased to 276 cm/sec as against the peak velocity of 80-
90 cm/sec in the aorta of a normal person [Daley 1985]. As discussed in 
the previous sections, it is hypothesized here that the CBF in CoA patients 
should increase as a consequence of these changes. 
 
It is surprising to see that such little attention is devoted on the effects of 
CoA on CBF. The first available study on the subject was conducted by 
Hafkenschiel et al [Hafkenschiel1949] in 1949. They measured CBF and 
cerebral oxygen consumption in two patients with CoA using nitrous 
oxide (NO) saturation method. They found that the CBF in patients with 
CoA was higher as compared to normal subjects.  
 
A similar study was done by Rowe and colleagues [Rowe 1964] in 1964 
that measured the CBF in 20 CoA patients using the same technique. The 
CBF was measured in these patients before and after the surgical 
correction of CoA and the results were compared with CBF values 
obtained in normal subjects in their previous study [Rowe 1959], as well 
as CBF values specific to hypertensive patients [Crumpton 1955]. No 
significant differences were noted in the CBF pre and post surgical repair 
of coarctation and, between CoA patients and hypertensive patients. 
Interestingly, whereas authors conclude that there were no significant 
differences in the CBF in CoA patients and healthy volunteers, the values 
of average CBF measured by them (63±13 ml/100 gm/ min) were 
approximately 21.2% higher compared to the CBF measured by same 
authors in 8 normal subjects (52±12 ml/100 gm/ min) [Rowe 1959] using 
same methodology. Apart from that, the postoperative measurements in 
the study were taken at an average interval of 21 months (maximum 9.25 
yrs.) from the time of surgery. Re-coarctation is a frequent complication of 
the coarctation surgery that can occur in 41-86% patients [Hesslein 1981]. 
The similar patterns were observed in our patient where 60-70% loss of 
luminal diameter occurred 14 years after repair. As Rowe and colleagues 
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did not assess the diameter of aorta at the time of CBF measurements, the 
possibility of re-coarctation in these patients cannot be ruled out which 
might account for the lack of difference in the CBF before and after 
surgical correction.   
 
Moreover, being over 40-60 years old, the measurements in both the 
studies were performed using the oldest available technique based on NO 
diffusion and Fick’s principle introduced by Kety and Schmidt in 1951 
[Kety 1951]. The technique has several limitations. Apart from being 
cumbersome and difficult to perform, it only provides the measurements 
of global CBF rather than the regional values. The accuracy of 
measurements is dependent upon the reliability of the blood sample 
withdrawn from a single jugular vein, which can be influenced by the flow 
variations in dural sinuses and torcula [Joseph 2000]. With the advent of 
technology, the technique of CBF measurement has evolved 
tremendously. The use of pc-MR in this context is gaining a rapid 
popularity [Ueda 1999, Rordorf 1999, Buijs 1998, Enzmann 1993, 
Enzmann 1994, Yamashita 2007]. The CBF can be measured using this 
technique in a simple non-invasive manner without the need of any 
intravenous contrast administration and has been validated widely by 
means of in vitro and in vivo experiments [Caputo 1991, Kondo 1991, 
Evans 1993, Bakker 1995].   
 
Apart from that, both the studies provide the estimation of global CBF in 
CoA patients. The recent evidence however indicates that it is the local 
variations in the haemodynamics that play an important role in the 
aetiopathogenesis of IAs [Gao 2008, Morimoto 2002, Handa 1983, 
Hashimoto 1987, Hashimoto 1980, Mantha 2006, Meng 2007, Wang 
2009] highlighting the importance of assessing the local CBF. No previous 
study however has examined the local CBF in presence of CoA. 
According to the Hagan-Poiseuille’s law I hypothesised that the local CBF 
should increase in patients with CoA. The results from current study 
demonstrate that my hypothesis is correct and the regional blood-flow in 
ICA and ACA of CoA patient was 27.1 to 54.9% higher (Table-6.9) when 
compared to healthy volunteers. Keeping in line with the increased flow-
rates in the cerebral arteries in presence of CoA (Table-6.9) the space and 
time averaged velocity and max time average velocities inside the 
coincidental IA present in the same patient were also increased by 35-44% 
(Table-6.10) when the BCs specific to CoA were used.  
 
I further hypothesize that this increased regional CBF can be an important 
contributory factor in the increased incidence of IAs in presence of CoA. 
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The possible mechanisms responsible for increased incidence of IAs in 
CoA patients are explored in the further sections of this manuscript.  
 
Eppinger was the first person to draw attention towards the association 
between CoA and IAs in 1871 [Eppinger 1871]. Whereas the exact 
mechanisms responsible for this increased incidence remained obscure, 
arterial hypertension (HTN) has been suggested as a possible underlying 
cause by most of the authors (Table-6.11) [Stehbens 1989, 1962, Walton 
1956, Patel 1971, Banna 1971, Orsi 1993, Ishii2001, Ahmetoğlu 2002]. 
Stehbens was the strongest proponent of this theory who particularly 
stressed on the importance of hypertension in this context while denying 
the role of all other factors including vessel wall abnormalities [Stebehns 
1989, 1962].  
 
This assumption is probably based on two observations. First, HTN is 
often a constant feature in CoA patients. Second, HTN has been 
considered as a major risk factor for the development of IAs even without 
CoA [de la Monte 1985, Taylor 1995]. In spite of an increased prevalence 
of IAs in hypertensive patients many authors have questioned the role of 
HTN in this context. McCormick and Schmalstieg found no relationship 
between arterial HTN and IAs in 250 patients they studied [McCormick 
1977]. In a similar study conducted in 212 cases Andrews and Spiegel 
[Andrews 1979] did not find significant elevation in the blood pressure in 
patients with IAs compared with the general population. However, studies 
supporting HTN as a risk factor for the development and rupture of IAs 
outnumber the studies refuting it. De la Monte et al [de la Monte 1985] 
found high degree of correlation (p<0.001) between systemic hypertension 
and development of saccular IAs. In one of the largest studies conducted 
including 20,767 elderly patients Taylor et al [Taylor 1995] found HTN as 
an independent major risk factor for aneurysmal SAH.  
 
It is argued here that whereas HTN can be an important contributory force 
in the aetiopathogenesis of IAs in these patients, it cannot be the sole 
perpetrator. Hudaoglu et al [Hudaoglu 2006] raised a question on HTN 
alone being a factor in the aetiopathogenesis of IAs in CoA patients. The 
fact is further supported by the observation that IAs may develop or 
rupture even in normotensive patients, years after the repair of CoA 
[Mercado2002, Forfang 1979, Laborde 1983, Ostergaard 1983]. Apart 
from that, HTN was not uniformly noted in the patients of CoA reported to 
have IAs [Connolly2003, Schievink1996]. The IAs were developed in our 
patient 17 years after the surgical correction of CoA. However, re-
coarctation of the repaired segment occurred during this period (>70% 
reduction in aortic diameter), the patient remained completely 
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asymptomatic with a very well controlled blood pressure (Figure-6.5). My 
findings also indicate towards the presence of the some factors working 
independently of arterial HTN. 
 
In their study conducted in 1960 Laitinen and Snellman [Laitinen1960] 
found that apart from CoA, aneurysms of Pericallosal artery region were 
also associated with other concomitant malformations such as 
craniosynostosis and kyphoscoliosis. They believed that coexistence of 
these malformations with IAs is secondary to a common developmental 
error-playing role in their aetiology. Embryologically- heart, aorta and 
cervicocephalic arteries all share a common origin from neural crest. After 
recognizing the association between a variety of congenital heart diseases 
and IAs, Schievink et al [Schievink1996] attributed the occurrence of IAs 
in CoA patients to the developmental errors of neural crest resulting in 
abnormal vessel wall collagen. The same theory was later supported many 
other authors (Table-6.11) [Mercado2002, Connolly2003, Cowan2004, 
Hudaoglu2006, Kan2007]. 
 
Haemodynamic stress due to increased blood flow has long been 
implicated in the pathogenesis of IAs. Development of IAs is reported in 
association with a wide range of conditions responsible for increased flow 
related WSS. Padget was first to draw attention towards the relationship 
between anatomical variations in CoW and increased incidence of IAs 
[Padget 1944]. The similar findings were confirmed by other workers 
[Riggs 1943, Stehbens 1963, Alpers 1963].  
 
Kayambe et al [Kayambe 1984] observed that there was a definitive 
correlation between the site of vascular asymmetry and the location of IA 
formation. This increased incidence of IAs in presence of vascular 
asymmetry is thought to be caused by increased haemodynamic stress 
secondary to compensatory increase in blood flow [Kayambe 1984, 
Stehbens 1963, Stehbens 1972].  
 
Iatrogenic carotid artery (ICA) ligation is a well-established technique to 
produce IAs in experimental animals [Jamous 2007, Handa 1983, 
Hashimoto 1987, Hashimoto 1978, Nagata 1980]. Increased 
haemodynamic shear stress has been considered a major factor in the 
production of these experimental IAs [Gao 2008, Jamous 2007, Handa 
1983, Hashimoto1987, Hashimoto1987, Nagata 1980]. Apart from the 
carotid ligation, induced hypertension and administration of BAPN (beta 
aminopionitrile; a lathyrogen used to render arterial walls fragile), have 
also been common adjuncts of these experiments. One might argue here 
on the importance of haemodynamic shear stress on the development of 
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these IAs in these situations. In order to test this assumption Handa et al 
[Handa 1983] divided their experimental animals into three cohorts: no 
carotid ligation, unilateral carotid ligation and bilateral carotid ligation. 
Whereas, all rats were made hypertensive and fed on BAPN, no IA was 
induced where carotid artery was not ligated. Furthermore, the IAs were 
always formed corresponding to the sites where haemodynamic stress was 
expected to increase after carotid ligation. 
 
Table-6.11: A comprehensive review of different mechanisms proposed for the increased incidence of 
IAs in CoA patients  
Author/ Year No. of 
Patients  
IA location/ 
No. 
HTN at the time 
IA diagnosed 
Associated features Proposed 
Mechanism(s) 
Abbot (1928)  6 ACA, 
AComA, VA, 
PcomA, MCA 
Yes Reported one case of his own 
(MCA), rest 5 cases collected 
from literature 
Congenital IA 
Laitinen et al 
(1960) 
1 Pericallosal/ 
Callosomargin
al 
Yes Oxycephalic deformity of skull Possible 
developmental 
errors 
Patel et al 
(1971)  
7 ICA, AComA 
(3), ACA (3), 
PcomA, BA 
Yes Only pediatric population (<19 
yrs.) reviewed, 12% had CoA 
coexisting with IAs 
HTN 
Banna et al 
(1971)  
1 PCA NA Source of SAH was dilated 
spinal collaterals  
Medial hypoplasia 
of arteries of CoW 
+ HTN 
Stehbens 
(1989)  
Review article HTN  
Orsi et al. 
(1993)  
1 MCA, ICA NA - HTN 
Schievink et 
al (1996) 
1 MCA No - Development 
errors of Neural 
Crest leading to 
defective collagen 
and elastin 
formation 
Ishii et al 
(2001) 
1 AComA Yes Coarctation of abdominal aorta HTN 
Ahmetoğlu et 
al (2002)  
1 B/L MCA Yes Coarctation of abdominal aorta HTN ± 
Haemodynamic 
shear stress 
Mercado et al. 
(2002) 
3 ICA, PcomA 
(2), PeriA 
Yes Provided a comprehensive 
review of the distinct clinical 
behavior of IAs in presence of 
CoA 
Development 
errors of Neural 
Crest 
Connolley et 
al (2003)[ 
10 ICA, MCA, 
PICA, PCA, 
PcomA, 
AChoA, BA 
tip 
Yes (in 7 out of 
10 patients) 
Found 10% incidence of IAs in 
patients with CoA, no significant 
difference in BP of patients with 
and without IAs  
Development 
errors of Neural 
Crest 
Cowan et al 
(2004) 
1 PcomA No Coexisting Alagille syndrome 
(arteriohepatic dysplasia), 
Progression of infundibulum to 
PcomA Aneurysm 
Developmental 
defects 
Harikrishnan 
(2005) 
1 BA, VA Yes CoA of Descending aorta, 
coronary artery aneurysms 
Atherosclerosis  
Hudaoglu et 
al (2006) 
1 PcomA No Raised strong suspicions about 
HTN alone being a factor for the 
increased incidence of IA in CoA 
Development 
errors of Neural 
Crest 
Kan et al 
(2007) 
1 ICA NA Fusiform aneurysm associated 
with PHACES syndrome, 
positive family history of IAs 
Development 
errors of Neural 
Crest 
Singh et al 
(2009) 
(Present 
study) 
1 ICA, MCA, 
PeriA 
No Measured the CBF in CoA 
patient and proposed WSS as an 
important factor in the formation 
of IAs in these patients 
Haemodynamic 
WSS 
NB: PHACES syndrome; posterior fossa malformations, facial haemangiomas, arterial anomalies, CoA, cardiac defects, eye 
abnormalities and sterna defects, NA; not available, B/L; bilateral, CoW; circle of Willis, BP; blood pressure, PeriA; pericallosal 
artery, AChoA; anterior choroidal artery, PCA; posterior cerebral artery, BA; basilar artery, VA; vertebral artery, PICA; posterior 
inferior cerebellar artery  
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Congenital absence of ICA [Chen 2008, Suyama 2009, Horie 2008], 
arteriovenous malformations (AVMs) [Meisel 2000, Redekop 1998, 
Thompson 1998], Takayasu’s arteritis [Takayama 2008, Kanda 2004], 
Moyamoya disease [Kawaguchi 1996, Konishi 1985, Adams 1979] and 
presence of persistent fetal circulation [Zada 2008, Ali 2007, Li 2004] are 
other similar conditions where increased IAs are encountered due to flow 
related WSS. Development of IAs has also been observed following extra-
intracranial bypass procedures [Kurokawa 2007, Nishimoto 2005, 
Fleischer 1979], again secondary to increased CBF. Resolution of these 
flow related IAs could occur once the cerebral haemodynamics is 
reestablished by addressing the underlying pathology [Takahashi 1997, 
Peltier 2008].  
 
It is surprising to see that in spite of its very well established role in the 
aetiopathogenesis of IAs, nobody discussed the importance of 
haemodynamic WSS in this context. Ahmetoğlu et al (2002) indicated that 
arterial wall injury secondary to increased haemodynamic shear forces 
may be an important factor in the IA formation while discussing their case 
of abdominal aortic coarctation (AbCoA). However, the statement 
probably reflects their opinion towards the aetiopathogenesis of IAs in 
general population rather than in patients with CoA. Furthermore, the 
inference of was merely based on the literature based evidence rather than 
any experimental work. They finally concluded that hypertension was the 
main factor responsible for the rupture and growth of IAs in patients with 
AbCoA [Ahmetoğlu 2002].  
 
I hypothesize that the higher WSS values secondary to increased flow-
rates in cerebral circulation can be an important contributory factor in the 
pathogenesis of IAs in presence of CoA. WSS is a frictional force exerted 
tangentially on the arterial endothelium by flowing blood. It is 
proportional to the blood viscosity and velocity gradients. The average 
physiological range of arterial WSS has been suggested to lie between 1.5-
2.0 Pa by Malek et al [Malek 1999]. It is widely accepted now that 
damage to the arterial and subsequently aneurysmal wall by 
haemodynamic forces plays a crucial role in the aetiopathogenesis of IAs 
[Burleson 1996, Gao 2008, Morimoto 2002, Handa 1983, Hashimoto1987, 
Hashimoto1987, Mantha 2006, Meng 2007, Wang 2009]. High supra-
physiological and low infra-physiological values of WSS have been 
associated with initiation, growth and rupture of aneurysms [Malek 1999, 
Burleson 1996, Gao 2008, Morimoto 2002, Handa 1983, Hashimoto1987, 
Hashimoto 1987, Mantha 2006, Meng 2007, Wang 2009]. The values of 
space and time averaged WSS as well as the area affected by 
supraphysiological WSS (>15Pa) were increased in our patient by 65% 
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and 650%, respectively (Table-6.10). This exponential rise in the high 
supraphysiological WSS may play an important role in the 
aetiopathogenesis of IAs in patients with CoA.  
 
Various authors have tried to explain the underlying mechanisms involved 
in the WSS induced vascular remodeling. The normal endothelial cell 
(EC) function and structure are regulated by WSS through a process called 
mechanotransduction [Davies 1993, Davies 1995]. The shear stress is 
sensed by a number of mechanoceptors including basal adhesion points of 
ECs, cell junctions and nuclear membrane [Davies 1993, Davies 1995]. 
WSS also activates stretch-sensitive ion channels such as phospholipids 
and integrins in cellular membrane [Davies 1993, Davies 1995]. Increased 
production of matrix metalloproteinase (MMP-13) by ECs has been 
demonstrated after their prolonged exposure to high WSS, which, in turn, 
leads to degeneration of the internal elastic lamina [Sho et al [69]].  It has 
been demonstrated by a number of workers [Cooke 1990, Fukuda 2000, 
Pohl 1991] that WSS increases endothelial production of nitric oxide (NO) 
by inducing an enzyme responsible for its synthesis (iNOS; inducible 
nitric oxide synthase). Fukuda et al [Fukuda 2000] found a high 
concentration of iNOS at the site of IA formation, in both rat and human 
arteries and concluded that iNOS is a prerequisite for de novo 
development of IAs in cerebral vessels. In 1995, Wang et al [Wang 1995] 
showed that smooth muscle cells (SMCs) in arterial wall can also respond 
to WSS in intact arteries by virtue of interstitial flow generated by 
transmural flow gradients, further accentuating the vessel wall damage. 
 
In addition to WSS, oscillatory shear index (OSI) has also been recognized 
as an important haemodynamic factor in the aneurysmal pathogenesis 
[Glor 2003, 2004, Goubergrits 2008, He 1996, Mantha 2006]. It is 
measure of the oscillatory nature of shear forces [Glor 2003, 2004, 
Goubergrits 2008, He 1996, Mantha 2006]. This index, which has a range 
of between 0 and 0.5, represents the fraction of the cardiac cycle over 
which the instantaneous shear force vector forms an angle greater than 90 
degrees to the time-average direction of the same force. Consistently high 
values of OSI have been associated with EC dysfunction [He et al 1996]. 
Changes in cell structure secondary to cyclic mechanical stress have been 
demonstrated by Wang et al [Wang et al 1995] resulting in disruption of 
the actin cytoskeleton of ECs. Glor and colleagues propose 0.2 as a 
threshold value for OSI above which endothelial damage is initiated [Glor 
et al 2003, 2004]. Whereas, no change was observed in the maximum OSI 
in presence of CoA (Table-6.10), the values obtained from both analyses 
(0.3) remained above this critical threshold. This indicates towards the 
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possible role of high OSI in the EC damage in patients with IAs 
irrespective of presence or absence of CoA.  
 
Apart from being a known risk factor for the formation of IAs, CoA has 
also been associated with increased incidence of IA rupture [Mercado 
2002, Connolly 2003, Hudaoglu 2006, Weir 1996]. No satisfactory 
explanation is provided for this increased association. This increased 
tendency for early aneurysmal rupture can possibly be explained by 
analyzing the haemodynamic factors computed for our patient (Table-
6.10). Whereas the values for maximum pressure on IA wall have 
increased by 15% in the patient with CoA, the area affected by high 
pressure is actually decreased by 50%. It means that CoA increases 
pressure applied per unit area. In other words, the pressure on the IA wall 
is more concentrated in nature in presence of CoA and may be an 
important underlying factor affecting the early aneurysmal rupture. Apart 
from that, high supra-physiological values of WSS have also been 
associated with endothelial cell dysfunction [Burleson et al. 1996, Handa 
et al 1996, Hashimoto et al 1978, Hashimoto et al 1980, Hashimoto et al 
1987, Malek et al 1999, Mantha et al 2006, Meng et al 2007, Morimoto et 
al. 2002 Singh et al 2009, Wang et al 1995]. The exponential rise (by 
650%) in the area affected by high supra-physiological WSS (>15Pa) may 
also play a role in early IA rupture in the patient with CoA.  
 
6.4.5 Limitations of the study 
Due to technical limitations, I could not perform extensive measurements 
in cerebral arteries other than ICA and ACA. It is however expected that 
the CBF will be increased in other arteries as well provided other 
parameters in the Hagan-Poiseuille’s equation remain constant. The 
current study therefore reflects the need of further studies performed on 
bigger cohort of patients with CoA.   
 
Moreover, as stated above the IAs are likely to share a multifactorial 
aetiology. Two other known risk factors in the formation of IAs are HTN 
and smoking. Whereas, our patient remained completely normotensive 
after the repair of her CoA (Figure-6.9) she had had high BP prior to 
surgery, managed by antihypertensives. Apart from that, she was also a 
chronic smoker smoking 10-15 cigarettes per day. The possibility of HTN 
and smoking playing some role in the formation of her IAs therefore 
cannot be ruled out.   
 
6.4.6 Conclusions 
My study demonstrates that the cerebral flow-rates in CoA patients are 
significantly higher when compared to average flow-rates in healthy 
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population. Furthermore, the values of space and time averaged WSS as 
well as the area affected by supraphysiological WSS (>15Pa) were 
increased in our patient by 65% and 650%, respectively. The values of 
maximum OSI however, remained unaffected by the presence of CoA. 
Increased haemodynamic WSS secondary to the increased flow-rates may 
play an important role in the pathogenesis of IAs in CoA patients. The 
increased per unit pressure on aneurysmal wall in CoA patients may be an 
important underlying factor affecting the early aneurysmal rupture.  
 
IAs can develop in patients with CoA years after the surgical repair. I 
recommend that a high index of suspicion should be kept and all CoA 
patients should be carefully examined and followed-up by MRA for the 
possible presence of co-existing IAs. The lack of clear knowledge about 
the cerebral blood-flow in CoA patients and the existing controversies in 
the aetiopathogenesis of IAs in these patients emphasizes the importance 
of this study. 	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Despite improvements in surgical and medical management, aneurysmal 
subarachnoid hemorrhage (SAH) remains a major cause of morbidity and 
mortality in neurosurgical patients. The current protocols used to treat the 
unruptured IAs are inadequate to provide clear guidelines, as they 
themselves remain descriptors for the poor prognosis for an intervention. 
In order to offer the best possible treatment to the patient with the least 
side effects, formulation of clear management protocols, directed by the 
natural history of unruptured IAs and, the risks associated with the active 
management, is required.  
 
Whereas, the aetiopathogenesis of IA formation and rupture remains 
multifactorial, consistent with studies performed by other researchers, my 
work indicates haemodynamics playing an important role. An evaluation 
of patient-specific haemodynamic indices can provide a useful alternative 
to predict the behavior of an unruptured IA at an early stage.  
 
In spite of their ability of guiding the correct management of IAs, 
limitations in current technology significantly restricts our ability to 
measure these haemodynamic indices in routine clinical practice. My 
studies demonstrate that Computational Fluid Dynamics (CFD) can 
provide a useful alternative to predict blood flows where detailed in vivo 
measurement of haemodynamic flow variables is not possible. 
 
European Commission funded Project @neurIST was the first project of 
it’s kind that brought together a number of multidisciplinary professionals 
from 32 European institutions and developed state of the art tools for 
personalised risk assessment and treatment IAs using CFD. These tools 
have been constantly improved and amended in the light of feedback 
gathered from their controlled exposures conducted world over, as 
described in the manuscript. However, need of a well-designed 
Randomized Controlled Trial in this context cannot be overemphasized, 
before these tools can be accepted by clinicians and patients. 
 
In my study on the validation of different concepts used in CFD, I 
demonstrated that there is no added advantage of complex Womersley-­‐flow-­‐profile	  over	  the	  much	  simpler	  plug-­‐flow	  profile.	   
 
One of my studies on initiation and rupture of IAs showed that the 
haemodynamic patterns of IAs during these two phases are significantly 
CHAPTER 7.0: CONCLUSIONS AND FUTURE WORK 
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different. Whereas, values of t-av-WSSmin and areas affected by supra-
physiological WSS were higher in preaneurysmal lesion the corresponding 
values were lower in ruptured IA. The area affected by infra-physiological 
WSS (<0.4Pa) was significantly higher in ruptured lesion as compared to 
preaneurysmal IA. Furthermore, heparin induces significant derangements 
in the haemodynamics of both, preaneurysmal as well as ruptured IA. In 
the light of current evidence, it is expected that whereas on the one hand 
such alterations in haemodynamics may facilitate the rupture of existing 
IAs, on the other hand they may suppress the formation of new IAs. 
Similar effects may be associated with other pharmacological agents, 
warranting further investigations. 
 
Another study on Modeled vs. Patient-Specific Boundary Conditions 
demonstrated significant differences in the results obtained with these two 
methods. These are largely attributable to the underlying differences in the 
waveforms (similar peak but higher mean flow was observed in the 
measured values). It is most likely that in future patient-specific BCs will 
be provided as a part of the routine clinical procedure. The results of this 
study show that the 1D circulation model adopted by @neurIST performs 
better than other approaches found in the literature and offers a viable 
means to find correlation with rupture in large cohort size studies. 
 
In the study on the effects of hypertension and smoking on the 
haemodynamic indices of an IA it was observed that when the high values 
of blood viscosity were used the values of WSS and OSI have increased 
significantly.  
 
In the interesting study performed on Coarctation of Aorta (CoA), it was 
demonstrated that the cerebral flow-rates in CoA patients were 
significantly higher when compared to average flow-rates in healthy 
population. Furthermore, the values of space and time averaged WSS as 
well as the area affected by supraphysiological WSS (>15Pa) were 
increased in our patient by 65% and 650%, respectively. The values of 
maximum OSI however, remained unaffected by the presence of CoA. 
Increased haemodynamic WSS secondary to the increased flow-rates may 
play an important role in the pathogenesis of IAs in CoA patients. The 
increased per unit pressure on aneurysmal wall in CoA patients may be an 
important underlying factor affecting the early aneurysmal rupture.  
 
Due to the relatively low incidence of CoA in general population (1 in 
5000) it may be difficult for the neurosurgeons and interventional 
neuroradiologists to get an opportunity to observe a case of IA coexisting 
with CoA. Moreover, IAs can develop in patients with CoA years after the 
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surgical repair. I recommend that a high index of suspicion should be kept 
and all CoA patients should be carefully examined and followed-up by 
MRA for the possible presence of co-existing IAs. The lack of clear 
knowledge about the cerebral blood-flow in CoA patients and the existing 
controversies in the aetiopathogenesis of IAs in these patients emphasizes 
the importance of this study. 
 
In terms of future applications of the CFD in clinical practice there are a 
number or practical challenges that we will have to address before this 
dream could be realized. One of the most important factors is the 
validation of these tools in the field. Whereas, the CFD has been 
extensively validated and is a very well established technique in other 
fields, its validations in the field of Intracranial Aneurysms still in a 
preliminary stage. As reflected by the feedback form the workshops I 
conducted, mistrust shown by the clinicians in the CFD results clearly 
indicates the need for validations.  
 
Before any technology or technique can be freely applied in clinical 
practice, one of the important prerequisite is conducting multi-centric, 
trials. Once the tools have been validated robustly and we are past the 
stage of mistrust, the second stage therefore will be need of a well 
designed multi-centric double blinded, randomized controlled clinical trial 
on a big cohort of patients. This again can be quite challenging especially 
due to the ethical issues related to making decisions of non-intervention 
treatment that can lead to the rupture of an aneurysm that obviously carries 
very high risk of mortality and morbidity. This can also lead to huge 
selection bias due to inherent inclination of clinicians to assign patient to 
the treatment group as against conservative. Apart form that, due to very 
long natural history of the Unruptured IAs, relatively longer period of 
observation will be required before any sensible conclusions can be 
drawn. All these factors can make logistics of conducting the clinical trails 
a herculean task.  
 
However, in spite of all these challenges and limitations, the expected 
significant improvements in the outcome of the IA treatment when guided 
by CFD predictions, make this painstaking task worth accomplishing. 
 
 
  
	   216	  
 
 
Anonymous 
@neurist "integrated biomedical informatics for the management of 
cerebral aneurysms" In: Annex 1 - v6.1. Sixth Framework Programme 
PIST (Ed) Barcelona, Spain (2007). Project Identifier: IST-2004-027703.  
 
ISUIA (1998). Unruptured intracranial aneurysms--risk of rupture 
and risks of surgical intervention. International study of unruptured 
intracranial aneurysms investigators. N Engl J Med (1998) 
339(24):1725-1733. 
 
A 
Abbott ME: Coarctation of aorta of adult type: II. A statistical study 
and historical retrospect of 200-recorded cases, with autopsy, of 
stenosis or obliteration of the descending arch in subjects above the 
age of two years. Am Heart J (1928) 3):392-421. 
 
Abruzzo T, Tun T, Sambanis A: Efficient transmicrocatheter delivery 
of functional fibroblasts with a bioengineered collagen gel-platinum 
microcoil complex: Toward the development of endovascular cell 
therapy for cerebral aneurysms.  AJNR Am J Neuroradiol (2007) 
Sep;28(8):1586-1593. 
 
Acevedo-Bolton G, Jou LD, Dispensa BP, Lawton MT, Higashida RT, 
Martin AJ, Young WL, Saloner D: Estimating the haemodynamic 
impact of interventional treatments of aneurysms: Numerical 
simulation with experimental validation: Technical case report. 
Neurosurgery (2006) 59(2):E429-430; author reply E429-430. 
 
Adams HP, Jr., Kassell NF, Wisoff HS, Drake CG: Intracranial saccular 
aneurysm and moyamoya disease. Stroke (1979) 10(2):174-179. 
 
Adamson J, Humphries SE, Ostergaard JR, Voldby B, Richards P, Powell 
JT: Are cerebral aneurysms atherosclerotic? Stroke (1994) 25(5):963-
966. 
 
Aenis M, Stancampiano AP, Wakhloo AK, Lieber BB: Modeling of flow 
in a straight stented and nonstented side wall aneurysm model. J 
Biomech Eng (1997) 119(2):206-212. 
 
CHAPTER 8.0 REFERENCES 
	  	  	  
	   217	  
Agarwal R: Computational fluid dynamics of whole-body aircraft. 
Annu Rev Fluid Mech (1999) 31(125-169. 
 
Ahmetoğlu A, Koşucu, P. Sari, A. Gümele, HR.: Abdominal aortic 
coarctation associated with multiple intracranial aneurysms. 
European Journal of Radiology (2003) Extra (46)(38-41. 
 
Alpers BJ, Berry RG: Circle of Willis in cerebral vascular disorders. 
The anatomical structure. Arch Neurol (1963) 8(398-402. 
 
Ali S, Walker MT: Bilateral persistent trigeminal arteries associated 
with bilateral carotid aneurysms. J Vasc Interv Radiol (2007) 
18(5):692-694. 
 
Alfano JM, Kolega J, Natarajan SK, Xiang J, Paluch RA, Levy EI, 
Siddiqui AH, Meng H: Intracranial aneurysms occur more frequently 
at bifurcation sites that typically experience higher haemodynamic 
stresses. Neurosurgery (2013) Jun 10. [Epub ahead of print] 
 
Alnaes MS, Isaksen J, Mardal KA, Romner B, Morgan MK, Ingebrigtsen 
T: Computation of haemodynamics in the circle of Willis. Stroke 
(2007) 38(9):2500-2505. 
 
Anderson JDJ: Computational fluid dynamics: The basics with 
application. McGraw-Hill, New York, USA (1995). 
 
Anderson CS, Feigin V, Bennett D, Lin RB, Hankey G, Jamrozik K: 
Active and passive smoking and the risk of subarachnoid 
hemorrhage: An international population-based case-control study. 
Stroke (2004) 35(3):633-637. 
 
Ando J, Komatsuda T, Kamiya A: Cytoplasmic calcium response to 
fluid shear stress in cultured vascular endothelial cells. In Vitro Cell 
Dev Biol (1988) 24(9):871-877. 
 
Andrews RJ, Spiegel PK: Intracranial aneurysms. Age, sex, blood 
pressure, and multiplicity in an unselected series of patients. J 
Neurosurg (1979) 51(1):27-32. 
 
Aoki T, Kataoka H, Morimoto M, Nozaki K, Hashimoto N: Macrophage-
derived matrix metalloproteinase-2 and -9 promote the progression of 
cerebral aneurysms in rats. Stroke (2007) 38(1):162-169. 
 
	   218	  
Aoki T, Kataoka H, Moriwaki T, Nozaki K, Hashimoto N: Role of timp-1 
and timp-2 in the progression of cerebral aneurysms. Stroke (2007) 
38(8):2337-2345. 
 
 
 
Aoki T, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N: Nifedipine 
inhibits the progression of an experimentally induced cerebral 
aneurysm in rats with associated down-regulation of nf-kappa b 
transcriptional activity. Curr Neurovasc Res (2008) 5(1):37-45. 
 
Aoki T, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N: Simvastatin 
suppresses the progression of experimentally induced cerebral 
aneurysms in rats. Stroke (2008) 39(4):1276-1285. 
 
Aoki T, Kataoka H, Ishibashi R, Nakagami H, Nozaki K, Morishita R, 
Hashimoto N: Pitavastatin suppresses formation and progression of 
cerebral aneurysms through inhibition of the nuclear factor kappab 
pathway. Neurosurgery (2009) 64(2):357-365; discussion 365-356. 
 
Atkinson JL, Sundt TM, Jr., Houser OW, Whisnant JP: Angiographic 
frequency of anterior circulation intracranial aneurysms. J Neurosurg 
(1989) 70(4):551-555. 
 
B 
Baek H, Jayaraman MV, Richardson PD, Karniadakis GE: Flow 
instability and wall shear stress variation in intracranial aneurysms. 
Journal of the Royal Society, Interface / the Royal Society (2010) 
7(47):967-988. 
 
Bakker CJ, Kouwenhoven M, Hartkamp MJ, Hoogeveen RM, Mali WP: 
Accuracy and precision of time-averaged flow as measured by 
nontriggered 2d phase-contrast mr angiography, a phantom 
evaluation. Magn Reson Imaging (1995) 13(7):959-965. 
 
Balossino R, Pennati G, Migliavacca F, Formaggia L, Veneziani A, Tuveri 
M, Dubini G: Computational models to predict stenosis growth in 
carotid arteries: Which is the role of boundary conditions? Computer 
methods in biomechanics and biomedical engineering (2009) 12(1):113-
123. 
 
Banna MM, Rose PG, Pearce GW: Coarctation of the aorta as a cause 
	   219	  
of spinal subarachnoid hemorrhage. Case report. J Neurosurg (1973) 
39(6):761-763. 
 
Bark DL, Jr., Ku DN: Wall shear over high degree stenoses pertinent to 
atherothrombosis. J Biomech (2010) 16(43(15)):2970-2977. 
 
Baskurt OK, Meiselman HJ: Blood rheology and haemodynamics. 
Semin Thromb Hemost (2003) 29(5):435-450. 
 
Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: 
Apparent hydroxyl radical production by peroxynitrite: Implications 
for endothelial injury from nitric oxide and superoxide. Proc Natl 
Acad Sci U S A (1990) 87(4):1620-1624. 
 
Bernardini A, Larrabide I, Morales HG, Pennati G, Petrini L, Cito S, 
Frangi AF: Influence of different computational approaches for stent 
deployment on cerebral aneurysm haemodynamics. Interface focus 
(2011) 1(3):338-348. 
 
Bhagyalakshmi A, Frangos JA: Mechanism of shear-induced 
prostacyclin production in endothelial cells. Biochem Biophys Res 
Commun (1989) 158(1):31-37. 
 
Bonert M, Myers JG, Fremes S, Williams J, Ethier CR: A numerical 
study of blood flow in coronary artery bypass graft side-to-side 
anastomoses. Ann Biomed Eng (2002) 30(5):599-611. 
 
Bonita R: Cigarette smoking, hypertension and the risk of 
subarachnoid hemorrhage: A population-based case-control study. 
Stroke (1986) 17(5):831-835. 
 
Bordas R, Seshadhri S, Janiga G, Skalej M, Thevenin D: Experimental 
validation of numerical simulations on a cerebral aneurysm phantom 
model. Interventional Medicine & Applied Science (2012) 4(4):13. 
 
Born GV, Palinski W: Unusually high concentrations of sialic acids on 
the surface of vascular endothelia. Br J Exp Pathol (1985) 66(5):543-
549. 
 
Boussel L, Rayz V, McCulloch C, Martin A, Acevedo-Bolton G, Lawton 
M, Higashida R, Smith WS, Young WL, Saloner D: Aneurysm growth 
occurs at region of low wall shear stress: Patient-specific correlation 
of haemodynamics and growth in a longitudinal study. Stroke (2008) 
	   220	  
39(11):2997-3002. 
 
Bove EL, Migliavacca F, de Leval MR, Balossino R, Pennati G, Lloyd 
TR, Khambadkone S, Hsia TY, Dubini G: Use of mathematic modeling 
to compare and predict haemodynamic effects of the modified 
blalock-taussig and right ventricle-pulmonary artery shunts for 
hypoplastic left heart syndrome. J Thorac Cardiovasc Surg (2008) 
136(2):312-320 e312. 
 
Brooks B: The treatment of traumatic arteriovenous fistula. South Med 
J (1930) 23(100 –106. 
 
 
Broderick JP, Viscoli CM, Brott T, Kernan WN, Brass LM, Feldmann E, 
Morgenstern LB, Wilterdink JL, Horwitz RI: Major risk factors for 
aneurysmal subarachnoid hemorrhage in the young are modifiable. 
Stroke (2003) 34(6):1375-1381. 
 
Brugger W, Imhof P, Muller P, Moser P, Reubi F: Effect of nitroglycerin 
on blood rheology in healthy subjects. Eur J Clin Pharmacol (1985) 
29(3):331-336. 
 
Buijs PC, Krabbe-Hartkamp MJ, Bakker CJ, de Lange EE, Ramos LM, 
Breteler MM, Mali WP: Effect of age on cerebral blood flow: 
Measurement with ungated two-dimensional phase-contrast mr 
angiography in 250 adults. Radiology (1998) 209(3):667-674. 
 
Burleson AC, Strother CM, Turitto VT: Computer modeling of 
intracranial saccular and lateral aneurysms for the study of their 
haemodynamics. Neurosurgery (1995) 37(4):774-782; discussion 782-
774. 
 
Burleson AC, Turitto VT: Identification of quantifiable haemodynamic 
factors in the assessment of cerebral aneurysm behavior. On behalf of 
the subcommittee on biorheology of the scientific and standardization 
committee of the isth. Thromb Haemost (1996) 76(1):118-123. 
 
Bulas D, Egloff A: Benefits and risks of mri in pregnancy. Seminars in 
perinatology (2013) 37(5):301-304. 
 
Busse R, Mulsch A: Calcium-dependent nitric oxide synthesis in 
endothelial cytosol is mediated by calmodulin. FEBS Lett (1990) 265(1-
2):133-136. 
	   221	  
 
Butty VD, Gudjonsson K, Buchel P, Makhijani VB, Ventikos Y, 
Poulikakos D: Residence times and basins of attraction for a realistic 
right internal carotid artery with two aneurysms. Biorheology (2002) 
39(3-4):387-393. 
 
Byrne JV, Guglielmi, G.: Endovascular treatment of intracranial 
aneurysms. Springer, (1998). 
 
C 
Caputo GR, Kondo C, Masui T, Geraci SJ, Foster E, O'Sullivan MM, 
Higgins CB: Right and left lung perfusion: In vitro and in vivo 
validation with oblique-angle, velocity-encoded cine mr imaging. 
Radiology (1991) 180(3):693-698. 
 
Carmichael R: The pathogenesis of noninflammatory cerebral 
aneurysms. J Pathol Bacteriol (1950) 62(1):1-19. 
 
Castro MA, Putman CM, Cebral JR: Computational fluid dynamics 
modeling of intracranial aneurysms: Effects of parent artery 
segmentation on intra-aneurysmal haemodynamics. AJNR Am J 
Neuroradiol (2006) 27(8):1703-1709. 
 
Castro MA, Putman CM, Cebral JR: Patient-specific computational 
fluid dynamics modeling of anterior communicating artery 
aneurysms: A study of the sensitivity of intra-aneurysmal flow 
patterns to flow conditions in the carotid arteries. AJNR Am J 
Neuroradiol (2006b) 27(10):2061-2068. 
 
Castro MA, Putman CM, Cebral JR: Patient-specific computational 
modeling of cerebral aneurysms with multiple avenues of flow from 
3d rotational angiography images. Acad Radiol (2006c) 13(7):811-821. 
 
Cebral JR, Castro MA, Appanaboyina S, Putman CM, Millan D, Frangi 
AF: Efficient pipeline for image-based patient-specific analysis of 
cerebral aneurysm haemodynamics: Technique and sensitivity. IEEE 
Trans Med Imaging (2005) 24(4):457-467. 
 
Cebral JR, Lohner R, Choyke PL, Yim PJ: Merging of intersecting 
triangulations for finite element modeling. Journal of biomechanics 
(2001) 34(6):815-819. 
 
	   222	  
Cebral JR, Castro MA, Burgess JE, Pergolizzi RS, Sheridan MJ, Putman 
CM: Characterization of cerebral aneurysms for assessing risk of 
rupture by using patient-specific computational haemodynamics 
models. AJNR Am J Neuroradiol (2005) 26(10):2550-2559. 
 
Cebral JR, Castro MA, Putman CM, Alperin N: Flow-area relationship 
in internal carotid and vertebral arteries. Physiol Meas (2008) 
29(5):585-594. 
 
Cebral JR, Hendrickson S, Putman CM: Haemodynamics in a lethal 
basilar artery aneurysm just before its rupture. AJNR Am J 
Neuroradiol (2009) 30(1):95-98. 
 
Cebral JR, Raschi M: Suggested connections between risk factors of 
intracranial aneurysms: A review. Ann Biomed Eng (2013) 
Jul;41(7):1366-1383. 
 
Cellina GU, Honour AJ, Littler WA: Direct arterial pressure, heart rate, 
and electrocardiogram during cigarette smoking in unrestricted 
patients. Am Heart J (1975) 89(1):18-25. 
 
Chan BT, Lim E, Chee KH, Abu-Osman NA: Review on cfd simulation 
in heart with dilated cardiomyopathy and myocardial infarction. 
Comput Biol Med (2013) 1(1;43(4)):377-385. 
 
Chason JL, Hindman WM: Berry aneurysms of the circle of willis; 
results of a planned autopsy study. Neurology (1958) 8(1):41-44. 
 
Chatziprodromou I, Butty, V.D., Makhijani, V. B. P, D.,, Ventikos Y: 
Pulsatile blood flow in anatomically accurate vessels with multiple 
aneurysms: A medical intervention planning application of 
computational haemodynamics. Flow, Turbulence and Combustion 
(2003) 71(333–346. 
 
Chen L, Liu JM, Zhou D: Congenital absence of the right common 
carotid artery, internal carotid artery and external carotid artery 
associated with anterior communicating artery aneurysm: A rare 
case. Neurol Sci (2008) 29(6):485-487. 
 
Cheng C, Helderman F, Tempel D, Segers D, Hierck B, Poelmann R, van 
Tol A, Duncker DJ, Robbers-Visser D, Ursem NT, van Haperen R et al: 
Large variations in absolute wall shear stress levels within one species 
and between species. Atherosclerosis (2007) 195(2):225-235. 
	   223	  
 
Coata G, Ventura F, Lombardini R, Ciuffetti G, Cosmi EV, Di Renzo GC: 
Effect of low-dose oral triphasic contraceptives on blood viscosity, 
coagulation and lipid metabolism. Contraception (1995) 52(3):151-157. 
 
Cohen MM: Cerebrovascular accidents; a study of two hundred one 
cases. AMA Arch Pathol (1955) 60(3):296-307. 
 
Connolly HM, Huston J, 3rd, Brown RD, Jr., Warnes CA, Ammash NM, 
Tajik AJ: Intracranial aneurysms in patients with coarctation of the 
aorta: A prospective magnetic resonance angiographic study of 100 
patients. Mayo Clin Proc (2003) 78(12):1491-1499. 
 
Cooke JP, Stamler J, Andon N, Davies PF, McKinley G, Loscalzo J: Flow 
stimulates endothelial cells to release a nitrovasodilator that is 
potentiated by reduced thiol. Am J Physiol (1990) 259(3 Pt 2):H804-
812. 
 
Cooper BB: Lectures on the principles and practice of surgery. Blanchard 
& Lee, Philadelphia (1852). 
 
Corbett SC, Ajdari A, Coskun AU, Nayeb-Hashemi H: Effect of pulsatile 
blood flow on thrombosis potential with a step wall transition. ASAIO 
J (2010) Jul-Aug;56(4):290-295. 
 
 
Cowan JA, Jr., Barkhoudarian G, Yang LJ, Thompson BG: Progression 
of a posterior communicating artery infundibulum into an aneurysm 
in a patient with alagille syndrome. Case report. J Neurosurg (2004) 
101(4):694-696. 
 
Crawford T: Some observations on the pathogenesis and natural 
history of intracranial aneurysms. J Neurol Neurosurg Psychiatry 
(1959) 22(259-266. 
 
Crompton MR: The pathogenesis of cerebral infarction following the 
rupture of cerebral berry aneurysms. Brain (1964) 87(491-510. 
 
Crompton MR: Mechanism of growth and rupture in cerebral berry 
aneurysms. Br Med J (1966) 1(5496):1138-1142. 
 
Crumpton CW, Rowe GG, Capps RC, Whitmore JJ, Murphy QR: The 
effect of hexamethonium upon cerebral blood flow and metabolism in 
	   224	  
patients with premalignant and malignant hypertension. Circulation 
(1955) 11(1):106-109. 
 
Crutchfield WG: Instruments for use in the treatment of certain 
intracranial vascular lesions. J Neurosurg (1959) 16(4):471-474. 
 
D 
Daley PJ, Sagar KB, Wann LS: Doppler echocardiographic 
measurement of flow velocity in the ascending aorta during supine 
and upright exercise. Br Heart J (1985) 54(6):562-567. 
 
Dandy WE: Intracranial aneurysm of the internal carotid artery: 
Cured by operation. Ann Surg (1938) 107(5):654-659. 
 
Danesh J, Collins R, Peto R, Lowe GD: Haematocrit, viscosity, 
erythrocyte sedimentation rate: Meta-analyses of prospective studies 
of coronary heart disease. Eur Heart J (2000) 21(7):515-520. 
 
 
Damadian R, Goldsmith M, Minkoff L: Nmr in cancer: Xvi. Fonar 
image of the live human body. Physiol Chem Phys (1977) 9(1):97-100, 
108. 
 
Davies PF: Flow-mediated endothelial mechanotransduction. Physiol 
Rev (1995) 75(3):519-560. 
Davies PF, Tripathi SC: Mechanical stress mechanisms and the cell. An 
endothelial paradigm. Circ Res (1993) 72(2):239-245. 
 
 
de la Monte SM, Moore GW, Monk MA, Hutchins GM: Risk factors for 
the development and rupture of intracranial berry aneurysms. Am J 
Med (1985) 78(6 Pt 1):957-964. 
 
de Simone G, Devereux RB, Chien S, Alderman MH, Atlas SA, Laragh 
JH: Relation of blood viscosity to demographic and physiologic 
variables and to cardiovascular risk factors in apparently normal 
adults. Circulation (1990) 81(1):107-117. 
 
Dempere-Marco L, Oubel E, Castro M, Putman C, Frangi A, Cebral J: 
Cfd analysis incorporating the influence of wall motion: Application 
to intracranial aneurysms. Med Image Comput Comput Assist Interv Int 
Conf Med Image Comput Comput Assist Interv (2006) 9(Pt 2):438-445. 
	   225	  
 
Dion JE, Gates PC, Fox AJ, Barnett HJ, Blom RJ: Clinical events 
following neuroangiography: A prospective study. Stroke (1987) 
18(6):997-1004. 
 
Dodge JT, Jr., Brown BG, Bolson EL, Dodge HT: Lumen diameter of 
normal human coronary arteries. Influence of age, sex, anatomic 
variation, and left ventricular hypertrophy or dilation. Circulation 
(1992) 86(1):232-246. 
 
Doenitz C, Schebesch KM, Zoephel R, Brawanski A: A mechanism for 
the rapid development of intracranial aneurysms: A case study. 
Neurosurgery (2010) Nov;67(5):1213-1221. 
 
Dott NM: Intracranial aneurysms: Cerebral arterio-radiography: 
Surgical treatment. Edinburgh Med J (1933) 40(219-234. 
 
Drake CG: Earlier times in aneurysm surgery. Clin Neurosurg (1985) 
32(41-50. 
 
Drake CG: Progress in cerebrovascular disease. Management of 
cerebral aneurysm. Stroke (1981) 12(3):273-283. 
 
Drexler H, Hornig B: Endothelial dysfunction in human disease. J Mol 
Cell Cardiol (1999) 31(1):51-60. 
 
DuBoulay GH: Some observation on the natural history of intracranial 
aneurysms. Brit J Radiol (1965) 38(721-757. 
 
Duncan J, Fraser TR: On the treatment of aneurism by electrolysis: 
With an account of an investigation into the action of galvanism on 
blood and on albuminous fluids. Medico-Chir Soc Edinb Med J (1867) 
13(101-120. 
 
E 
Ecker A, Riemenschneider PA: Arteriographic demonstration of spasm 
of the intracranial arteries, with special reference to saccular arterial 
aneurysms. J Neurosurg (1951) 8(6):660-667. 
 
Engelson E: Catheter for guide-wire tracking. In: 4739768. USPTO 
(Ed) USA (1986). 
 
	   226	  
Ene-Iordache B, Remuzzi A: Disturbed flow in radial-cephalic 
arteriovenous fistulae for haemodialysis: Low and oscillating shear 
stress locates the sites of stenosis. Nephrol Dial Transplant (2011) Jul 
18.([Epub ahead of print]. 
 
Enzmann DR, Marks MP, Pelc NJ: Comparison of cerebral artery blood 
flow measurements with gated cine and ungated phase-contrast 
techniques. J Magn Reson Imaging (1993) 3(5):705-712. 
 
Enzmann DR, Ross MR, Marks MP, Pelc NJ: Blood flow in major 
cerebral arteries measured by phase-contrast cine mr. AJNR Am J 
Neuroradiol (1994) 15(1):123-129. 
 
Eppinger H: Pathogenesis (histogenesis and aetiologie) der aneurysmen 
einschliesslich des aneurysma equi verminosum. Arch Klin Chir (1887) 
35(Suppl 1):1-563. 
 
Erbengi A, Inci S: Pheochromocytoma and multiple intracranial 
aneurysms: Is it a coincidence? Case report. J Neurosurg (1997) 
87(5):764-767. 
 
Evans AJ, Iwai F, Grist TA, Sostman HD, Hedlund LW, Spritzer CE, 
Negro-Vilar R, Beam CA, Pelc NJ: Magnetic resonance imaging of 
blood flow with a phase subtraction technique. In vitro and in vivo 
validation. Invest Radiol (1993) 28(2):109-115. 
 
F 
Fedorov BM, Sebekina TV, Sinitsyna TM, Strel'tsova EN, Vakulenko 
VM, Nikolaeva TG: [stress and blood circulation in man]. Kosm Biol 
Aviakosm Med (1990) 24(3):35-40. 
 
Feng R, Xenos M, Girdhar G, Kang W, Davenport JW, Deng Y, Bluestein 
D: Viscous flow simulation in a stenosis model using discrete particle 
dynamics: A comparison between dpd and cfd. Biomech Model 
Mechanobiol (2011 [Epub ahead of print]) Mar 3( 
 
Ferrua MJ, Singh RP: Modeling the fluid dynamics in a human 
stomach to gain insight of food digestion. J Food Sci (2010) 
Sep;75(7):R151-162. 
 
Fifi JT, Meyers PM, Lavine SD, Cox V, Silverberg L, Mangla S, Pile-
Spellman J: Complications of modern diagnostic cerebral angiography 
	   227	  
in an academic medical center. J Vasc Interv Radiol (2009) 20(4):442-
447. 
 
Fleischer AS, Faria MA, Jr., Hoffmann JC, Jr.: Pseudoaneurysm 
complicating superficial temporal artery--middle cerebral artery 
bypass. Surg Neurol (1979) 12(4):305-306. 
 
Fogarty TJ, Cranley JJ, Krause RJ, Strasser ES, Hafner CD: A method for 
extraction of arterial emboli and thrombi. Surg Gynecol Obstet (1963) 
116(241-244. 
 
Forbus WD: On the origin of miliary aneurysms of the superficial 
cerebral arteries. Bull Johns Hopkins Hosp (1930) 47(239-284. 
 
Ford MD, Nikolov HN, Milner JS, Lownie SP, Demont EM, Kalata W, 
Loth F, Holdsworth DW, Steinman DA: Piv-measured versus cfd-
predicted flow dynamics in anatomically realistic cerebral aneurysm 
models. J Biomech Eng (2008) 130(2):021015. 
 
Ford MD, Stuhne GR, Nikolov HN, Habets DF, Lownie SP, Holdsworth 
DW, Steinman DA: Virtual angiography for visualization and 
validation of computational models of aneurysm haemodynamics. 
IEEE Trans Med Imaging (2005) 24(12):1586-1592. 
 
Forfang K, Rostad H, Sorland S, Levorstad K: Late sudden death after 
surgical correction of coarctation of the aorta. Importance of 
aneurysm of the ascending aorta. Acta Med Scand (1979) 206(5):375-
379. 
 
Formaggia L, Nobile F, Quarteroni A, Veneziani A: Multiscale modelling 
of the circulatory system: A preliminary analysis. Comput Vis Sci 
(1999) 2(75–83. 
 
Forbus WD: On the origin of miliary aneurysms of the superficial 
cerebral arteries. Bull Johns Hopkins Hosp (1930) 47(239-284. 
 
Foutrakis GN, Yonas H, Sclabassi RJ: Saccular aneurysm formation in 
curved and bifurcating arteries. AJNR Am J Neuroradiol (1999) 
20(7):1309-1317. 
 
Fox C, Davies MJ, Webb-Peploe MM: Length of left main coronary 
artery. Br Heart J (1973) 35(8):796-798. 
 
	   228	  
Frawley P, Geron M: Combination of cfd and doe to analyze and 
improve the mass flow rate in urinary catheters. J Biomech Eng (2009) 
Aug;131(8):084501. 
 
Frei EH, Driller J, Neufeld HN, Barr I, Bleiden L, Askenazy HN: The pod 
and its applications. Med Res Eng (1966) 5(4):11-18. 
 
Fukuda S, Hashimoto N, Naritomi H, Nagata I, Nozaki K, Kondo S, 
Kurino M, Kikuchi H: Prevention of rat cerebral aneurysm formation 
by inhibition of nitric oxide synthase. Circulation (2000) 101(21):2532-
2538. 
 
G 
Gaetani P, Tartara F, Tancioni F, Klersy C, Forlino A, Baena RR: Activity 
of alpha 1-antitrypsin and cigarette smoking in subarachnoid 
haemorrhage from ruptured aneurysm. J Neurol Sci (1996) 141(1-
2):33-38. 
 
Gabrielsen TO, Greitz T: Normal size of the internal carotid, middle 
cerebral and anterior cerebral arteries. Acta Radiol Diagn (Stockh) 
(1970) 10(1):1-10. 
 
Gao L, Hoi Y, Swartz DD, Kolega J, Siddiqui A, Meng H: Nascent 
aneurysm formation at the basilar terminus induced by 
haemodynamics. Stroke (2008) 39(7):2085-2090. 
 
Gardner WJ: Cerebral angiomas and aneurysms. Surg Clin North Am 
(1936) 16(1019–1030. 
 
Geng Y, Hansson GK, Holme E: Interferon-gamma and tumor necrosis 
factor synergize to induce nitric oxide production and inhibit 
mitochondrial respiration in vascular smooth muscle cells. Circ Res 
(1992) 71(5):1268-1276. 
 
Gianturco C, Anderson JH, Wallace S: Mechanical devices for arterial 
occlusion. Am J Roentgenol Radium Ther Nucl Med (1975) 124(3):428-
435. 
 
Glor FP, Long Q, Hughes AD, Augst AD, Ariff B, Thom SA, Verdonck 
PR, Xu XY: Reproducibility study of magnetic resonance image-based 
computational fluid dynamics prediction of carotid bifurcation flow. 
Ann Biomed Eng (2003) 31(2):142-151. 
	   229	  
 
Glor FP, Ariff B, Hughes AD, Crowe LA, Verdonck PR, Barratt DC, Mc 
GTSA, Firmin DN, Xu XY: The integration of medical imaging and 
computational fluid dynamics for measuring wall shear stress in 
carotid arteries. Conf Proc IEEE Eng Med Biol Soc (2004) 2(1415-1418. 
 
Glynn LE: Medial defects in the circle of willis and their relation to 
aneurysm formation. J Pathol Bacteriol (1940) 51(213-222. 
 
Gonzalez CF, Cho YI, Ortega HV, Moret J: Intracranial aneurysms: 
Flow analysis of their origin and progression. AJNR Am J Neuroradiol 
(1992) 13(1):181-188. 
 
Gonzalez-Alonso J, Dalsgaard MK, Osada T, Volianitis S, Dawson EA, 
Yoshiga CC, Secher NH: Brain and central haemodynamics and 
oxygenation during maximal exercise in humans. J Physiol (2004) 
557(Pt 1):331-342. 
 
Goubergrits L, Kertzscher U, Schoneberg B, Wellnhofer E, Petz C, Hege 
HC: Cfd analysis in an anatomically realistic coronary artery model 
based on non-invasive 3d imaging: Comparison of magnetic resonance 
imaging with computed tomography. Int J Cardiovasc Imaging (2008) 
24(4):411-421. 
 
Greenfield AJ: Transcatheter vessel occlusion: Selection of methods 
and materials. Cardiovasc Intervent Radiol (1980) 3(4):222-228. 
 
Greenhalgh RM, Laing S, Taylor GW: Risk factors in carotid artery 
stenosis and intracranial aneurysms. J Cardiovasc Surg (Torino) (1980) 
21(5):559-567. 
 
Greenwood J, Jr.: Two point coagulation: A follow-up report of a new 
technic and instrument for electrocoagulation in neurosurgery. Arch 
Phys Ther (1942) 23(9):552-554. 
 
Guglielmi G: History of the genesis of detachable coils. A review. J 
Neurosurg (2009) 111(1):1-8. 
 
H 
Hafkenschiel JH, Jr., Crumpton CW, Moyer JH: Blood flow and oxygen 
consumption of the brain in coarctation of the aorta. Proc Soc Exp Biol 
Med (1949) 71(1):165-167. 
	   230	  
 
Hajjar I, Selim M, Novak P, Novak V: The relationship between 
nighttime dipping in blood pressure and cerebral haemodynamics in 
nonstroke patients. J Clin Hypertens (Greenwich) (2007) 9(12):929-936. 
 
Handa H, Hashimoto N, Nagata I, Hazama F: Saccular cerebral 
aneurysms in rats: A newly developed animal model of the disease. 
Stroke (1983) 14(6):857-866. 
 
Handler FP, Blumenthal HT: Inflammatory factor in pathogenesis of 
cerebrovascular aneurysms. J Am Med Assoc (1954) 155(17):1479-
1483. 
 
Harikrishnan S, Stigimon J, Tharakan JM: Intracranial aneurysms, 
coronary aneurysms and descending aortic coarctation--unreported 
association. Int J Cardiol (2005) 99(2):329-330. 
 
Hashimoto N, Handa H, Hazama F: Experimentally induced cerebral 
aneurysms in rats. Surg Neurol (1978) 10(1):3-8. 
 
Hashimoto N, Handa H, Nagata I, Hazama F: Experimentally induced 
cerebral aneurysms in rats: Part v. Relation of haemodynamics in the 
circle of willis to formation of aneurysms. Surg Neurol (1980) 13(1):41-
45. 
 
Hashimoto N, Kim C, Kikuchi H, Kojima M, Kang Y, Hazama F: 
Experimental induction of cerebral aneurysms in monkeys. J 
Neurosurg (1987) 67(6):903-905. 
 
Hassan T, Ahmed YM, Hassan AA: The adverse effects of flow-diverter 
stent-like devices on the flow pattern of saccular intracranial 
aneurysm models: Computational fluid dynamics study. Acta 
Neurochir (Wien) (2011) Aug;153(8):1633-1640. 
 
Hassan T, Ezura M, Timofeev EV, Tominaga T, Saito T, Takahashi A, 
Takayama K, Yoshimoto T: Computational simulation of therapeutic 
parent artery occlusion to treat giant vertebrobasilar aneurysm. AJNR 
Am J Neuroradiol (2004) 25(1):63-68. 
 
He X, Ku DN: Pulsatile flow in the human left coronary artery 
bifurcation: Average conditions. J Biomech Eng (1996) 118(1):74-82. 
 
	   231	  
Hesslein PS, McNamara DG, Morriss MJ, Hallman GL, Cooley DA: 
Comparison of resection versus patch aortoplasty for repair of 
coarctation in infants and children. Circulation (1981) 64(1):164-168. 
 
Hernandez M, Frangi AF: Non-parametric geodesic active regions: 
Method and evaluation for cerebral aneurysms segmentation in 3dra 
and cta. Med Image Anal (2007) 11(3):224-241. 
 
Hilal SK, Michelsen WJ, Driller J, Leonard E: Magnetically guided 
devices for vascular exploration and treatment. Radiology (1974) 
113(3):529-540. 
 
Hillen B, Hoogstraten HW, Post L: A mathematical model of the flow in 
the circle of willis. J Biomech (1986) 19(3):187-194. 
 
Hitosugi M, Niwa M, Takatsu A: Changes in blood viscosity by heparin 
and argatroban. Thromb Res (2001) 104(5):371-374. 
 
Hoi Y, Meng H, Woodward SH, Bendok BR, Hanel RA, Guterman LR, 
Hopkins LN: Effects of arterial geometry on aneurysm growth: Three-
dimensional computational fluid dynamics study. J Neurosurg (2004) 
101(4):676-681. 
 
Holdsworth DW, Norley CJ, Frayne R, Steinman DA, Rutt BK: 
Characterization of common carotid artery blood-flow waveforms in 
normal human subjects. Physiol Meas (1999) 20(3):219-240. 
 
Holenstein R, Niederer P, Anliker M: A viscoelastic model for use in 
predicting arterial pulse waves. J Biomech Eng (1980) 102(4):318-325. 
 
Hom JJ, Ordovas K, Reddy GP: Velocity-encoded cine mr imaging in 
aortic coarctation: Functional assessment of haemodynamic events. 
Radiographics (2008) 28(2):407-416. 
 
Hop JW, Rinkel GJ, Algra A, van Gijn J: Case-fatality rates and 
functional outcome after subarachnoid hemorrhage: A systematic 
review. Stroke (1997) 28(3):660-664. 
 
Horie N, Tsutsumi K, Kaminogo M, Morikawa M, Kitagawa N, Nagata I: 
Agenesis of the internal carotid artery with transcavernous 
anastomosis presenting with an anterior communicating artery 
aneurysm--a case report and review of the literature. Clin Neurol 
Neurosurg (2008) 110(6):622-626. 
	   232	  
 
Hounsfield GN: Computerized transverse axial scanning 
(tomography). 1. Description of system. The British journal of radiology 
(1973) 46(552):1016-1022. 
 
Hudaoglu O, Kurul S, Cakmakci H, Men S, Yis U, Dirik E: Aorta 
coarctation presenting with intracranial aneurysm rupture. J Paediatr 
Child Health (2006) 42(7-8):477-479. 
 
Hutchinson J: Aneurism of internal carotid within the skull diagnosed 
eleven years before patient’s death: Spontaneous cure. . Trans Clin Soc 
Lond (1875) 8(127-131. 
 
I 
Ide K, Secher NH: Cerebral blood flow and metabolism during 
exercise. Prog Neurobiol (2000) 61(4):397-414. 
 
Inagawa T, Takechi A, Yahara K, Saito J, Moritake K, Kobayashi S, Fujii 
Y, Sugimura C: Primary intracerebral and aneurysmal subarachnoid 
hemorrhage in izumo city, japan. Part i: Incidence and seasonal and 
diurnal variations. J Neurosurg (2000) 93(6):958-966. 
 
Inagawa T: Trends in incidence and case fatality rates of aneurysmal 
subarachnoid hemorrhage in izumo city, japan, between 1980-1989 
and 1990-1998. Stroke (2001) 32(7):1499-1507. 
 
Inagawa T: Seasonal variation in the incidence of aneurysmal 
subarachnoid hemorrhage in hospital- and community-based studies. 
J Neurosurg (2002) 96(3):497-509. 
 
Inagawa T: Risk factors for aneurysmal subarachnoid hemorrhage in 
patients in izumo city, japan. J Neurosurg (2005) 102(1):60-67. 
 
Inci S, Spetzler RF: Intracranial aneurysms and arterial hypertension: 
A review and hypothesis. Surg Neurol (2000) 53(6):530-540; discussion 
540-532. 
 
Ishii K, Isono M, Kasai N, Nakano T, Kubo T, Inoue R, Nomura Y: 
Midaortic syndrome in childhood associated with a ruptured cerebral 
aneurysm: A case report. Surg Neurol (2001) 55(4):209-212. 
 
	   233	  
Isoda H, Ohkura Y, Kosugi T, Hirano M, Takeda H, Hiramatsu H, 
Yamashita S, Takehara Y, Alley MT, Bammer R, Pelc NJ et al: In vivo 
haemodynamic analysis of intracranial aneurysms obtained by 
magnetic resonance fluid dynamics (mrfd) based on time-resolved 
three-dimensional phase-contrast mri. Neuroradiology (2009). 
 
J 
Jakubowski J, Kendall B: Coincidental aneurysms with tumours of 
pituitary origin. J Neurol Neurosurg Psychiatry (1978) 41(11):972-979. 
 
Jamous MA, Nagahiro S, Kitazato KT, Tamura T, Aziz HA, Shono M, 
Satoh K: Endothelial injury and inflammatory response induced by 
haemodynamic changes preceding intracranial aneurysm formation: 
Experimental study in rats. J Neurosurg (2007) 107(2):405-411. 
 
Jeays AD, Lawford PV, Gillott R, Spencer P, Barber DC, Bardhan KD, 
Hose DR: Characterisation of the haemodynamics of the superior 
mesenteric artery. J Biomech (2007) 40(9):1916-1926. 
 
Joseph M, Nates, J.L.: Stable xenon computed tomography cerebral 
blood flow measurement in neurological disease: Review and 
protocols. The Internet Journal of Emergency and Intensive Care 
Medicine (2000) 4(2). 
 
Jou LD, Lee DH, Morsi H, Mawad ME: Wall shear stress on ruptured 
and unruptured intracranial aneurysms at the internal carotid artery. 
AJNR Am J Neuroradiol (2008). 
 
Jou LD, Quick CM, Young WL, Lawton MT, Higashida R, Martin A, 
Saloner D: Computational approach to quantifying haemodynamic 
forces in giant cerebral aneurysms. AJNR Am J Neuroradiol (2003) 
24(9):1804-1810. 
 
Jou LD, Wong G, Dispensa B, Lawton MT, Higashida RT, Young WL, 
Saloner D: Correlation between lumenal geometry changes and 
haemodynamics in fusiform intracranial aneurysms. AJNR Am J 
Neuroradiol (2005) 26(9):2357-2363. 
 
Juvela S: Risk factors for multiple intracranial aneurysms. Stroke 
(2000) 31(2):392-397. 
 
	   234	  
Juvela S, Poussa K, Porras M: Factors affecting formation and growth 
of intracranial aneurysms: A long-term follow-up study. Stroke; a 
journal of cerebral circulation (2001) 32(2):485-491. 
 
Juvela S, Hillbom M, Numminen H, Koskinen P: Cigarette smoking and 
alcohol consumption as risk factors for aneurysmal subarachnoid 
hemorrhage. Stroke (1993) 24(5):639-646. 
 
K 
Kan P, Liu JK, Couldwell WT: Giant fusiform aneurysm in an 
adolescent with phaces syndrome treated with a high-flow external 
carotid artery-m3 bypass. Case report and review of the literature. J 
Neurosurg (2007) 106(6 Suppl):495-500. 
 
Kanda M, Shinoda S, Masuzawa T: Ruptured vertebral artery-posterior 
inferior cerebellar artery aneurysm associated with pulseless disease--
case report. Neurol Med Chir (Tokyo) (2004) 44(7):363-367. 
 
Karmonik C, Benndorf G, Klucznik R, Haykal H, Strother CM: Wall 
shear stress variations in basilar tip aneurysms investigated with 
computational fluid dynamics. Conf Proc IEEE Eng Med Biol Soc 
(2006) 1(3214-3217. 
 
Kashiwazaki D, Kuroda S: On behalf of the sapporo sah study group. 
Size ratio can highly predict rupture risk in intracranial small (<5 
mm) aneurysms. Stroke (2013) Jun 6([Epub ahead of print]. 
 
Kassell NF, Torner JC, Haley EC, Jr., Jane JA, Adams HP, Kongable GL: 
The international cooperative study on the timing of aneurysm 
surgery. Part 1: Overall management results. J Neurosurg (1990) 
73(1):18-36. 
 
Kaufmann TA, Linde T, Cuenca-Navalon E, Schmitz C, Hormes M, 
Schmitz-Rode T, Steinseifer U: Transient, three-dimensional flow field 
simulation through a mechanical, trileaflet heart valve prosthesis. 
ASAIO J (2011) 57(4):278-282. 
 
Kawaguchi S, Sakaki T, Morimoto T, Kakizaki T, Kamada K: 
Characteristics of intracranial aneurysms associated with moyamoya 
disease. A review of 111 cases. Acta Neurochir (Wien) (1996) 
138(11):1287-1294. 
 
	   235	  
Kayembe KN, Sasahara M, Hazama F: Cerebral aneurysms and 
variations in the circle of willis. Stroke (1984) 15(5):846-850. 
 
Keen W, DaCosta J: Surgery its principles and practice. WB Saunders, 
Philadelphia. (1916). 
 
Kety SS: The theory and applications of the exchange of inert gas at 
the lungs and tissues. Pharmacol Rev (1951) 3(1):1-41. 
 
Khanna RK, Malik GM, Qureshi N: Predicting outcome following 
surgical treatment of unruptured intracranial aneurysms: A proposed 
grading system. J Neurosurg (1996) 84(1):49-54. 
 
Kharboutly Z, Deplano V, Bertrand E, Legallais C: Numerical and 
experimental study of blood flow through a patient-specific 
arteriovenous fistula used for hemodialysis. Med Eng Phys (2010) 
Mar;32(2):111-118. 
 
Kim C, Cervos-Navarro J, Kikuchi H, Hashimoto N, Hazama F: 
Alterations in cerebral vessels in experimental animals and their 
possible relationship to the development of aneurysms. Surg Neurol 
(1992) 38(5):331-337. 
 
Kim EJ, Halim AX, Dowd CF, Lawton MT, Singh V, Bennett J, Young 
WL: The relationship of coexisting extranidal aneurysms to 
intracranial hemorrhage in patients harboring brain arteriovenous 
malformations. Neurosurgery (2004) 54(6):1349-1357; discussion 1357-
1348. 
 
Kim C, Kikuchi H, Hashimoto N, Hazama F, Kataoka H: Establishment 
of the experimental conditions for inducing saccular cerebral 
aneurysms in primates with special reference to hypertension. Acta 
Neurochir (Wien) (1989) 96(3-4):132-136. 
 
Kinugasa K, Mandai S, Terai Y, Kamata I, Sugiu K, Ohmoto T, 
Nishimoto A: Direct thrombosis of aneurysms with cellulose acetate 
polymer. Part ii: Preliminary clinical experience. Journal of 
neurosurgery (1992) 77(4):501-507. 
 
Knekt P, Reunanen A, Aho K, Heliovaara M, Rissanen A, Aromaa A, 
Impivaara O: Risk factors for subarachnoid hemorrhage in a 
longitudinal population study. J Clin Epidemiol (1991) 44(9):933-939. 
 
	   236	  
Koffijberg H, Buskens E, Algra A, Wermer MJ, Rinkel GJ: Growth rates 
of intracranial aneurysms: Exploring constancy. J Neurosurg (2008) 
109(2):176-185. 
 
Komotar RJ, Mocco J, Solomon RA: Guidelines for the surgical 
treatment of unruptured intracranial aneurysms: The first annual j. 
Lawrence pool memorial research symposium--controversies in the 
management of cerebral aneurysms. Neurosurgery (2008) 62(1):183-
193; discussion 193-184. 
 
Kondo C, Caputo GR, Semelka R, Foster E, Shimakawa A, Higgins CB: 
Right and left ventricular stroke volume measurements with velocity-
encoded cine mr imaging: In vitro and in vivo validation. AJR Am J 
Roentgenol (1991) 157(1):9-16. 
 
Kondo S, Hashimoto N, Kikuchi H, Hazama F, Nagata I, Kataoka H: 
Cerebral aneurysms arising at nonbranching sites. An experimental 
study. Stroke (1997) 28(2):398-403; discussion 403-394. 
 
Konishi Y, Kadowaki C, Hara M, Takeuchi K: Aneurysms associated 
with moyamoya disease. Neurosurgery (1985) 16(4):484-491. 
 
Kono K, Fujimoto T, Shintani A, Terada T: Haemodynamic 
characteristics at the rupture site of cerebral aneurysms: A case 
study. Neurosurgery (2012) 71(6):E1202-1208; discussion 1209. 
 
Krabbe-Hartkamp MJ, van der Grond J, de Leeuw FE, de Groot JC, Algra 
A, Hillen B, Breteler MM, Mali WP: Circle of willis: Morphologic 
variation on three-dimensional time-of-flight mr angiograms. 
Radiology (1998) 207(1):103-111. 
 
Krampe C: Zeiss operating microscopes for neurosurgery. Neurosurg 
Rev (1984) 7(2-3):89-97. 
 
Krayenbuehl H, Yasargil MG: Cerebral angiography. Thieme Medical 
Publishers., Stuttgart (1982). 
 
Kuivaniemi H, Prockop DJ, Wu Y, Madhatheri SL, Kleinert C, Earley JJ, 
Jokinen A, Stolle C, Majamaa K, Myllyla VV, et al.: Exclusion of 
mutations in the gene for type iii collagen (col3a1) as a common cause 
of intracranial aneurysms or cervical artery dissections: Results from 
sequence analysis of the coding sequences of type iii collagen from 55 
unrelated patients. Neurology (1993) 43(12):2652-2658. 
	   237	  
Kulikov VP, Grechishnikov VN, Sidor MV: [response of cerebral 
haemodynamics to combined stress impacts]. Patol Fiziol Eksp Ter 
(2005) 1):7-9. 
 
Kurokawa T, Harada K, Ishihara H, Fujisawa H, Kato S, Kajiwara K, 
Suzuki M: De novo aneurysm formation on middle cerebral artery 
branches adjacent to the anastomotic site of superficial temporal 
artery-middle cerebral artery bypass surgery in two patients: 
Technical case report. Neurosurgery (2007) 61(5 Suppl 2):E297-298; 
discussion E298. 
 
Kurze T: Microtechniques in neurological surgery. Clin Neurosurg 
(1964) 11(128-137. 
 
Kwak R, Mizoi K, Katakura R, Suzuki J: The correlation between 
hypertension in past history and the incidence of cerebral aneurysms. 
Tohoku J Exp Med (1979) 128(3):267-271. 
 
Kwan ES, Heilman CB, Shucart WA, Klucznik RP: Enlargement of 
basilar artery aneurysms following balloon occlusion--"water-
hammer effect". Report of two cases. J Neurosurg (1991) 75(6):963-
968. 
 
L 
Laborde F, Bical O, Lemoine G, Neveux JY: [rupture of a dissecting 
aneurysm of the ascending aorta 10 years after therapy of coarctation. 
Apropos of a case of a 10-year-old girl]. Sem Hop (1983) 59(42):2937-
2938. 
 
Lagana K, Dubini G, Migliavacca F, Pietrabissa R, Pennati G, Veneziani 
A, Quarteroni A: Multiscale modelling as a tool to prescribe realistic 
boundary conditions for the study of surgical procedures. Biorheology 
(2002) 39(3-4):359-364. 
 
Laitinen L, Snellman A: Aneurysms of the pericallosal artery: A study 
of 14 cases verified angiographically and treated mainly by direct 
surgical attack. J Neurosurg (1960) 17(447-458. 
 
Lall RR, Eddleman CS, Bendok BR, Batjer HH: Unruptured 
intracranial aneurysms and the assessment of rupture risk based on 
anatomical and morphological factors: Sifting through the sands of 
data. Neurosurg Focus (2009) 26(5):E2. 
	   238	  
 
Langewouters GJ: Visco-elasticity of the human aorta in vitro in 
relation to pressure and age [thesis]. . In: University of Amsterdam, The 
Netherlands, Amsterdam, The Netherlands (1982). 
 
Lauterbur PC: Image formation by induced local interactions. 
Examples employing nuclear magnetic resonance. 1973. Clinical 
orthopaedics and related research (1989) 244):3-6. 
 
Leppala JM, Virtamo J, Fogelholm R, Albanes D, Heinonen OP: 
Different risk factors for different stroke subtypes: Association of 
blood pressure, cholesterol, and antioxidants. Stroke (1999) 
30(12):2535-2540. 
 
Letcher RL, Chien S, Pickering TG, Laragh JH: Elevated blood viscosity 
in patients with borderline essential hypertension. Hypertension (1983) 
5(5):757-762. 
 
Levitt MR, McGah PM, Aliseda A, Mourad PD, Nerva JD, Vaidya SS, 
Morton RP, Ghodke BV, Kim LJ: Cerebral aneurysms treated with 
flow-diverting stents: Computational models with intravascular blood 
flow measurements. AJNR American journal of neuroradiology (2014) 
35(1):143-148. 
 
Li MH, Li WB, Pan YP, Fang C, Wang W: Persistent primitive 
trigeminal artery associated with aneurysm: Report of two cases and 
review of the literature. Acta Radiol (2004) 45(6):664-668. 
 
Li C, Wang S, Chen J, Yu H, Zhang Y, Jiang F, Mu S, Li H, Yang X: 
Influence of haemodynamics on recanalization of totally occluded 
intracranial aneurysms: A patient-specific computational fluid 
dynamic simulation study. Journal of neurosurgery (2012) 117(2):276-
283. 
 
Linde T, Sandhagen B, Hagg A, Morlin C, Danielson BG: Decreased 
blood viscosity and serum levels of erythropoietin after anti-
hypertensive treatment with amlodipine or metoprolol: Results of a 
cross-over study. J Hum Hypertens (1996) 10(3):199-205. 
 
Linge SO, Haughton V, Løvgren AE, Mardal KA, Helgeland A, 
Langtangen HP: Effect of tonsillar herniation on cyclic csf flow studied 
with computational flow analysis. AJNR Am J Neuroradiol (2011) 
Sep;32(8):1474-1481. 
	   239	  
 
Lippi D: An aneurysm in the papyrus of ebers (108, 3-9). Med Secoli 
(1990) 2(1-4. 
 
Longstreth WT, Jr., Nelson LM, Koepsell TD, van Belle G: Cigarette 
smoking, alcohol use, and subarachnoid hemorrhage. Stroke (1992) 
23(9):1242-1249. 
 
Lorensen WE, Cline, H.E.: Marching cubes: A high resolution 3d 
surface construction algorithm. Computer Graphics (1987) 21(163-169. 
 
Lougheed WM, Sweet WH, White JC, Brewster WR: The use of 
hypothermia in surgical treatment of cerebral vascular lesions; a 
preliminary report. J Neurosurg (1955) 12(3):240-255. 
 
Low M, Perktold K, Raunig R: Haemodynamics in rigid and distensible 
saccular aneurysms: A numerical study of pulsatile flow 
characteristics. Biorheology (1993) 30(3-4):287-298. 
 
Lu G, Huang L, Zhang XL, Wang SZ, Hong Y, Hu Z, Geng DY: 
Influence of haemodynamic factors on rupture of intracranial 
aneurysms: Patient-specific 3d mirror aneurysms model 
computational fluid dynamics simulation. AJNR Am J Neuroradiol 
(2011) Aug;32(7):1255-1261. 
 
Luessenhop AJ, Spence WT: Artificial embolization of cerebral 
arteries. Report of use in a case of arteriovenous malformation. J Am 
Med Assoc (1960) 172(1153-1155. 
 
Luo XY, Hinton JS, Liew TT, Tan KK: Les modelling of flow in a 
simple airway model. Med Eng Phys (2004) Jun;26.(5):403-413. 
 
Luscher TF, Tanner FC: Endothelial regulation of vascular tone and 
growth. Am J Hypertens (1993) 6(7 Pt 2):283S-293S. 
 
 
M 
Malek AM, Alper SL, Izumo S: Haemodynamic shear stress and its role 
in atherosclerosis. JAMA (1999) 282(21):2035-2042. 
 
Malvè M, Pérez-del-Palomar A, Chandra S, López-Villalobos JL, Mena 
A, Finol EA, Ginel A, Doblaré M: Fsi analysis of a healthy and a 
	   240	  
stenotic human trachea under impedance-based boundary conditions. 
J Biomech Eng (2011) Feb;133(2):021001. 
 
Mansfield P, Morris PG, Ordidge R, Coupland RE, Bishop HM, Blamey 
RW: Carcinoma of the breast imaged by nuclear magnetic resonance 
(nmr). The British journal of radiology (1979) 52(615):242-243. 
 
Mantha A, Karmonik C, Benndorf G, Strother C, Metcalfe R: 
Haemodynamics in a cerebral artery before and after the formation of 
an aneurysm. AJNR Am J Neuroradiol (2006) 27(5):1113-1118. 
 
Mark M, Walter R, Meredith DO, Reinhart WH: Commercial taxane 
formulations induce stomatocytosis and increase blood viscosity. Br J 
Pharmacol (2001) 134(6):1207-1214. 
 
Marzo A, Singh P, Larrabide I, Radaelli A, Coley S, Gwilliam M, 
Wilkinson ID, Lawford P, Reymond P, Patel U, Frangi A et al: 
Computational haemodynamics in cerebral aneurysms: The effects of 
modeled versus measured boundary conditions. Ann Biomed Eng 
(2011) 39(2):884-896. 
 
Marzo A, Singh P, Reymond P, Stergiopulos N, Patel U, Hose R: 
Influence of inlet boundary conditions on the local haemodynamics of 
intracranial aneurysms. Comput Methods Biomech Biomed Engin (2009) 
12(4):431-444. 
 
Matas R: Surgery of the vascular system. Surgery, its principles and 
practice. W.B. Saunders Company, Philadelphia, Pennsylvania (1914). 
 
Matsuda M, Watanabe K, Saito A, Matsumura K, Ichikawa M: 
Circumstances, activities, and events precipitating aneurysmal 
subarachnoid hemorrhage. J Stroke Cerebrovasc Dis (2007) 16(1):25-
29. 
 
Mattson DL, Maeda CY, Bachman TD, Cowley AW, Jr.: Inducible nitric 
oxide synthase and blood pressure. Hypertension (1998) 31(1):15-20. 
 
Mayberg MR, Batjer HH, Dacey R, Diringer M, Haley EC, Heros RC, 
Sternau LL, Torner J, Adams HP, Jr., Feinberg W, et al.: Guidelines for 
the management of aneurysmal subarachnoid hemorrhage. A 
statement for healthcare professionals from a special writing group of 
the stroke council, american heart association. Stroke (1994) 
25(11):2315-2328. 
	   241	  
 
McCormick WF, Schmalstieg EJ: The relationship of arterial 
hypertension to intracranial aneurysms. Arch Neurol (1977) 34(5):285-
287. 
 
Meisel HJ, Mansmann U, Alvarez H, Rodesch G, Brock M, Lasjaunias P: 
Cerebral arteriovenous malformations and associated aneurysms: 
Analysis of 305 cases from a series of 662 patients. Neurosurgery 
(2000) 46(4):793-800; discussion 800-792. 
 
Meng H, Tutino VM, Xiang J, Siddiqui A: High wss or low wss? 
Complex interactions of haemodynamics with intracranial aneurysm 
initiation, growth, and rupture: Toward a unifying hypothesis. AJNR 
Am J Neuroradiol (2013). 
 
Meng H, Wang Z, Hoi Y, Gao L, Metaxa E, Swartz DD, Kolega J: 
Complex haemodynamics at the apex of an arterial bifurcation 
induces vascular remodeling resembling cerebral aneurysm initiation. 
Stroke (2007) 38(6):1924-1931. 
 
Mellado X, Larrabide, I. Hernandez, M. Frangi, A.F.: Flux driven medial 
curve extraction. The Insight Journal (2007) 1926( 
 
Mercado R, Lopez S, Cantu C, Sanchez A, Revuelta R, Gomez-Llata S, 
Bouffard JA, Pineda C: Intracranial aneurysms associated with 
unsuspected aortic coarctation. J Neurosurg (2002) 97(5):1221-1225. 
 
Mhurchu CN, Anderson C, Jamrozik K, Hankey G, Dunbabin D: 
Hormonal factors and risk of aneurysmal subarachnoid hemorrhage: 
An international population-based, case-control study. Stroke (2001) 
32(3):606-612. 
 
Milner P, Kirkpatrick KA, Ralevic V, Toothill V, Pearson J, Burnstock G: 
Endothelial cells cultured from human umbilical vein release atp, 
substance p and acetylcholine in response to increased flow. Proc Biol 
Sci (1990) 241(1302):245-248. 
 
Mitsos AP, Kakalis NM, Ventikos YP, Byrne JV: Haemodynamic 
simulation of aneurysm coiling in an anatomically accurate 
computational fluid dynamics model: Technical note. Neuroradiology 
(2008) 50(4):341-347. 
 
	   242	  
Mohiaddin RH, Kilner PJ, Rees S, Longmore DB: Magnetic resonance 
volume flow and jet velocity mapping in aortic coarctation. J Am Coll 
Cardiol (1993) 22(5):1515-1521. 
 
Moniz E: L’encephalographic arterielle dans la localoisation des 
tumeurs cerebrales. . Rev Neurol (Paris) (1927) 2(72-90. 
 
Morales HG, Kim M, Vivas EE, Villa-Uriol MC, Larrabide I, Sola T, 
Guimaraens L, Frangi AF: How do coil configuration and packing 
density influence intra-aneurysmal haemodynamics? AJNR Am J 
Neuroradiol (2011) Nov-Dec;32(10):1935-1941. 
 
Morgagni JB: De sebiuset causis morborumper anatomenin sagatis 
venetis et topog remondiama, book 1, letter 4. (1761) 2(VXCVI):298. 
 
Morimoto M, Miyamoto S, Mizoguchi A, Kume N, Kita T, Hashimoto N: 
Mouse model of cerebral aneurysm: Experimental induction by renal 
hypertension and local haemodynamic changes. Stroke (2002) 
33(7):1911-1915. 
 
Moyle KR, Antiga L, Steinman DA: Inlet conditions for image-based 
cfd models of the carotid bifurcation: Is it reasonable to assume fully 
developed flow? J Biomech Eng (2006) 128(3):371-379. 
 
Myers JG, Moore JA, Ojha M, Johnston KW, Ethier CR: Factors 
influencing blood flow patterns in the human right coronary artery. 
Ann Biomed Eng (2001) 29(2):109-120. 
 
N 
Nagata I, Handa H, Hashimoto N, Hazama F: Experimentally induced 
cerebral aneurysms in rats: Part vi. Hypertension. Surg Neurol (1980) 
14(6):477-479. 
 
Nishimoto T, Yuki K, Sasaki T, Murakami T, Kodama Y, Kurisu K: A 
ruptured middle cerebral artery aneurysm originating from the site of 
anastomosis 20 years after extracranial-intracranial bypass for 
moyamoya disease: Case report. Surg Neurol (2005) 64(3):261-265; 
discussion 265. 
 
Noordergraaf A: Physical basis of ballistocardiography. ’s-Gravenhage: 
Excelsior (1956) 146. 
 
	   243	  
Norlen G: Some aspects of the surgical treatment of intracranial 
aneurysms. Clinical neurosurgery (1963) 9(214-222. 
 
Numminen H, Kotila M, Waltimo O, Aho K, Kaste M: Declining 
incidence and mortality rates of stroke in finland from 1972 to 1991. 
Results of three population-based stroke registers. Stroke (1996) 
27(9):1487-1491. 
 
O 
Ohba M, Aoyama, M.: Defibrinogenating effect of batroxobin (df-521) 
on plasma fibrinogen concentration of experimental animals: A 
comparative study on seven different species. Jpn J Med Pharmacol 
(1985) 14(1061-1071. 
 
Oka S: Cardiovascular hemorheology. Cambridge, UK (1981). 
 
Olesen SP, Clapham DE, Davies PF: Haemodynamic shear stress 
activates a k+ current in vascular endothelial cells. Nature (1988) 
331(6152):168-170. 
 
Omodaka S, Sugiyama S, Inoue T, Funamoto K, Fujimura M, Shimizu H, 
Hayase T, Takahashi A, Tominaga T: Local haemodynamics at the 
rupture point of cerebral aneurysms determined by computational 
fluid dynamics analysis. Cerebrovasc Dis (2012) 34(2):121-129. 
 
Orsi P, Rosa G, Liberatori G, Lunardi PP, Ferrante L: Repair of two 
unruptured intracranial aneurysms in the presence of coarctation of 
the aorta-anesthetic implications and management. J Neurosurg 
Anesthesiol (1993) 5(1):48-51. 
 
Ortega HV: Computer simulation helps predict cerebral aneurysms. 
Journal of medical engineering & technology (1998) 22(4):179-181. 
 
Oshima M, Sakai H, Torii R: Modelling of inflow boundary conditions 
for image-based simulation of cerebrovascular flow. Int J Numer 
Methods Fluids (2005) 47(603–617. 
 
Ostergaard JR, Hog E: Incidence of multiple intracranial aneurysms. 
Influence of arterial hypertension and gender. J Neurosurg (1985) 
63(1):49-55. 
 
P 
	   244	  
Padget DH: The circle of willis: Its embryology and anatomy. In: 
Intracranial arterial aneurysms. Dandy WE (Ed) Comstock Publishing 
Co., New York (1944):67-90. 
 
Patel AN, Richardson AE: Ruptured intracranial aneurysms in the first 
two decades of life. A study of 58 patients. J Neurosurg (1971) 
35(5):571-576. 
 
Peltier J, Vinchon M, Soto-Ares G, Dhellemmes P: Disappearance of a 
middle cerebral artery aneurysm associated with moyamoya 
syndrome after revascularization in a child: Case report. Childs Nerv 
Syst (2008) 24(12):1483-1487. 
 
Penn RD, Basati S, Sweetman B, Guo X, Linninger A: Ventricle wall 
movements and cerebrospinal fluid flow in hydrocephalus. J 
Neurosurg (2011) Jul;115(1):159-164. 
 
Peters DG, Kassam A, St Jean PL, Yonas H, Ferrell RE: Functional 
polymorphism in the matrix metalloproteinase-9 promoter as a 
potential risk factor for intracranial aneurysm. Stroke (1999) 
30(12):2612-2616. 
 
Pezzini A, Caso V, Zanferrari C, Del Zotto E, Paciaroni M, Bertolino C, 
Grassi M, Agnelli G, Padovani A: Arterial hypertension as risk factor 
for spontaneous cervical artery dissection. A case-control study. J 
Neurol Neurosurg Psychiatry (2006) 77(1):95-97. 
 
Phillips B: A series of experiments performed for the purpose of showing 
that arteries may be obliterated without ligature, compression or the knife. 
Pamphlet published in London, Longman & Co, London, Churchill, 
London (1832 (reference unverified)). 
 
Pohl U, Herlan K, Huang A, Bassenge E: Edrf-mediated shear-induced 
dilation opposes myogenic vasoconstriction in small rabbit arteries. 
Am J Physiol (1991) 261(6 Pt 2):H2016-2023. 
 
Prasad A, To LK, Gorrepati ML, Zarins CK, Figueroa CA: 
Computational analysis of stresses acting on intermodular junctions 
in thoracic aortic endografts. J Endovasc Ther (2011) Aug 18(4):559-
568. 
 
Price JF, Mowbray PI, Lee AJ, Rumley A, Lowe GD, Fowkes FG: 
Relationship between smoking and cardiovascular risk factors in the 
	   245	  
development of peripheral arterial disease and coronary artery 
disease: Edinburgh artery study. Eur Heart J (1999) 20(5):344-353. 
 
Q 
Quarteroni A, Formaggia L: Mathematical modelling and numerical 
simulation of the cardiovascular system. Handbook of Numerical 
Analysis (2004) 12(3-127. 
 
Quarteroni A, Ragni S, Veneziani A: Coupling between lumped and 
distributed models for blood flow problems. Comput Vis Sci (2001) 
4(111–124. 
 
Quigley MR, Heiferman K, Kwaan HC, Vidovich D, Nora P, Cerullo LJ: 
Laser-sealed arteriotomy: A reliable aneurysm model. J Neurosurg 
(1987) 67(2):284-287. 
 
Qureshi AI, Suarez JI, Parekh PD, Sung G, Geocadin R, Bhardwaj A, 
Tamargo RJ, Ulatowski JA: Risk factors for multiple intracranial 
aneurysms. Neurosurgery (1998) 43(1):22-26; discussion 26-27. 
 
Quincke H: Die lumberpunction des hydrocephalus. Klin Wochenscher 
(1891) 28(929-965. 
 
R 
Raaymakers TW, Rinkel GJ, Limburg M, Algra A: Mortality and 
morbidity of surgery for unruptured intracranial aneurysms: A meta-
analysis. Stroke (1998) 29(8):1531-1538. 
 
Radaelli AG, Augsburger L, Cebral JR, Ohta M, Rufenacht DA, Balossino 
R, Benndorf G, Hose DR, Marzo A, Metcalfe R, Mortier P et al: 
Reproducibility of haemodynamical simulations in a subject-specific 
stented aneurysm model--a report on the virtual intracranial stenting 
challenge 2007. J Biomech (2008) 41(10):2069-2081. 
 
Rajasekaran H: @neurist - towards a system architecture for advanced 
disease management through integration of heterogeneous data, 
computing, and complex processing services. Proceedings of the 2008 
21st IEEE International Symposium on Computer-Based Medical Systems 
(2008) 00( 
 
Ransohoff J: A case of aortic aneurism treated by the insertion of wire. 
JAMA (1886 ) 7(481–485  
	   246	  
 
Rayz VL, Boussel L, Acevedo-Bolton G, Martin AJ, Young WL, Lawton 
MT, Higashida R, Saloner D: Numerical simulations of flow in cerebral 
aneurysms: Comparison of cfd results and in vivo mri measurements. 
J Biomech Eng (2008) 130(5):051011. 
 
Rayz VL, Boussel L, Lawton MT, Acevedo-Bolton G, Ge L, Young WL, 
Higashida RT, Saloner D: Numerical modeling of the flow in 
intracranial aneurysms: Prediction of regions prone to thrombus 
formation. Ann Biomed Eng (2008) 36(11):1793-1804. 
 
Redekop G, TerBrugge K, Montanera W, Willinsky R: Arterial 
aneurysms associated with cerebral arteriovenous malformations: 
Classification, incidence, and risk of hemorrhage. J Neurosurg (1998) 
89(4):539-546. 
 
Reifenstein GH, Levine, S.A. Gross, R.E.: Coarctation of the aorta. A 
review of 104 autopsied cases of the "adult type", 2 years of age or 
older. Am Heart J (1947) 33):146-168. 
 
Rengachary SS, Wilkins RH: Principles of neurosurgery. McGraw Hill, 
USA (1996). 
 
Resnick N, Collins T, Atkinson W, Bonthron DT, Dewey CF, Jr., 
Gimbron MA, Jr.: Platelet-derived growth factor b chain promoter 
contains a cis-acting fluid shear-stress-responsive element. Proc Natl 
Acad Sci U S A (1993) 90(16):7908. 
 
Reymond P, Merenda F, Perren F, Rufenacht D, Stergiopulos N: 
Validation of a one-dimensional model of the systemic arterial tree. 
Am J Physiol Heart Circ Physiol (2009). 
 
Rhoton AL, Jr.: Anatomy of saccular aneurysms. Surg Neurol (1980) 
14(1):59-66. 
 
Riggs HE, Rupp C.: Miliary aneurysms: Relations of anomalies of 
circle of willis to formation of aneurysms. Arch Neurol Psychiat (1943) 
49(615-616. 
 
Rinkel GJ, Djibuti M, Algra A, van Gijn J: Prevalence and risk of 
rupture of intracranial aneurysms: A systematic review. Stroke (1998) 
29(1):251-256. 
 
	   247	  
Rinne J, Hernesniemi J, Puranen M, Saari T: Multiple intracranial 
aneurysms in a defined population: Prospective angiographic and 
clinical study. Neurosurgery (1994) 35(5):803-808. 
 
Rordorf G, Koroshetz WJ, Copen WA, Gonzalez G, Yamada K, Schaefer 
PW, Schwamm LH, Ogilvy CS, Sorensen AG: Diffusion- and perfusion-
weighted imaging in vasospasm after subarachnoid hemorrhage. 
Stroke (1999) 30(3):599-605. 
 
Ronkainen A, Miettinen H, Karkola K, Papinaho S, Vanninen R, Puranen 
M, Hernesniemi J: Risk of harboring an unruptured intracranial 
aneurysm. Stroke (1998) 29(2):359-362. 
 
Rosenson RS, Tangney CC: Antiatherothrombotic properties of statins: 
Implications for cardiovascular event reduction. JAMA (1998) 
279(20):1643-1650. 
 
Rossitti S: Shear stress in cerebral arteries carrying saccular 
aneurysms. A preliminary study. Acta Radiol (1998) 39(6):711-717. 
 
Rowe GG, Castillo CA, Afonso S, Young WP, Crumpton CW: Cerebral 
blood flow in coarctation of the aorta. J Clin Invest (1964) 43(1922-
1927. 
 
S 
Sacco RL, Wolf PA, Bharucha NE, Meeks SL, Kannel WB, Charette LJ, 
McNamara PM, Palmer EP, D'Agostino R: Subarachnoid and 
intracerebral hemorrhage: Natural history, prognosis, and precursive 
factors in the framingham study. Neurology (1984) 34(7):847-854. 
 
Sadasivan C, Fiorella DJ, Woo HH, Lieber BB: Physical factors effecting 
cerebral aneurysm pathophysiology. Ann Biomed Eng (2013) 
Jul;41(7):1347-1365. 
 
Sadatomo T, Yuki K, Migita K, Taniguchi E, Kodama Y, Kurisu K: 
Morphological differences between ruptured and unruptured cases in 
middle cerebral artery aneurysms. Neurosurgery (2008) 62(3):602-609; 
discussion 602-609. 
Sah AL, Perett, G.E., Locksley, H.B. et al.: Intracranial aneurysms sand 
sah: A co-operative study. . JB Lippincott, Philadelphia (1969). 
 
	   248	  
Sakai N, Nakayama K, Tanabe Y, Izumiya Y, Nishizawa S, Uemuara K: 
Absence of plasma protease-antiprotease imbalance in the formation 
of saccular cerebral aneurysms. Neurosurgery (1999) 45(1):34-38; 
discussion 38-39. 
 
Sakaki T, Tominaga M, Miyamoto K, Tsunoda S, Hiasa Y: Clinical 
studies of de novo aneurysms. Neurosurgery (1993) 32(4):512-516; 
discussion 516-517. 
 
San Millan Ruiz D, Yilmaz H, Dehdashti AR, Alimenti A, de Tribolet N, 
Rufenacht DA: The perianeurysmal environment: Influence on 
saccular aneurysm shape and rupture. AJNR Am J Neuroradiol (2006) 
27(3):504-512. 
 
Sarner M, Crawford MD: Ruptured intracranial aneurysm. Clinical 
series. Lancet (1965) 2(7425):1251-1254. 
 
Sauerbeck LR, Hornung R, Moomaw CJ, Woo D, Curry R, Brown RD, 
Jr., Broderick J: The effects of study participation in the familial 
intracranial aneurysm study on cigarette smoking. J Stroke 
Cerebrovasc Dis (2008) 17(6):370-372. 
 
Schievink WI, Schaid DJ, Michels VV, Piepgras DG: Familial 
aneurysmal subarachnoid hemorrhage: A community-based study. J 
Neurosurg (1995) 83(3):426-429. 
 
Schmetterer L, Kemmler D, Breiteneder H, Alschinger C, Koppensteiner 
R, Lexer F, Fercher AF, Eichler HG, Wolzt M: A randomized, placebo-
controlled, double-blind crossover study of the effect of pentoxifylline 
on ocular fundus pulsations. Am J Ophthalmol (1996) 121(2):169-176. 
 
Sekhar LN, Heros RC: Origin, growth, and rupture of saccular 
aneurysms: A review. Neurosurgery (1981) 8(2):248-260. 
 
Serbinenko FA: Balloon catheterization and occlusion of major 
cerebral vessels. J Neurosurg (1974) 41(2):125-145. 
 
Sforza DM, Putman CM, Scrivano E, Lylyk P, Cebral JR: Blood-flow 
characteristics in a terminal basilar tip aneurysm prior to its fatal 
rupture. AJNR Am J Neuroradiol (2010) Jun;31(6):1127-1131. 
 
	   249	  
Shearer WT, Rutman JY, Weinberg WA, Goldring D: Coarctation of the 
aorta and cerebrovascular accident: A proposal for early corrective 
surgery. J Pediatr (1970) 77(6):1004-1009. 
 
Shimogonya Y, Ishikawa T, Imai Y, Matsuki N, Yamaguchi T: Can 
temporal fluctuation in spatial wall shear stress gradient initiate a 
cerebral aneurysm? A proposed novel haemodynamic index, the 
gradient oscillatory number (gon). J Biomech (2009) 42(4):550-554. 
 
Sho E, Sho M, Singh TM, Nanjo H, Komatsu M, Xu C, Masuda H, Zarins 
CK: Arterial enlargement in response to high flow requires early 
expression of matrix metalloproteinases to degrade extracellular 
matrix. Exp Mol Pathol (2002) 73(2):142-153. 
 
Shojima M, Oshima M, Takagi K, Torii R, Hayakawa M, Katada K, 
Morita A, Kirino T: Magnitude and role of wall shear stress on 
cerebral aneurysm: Computational fluid dynamic study of 20 middle 
cerebral artery aneurysms. Stroke (2004) 35(11):2500-2505. 
 
Shojima M, Oshima M, Takagi K, Torii R, Nagata K, Shirouzu I, Morita 
A, Kirino T: Role of the bloodstream impacting force and the local 
pressure elevation in the rupture of cerebral aneurysms. Stroke (2005) 
36(9):1933-1938. 
 
Singh PK, Marzo A, Coley SC, Berti G, Bijlenga P, Lawford PV, Villa-
Uriol MC, Rufenacht DA, McCormack KM, Frangi A, Patel UJ et al: The 
role of computational fluid dynamics in the management of 
unruptured intracranial aneurysms: A clinicians' view. Comput Intell 
Neurosci (2009) 760364. 
 
Siouffi M, Deplano V, Pélissier R: Experimental analysis of unsteady 
flows through a stenosis. J Biomech (1998) 31(1):11-19. 
 
Solenski NJ, Haley EC, Jr., Kassell NF, Kongable G, Germanson T, 
Truskowski L, Torner JC: Medical complications of aneurysmal 
subarachnoid hemorrhage: A report of the multicenter, cooperative 
aneurysm study. Participants of the multicenter cooperative 
aneurysm study. Crit Care Med (1995) 23(6):1007-1017. 
 
Solomon RA, Fink ME, Pile-Spellman J: Surgical management of 
unruptured intracranial aneurysms. J Neurosurg (1994) 80(3):440-446. 
 
	   250	  
St Jean P, Hart, B. Webster, M. Steed, D. Adamson, J. Powell, J. Ferrell, 
R.: Alpha-1-antitrypsin deficiency in aneurysmal disease. Hum Hered 
(1996) 46(92-97. 
 
Stehbens WE: Medial defects of the cerebral arteries of man. J Pathol 
Bacteriol (1959) 78(179-185. 
 
Stehbens WE: Cerebral aneurysms and congenital abnormalities. 
Australas Ann Med (1962) 11(102-112. 
 
Stehbens WE: Histopathology of cerebral aneurysms. Arch Neurol 
(1963) 8(272-285. 
 
Stehbens WE: Aneurysms and anatomical variation of cerebral 
arteries. Arch Pathol (1963b) 75(45-64. 
 
Stehbens WE: Pathology of the cerebral blood vessels. Mosby, St. Louis 
(1972). 
 
Stehbens WE: Aetiology of intracranial berry aneurysms. J Neurosurg 
(1989) 70(6):823-831. 
 
Steiger HJ, Aaslid R, Keller S, Reulen HJ: Growth of aneurysms can be 
understood as passive yield to blood pressure. An experimental study. 
Acta Neurochir (Wien) (1989) 100(1-2):74-78. 
 
Steinman DA, Milner JS, Norley CJ, Lownie SP, Holdsworth DW: 
Image-based computational simulation of flow dynamics in a giant 
intracranial aneurysm. AJNR Am J Neuroradiol (2003) 24(4):559-566. 
 
Steinman DA: Image-based computational fluid dynamics: A new 
paradigm for monitoring haemodynamics and atherosclerosis. Current 
drug targets Cardiovascular & haematological disorders (2004) 4(2):183-
197. 
 
Stergiopulos N, Young DF, Rogge TR: Computer simulation of arterial 
flow with applications to arterial and aortic stenoses. J Biomech (1992) 
25(12):1477–1488. 
 
Strother CM, Graves VB, Rappe A: Aneurysm haemodynamics: An 
experimental study. AJNR Am J Neuroradiol (1992) 13(4):1089-1095. 
 
	   251	  
Stuntz JT, Ojemann GA, Alvord EC, Jr.: Radiographic and histologic 
demonstration of an aneurysm developing on the infundibulum of the 
posterior communicating artery. Case report. J Neurosurg (1970) 
33(5):591-595. 
 
Sun Q, Groth A, Aach T: Comprehensive validation of computational 
fluid dynamics simulations of in-vivo blood flow in patient-specific 
cerebral aneurysms. Med Phys (2012) Feb;39(2):742-754. 
 
Sun Q, Groth A, Bertram M, Waechter I, Bruijns T, Hermans R, Aach T: 
Phantom-based experimental validation of computational fluid 
dynamics simulations on cerebral aneurysms. Med Phys (2010) 
Sep;37(9):5054-5065. 
 
Suyama K, Mizota S, Minagawa T, Hayashi K, Miyazaki H, Nagata I: A 
ruptured anterior communicating artery aneurysm associated with 
internal carotid artery agenesis and a middle cerebral artery 
anomaly. J Clin Neurosci (2009) 16(4):585-586. 
 
Suzuki J, Hori S, Sakurai Y: Intracranial aneurysms in the 
neurosurgical clinics in japan. J Neurosurg (1971) 35(1):34-39. 
 
 
 
T 
Takahashi M, Fujimoto T, Suzuki R, Asai J, Miyo T, Hokaku H: [a case 
of spontaneous middle cerebral artery occlusion associated with a 
cerebral aneurysm angiographically disappearing after sta-mca 
anastomosis]. No Shinkei Geka (1997) 25(8):727-732. 
 
Takayama K, Nakagawa H, Iwasaki S, Taoka T, Myouchin K, Wada T, 
Sakamoto M, Fukusumi A, Kurokawa S, Kichikawa K: Multiple cerebral 
aneurysms associated with takayasu arteritis successfully treated with 
coil embolization. Radiat Med (2008) 26(1):33-38. 
 
Tang BT, Pickard SS, Chan FP, Tsao PS, Taylor CA, Feinstein JA: Wall 
shear stress is decreased in the pulmonary arteries of patients with 
pulmonary arterial hypertension: An image-based, computational 
fluid dynamics study. Pulm Circ (2012) 2(4):470-476. 
 
	   252	  
Tappura M: Prognosis of subarachnoid haemorrhage. A study of 120 
patients with unoperated intracranial aneurysms and 267 patients 
without vascular lesions demonstrable in bilateral carotid 
angiograms. Acta Med Scand Suppl (1962) 392(1):75. 
 
Tateshima S, Murayama Y, Villablanca JP, Morino T, Nomura K, 
Tanishita K, Vinuela F: In vitro measurement of fluid-induced wall 
shear stress in unruptured cerebral aneurysms harboring blebs. 
Stroke (2003) 34(1):187-192. 
 
Tateshima S, Tanishita K, Omura H, Villablanca JP, Vinuela F: Intra-
aneurysmal haemodynamics during the growth of an unruptured 
aneurysm: In vitro study using longitudinal ct angiogram database. 
AJNR Am J Neuroradiol (2007) 28(4):622-627. 
 
Taylor CL, Yuan Z, Selman WR, Ratcheson RA, Rimm AA: Cerebral 
arterial aneurysm formation and rupture in 20,767 elderly patients: 
Hypertension and other risk factors. J Neurosurg (1995) 83(5):812-819. 
 
Taylor CL, Yuan Z, Selman WR, Ratcheson RA, Rimm AA: Cerebral 
arterial aneurysm formation and rupture in 20,767 elderly patients: 
Hypertension and other risk factors. J Neurosurg (1995) 83(5):812-819. 
 
Thiex R, Norbash AM, Frerichs KU: The safety of dedicated-team 
catheter-based diagnostic cerebral angiography in the era of advanced 
noninvasive imaging. AJNR Am J Neuroradiol (2010) 31(2):230-234. 
 
Thompson RC, Steinberg GK, Levy RP, Marks MP: The management of 
patients with arteriovenous malformations and associated intracranial 
aneurysms. Neurosurgery (1998) 43(2):202-211; discussion 211-202. 
 
Tian G, Longest PW, Su G, Hindle M: Characterization of respiratory 
drug delivery with enhanced condensational growth using an 
individual path model of the entire tracheobronchial airways. Ann 
Biomed Eng (2011) Mar;39(3):1136-1153. 
 
Toftdahl DB, Torp-Pedersen C, Engel UH, Strandgaard S, Jespersen B: 
Hypertension and left ventricular hypertrophy in patients with 
spontaneous subarachnoid hemorrhage. Neurosurgery (1995) 
37(2):235-239; discussion 239-240. 
 
	   253	  
Tromp G, Gatalica Z, Skunca M, Berguer R, Siegel T, Kline RA, 
Kuivaniemi H: Elevated expression of matrix metalloproteinase-13 in 
abdominal aortic aneurysms. Ann Vasc Surg (2004) 18(4):414-420. 
 
Teunissen LL, Rinkel GJ, Algra A, van Gijn J: Risk factors for 
subarachnoid hemorrhage: A systematic review. Stroke (1996) 
27(3):544-549. 
 
Turjman F, Massoud TF, Ji C, Guglielmi G, Vinuela F, Robert J: 
Combined stent implantation and endosaccular coil placement for 
treatment of experimental wide-necked aneurysms: A feasibility study 
in swine. AJNR American journal of neuroradiology (1994) 15(6):1087-
1090. 
 
Turowski B, Hanggi D, Siebler M: Intracranial bilateral vertebral 
artery dissection during anticoagulation after cerebral venous and 
sinus thrombosis (csvt). Acta Neurochir (Wien) (2007) 149(8):793-797; 
discussion 797. 
 
U 
Ujiie H, Tachibana H, Hiramatsu O, Hazel AL, Matsumoto T, Ogasawara 
Y, Nakajima H, Hori T, Takakura K, Kajiya F: Effects of size and shape 
(aspect ratio) on the haemodynamics of saccular aneurysms: A 
possible index for surgical treatment of intracranial aneurysms. 
Neurosurgery (1999) 45(1):119-129; discussion 129-130. 
 
Uihlein A: Profound hypothermia and circulatory arrest in operations 
for intracranial aneurysms. Ann Chir Thorac Cardiovasc (1962) 1(811-
812. 
 
 
V 
Varaprasathan GA, Araoz PA, Higgins CB, Reddy GP: Quantification of 
flow dynamics in congenital heart disease: Applications of velocity-
encoded cine mr imaging. Radiographics (2002) 22(4):895-905; 
discussion 905-896. 
 
Vardoulis O, Coppens E, Martin B, Reymond P, Tozzi P, Stergiopulos N: 
Impact of aortic grafts on arterial pressure: A computational fluid 
dynamics study. Eur J Vasc Endovasc Surg (2011) Aug 31.([Epub ahead 
of print]). 
	   254	  
 
Verheugt CL, Uiterwaal CS, Grobbee DE, Mulder BJ: Long-term 
prognosis of congenital heart defects: A systematic review. Int J 
Cardiol (2008) 131(1):25-32. 
 
Vignon-Clementel IE, Figueroa C.A., Jansen K.E., Taylor C.A.: Outflow 
boundary conditions for three-dimensional finite element modeling of 
blood flow and pressure in arteries. Comput Methods Appl Mech Eng 
(2006) 195(3776–3796  
 
Villa-Uriol MC, Berti G, Hose DR, Marzo A, Chiarini A, Penrose J, Pozo 
J, Schmidt JG, Singh P, Lycett R, Larrabide I et al: @neurist complex 
information processing toolchain for the integrated management of 
cerebral aneurysms. Interface Focus (2011) Jun 6(3):308-319. 
 
Venugopal P, Valentino D, Schmitt H, Villablanca JP, Vinuela F, 
Duckwiler G: Sensitivity of patient-specific numerical simulation of 
cerebal aneurysm haemodynamics to inflow boundary conditions. J 
Neurosurg (2007) 106(6):1051-1060. 
 
Viceconti M, Astolfi, L., Leardini, A., Imboden, S., Petrone, M., 
Quadrani, P., Taddei, F., Testi, D., Zannoni, C.: The multimod 
application framework.:Abs 15-20. 2004. 
 
Vignon-Clementel IE, Figueroa C.A., Jansen K.E., Taylor C.A.: Outflow 
boundary conditions for three-dimensional finite element modeling of 
blood flow and pressure in arteries. Comput Methods Appl Mech Eng 
(2006) 195(3776–3796  
 
W 
Waga S, Morikawa A: Aneurysm developing on the infundibular 
widening of the posterior communicating artery. Surg Neurol (1979) 
11(2):125-127. 
 
Wagner CT, Durante W, Christodoulides N, Hellums JD, Schafer AI: 
Haemodynamic forces induce the expression of heme oxygenase in 
cultured vascular smooth muscle cells. J Clin Invest (1997) 100(3):589-
596. 
 
Walker AE, Allegre GW: The pathology and pathogenesis of cerebral 
aneurysms. J Neuropathol Exp Neurol (1954) 13(1):248-259. 
 
	   255	  
Wang DM, Tarbell JM: Modeling interstitial flow in an artery wall 
allows estimation of wall shear stress on smooth muscle cells. J 
Biomech Eng (1995) 117(3):358-363. 
 
Wang Z, Kolega J, Hoi Y, Gao L, Swartz DD, Levy EI, Mocco J, Meng H: 
Molecular alterations associated with aneurysmal remodeling are 
localized in the high haemodynamic stress region of a created carotid 
bifurcation. Neurosurgery (2009) 65(1):169-177; discussion 177-168. 
 
Weichert F, Walczak L, Fisseler D, Opfermann T, Razzaq M, Münster R, 
Turek S, Grunwald I, Roth C, Veith C, Wagner M: Simulation of intra-
aneurysmal blood flow by different numerical methods. Comput Math 
Methods Med (2013) Epub 2013 Apr 15(527654. 
 
Weir B, Macdonald, R.L.: Intracranial aneurysms and subarachnoid 
hemorrhage: An overview. In: Neurosurgery. 2. Wilkins RH, 
Rengachary, S.S. (Ed) McGraw-Hill, New York (1996):2191–2213. 
 
Wermer MJ, van der Schaaf IC, Velthuis BK, Algra A, Buskens E, Rinkel 
GJ, Group AS: Follow-up screening after subarachnoid haemorrhage: 
Frequency and determinants of new aneurysms and enlargement of 
existing aneurysms. Brain (2005) 128(Pt 10):2421-2429. 
 
Werner SC, Blackemore, A.H., King, B.C.: Aneurysm of internal 
carotid artery within skull, wiring and electrothermic coagulation. 
JAMA (1941) 116(578-582. 
 
Westerhof N, Bosman F, De Vries CJ, Noordergraaf A: Analog studies of 
the human systemic arterial tree. J Biomech (1969) 2(2):121-143. 
 
Wiebers DO, Whisnant JP, Huston J, 3rd, Meissner I, Brown RD, Jr., 
Piepgras DG, Forbes GS, Thielen K, Nichols D, O'Fallon WM, Peacock J 
et al: Unruptured intracranial aneurysms: Natural history, clinical 
outcome, and risks of surgical and endovascular treatment. Lancet 
(2003) 362(9378):103-110. 
 
Willis T: Cerebri anatome cui accessit nervorum descriptio et usus. 
(1664). 
 
Wirth FP, Laws ER, Jr., Piepgras D, Scott RM: Surgical treatment of 
incidental intracranial aneurysms. Neurosurgery (1983) 12(5):507-511. 
 
	   256	  
Womersley JR: Method for the calculation of velocity, rate of flow and 
viscous drag in arteries when the pressure gradient is known. J 
Physiol (1955) 127(3):553-563. 
 
Wong GK, Poon WS: Current status of computational fluid dynamics 
for cerebral aneurysms: The clinician's perspective. J Clin Neurosci 
(2011) Oct;18(10):1285-1288. 
 
X 
Xu J, Yu Y, Wu X, Wu Y, Jiang C, Wang S, Huang Q, Liu J: 
Morphological and haemodynamic analysis of mirror posterior 
communicating artery aneurysms. PLoS One (2013) 8(1):e55413. 
 
Y 
Yasui N, Magarisawa S, Suzuki A, Nishimura H, Okudera T, Abe T: 
Subarachnoid hemorrhage caused by previously diagnosed, 
previously unruptured intracranial aneurysms: A retrospective 
analysis of 25 cases. Neurosurgery (1996) 39(6):1096-1100; discussion 
1100-1091. 
 
Yamashita K, Kashiwagi S, Kato S, Takasago T, Ito H: Cerebral 
aneurysms in the elderly in yamaguchi, japan. Analysis of the 
yamaguchi data bank of cerebral aneurysm from 1985 to 1995. Stroke 
(1997) 28(10):1926-1931. 
 
Yong-Zhong G, van Alphen HA: Pathogenesis and histopathology of 
saccular aneurysms: Review of the literature. Neurol Res (1990) 
12(4):249-255. 
 
Z 
Zada G, Breault J, Liu CY, Khalessi AA, Larsen DW, Teitelbaum GP, 
Giannotta SL: Internal carotid artery aneurysms occurring at the 
origin of fetal variant posterior cerebral arteries: Surgical and 
endovascular experience. Neurosurgery (2008) 63(1 Suppl 1):ONS55-
61; discussion ONS61-52. 
 
Zeng Z, Kallmes DF, Durka MJ, Ding Y, Lewis D, Kadirvel R, Robertson 
AM: Sensitivity of cfd based haemodynamic results in rabbit 
aneurysm models to idealizations in surrounding vasculature. J 
Biomech Eng (2010) Sep;132(9):091009.	  
 	  
 17Journal of Vascular and Interventional Neurology, Volume 3, Number 1, January 2010
`
The Effects of Aortic Coarctation on Cerebral Hemodynamics and its Importance in the 
Etiopathogenesis of Intracranial Aneurysms
Abstract
Objectives: Hemodynamic changes in the cerebral circulation in presence of coarctation of aorta (CoA) and their significance in the 
increased intracranial aneurysms (IAs) formation in these patients remain unclear. In the present study, we measured the flow-rate 
waveforms in the cerebral arteries of a patient with CoA, followed by an analysis of different hemodynamic indices in a coexisting IA.
Materials and Methods: Phase-contrast Magnetic Resonance (pc-MR) volumetric 
flow-rate (VFR) measurements were performed in cerebral arteries of a 51 
years old woman with coexisting CoA, and five healthy volunteers. Numerical 
predictions of a number of relevant hemodynamic indices were performed in 
an IA located in sub-clinoid part of left internal carotid artery (ICA) of the 
patient. Computations were performed using Ansys®-CFX™ solver using 
the VFR values measured in the patient as boundary conditions (BCs). A 
second analysis was performed using the average VFR values measured in 
healthy volunteers. The VFR waveforms measured in the patient and healthy 
volunteers were compared followed by a comparison of the hemodynamic 
indices obtained using both approaches. The results are discussed in the 
background of relevant literature.
Results: Mean flow-rates were increased by 27.1% to 54.9% (2.66-5.44 ml/
sec) in the cerebral circulation of patients with CoA as compared to healthy 
volunteers (1.2-3.95 ml/sec). Velocities were increased inside the IA by 35-
45%. An exponential rise of 650% was observed in the area affected by high 
wall shear stress (WSS>15Pa) when flow-rates specific to CoA were used as 
compared to population average flow-rates. Absolute values of space and time 
averaged WSS were increased by 65%. Whereas values of maximum pressure 
on the IA wall were increased by 15% the area of elevated pressure was actually 
decreased by 50%, reflecting a more focalized jet impingement within the IA 
of the CoA patient.
Conclusions: IAs can develop in patients with CoA several years after the surgical repair. Cerebral flow-rates in CoA patients are 
significantly higher as compared to average flow-rates in healthy population. The increased supra-physiological WSS (>15Pa), OSI 
(>0.2) and focalized pressure may play an important role in the etiopathogenesis of IAs in patients with CoA.
Keywords: Coarctation of aorta, intracranial aneurysms, cerebral circulation, flow-rates, hemodynamics, wall shear stress, computational 
fluid dynamics
Journal of Vascular and Interventional Neurology 2010;3(1) 17-30
Introduction:
Estimated annual incidence of IAs in most Western countries is estimated to be at 1 to 2%.7,49 Subarachnoid hemorrhage (SAH) can be a 
consequence with a high overall mortality rates approximating 45% (range 32-67%).46 About 30% of survivors have moderate to severe 
disabilities and 66% of those who have ‘successful’ clip placement, never return to same quality of life as before SAH.23,46 The current 
evidence convincingly supports a multi-factorial basis for the initiation and rupture of IAs.88,92,108
Amongst other etiologies proposed, CoA has been highlighted as a major risk factor in the etiopathogenesis of IAs.1,3,15,24,27,48,50,53,62,70,75,78,87 A 
wide range for the incidence of IAs in patients with CoA has been reported starting from 2.5%1 to as high as 50%,89 all above the estimated 
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incidence of IAs in general population. Connolly and colleagues 
in their recent study confirmed that the frequency of IAs among 
patients with CoA is approximately 5 times higher than that of the 
general population.15 The incidence of IA rupture in CoA patients 
(4.8%)70,83 is also higher than the estimated rate of rupture in the 
general population which is less than 1%.106 In spite of CoA being a 
well-established risk factor for IA formation,1,3,15,24,27,48,50,53,62,70,75,78,87 
the exact underlying mechanisms for this association remain 
poorly understood. Hypertension3,9,24,50,75,78,92,95 and developmental 
errors of neural crest resulting in abnormal vessel wall 
collagen15,17,48,53,62,70,87, are two main factors thought to facilitate 
the formation of IAs in presence of CoA. It is surprising to note 
that in spite of well established role of wall shear stress (WSS) in 
the genesis of IAs,11,32,38,40-42,65,69,72,91,104 none of the workers explored 
this important link in this context.
Owing to their direct origin from the pre-coarctation segment 
of aorta, cerebro-cephalic arteries are most likely to be affected 
by the hemodynamic changes occurring in this part of aorta. 
Secondary to the increased resistance to outflow, increased 
aorto-cranial pressure gradients have been demonstrated by a 
number of authors correlating to the severity of stenosis.1,36,45,71,102 
Dilatation of cervico-cephalic arteries in CoA secondary to this 
increased pressure gradient is has also been reported.1,85
An increase in the radius (r) of cerebral arteries and increased 
aorto-cranial pressure gradient (ΔP) in CoA are expected to 
result in an exponential rise in flow-rates (Q) as per the Hagan-
Poiseuille law (Equation-1), given the viscosity (µ) and length (L) 
remain constant.
............. (Eq-1)
Furthermore, bradycardia coupled with increased stroke volume 
and cardiac output is a known feature of CoA.36 These increments 
will further increase the cerebral blood-flow (CBF).
An increased flow-rate (Q), in turn is one of the major factors 
responsible for increased wall shear stress (WSS) in the 
intracranial arteries (Equation-2).
................. (Eq-2)
Where τ is WSS
Literature seems to be particularly deficient and controversial on 
the effects of CoA on cerebral arterial flow-rates. After a thorough 
search (PubMed®, Embase® and Google-Scholar™ searched from 
the year 1900 up to 2009) we could retrieve only two relevant 
studies. In 1949 Hafkenschiel et al37 demonstrated a significant 
increase in cerebral arterial flow-rates in patients with CoA. Rowe 
and colleagues85 found no significant differences in the flow-rates 
before and after the repair of CoA in their study done in 1964. 
No apparent efforts were done since then to measure the cerebral 
arterial flow-rates in patients with CoA. Paucity of information 
about the flow patterns inside the cerebral circulation in presence 
of CoA provided us a rationale to measure the cerebral arterial 
flow-rates in the present patient. Furthermore, given the widely 
accepted importance of hemodynamics in the etiopathogenesis 
of IAs11,32,38,40-42,65,69,72,91,104 it is logical to analyze the hemodynamic 
factors in the coexisting IA of our patient. A better understanding 
of the etiopathogenesis of the IA formation and rupture may help 
clinicians in preventing and treating the disease effectively.
In the current study, we preformed pc-MR measurements 
in the cerebral arteries of a CoA patient with coexisting IA 
and five healthy volunteers followed by an analysis of the 
different hemodynamic factors inside IA. The possible role of 
Figure 1: 24 hours ambulatory Non-invasive BP 
(NIBP) monitoring showing satisfactory BP control 
for both systolic and diastolic values.
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hemodynamics is discussed in this context in a background of 
relevant literature.
Materials and methods
The study was conducted jointly in the departments of 
Neurosurgery and Neuroradiology, Royal Hallamshire Hospital, 
and the Academic Unit of Medical Physics, and Radiology, School 
of Medicine and Biomedical Sciences, University of Sheffield, 
Sheffield, UK. After obtaining appropriate consent and ethical 
approval the patient was recruited to the @neurIST project 
(www.aneurist.org).
Clinical details: This 51 years old woman, presented for the first 
time to cardiovascular surgeons in 1989 at the age of 31 years 
through obstetric unit. She had hypertension during both 
her pregnancies but was otherwise asymptomatic. She was a 
cigarette smoker, smoking 10-15 cigarettes per day. On clinical 
examination, she appeared fit and well with a blood pressure 
(BP) of 160/90 mm Hg. No femoral pulses were palpable and there 
was an ejection systolic murmur in the aortic area coupled with 
a continuous machinery murmur at left scapula. She was taking 
oral antihypertensives (Atenolol and Nifedipine) to control her 
hypertension. Subsequent investigations including DVI (digital 
vascular scan) done at that time revealed a severe (>80% reduction 
in diameter) post-ductal aortic coarctation distal to origin of left 
subclavian artery. X-ray chest showed typical inferior notching 
of 3rd and 8th ribs, bilaterally. No other congenital anomalies were 
detected apart from a pseudo-bicuspid aortic valve, without any 
evidence of regurgitation or stenosis. One year later, the patient 
was treated with Dacron onlay patch graft (DOPG) repair for her 
coarctation with an uneventful postoperative recovery.
A follow-up MRI of heart done in July 2004 after 15 years of 
primary procedure demonstrated evidence of re-occurrence of 
coarctation with significant (60-70%) loss of luminal diameter. 
The stenosis occurred just distal to the origin of left subclavian 
artery coinciding with the site of repair. Presence of significant 
collaterals was also noted along with marginal concentric 
hypertrophy of left ventricle but adequate ejection fraction. A 
BRUCE treadmill stress test done to evaluate cardiac fitness 
demonstrated an appropriate exercise tolerance without any 
chest pain or ECG changes. A 24-hour BP monitoring further 
confirmed a satisfactory BP control (Fig-1). A completely 
asymptomatic status with no signs of cardiac failure was the 
reason to manage her conservatively.
The patient was referred to Neurosurgery in May 2007 with 
complaints of tingling and numbness affecting right side of 
her face. On further interrogation, she gave history of a similar 
episode three years back resulting in spontaneous resolution, but 
no other neurological symptoms. On clinical examination, she 
had no neurological deficits. An MRI demonstrated presence of 
two incidental IAs. First aneurysm was located in the pericallosal 
artery and was 4.2 mm in maximum diameter. A second small 
broad necked 1 mm aneurysm was also present at the origin of 
left anterior temporal artery arising from the proximal left middle 
cerebral artery (MCA). The findings were further confirmed by a 
Figure 2: Intracranial aneurysm included in the study shown in (a) circle of Willis (yellow sphere- arrowhead) and (b) in subclinoid part of ICA (arrow)
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3D rotational angiogram (3DRA), which apart from two previous 
IAs, also revealed an approximately 1.8 mm aneurysm in the 
subclinoid segment of left internal carotid artery (ICA), pointing 
medially (Fig-2). The case was discussed in a multidisciplinary 
meeting with Neuroradiologists and it was found that due to its 
small neck the pericallosal IA was suitable for coil embolization.
3DRA acquisition: All medical images were obtained using 
rotational acquisition in a Philips® Integris™ Allura machine 
(Philips® Medical Systems, Best, The Netherlands), producing 
100 images in 6 seconds, with 5 ms exposure per image. Voxel 
size in the reconstructed 3D images was 121 microns with 
reconstruction matrix of 512 x 512 x 512.
Endovascular Interventions: The pericallosal artery aneurysm was 
embolized under general anaesthesia in May 2008 with GDC® 
(Guglielmi Detachable Coils). A 6-french guided catheter was 
gently placed within the distal right internal carotid artery 
(ICA). The aneurysm was catheterized with an Excelsior® 
SL-10 microcatheter using a Transend® 14 guidewire (Boston 
Scientific, USA). The IA was packed satisfactorily using four 
Micrus® Cerecyte® endovascular bare platinum coils. She made 
an uneventful recovery from the procedure. Owing to their small 
size and anticipated difficulties for endovascular coiling (broad 
neck) remaining two aneurysms were decided to be observed by 
follow-up MRAs.
Flow Measurements & pc-MR protocol: MR imaging was performed 
at high field strength (Achieva™ 3.0T, Philips® Medical 
Systems, Best, The Netherlands) using a standard 8-channel, 
radiofrequency receive-only head coil. The same radiographer 
imaged the patient and all volunteers to maximize reproducibility 
of overall acquisition technique. Macroscopic vascular flow and 
IA location were visualized using a qualitative Time-Of-Flight 
(TOF) MR angiography sequence (TR=25 ms; TE=3.5 ms; α=20˚; 
visualization voxel size = 0.39 x 0.39 x 1.00 mm3). Maximum 
intensity projections from this 3D dataset were used to define the 
placement of each quantitative phase contrast measurement plane 
perpendicular to the vessel under investigation. A 2D acquisition 
sequence (TR=8 ms; TE=4.4 ms; α=10˚; field of view=220 x 179 mm;2 
in-plane acquisition matrix=128 x 112; slice thickness=5 mm) was 
used to acquire 40 velocity-encoded ‘time points’ over the cardiac 
cycle at each vascular location. Vector ECG triggering was used 
to standardize each quantitative acquisition.
The measurements were performed at three locations, both in 
healthy volunteers and in patient viz. left proximal ICA, left 
distal ICA, and left ACA A-1 segment. An appropriate maximum 
velocity-encoding (VENC) value was chosen (100 cm/sec) for 
ICA to ensure that appropriate dynamic ranges were sampled 
in all cases and no phase-aliasing occurred. As proximal vessels 
geometry has an important influence on intra-aneurysmal 
hemodynamics,13 measurements were taken at a distance of 
approximately 10 vessel diameters from the aneurysm location so 
that BCs to the numerical models could be applied at a sufficient 
distance from the location of the aneurysm. Measurement 
Figure 3: A comparison of VFR waveforms from CoA patient (marked-red) measured in proximal ICA and average VFR waveforms from healthy volunteers (marked-
blue) in the same location. The flow-rates in presence of CoA are 1.5 times higher (5.44 ml/sec) as compared with the normal healthy individuals (3.62 ml/sec). Solid 
horizontal lines represent average values of VFR for CoA (red) and typical (blue).
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location in distal vessels was approximately 3 diameters from the 
IA.
Measurements are reported in Fig-3 and Table-1. The 
manufacturer’s proprietary post-data-acquisition processing 
software (Q-Flow™, Philips® Medical Systems, Best, The 
Netherlands) was used to estimate VFR waveforms at each 
spatial location.
Transthoracic Doppler echocardiography: Flow and pressure 
measurements were performed using transthoracic Doppler 
echocardiography (Philips® Sonos™ 5500). The results are 
reported in Fig-5.
Numerical 3D models and computational fluid dynamics (CFD) 
analysis: The @neurIST computational tool-chain was used to 
reconstruct vessel and aneurysmal geometries, as described by 
Marzo et al.66 The 3D transient Navier–Stokes equations were 
solved by using the finite-control-volume software ANSYS®-
CFX™. Blood was assumed to be incompressible, with density 
ρ=1060 kg/m3 and Newtonian, with viscosity µ=0.0035 Pa∙s. The 
relevant hemodynamic indices were computed (Table-2) in the 
IA located in subclinoid part of left ICA (Fig-2) of the patient 
using the VFR values measured in the patient as BCs. A second 
analysis was performed with BCs derived from the average 
VFR values measured in healthy volunteers. Location, type and 
method of BC applied in the study are indicated in Table-1. All 
analyses were run in parallel on two Itanium2® 900 MHz 64-bit 
processors. The average time required to solve one cardiac cycle 
was approximately 8.6 Hr. Analyses were run for three cardiac 
cycles, to minimize the effects of the initial transient effects, and 
only results from the last cardiac cycle were post-processed.
Results
Flow measurements in intracranial arteries of healthy 
volunteers and patient with CoA
On comparing the patient-specific waveforms (Fig-3) from CoA 
patient (red) with that of typical normal individual (blue) it 
becomes apparent that the VFR waveform in the proximal ICA of 
CoA patient is higher than the one for the healthy volunteers. This 
is also reflected by the average values reported in Table-1 where 
the flow-rates for the CoA patient are 1.5 times higher (5.44 ml/
sec) as compared to the normal healthy individuals (3.62 ml/sec).
The flow waveforms further illustrate that the cerebral arterial 
flow in CoA rises and falls slowly than that of a typical individual 
but the overall volume over one cardiac cycle is increased from 
3.48 ml to 4.54 ml. A new broad hump (arrow-b) is seen just after 
the original peak (arrow-a). The systolic upstroke is delayed 
and slow; the peak is broader (between arrows a & b), slightly 
lower and dumped. The flow during diastole is almost a smooth 
decline curve (arrow-c) and the notch indicating the beginning of 
diastole is absent (arrow-d).
Table-1: Radiological characteristics of the IA included in the study, the pc-MR measurements in CoA patient and healthy volunteers along with the locations, types 
and methods of BC application
IA Location, 
Size* and Neck 
Size*
Q-flow measurements using pc-MR and BC application
Lt ICA 
Subclinoid, 
1.8mm, 
3.1mm
Location of Q-Flow 
measurements
Q-av-Typical  
Healthy 
Volunteers (ml/s)
Q-av-CoA 
patient (ml/s)
Change 
(%)
BC location BC type BC Method†
1. Lt ICA Proximal 3.95 5.44 +27.4 1. Lt ICA Proximal Inlet/velocity pc-MR
2. Lt ICA Distal 3.7 5.07 +27.1 2. Lt ICA Distal Outlet/velocity pc-MR
4. Lt ACA 1.2 2.66 +54.9 3. Lt OphthA Outlet/pressure
Typical/population 
average
NB: Q-av; average blood flow, BC; boundary condition, Lt; left, Rt; right, ICA; internal carotid artery, MCA; middle cerebral artery, OphthA; ophthalmic artery, *size 
is reported as max diameter. †BC method refers to the analyses based on patient-specific BC from CoA patient.
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Contour plots for hemodynamic indices and their absolute values
Figure 4: Time-averaged WSS (top) and OSI (Oscillatory shear index) (bottom) contour plots in the left subclinoid intracranial aneurysm of the CoA patient. Whereas, 
areas affected by high WSS are increased in CoA patient (top, right) as compared with healthy volunteers (top, left) OSI patterns  are minimally changed.
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Figure 5: Transthoracic Doppler echocardiogram showing aortic coarctation with a diastolic tail. A coarctation gradient of 30-40mmHg was seen (arrowhead) while 
the average aortic pressure gradient was 16 mmHg. The peak velocity in aorta was 276cm/sec.
Table 2: Absolute values of WSS, OSI, velocity and pressure for IA, obtained using BCs derived from healthy volunteers and measurements taken in CoA patient by 
pc-MR
Hemodynamic Indices BCs derived from healthy volunteers 
(without CoA)
BCs derived from patient 
(with CoA)
% difference
Max t-ave velocity (m/s) 0.5 0.72 +44
Space and t-ave velocity (m/s) 0.072 0.097 +35
Max OSI 0.3 0.3 0
Area of WSS below 0.4 Pa (mm2) 0.05 (0.3%) 0.03 (0.2%) -34
Area of WSS above 15 Pa (mm2) 0.4 (0.4%) 3.0 (17.2%) +650
Space and t-ave WSS in aneurysm (Pa) 5.7 9.4 +65
Max pressure on aneurysm wall 
(mmHg)*
122.4 140.8 +15
Area of elevated pressure (mm2)* 3.0 (17.1%) 1.5 (8.5%) -50%
NB: WSS; wall shear stress, OSI; oscillatory shear index, Max; maximum, ave; average, t; time, BC; boundary condition, * indicates the values at peak systole
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Discussion
The CoA is a connective tissue disorder accounting for 10% 
of the cases of congenital heart disease.103 The most common 
site of narrowing is distal to the left subclavian artery. Due to 
the mechanical outflow obstruction and extensive collateral 
formation a number of hemodynamic changes are seen in CoA. 
The most notable is a differential hypertension produced in the 
segment of aorta above the site of narrowing leading to increased 
aorto-cranial pressure gradients1,36,45,71,102 and dilatation of cervico-
cephalic arteries.1,85 Similar changes were seen in our patient (Fig-
5). A pressure gradient of 30-40 mmHg was present at the site of 
coarctation as compared to the mean aortic pressure gradient of 
16 mmHg. The peak velocity in aorta was also increased to 276 
cm/sec when compared to the peak velocity of 80-90 cm/sec 
in the aorta of a normal person.19 As discussed in the previous 
sections, it is hypothesized here that the regional cerebral blood 
flow (rCBF) in CoA patients should increase as a consequence of 
these changes.
It is surprising to see that such little attention is devoted on the 
effects of CoA on rCBF. The first available study on the subject 
was conducted by Hafkenschiel et al37 in 1949. They measured 
rCBF and cerebral oxygen consumption in two patients with 
CoA using nitrous oxide (N
2
O) saturation method and found 
that the rCBF in patients with CoA was higher as compared with 
normal subjects.
A similar study was done by Rowe and colleagues85 in 1964 who 
measured the rCBF in 20 CoA patients using the same technique. 
The rCBF was measured in these patients before and after the 
surgical correction of CoA and the results were compared with 
rCBF values obtained in normal subjects in their previous study,86 
and rCBF values specific to hypertensive patients.18 No significant 
differences were noted in the rCBF pre and post surgical repair 
of coarctation and, between CoA patients and hypertensive 
patients. Interestingly, the comparison of rCBF in CoA patients 
and healthy volunteers suggested that the values of average rCBF 
measured by them (63±13 ml/100 gm/ min) were approximately 
21% higher compared to the rCBF measured in 8 normal subjects 
(52±12 ml/100 gm/ min)86 but not statistically significant . The 
postoperative measurements in this study were taken at an 
average interval of 21 months (maximum 9.25 yrs) from the time 
of surgery which may have obscured some of the differences. Re-
occurrence of coarctation is a frequent complication following 
surgery that can occur in 41-86% patients.44 The similar patterns 
were observed in our patient where 60-70% loss of luminal 
diameter occurred 14 years after repair. As the diameter of aorta 
was not assessed by Rowe and colleagues85 at the time of rCBF 
measurements, the possibility of recoarctation in these patients 
cannot be ruled out which might account for the lack of difference 
in the rCBF before and after surgical correction.
The measurements of rCBF in both studies were performed 
using the oldest available technique based on N
2
O diffusion 
and Fick’s principle introduced by Kety and Schmidt in 1951.57 
The technique provides the measurements of global CBF rather 
than the regional values. The accuracy of measurements is 
dependent upon the reliability of the blood sample withdrawn 
from a single jugular vein which can be influenced by the flow 
variations in dural sinuses and torcula.52 With the advent of new 
technology, the technique of rCBF measurement has evolved 
tremendously. The use of pc-MR in this context is gaining a 
rapid popularity.10,25,26,84,101,107 The rCBF can be measured using this 
technique in a simple non-invasive manner without the need of 
any intravenous contrast administration and has been validated 
widely by means of in vitro and in vivo experiments.8,12,28,58
Recent evidence however indicates that the local variations in the 
hemodynamics that play an important role in the etiopathogenesis 
of IAs32,38,40-42,65,69,72,104 highlighting the importance of assessing the 
local flow patterns. No previous study however has examined 
the local hemodynamics in presence of CoA. According to the 
Hagan-Poiseuille law, we hypothesized that the local VFR 
should increase in patients with CoA. The pc-MR measurements 
performed prior to repair of the CoA in our study confirmed this 
hypothesis by demonstrating an increase of local regional CBF 
by 27.1 to 54.9% (Table-1) in ICA and ACA respectively, when 
compared to healthy volunteers. As a result space and time 
averaged velocity and max time average velocities inside the 
coincidental IA present were also increased by 35-44% (Table-2) 
when the BCs specific to CoA were used.
We further hypothesize that the increased VFR can be an 
important contributory factor in the increased incidence of IAs 
in presence of CoA. The possible mechanisms responsible for 
increased incidence of IAs in CoA patients are explored in the 
further sections of this manuscript. Eppinger was the first person 
to draw attention towards the association between CoA and IAs 
in 1871.27 Whereas the exact mechanisms responsible for this 
increased incidence remained obscure, arterial hypertension 
has been suggested as a possible underlying cause by most of 
the authors (Table-3).3,9,24,50,75,78,92,95 Stehbens was the strongest 
proponent of this theory who particularly stressed on the 
importance of hypertension in this context while denying the 
role of all other factors including vessel wall abnormalities.92,95 
This assumption is probably based on two observations. First, 
hypertension is often a constant feature in CoA patients. Second, 
hypertension has been considered as a major risk factor for 
the development of IAs even without CoA.22,99 In spite of an 
increased prevalence of IAs in hypertensive patients the role 
of hypertension in this context has been questioned by many 
authors. McCormick and Schmalstieg found no relationship 
between arterial hypertension and IAs in 250 patients they 
studied.67 In a similar study conducted in 212 cases, Andrews and 
Spiegel6 did not find significant elevation in the blood pressure 
in patients with IAs compared with the general population. 
However, studies supporting hypertension as a risk factor for the 
development and rupture of IAs outnumber the studies refuting 
it. De la Monte et al22 found high degree of correlation (p<0.001) 
between systemic hypertension and development of saccular IAs. 
In one of the largest studies conducted including 20,767 elderly 
patients Taylor et al99 found hypertension as an independent 
major risk factor for aneurysmal SAH.
Although, hypertension can be an important contributory 
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Table-3: A comprehensive review of different mechanisms proposed for the increased incidence of IAs in CoA patients 
Author/ Year
No. of  
Patients 
IA 
location/No.
HTN at 
the time IA 
diagnosed
Associated features Proposed Mechanism(s)
Abbot (1928) [1] 6
ACA, AcomA, 
VA, PcomA, 
MCA
Yes
Reported one case of his own (MCA), rest 5 cases collected 
from literature
Congenital IA
Laitinen et al 
(1960) [62]
1
Pericallosal/ 
Callosomarginal
Yes Oxycephalic deformity of skull Possible developmental errors
Patel et al (1971) 
[78]
7
ICA, AcomA(3), 
ACA(3), PcomA, 
BA
Yes
Only pediatric population (<19 yrs) reviewed, 12% had CoA 
coexisting with IAs
HTN
Banna et al 
(1971) [9]
1 PCA NA Source of SAH was dilated spinal collaterals 
Medial hypoplasia of  arteries of 
CoW + HTN
Stehbens (1989) 
[92]
Review article HTN 
Orsi et al. (1993) 
[75]
1 MCA, ICA NA - HTN
Schievink et al 
(1996)[87]
1 MCA No -
Development errors of Neural Crest 
leading to defective collagen and 
elastin formation
Ishii et al (2001)
[50]
1 AcomA Yes Coarctation of abdominal aorta HTN
Ahmetoglu et al 
(2002) [3]
1 B/L MCA Yes Coarctation of abdominal aorta HTN ± hemodynamic shear stress
Mercado et al. 
(2002)[70]
3
ICA, PcomA(2), 
PeriA
Yes
Provided a comprehensive review of the distinct clinical 
behavior of IAs in presence of CoA
Development errors of Neural Crest
Connolley et al 
(2003)[15]
10
ICA, MCA, 
PICA, PCA, 
PcomA, AChoA, 
BA tip
Yes 
(in 7 out of 10 
patients)
Found 10% incidence of IAs in patients with CoA, no 
significant difference in BP of patients with and without IAs 
Development errors of Neural Crest
Cowan et al 
(2004)[17]
1 PcomA No
Coexisting Alagille syndrome (arteriohepatic dysplasia), 
progression of infundibulum to PcomA Aneurysm
Developmental defects
Harikrishnan 
(2005) [39]
1 BA, VA Yes CoA of Descending aorta, coronary artery aneurysms Atherosclerosis 
Hudaoglu et al 
(2006)[48]
1 PcomA No
Raised strong suspicions about HTN alone being a factor for 
the increased incidence of IA in CoA
Development errors of Neural Crest
Kan et al (2007)
[53]
1 ICA NA
Fusiform aneurysm associated with PHACES syndrome, 
positive family history of IAs
Development errors of Neural Crest
Singh et al 
(2009) 
(Present study)
1
ICA, MCA, 
PeriA
No
Measured the CBF in CoA patient and proposed WSS as an 
important factor in the formation of IAs in these patients
Hemodynamic WSS
NB: PHACES syndrome; posterior fossa malformations, facial hemangiomas, arterial anomalies, CoA, cardiac defects, eye abnormalities and sterna defects, NA; not 
available, B/L; bilateral, CoW; circle of Willis, BP; blood pressure, PeriA; pericallosal artery, AChoA; anterior choroidal artery, PCA; posterior cerebral artery, BA; 
basilar artery, VA; vertebral artery, PICA; posterior inferior cerebeller artery, HTN; Hypertension, MCA,ICA & ACA; middle, internal & anterior cerebral arteries. 
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force in the etiopathogenesis of IAs in these patients, it cannot 
be the sole contributor. Hudaoglu et al48 raised a question on 
hypertension alone being a factor in the etiopathogenesis of IAs 
in CoA patients. The fact is further supported by the observation 
that IAs may develop or rupture even in normotensive patients, 
years after the repair of CoA.30,61,70,76 Additionally, hypertension 
was not uniformly noted in the patients of CoA reported to have 
IAs.15,87 The IAs were developed in our patient 17 years after the 
surgical correction of CoA. However, recoarctation of the repaired 
segment occurred during this period (>70% reduction in aortic 
diameter), the patient remained completely asymptomatic with 
a very well controlled blood pressure (Fig-1). Our findings also 
indicate towards the role of other factors working independent 
of arterial hypertension.
Laitinen and Snellman62 in 1960 found that apart from CoA, 
aneurysms of Pericallosal artery region were also associated 
with other concomitant malformations such as craniosynostosis 
and kyphoscoliosis. They believed that coexistence of these 
malformations with IAs is secondary to a common developmental 
error playing a role in their etiology. Embryologically; heart, aorta 
and cervico-cephalic arteries all share a common origin from 
neural crest. After recognizing the association between a variety 
of congenital heart diseases and IAs, Schievink et al87 attributed 
the occurrence of IAs in CoA patients to the developmental 
errors of neural crest resulting in abnormal vessel wall collagen. 
The same theory was later supported many other authors 
(Table-3).15,17,48,53,70
Hemodynamic stress due to increased blood flow has long 
been implicated in the pathogenesis of IAs. Development of 
IAs is reported in association with a wide range of conditions 
responsible for increased flow related WSS. Padget was first to 
draw attention towards the relationship between anatomical 
variations in circle of Willis and increased incidence of IAs.77 
The similar findings were confirmed by other workers.4,82,94 
Kayambe et al56 observed that there was a definitive correlation 
between the site of vascular asymmetry and the location of IA 
formation. This increased incidence of IAs in presence of vascular 
asymmetry is thought to be caused by increased hemodynamic 
stress secondary to compensatory increase in blood flow.56,93,94
Iatrogenic carotid artery ligation is a well established technique 
to produce IAs in experimental animals.38,40-42,51,73 Increased 
hemodynamic shear stress has been considered a major factor in 
the production of these experimental IAs.32,38,40-42,51,73 Apart from 
the carotid ligation, induced hypertension and administration 
of BAPN (beta aminopionitrile; a lathyrogen used to render 
arterial walls fragile), can potentiate the occurrence of IAs in 
these models . Handa et al38 divided their experimental animals 
into three cohorts: no carotid ligation, unilateral carotid ligation 
and bilateral carotid ligation. Whereas, all rats were made 
hypertensive and fed on BAPN, no IA was induced where carotid 
artery was not ligated. Furthermore, the IAs was always formed 
corresponding to the sites where hemodynamic stress was 
expected to increase after carotid ligation.
Congenital absence of ICA,14,47,96 arterivenous malformations 
(AVMs),68,81,100 Takayasu’s arteritis,54,98 Moyamoya disease,2,55,59 
and presence of persistent fetal circulation5,63,109 are other similar 
conditions where increased IAs are encountered due to increased-
flow-related WSS. Development of IAs has also been observed 
following extra-intracranial bypass procedures,29,60,74 again 
secondary to increased rCBF. Resolution of these flow related 
IAs can occur once the cerebral hemodynamics is reestablished 
by addressing the underlying pathology.79,97
The importance of hemodynamic WSS in the context of CoA is 
somewhat poorly explored. Ahmetoglu et al (2002)3 indicated 
that arterial wall injury secondary to increased hemodynamic 
shear forces may be an important factor in the IA formation while 
discussing their case of abdominal aortic coarctation (AbCoA). 
However, the statement probably reflects their opinion towards 
the etiopathogenesis of IAs in general population rather than in 
patients with CoA. Furthermore, the inference was merely based 
on the literature based evidence rather than any experimental 
work. They finally concluded that hypertension was the main 
factor responsible for the rupture and growth of IAs in patients 
with AbCoA.3
We hypothesize that the higher WSS values secondary to 
increased flow-rates in cerebral circulation can be an important 
contributory factor in the pathogenesis of IAs in presence 
of CoA. WSS is a frictional force exerted tangentially on the 
arterial endothelium by flowing blood. It is proportional to the 
blood viscosity and velocity gradients. The average physiological 
range of arterial WSS has been suggested to lie between 1.5-2.0 
Pa by Malek et al.64 It is widely accepted now that damage to 
the arterial and subsequently aneurysmal wall by hemodynamic 
forces plays a crucial role in the etiopathogenesis of IAs.11,32,38,40-
42,65,69,72,91,104 High supra-physiological and low infra-physiological 
values of WSS have been associated with initiation, growth 
and rupture of aneurysms.11,32,38,40-42,65,69,72,91,104 The values of space 
and time averaged WSS as well as the area affected by supra-
physiological WSS (>15Pa) were increased in our patient by 65% 
and 650%, respectively (Table-2). This exponential rise in the 
high supra-physiological WSS may play an important role in the 
etiopathogenesis of IAs in patients with CoA.
Various authors tried to explain the underlying mechanisms 
involved in the WSS induced vascular remodeling. The normal 
endothelial cell (EC) function and structure are regulated by 
WSS through a process called mechanotransduction.21,20 The 
shear stress is sensed by a number of mechanoceptors including 
basal adhesion points of ECs, cell junctions, and nuclear 
membrane.21,20 WSS also activates stretch-sensitive ion channels 
such as phospholipids and integrins in cellular membrane.21,20 
Increased production of matrix metalloproteinase (MMP-13) by 
ECs has been demonstrated after their prolonged exposure to 
high WSS which, in turn, leads to degeneration of the internal 
elastic lamina.90 It has been demonstrated by a number of 
workers16,31,80 that WSS increases endothelial production of nitric 
oxide (NO) by inducing an enzyme responsible for its synthesis 
(iNOS; inducible nitric oxide synthase). Fukuda et al31 found a 
high concentration of iNOS at the site of IA formation, in both rat 
and human arteries and concluded that iNOS is a prerequisite for 
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de novo development of IAs in cerebral vessels. In 1995, Wang et 
al104 showed that smooth muscle cells (SMCs) in arterial wall can 
also respond to WSS in intact arteries by virtue of interstitial flow 
generated by transmural flow gradients, further accentuating the 
vessel wall damage.
In addition to WSS, oscillatory shear index (OSI) has also 
been recognized as an important hemodynamic factor in the 
aneurysmal pathogenesis.33-35,43,65 It is a measure of the oscillatory 
nature of shear forces.33-35,43,65 This index, which has a range of 
between 0 and 0.5, represents the fraction of the cardiac cycle 
over which the instantaneous shear force vector forms an angle 
greater than 90 degrees to the time-average direction of the same 
force. Consistently high values of OSI have been associated with 
EC dysfunction.43 Changes in cell structure secondary to cyclic 
mechanical stress have been demonstrated by Wang et al.104 
resulting in disruption of the actin cytoskeleton of ECs. Glor 
and colleagues propose 0.2 as a threshold value for OSI above 
which endothelial damage is initiated.33,34 Whereas, no change 
was observed in the maximum OSI in presence of CoA (Table-2), 
the values obtained from both analyses (0.3) remained above this 
critical threshold. This indicates towards the possible role of 
high OSI in the EC damage in patients with IAs irrespective of 
presence or absence of CoA.
Apart from being a known risk factor for the formation of IAs, 
CoA has also been associated with increased incidence of IA 
rupture (4.8%).15,48,70,106 No satisfactory explanation is provided 
for the association between the two entities. This increased 
tendency for early aneurysmal rupture can possibly be explained 
by analyzing the hemodynamic factors computed for our patient 
(Table-2). Whereas the values for maximum pressure on IA wall 
have increased by 15% in patient with CoA, the area affected by 
high pressure is actually decreased by 50%. In other words, in 
the context of our CoA patient, the pressure on the IA wall is 
more focal in nature in presence of CoA and may be an important 
underlying factor predisposing to early aneurysmal rupture. High 
supra-physiological values of WSS have also been associated with 
endothelial cell dysfunction.11,32,38,40-42,64,65,69,72,91,104 The exponential 
rise (by 650%) in the area affected by high supra-physiological 
WSS (>15Pa) may also play a role in early IA rupture in patient 
with CoA.
Limitations of the study
Due to technical limitations, we could not perform extensive 
measurements in cerebral arteries other than ICA and ACA. It 
is however expected that the VFR will increase in other arteries 
as well provided other parameters in the Hagan-Poiseuille (Eq-
1) equation remain constant. The current study therefore reflects 
the need of further studies performed in larger cohort of patients 
with CoA.
Conclusions
Our study demonstrates that the cerebral arterial flow-rates 
in CoA patients are significantly higher when compared with 
average arterial flow-rates in healthy population. Furthermore, 
the values of space and time averaged WSS and the area affected 
by supraphysiological WSS (>15Pa) were increased in our patient 
by 65% and 650%, respectively. The values of maximum OSI 
however, remained unaffected by the presence of CoA. Increased 
hemodynamic WSS secondary to the increased rCBF may play an 
important role in the pathogenesis of IAs in CoA patients. The 
more focalized pressure impingement on the aneurysmal wall in 
CoA patients may be an important underlying factor affecting the 
early aneurysmal rupture.
The lack of clear knowledge about the rCBF in CoA patients and 
the existing controversies in the etiopathogenesis of IAs in these 
patients emphasizes the importance of the findings of the current 
study.
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Objective. The importance of hemodynamics in the etiopathogenesis of intracranial aneurysms (IAs) is widely accepted.
Computational fluid dynamics (CFD) is being used increasingly for hemodynamic predictions. However, alogn with the
continuing development and validation of these tools, it is imperative to collect the opinion of the clinicians. Methods. A workshop
on CFD was conducted during the European Society of Minimally Invasive Neurological Therapy (ESMINT) Teaching Course,
Lisbon, Portugal. 36 delegates, mostly clinicians, performed supervised CFD analysis for an IA, using the @neuFuse software
developed within the European project @neurIST. Feedback on the workshop was collected and analyzed. The performance
was assessed on a scale of 1 to 4 and, compared with experts’ performance. Results. Current dilemmas in the management of
unruptured IAs remained the most important motivating factor to attend the workshop and majority of participants showed
interest in participating in a multicentric trial. The participants achieved an average score of 2.52 (range 0–4) which was 63%
(range 0–100%) of an expert user. Conclusions. Although participants showed a manifest interest in CFD, there was a clear lack of
awareness concerning the role of hemodynamics in the etiopathogenesis of IAs and the use of CFD in this context. More eﬀorts
therefore are required to enhance understanding of the clinicians in the subject.
Copyright © 2009 Pankaj K. Singh et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. Introduction
The management of unruptured cerebral aneurysms remains
one of the most controversial topics in neurosurgery. These
uncertainties are multifactorial owing mainly to an incom-
plete understanding of the natural history of these lesions
and risks associated with active management [1–4]. Recent
evidence, however, suggests a good correlation between
diﬀerent hemodynamic factors and etiopathogenesis of IAs
[5–8]. This, together with the fact that current technologies
do not allow detailed in vivo measurements of blood flow
[9, 10] in cerebral arteries has given computational fluid
dynamics (CFD) new strength and a chance to aﬃrm itself as
a technology that can help in the management of unruptured
IAs. Many studies have been published where patient-
specific medical images and CFD are used to predict relevant
hemodynamic variables that correlate well with initiation,
growth and rupture of an IA [9–15]. Until recently, these
analyses were performed primarily by engineers, physicists
or mathematicians in collaboration with select clinicians.
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However, in order to make an impact on clinical practice and
to enhance trust among clinicians, a controlled and extensive
exposure of the software and its concepts to the broader
clinical community is crucial along with its continuing
validations.
The current study is the first eﬀort of its kind where the
concept and application of CFD software was exposed to
the clinical community, followed by analysis of their views,
understanding and performance.
2. Material and Methods
The first gathering of the European Society of Minimally
Invasive Neurological Therapy (ESMINT) Teaching Course
on IAs provided an ideal opportunity to expose the
computational tools being developed within the European
project @neurIST [16], to the attention of its audience. The
workshop was held near the birthplace of angiography at the
“Edificio Egas Moniz” of the Hospital Santa Maria in Lisbon,
Portugal between 7th and 12th September 2008.
2.1. Participants’ Demography and Overview. The workshop
was attended mainly by neurosurgeons and neuroradiolo-
gists. Out of all participants 86% had a clinical, 8% an
engineering, and 6% a scientific background. Participants
broadly fell into four age groups: 20–30 years old (3
participants, 8%), 31–40 (22, 61%), 41–50 (9, 25%), 50+ (2,
6%). Participants were prevalently male with a ratio M : F =
8 : 1. These data are summarized in Figure 1.
Participants were subdivided into groups of about 8
individuals per session to maximize teacher-to-attendee
ratio. Two tutors were available during each session, one
with a clinical background (neurosurgeon) and one with
an engineering background (biomedical engineer). Teaching
was delivered via a lecture of 75 minutes, which included
a discussion of the clinical background and relevance of
hemodynamic factors in etiopathogenesis of IAs, a brief
introduction on the use of CFD in hemodynamic predic-
tions, and explanation of key fluid dynamics concepts in
this context, for example, wall shear stress (WSS), boundary
conditions, and so forth. This was followed by a supervised
hands-on experience with the software.
The exercise was presented to the audience via a clinical
vignette of a typical diﬃcult scenario encountered in the
clinic, represented in Figure 2. The vignette illustrates a
typical case of an incidentally-discovered IA in an anxious
young patient. Due to its size (5 mm maximum diame-
ter) and absence of any other major known risk factors
the aneurysm should be managed conservatively as per
ISUIA (International Studies for Unruptured Intracranial
Aneurysms) guidelines [1, 4]. However due to patient’s con-
cerns and insistence for active intervention the management
plan becomes controversial.
The participants were then asked to use the software
@neuFuse to extract additional and nonobservable hemody-
namic data from the 3-dimensional rotational angiographic
(3DRA) image of this case. Attendees performed the tasks
independently with the help of a ready-reckoner containing
Table 1: Aneurysm radiological characteristics.
Localization Carotid artery/ophthalmic
segment/medial wall
Side Left
Dome status Unruptured
Depth 4.2 mm
Max diameter 5 mm
Max neck width 3.7 mm
Type Side-wall, saccular
Aspect Smooth
the complete guided procedure with illustrations to facilitate
the exercise. One-to-one support and supervision was pro-
vided during each session, as required.
2.2. Image Acquisition and Processing. The medical image
used in the workshop was obtained using rotational acqui-
sition in a Philips Integris Allura machine (Philips Medical
Systems, Best, The Netherlands), producing 100 images in
6 seconds, with 5 ms exposure per image. Voxel size in the
reconstructed 3D images was 234 microns with reconstruc-
tion matrix 256 × 256 × 256. Images were anonymized,
respecting the @neurIST ethical approval for use of patient
data. The characteristics of the aneurysm considered in this
study are reported in Table 1.
The current version of the @neuFuse software (prototype
4), based on the Multimod Application Framework [17]
and developed within the @neurIST project, was used to
reconstruct the vessel surfaces, create the model and set
up the hemodynamic analysis. The solvers used within
@neuFuse to solve the fundamental equations describing
the blood flow behavior within the region of interest were
ANSYS-ICEM and ANSYS-CFX (Ansys, Inc., Canonsburg,
PA, USA).
For the purpose of the workshop a simple stationary
analysis (nonpulsatile but constant flow rate and pressure
at the openings of the region of interest) was performed by
the participants using Intel core duo 2.4 GHz machines, with
2 GB RAM and 512 MB of dedicated graphic memory.
2.3. CFD Analysis. Figure 3 shows the overall workflow of
the operations performed from uploading the raw medical
image to the software through the visualization of relevant
hemodynamic data in @neuFuse.
Any CFD analysis requires knowledge of the volumetric
region traversed by the fluid (i.e., aneurysm including
connected surrounding vasculature) plus information about
velocity and pressure of the fluid at the boundaries of
the chosen region of interest (boundary conditions). Par-
ticipants were asked to reconstruct the region of interest
starting from the medical image, and specify the boundary
conditions using the software @neuFuse. The first step
was to launch @neuFuse and import the medical image
(Figure 3(a)). The geometry of the vessel, including the IA,
was then extracted from the imported image (Figure 3(b)).
As only a subregion of the extracted vasculature around the
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Figure 1: Participants’ demographic constitution.
Clinical vignette:
A 23-year lady attends neurovascular clinic with
her partner. Her mother died one month back due
to subarachnoid hemorrhage from a cerebral
aneurysm. She smokes around 10 cigarettes a day
but is otherwise fit and asymptomatic. After a long
discussion it was decided to screen her for the
possibility of an intracranial aneurysm. The MRA
revealed the presence of an aneurysm of 5
millimetre  maximum diameter in the region of  left
terminal ICA. She expresses great concerns about
the diagnosis and is keen on exploring the active
treatment options rather than being observed by
routine follow-up.    
Figure 2: Clinical vignette: typical challenging case scenario.
aneurysm has influence on the hemodynamic computation,
all vessels entering or leaving the IA were identified and
cropped at desired locations to define the region of interest
(ROI). The ascending carotid artery, which was an inlet
(blood enters the domain through it), was cropped at ten
vessel diameters proximal to the IA as shown in Figure 3(c).
The distal carotid artery in the region of cavernous sinus
and the ophthalmic artery were identified as the two outlets
of ROI (blood exits the domain through these two vessels).
These are shown in Figure 3(c). For the sake of simplicity
and time constrains the mesh used in the analysis was coarse
and was constructed using simple tetrahedral elements. As
is often the case in real-life clinical situations, information
on pressure or velocity of the blood at these locations for
the patient under examination was not available. Boundary
conditions were therefore provided by using a 1D mathemat-
ical model of the systemic tree, which has been developed
within @neurIST [18]. A representation of the @neurIST
1D circulation model is depicted in Figure 3(d). This model
provides values of pressure and flow of blood at several
locations along the systemic arterial tree, including locations
in the circle of Willis for a typical individual. Plug-flow BCs
were applied at inlet and pressure BC at outlet, using average
values from the waveforms provided by the 1D circulation
model. Typical values of blood viscosity (μ = 0.004 Pa·s) and
density (ρ = 1066 kg/m3) were applied to define the blood
properties. Although the blood is a nonNewtonian fluid for
the sake of simplicity and time-constraints, and also in view
of recent findings from Cebral et al. [13], we decided to
assume constant blood viscosity.
While arterial walls move under the eﬀect of the
propagating pressure waves, it has been shown that the
eﬀects of this movement on hemodynamic predictions are
negligible [19, 20]. Fixed walls were thus considered in this
analysis. The computation was automatically performed by
the software and participants were asked to display diﬀer-
ent predicted hemodynamic variables like flow streamlines
(Figure 3(e)), pressure distribution within the aneurysm or
arterial wall, and WSS (Figure 3(f)). Participants were then
asked to compare the WSS values computed within the
aneurysm with the critical values found in the experimental
studies of Malek et al. [21] below which the endothelium is
aﬀected by cell loss, desquamation and deranged activity of
wall-growth regulators.
4 Computational Intelligence and Neuroscience
0. 0.
Wallshearmag
1. 1. 1. 11653. 12012. 12370. 12729. 13067.
Pressure
Out
Out
In
(a)
(e)(f) (d)
(c)(b)
Figure 3: Operation workflow from medical image to hemodynamic results. (a) Orthoslice visualization of the 3DRA medical image in
@neuFuse. (b) Visualization of the extracted vessel surface. (c) Visualization of reduced region of interest with location of inlet and outlet
openings. (d) 1D circulation model. (e) Visualization of predicted streamlines. (f) Visualization of predicted wall shear stress.
2.4. Evaluation. Finally, the feedback was collected via a
questionnaire consisting of 48 questions. These were broadly
divided into 6 categories (Table 2): general feedback, course
design and conduct, experience with the software, hemody-
namics understanding, impact of CFD in neurosurgery, and
bringing this software into routine use. Each section of the
questionnaire was carefully designed to collect information
on diﬀerent aspects of the participant experience as described
in Table 2. The questionnaire with the complete list of
questions is reported in The questionnaire with the complete
list of questions is reported in supplementary appendix
questionnaire in Supplementary Material available online at
doi:10.1155/2009/760364.
Performance of participants was measured by analyzing
the file containing an audit trail of the operations performed
during the analysis. The performance criteria were based
on the analysis settings that have major influence on the
outcome of the numerical predictions, namely, the quality
of the reconstructed geometry, its extension, the locations in
the 1D circulation model from which boundary conditions
were extracted, and the correctness of the applied boundary
condition type (i.e., whether it was correctly set to inlet
or outlet). Each correct operation was assigned one point,
leading to a maximum score of four. Expert performance
was considered as gold standard (4 out of 4) and participants
performance rate was compared against this.
3. Results
For each section of the questionnaire only data gathered
for the most representative questions were reported in
this manuscript. Results were represented using tables with
percentage distribution for a ready appreciation of feedback
across the participants. These are reported section by section
below.
Section 1: General Feedback. As shown in Table 3, the overall
feedback about the workshop was positive. The 86% of
participants would recommend the software to a colleague,
75% found the workshop useful and 78% rated their
overall experience between good and very good. Negative
feedback was confined averagely within less than 5%. Most
participants recognized the need to improve management of
IAs and for 47% this was the main reason for attending the
workshop.
Section 2: Course Design and Conduct. 80% of candidates
found that the workshop to be of the right duration, 14%
found that it to be too short while for 6% it was too long
(Table 4). Participants-to-instructor ratio was right for 91%
while 6% thought that there were too many participants.
Most of the participants did not have any diﬃculty in
understanding the instructions. On a scale of 1 to 5, where
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Table 2: Questionnaire sections and objectives.
Section Category Objectives
1 General feedback
To gather impressions
on the overall experience
2 Course design
and conduct
To gather suggestions on
possible improvements
and identify any
shortcomings in the
design of the workshop
3 Experience with
the software
To identify weak points
as perceived by clinicians
in the graphical user
interface of the current
version of the software
4 Haemodynamics
understanding
To assess their current
knowledge and
understanding in the
role of haemodynamics
in the aetiopathogenesis
of intracranial
aneurysms
5 Impact of CFD in
neurosurgery
To assess their faith in
the principles of CFD
and its use in the clinical
environment, along with
the need of validation
through a multicentre
trial
6
Bringing this
software into
routine use
To explore the
participants view on cost
related issues and gather
information on future
marketing potentials of
this kind of software
1 is not clear and 5 is very clear, 86% rated it 4-5, while
14% were not sure. 94% of the participants thought that the
course content was scientifically appropriate.
Section 3: Experience with the Software. 34% of the candi-
dates found the current version of the software user friendly,
11% think that it needs some improvement, while 6% found
that it was not user-friendly (Table 5). The remaining 46%
were unsure. 48% of the participants think that clinicians
with limited IT skills will find using the software challenging,
11% disagree with this assumption and 33% were not sure.
86% of all attendees were able to complete all the steps
of the hemodynamic analysis within the time allocated
(approximately 50 minutes). 11% missed one or more steps.
Application of boundary conditions and clipping the region
of interest were among the most diﬃcult steps reported
by majority of participants. These were equally distributed
among participants with scientific and clinical background.
Section 4: Haemodynamics Understanding. Whereas for 78%
of the participants it was easy to understand the technical
concepts used throughout the course (Table 6), 19% faced
Table 3: General feedback.
Question/Answer options Number of participants (%)
Would you recommend the
software to a colleague?
Yes 31 (86)
No 3 (8)
n.a. 2 (6)
Why did you decide to
participate to this workshop?
Working in the field 16 (45)
Interested in CFD 2 (6)
Improve management of
aneurysms
17 (47)
Other 1 (2)
How useful did you find this
workshop?
Not useful 1 (3)
Not sure 8 (22)
Useful 16 (45)
Very useful 11 (30)
Rate your overall experience
Poor 1 (3)
Average 7 (19)
Good 15 (42)
Very good 13 (36)
Table 4: Course design and conduct.
Question/Answers Number of participants (%)
Was the duration of the
workshop. . .
Right 29 (80)
Short 5 (14)
Long 2 (6)
Was the
participant-to-instructor
ratio. . .
Right 33 (91)
Too-many 2 (6)
n.a. 1 (3)
Were the instructions given in a
clear way?
Not sure 5 (14)
Clear 18 (50)
Very clear 13 (36)
Was the content of the course
scientifically appropriate?
Yes 34 (94)
No 2 (6)
some diﬃculties in understanding the terminology, mostly
related to concepts such as boundary conditions and WSS.
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Table 5: Experience with the software.
Question/Answers Number of participants (%)
Do you find the software user
friendly?
No 2 (6)
Needs improvement 4 (11)
Not sure 17 (46)
User friendly 11 (31)
Very user friendly 1 (3)
n.a. 1 (3)
Will clinicians without tech/IT
experience have trouble?
Yes 17 (48)
Not sure 12 (33)
No 4 (11)
n.a. 3 (8)
Were you able to complete all
the steps of the hemodynamic
analysis?
Yes 30 (86)
No 4 (11)
n.a. 1 (3)
36% of the participants showed trust in the results
predicted by the software and think that they are realistic.
However, 58% were unsure. 48% believe that there is good
scientific evidence to justify the role of hemodynamics in
the etiopathogenesis of IAs, 3% did not agree with this.
43% of the candidates were not sure. Whereas 50% of the
participants were aware of the use of CFD as a tool in the
prediction of rupture in IAs, 42% were hearing the concept
for the first time.
Interestingly, 84% of all participants were willing to read
further peer-reviewed articles published on CFD and role of
hemodynamics in IAs.
Section 5: Impact of CFD in Neurosurgery. Responding to the
question “who should perform the CFD analysis for your
patient”, 19% answered a consultant, 6% thought that it
should be done by a registrar or a junior member of the team
(Table 7). 25% believed that analysis should be performed by
a dedicated clinical scientist/engineer, while 25% think that
it can be done by anyone provided that they have adequate
training.
84% of the participants were of the view that the software
can be used as a diagnostic tool on outpatient basis, 8% did
not agree with them. 84% of the participants were aware
of similar software, whereas for 8% of them it was the
first exposure to this kind of software. When asked about
automated versus user controlled software, interestingly 35%
expressed a wish to retain user control. 26% preferred a fully-
automated tool, while 26% were unsure.
Although the majority of participants (88%) were con-
vinced that there is a future for CFD as a risk prediction tool,
and that there is a significant, or emerging clinical need for
Table 6: Haemodynamics understanding.
Question/Answers Number of participants (%)
Did you have diﬃculty with the
technical concepts (boundary
conditions, wall shear stress,
etc.)?
Yes 7 (19)
No 28 (78)
n.a. 1 (3)
Are the results from this
software realistic?
Yes 13 (36)
Not sure 21 (58)
No 0 (0)
n.a. 2 (6)
Is current evidence suﬃcient to
justify a role for
haemodynamics in the
pathogenesis of aneurysms?
No 1 (3)
Not sure 15 (43)
Yes 17 (48)
n.a. 2 6
Were you previously aware of
the use of CFD to predict the
risk of rupture in intracranial
aneurysms?
No 15 (42)
Yes 18 (50)
n.a. 3 (8)
If you see a publication on
computational predictions for
IA in a peer-reviewed journal,
will you read it?
No 3 (8)
Yes 30 (84)
n.a. 3 (8)
these kinds of innovative tools (84%), most of them (75%)
thought that the current version of the software was not
yet ready and would require refinement before it could be
introduced into clinical practice.
64% of the candidates believed that an early prediction of
the risk of rupture computed with the help of this software
could influence their decision making in the management
of an IA. Out of the 64% over half (39%) think that
small asymptomatic unruptured cases specially falling in
the border-line category based on current evidence, are the
best cases where such software can provide definitive help.
Interestingly, 19% thought that it could be useful in all cases.
69% of the participants were convinced of the need for
a multicentric trial for the evaluation of the software and
expressed their willingness to participate in it.
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Table 7: Impact of CFD in neurosurgery.
Question/Answers Number of participants (%)
Ideally, who should perform
this type of computational
analysis for patients?
Consultant 7 (19)
Dedicated clinical scientist 9 (25)
Registrar 2 (6)
Anyone with training 14 (38)
Oﬃce member 1 (3)
All 1 (3)
n.a. 2 (6)
When ready could this
software be used
diagnostically in an
outpatient clinic?
Yes 30 (84)
No 3 (8)
n.a. 3 (8)
Are you aware of any similar
software?
Yes 30 (84)
No 3 (8)
n.a. 3 (8)
Should this type of analysis be
fully automated, or is it better
that the user has control?
Automated 10 (26)
User control 14 (35)
Not sure 10 (26)
n.a. 5 (13)
Is there a future for
computational tools for risk
prediction of intracranial
aneurysm rupture?
Yes 29 (80)
No 2 (6)
Not sure 2 (6)
n.a. 3 (8)
How great a clinical need is
there for this software?
Significant 17 (48)
Emerging 13 (36)
Low 3 (8)
n.a. 3 (8)
Do you think that this type of
analytical software is ready
for introduction into the
clinical environment?
Ready 4 (11)
Needs work 26 (75)
n.a. 5 (14)
Table 7: Continued.
Question/Answers Number of participants (%)
In which cases might this
software influence your
decision-making about
patient management?
All 7 (19)
Small unruptured
asymptomatic
14 (39)
Other 2 (6)
Not sure 1 (3)
None 3 (8)
n.a. 9 (25)
Would you be interested in
participating in a multicentre
trial on the evaluation of this
software?
Yes 25 (69)
No 5 (14)
n.a. 6 (17)
Table 8: Bringing this software into routine use.
Question/Answers Number of participants (%)
Would you expect this software
to be provided as part of a
scanner, or as a stand-alone
product?
Scanner 11 (30)
Standalone 10 (27)
Both 12 (32)
n.a. 4 (11)
Would the price of this software
be an important factor in your
deciding to obtain/use it?
Important 26 (72)
Low priority 6 (17)
n.a. 4 (11)
Would you expect to pay for
this software, or would you
prefer a freeware/shareware
arrangement?
Pay 4 (11)
Shareware 14 (37)
Freeware 17 (44)
n.a. 3 (8)
Section 6: Bringing This Software into Routine Use. Once the
software is in routine use, 30% of the participants believed
that it should be an integral part of the scanner (Table 8).
27% thought that it should be supplied as a standalone
product, while 32% say it could be provided in either way.
Cost will be an important deciding factor for 72% and
81% prefer it to be a freeware or shareware. However, cost is
a low priority for 17% and 11% will not mind paying for it.
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Table 9: Attendees’ performance.
Score %
Average 2.52 (63)
Performance with age
20–30 years 2.58 (65)
31–40 years 2.50 (63)
41–50 years 2.36 (59)
50+ years 2.22 (56)
Performance with background
Clinicians 2.5 (63)
Scientists 2.7 (68)
Performance. Attendees totalized an average score of 63% of
experts’ performance (Table 9). When age is taken into con-
sideration youngest delegates in the group 20–30 years scored
highest (65%) with score figures reducing progressively with
age. Age group 50+ obtained the lowest scores (56%).
Performance was slightly higher in scientific community
(2.7), as compared to the clinicians (2.5).
4. Discussion
4.1. The Current Challenges Posed by Unruptured IAs. The
easy availability and widespread use of relatively nonin-
vasive and sophisticated neurodiagnostic modalities such
as high resolution CT, MRI and MRA, have brought to
clinical attention a large and ever increasing, group of
patients harboring unruptured and asymptomatic IAs. These
unruptured lesions are also diagnosed coincidentally at the
time of catheter angiography carried out for a ruptured
aneurysm in patients having multiple aneurysms. The
increasing awareness of relatively bleak prognosis related to
aneurysmal rupture in general public and clinicians, forces
neurosurgeons to come up with a definitive answer for these
unruptured lesions.
With the advancements in microsurgical techniques and
improved neuroanesthetic and interventional neuroradio-
logical approaches, the morbidity and mortality figures
associated with active management of the ruptured IAs have
improved significantly when compared to their conservative
management. In other words, the indications for the active
interventions in ruptured IAs are now well established. The
situation unfortunately is not as straightforward in cases
of unruptured IAs and, the management of these lesions
remains one of the most controversial topics in Neurosurgery
[1–4]. Most large series including the ISUIA studies, agree on
the low risk of rupture for unruptured IAs. The cumulative
rupture rates in the ISUIA studies were between 0.05 and
<1 percent per annum [1, 4]. The fact that the prevalence
of unruptured IAs in general population outnumbers the
incidence of subarachnoid hemorrhage suggests that not all
unruptured IAs share a common natural history. The annual
prevalence of unruptured IAs in a population is around
5% while the incidence of subarachnoid hemorrhage in the
corresponding population is observed up to a maximum of
10 cases per 100 000 persons per year [1]. It is clear from these
figures that 80% to 85% of all IAs will never rupture.
The current uncertainties in the management of unrup-
tured IAs are well acknowledged by the clinical community,
and were among the most important motivating factors for
the majority of the participants (47%, Table 3) to attend this
workshop.
In order to oﬀer the best possible treatment to the
patient with the least side eﬀects, formulation of a clear
management protocol, directed by the natural history of
unruptured IAs and the risks associated with the active
management, is required. Whereas the endovascular coiling
is increasingly being accepted as a preferred treatment
modality for ruptured IAs, surgery is advocated as a first line
treatment for unruptured lesions [2, 4]. Although there are
no strict guidelines, most of the studies [22–24] including
ISUIA trials [1, 4], almost unanimously recommend certain
factors as indications of surgery in unruptured IAs, namely,
large aneurysmal size, symptomatic lesions, evidence of
growth, multiple lesions, posterior circulation location, and
past history of SAH. All these criteria have been established
to have good correlation with increased risk of rupture and
hence, surgery is advocated in these situations to avoid the
poor outcome. It is interesting to note that whereas on the
one hand the above mentioned criteria are used to decide the
need and suitability for surgery in an unruptured IA, all of
these factors also remain the underlying descriptors for poor
surgical outcome [25–27].
In the light of current evidence, it is clear that the group
which will stand the best chance of an excellent outcome
after surgery is the one with solitary, very small (<5 mm),
truly asymptomatic IAs located in the anterior circulation,
without any evidence of growth. Quite the contrary, current
protocols dictate clinicians not to operate upon this group
[1, 4, 25]; and in fact contraindicate any active management
option in such patients [1, 4, 25]. Moreover, the small
aneurysms of <5 mm size which are traditionally thought to
be “safe”, are not “rupture-proof”. In a study Yasui et al. [28]
found that in a group of 25 ruptured aneurysms, 16 (64%)
were <5 mm in size. Similarly, Juvela et al. [29] who followed
142 patients with 181 aneurysms for a mean period of 13.9
years with an aneurysmal size of <4 mm, demonstrated a
19% rupture rate, that is, 27 out of 142 patients had a
rupture.
In order to improve the surgical outcome if we choose
to operate on these smaller and “safe” lesions, we have to
operate on every single patient. The ideal situation, however,
would be if we could identify the aneurysms at greater risk
of rupture while they are still small in size and operate upon
them, leaving others to be monitored expectantly.
4.2. The Emerging Need for New Alternatives. It is evident
that, due to the limitations associated with conventional risk
factors used to assess the risk of growth and rupture, it is
currently impossible to identify those patients who are at an
increased risk in this subset having a real need of an early
surgery from those who can be monitored safely without
any active intervention. The situation consequently leaves us
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with no options other than searching some new descriptors
which can predict the risk of rupture independently in small
IAs before they join the cohort destined for a poor surgical
outcome. This fact is in part reflected by the large number of
participants’ views (84%, Table 7), who believe that there is a
significant or emerging need of new alternatives.
There is a rapidly growing body of literature aﬃrming
the importance of hemodynamics in the etiopathogenesis of
IAs [5–8]. The hemodynamic variables often considered in
these studies are WSS, oscillatory shear index (OSI), blood
pressure and other quantities used to characterize blood flow.
Proportional to blood viscosity and its velocity, WSS is the
tangential frictional force exerted by the flowing blood on
the walls of each vessel. High supra-physiological and low
infra-physiological values of WSS have been associated with
initiation, growth and rupture of aneurysms [7, 9, 11, 21, 30–
33]. A measure of the oscillatory nature of these viscous
forces is given by the OSI, often associated with endothelial
cells degeneration [6, 15, 34]. Table 10 gives a comprehensive
list of hemodynamic variables from literature and their
association with IA evolution.
An evaluation of these variables can provide a useful
alternative to predict the behavior of an unruptured IA at an
early stage before it changes in size, shape or becomes symp-
tomatic. Unfortunately, the detailed in vivo measurements
of all relevant flow variables in the regions aﬀected by the
disease are currently impossible [9, 10].
4.3. Computational Fluid Dynamics: A Brief Overview. Moti-
vated by the important role played by hemodynamics and
the diﬃculty of conducting detailed in vivo observations of
relevant hemodynamic variables, engineers and computer
scientists have started using CFD to predict blood flows in
IAs [9–15].
CFD is the science of predicting fluid flow, heat and
mass transfer, chemical reactions, and related phenomena
by solving numerically the set of mathematical equations
that govern a particular physical system (conservation of
mass, momentum, energy, species, etc.). Since its early
development in the 1960s and 1970s in the field of aerospace,
where it was used mainly to improve the design and eﬃciency
of aircrafts [40], CFD has been successfully used in many
other applications. In the past decades engineers used CFD in
the automotive, nautical, and civil engineering industries for
conceptual studies of new designs, troubleshooting redesign,
or improving the physical understanding of a novel fluid
mechanical phenomenon. Supported by experimental stud-
ies and a profound theoretical knowledge of the application
at hand, CFD can be applied anywhere the flow of a
fluid is important. Validation, through comparisons with
experimental data, has always been a key aspect in successful
applications of CFD. In the context of its use in IAs, although
early validation work shows promising results [19, 41–43],
a more systematic validation remains a prerequisite before
CFD can be adopted as a routine tool in clinical practice. As
it is evident from Table 7, 58% of the participants agreed that
the results obtained using the software may influence their
decision making in the small unruptured IA presented in the
clinical vignette or all cases, provided they are backed by a
larger clinical trial. Whereas the software at the moment can
successfully predict the relevant haemodynamic indices in
the context of IAs, it is expected that after the larger clinical
trials, significant statistical correlations can be established
forming the basis of novel clinical protocols. Whereas the
majority of participants (78%, Table 6) did not find any
diﬃculty in understanding the technical concepts used in
CFD, only 36% (Table 6) of them believed that the results
produced by its application were realistic. The mistrust in
the results emphasises the importance of validation. This is
further supported by the fact that most of the participants
(84%, Table 7) readily wanted to participate in a multicentric
clinical trial.
Although participants showed a manifest interest in
computational predictions (Table 6), there is a clear lack
of awareness concerning the role of hemodynamics in the
etiopathogenesis of IAs and the use of CFD in this context
(42%, Table 6). More eﬀorts therefore are required by the
scientific community to enhance understanding of the role
of hemodynamics and awareness of the use of CFD in this
field.
4.4. The Concept of Controlled Exposure. The use of CFD in
this context represents a significant change in the clinical
workflow and a successful transfer of knowledge will only
happen via carefully planned, controlled exposure. Clinical
sites must be supported locally, underpinning the training
for clinicians with the involvement of clinical scientists. The
eﬀectiveness of interdisciplinary transfer of knowledge is
largely dependent on the course design and the methodology
used. As reflected by the results (Table 9), a hands-on
workshop using multimedia PowerPoint presentation, one-
to-one supervision, and low participants-to-instructor ratio
with a carefully designed course based on sound scientific
principles, can lead to good results. The correct duration
of such a course is also an important factor (Table 4).
A close collaboration between engineers and the clinical
community is also a prerequisite for successful transfer of
knowledge. Supervision during this workshop was hence,
jointly provided by a biomedical engineer and a clinician.
Given a short training period of only 75 minute, the first
ever exposure of the software and its concepts to most of the
participants (Table 6), together with the fact that the software
is still in its prototype stage, the overall response and average
performance of 63% was remarkable. It is anticipated that
performance can be enhanced to the level of the expert-user
by means of a more user-friendly version of the software and
more intensive training. The results also show a decline in
performance with age. It may be associated with the IT skills
necessary to use this type of software eﬃciently. This fact
should be kept in mind when interpreting the results and
formulating future training and translational requirements.
4.5. Software Design Improvement. Many valuable sugges-
tions were collected from participants on the possible
improvements in the software design and its functionalities.
Among the important suggestions included automating the
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Table 10: Literature-based evidence on the importance of hemodynamics in the etiopathogenesis of ICAs. NB: WSS; wall shear stress,
MMP-13; matrixmetalloproteneases-13, iNOS; inducible-nitric oxide synthase, NO; nitric oxide, OSI; oscillatory shear index.
Hemodynamic
factors
Intracranial aneurysm
Proposed mechanism(s) References
Initiation Growth Rupture
Dynamic
Wall shear stress
(WSS)
High Low Low
Increased WSS increases the
production of MMP-13 which in
turn leads to vessel wall damage.
Decreased WSS increases iNOS
synthesis—NO induced damage
to vessel wall.
Low WSS increases endothelial
proliferation and apoptosis
Boussel et al. [11], Fukuda et al.
[30], Gao et al. [7], Jou et al.
[31], Malek et al. [21], Meng et
al. [32], Shojima et al. [9], Ujiie
et al. [33]
Oscillatory shear
index (OSI)
High/Low High High Degenerative changes in
endothelium
Glor et al. [35], Goubergrits et al.
[34], Mantha et al. [15]
Jet of blood
stream
Impingement Impingement Impingement Localized endothelial cell injury
Foutrakis et al. [36], Cebral et al.
[14], Cebral et al. [37]
Flow pattern — — Complex Statistical association Cebral et al. [14, 37]
Hydrostatic
Pressure High High High
Passive yield/water hammer
eﬀect
Inci and Spetzler [38], Morimoto
et al. [8] Steiger et al. [39]
steps for which user intervention is not strictly necessary,
improving user friendliness through a more intuitive graph-
ical user interface (GUI) where the user is guided through
the number of operations required, or use of the icons in
place of the more cumbersome operation from the menu bar
and, finally graphical representation of the 1D circulation
model for easier application of boundary conditions. After
discussing the feasibility with developers, most of these
suggestions were implemented in the latest version of the
software @neuFuse.
4.6. The Expected Place of CFD in Neurosurgery. It is
interesting to note that the majority of the participants (63%,
Table 7) want these analyses to be performed either by an
expert clinical scientist/engineer or by a person with the
same level of expertise, rather than a clinician. The fact
may reflect clinicians’ reluctance to conduct the analyses
themselves due to their understandable concern over time-
constraints and may indicate the requirement of a dedicated
team with suﬃcient infrastructure for the purpose. In spite
of this, most of the clinicians (84%, Table 7) see the software
as a handy tool which can be used on an outpatient
basis (e.g., ophthalmoscope, otoscope, etc.) rather than
a specialist department-based facility (e.g., 3DRA, MRA,
etc.). On comparing the software in terms of the diﬀerent
properties of a diagnostic modality which makes it an ideal
outpatient tool versus those requiring a dedicated setup, we
find that this software has some important features of an
ideal outpatient tool. It is noninvasive and is not directly
performed on the patient (patients do not have to come
prepared, e.g., empty stomach). As it is totally noninvasive,
there is no risk of cross-infection or contamination. Due
to no associated side eﬀects, no admission or postoperative
care is necessary. Although only time will decide, in authors’
view only a dedicated department with suﬃcient IT facilities
and dedicated biomedical engineers can take the burden of
the extensive computational time required by more realistic
transient analyses and, eﬀort to visualize and extract the
hemodynamic characteristics required for clinical decision
making.
Whereas the current study indicates a positive response
among the clinical community for CFD and its use in IAs, it
will be necessary to expose the software to a larger number of
clinicians before definitive conclusions can be drawn.
5. Conclusions
Although participants showed a manifest interest in com-
putational predictions, there is a clear lack of awareness
concerning the role of hemodynamics in the etiopatho-
genesis of IAs and the use of CFD in this context. More
eﬀorts therefore are required by the scientific community to
enhance awareness and understanding of the clinicians in the
subject. There is a clear willingness to use such software as
an outpatient tool. The mistrust in the results indicates the
need for validations, and most of the participants supported
with the need of a multicentric trial, when software is ready.
Keeping in mind the very first exposure to CFD for most
of the participants and the inherent diﬃculties associated
with a developing-software, the average performance of 2.5
(63% of an expert) was remarkable. Adequate training,
controlled exposure, and further development of these tools
are necessary before these can be eﬃciently used by a
common clinician.
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a b s t r a c t
Objective:Themechanismsbywhich smokingandhypertension lead to increased incidenceof intracranial
aneurysm (IA) formation remain poorly understood. The current study investigates the effects of these
risk factors on wall shear stress (WSS) and oscillatory shear index (OSI) at the site of IA initiation.
Methods: Two (n=2) IAs from two patients with history of smoking and hypertension were artificially
removedwith the help of software @neuFuse (Supercomputing Solutions®, Bologna, Italy) and the vessel
geometry reconstructed tomimic the condition prior to IA formation. Two computational fluid dynamics
(CFD) analyseswere performed on each data-set by using in turn the normal physiological values of blood
viscosity (BV), and high BV values specific to smoking and hypertension, obtained from literature.
Results:Atnormal BV, highWSS (>15Pa)was observed at the site of IA initiation in bothpatients.WhenBV
values specific to smoking and hypertensionwere used, both the areas affected by highWSS (>15Pa) and
the maximum WSS were increased whilst the magnitude and distribution of OSI showed no significant
change.
Conclusions: Long-term exposure to high WSS may result in an increased risk of IA development. An
incremental increase in areas of highWSS observed secondary to smoking andhypertensionmay indicate
a further increase in the risk of IA initiation. Interestingly, the relationship between BV and the area of
increased WSS was not linear, reflecting the need for patient-specific CFD analysis.
Crown Copyright © 2010 Published by Elsevier B.V. All rights reserved.
1. Introduction
Aneurysmal subarachnoid hemorrhage (SAH) remains a major
cause of morbidity andmortality in neurosurgical patients [34,51].
Smoking and hypertension are well-established risk factors in IA
formation [6,16,35,38,40]. However, their roles in the mechanisms
that regulate aneurysm formation are poorly understood and are
essentially limited to their statistical associations.
∗ Corresponding author at: Department of Neurosurgery, Royal Hallamshire Hos-
pital, Glossop Road, Sheffield S10 2JF, UK. Tel.: +44 114 2712180;
fax: +44 114 2713314.
E-mail address: neurosurgery2007@gmail.com (P.K. Singh).
Recent evidence indicates WSS and OSI as important underly-
ing hemodynamic factors in IA formation [9,11,24,49]. One of the
important parameters influencing WSS is blood viscosity, which
in turn is influenced by smoking and hypertension [17,41]. The
current study employs CFD to predict the effect of smoking and
hypertension on the WSS patterns at the site of IA initiation with
aim to explore the possible underlyingmechanisms leading to their
formation.
2. Materials and methods
2.1.1. Study design and patients’ recruitment
The study was conducted jointly in the Departments of Neu-
rosurgery and Neuroradiology, Royal Hallamshire Hospital, and
0303-8467/$ – see front matter. Crown Copyright © 2010 Published by Elsevier B.V. All rights reserved.
doi:10.1016/j.clineuro.2009.12.018
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Table 1
Patients’ demography, clinical presentations of IAs included in the study, their management and the known risk factors.
Pt Age/sex Clinical presentation Ruptured/
unruptured
Management Location of IA Smoking Hypertension Other risk
factors
1 45/M Asymptomatic Unruptured Observed Lt terminal ICA >60 cigarettes/day/25 years Poorly controlled None
2 45/F Asymptomatic Unruptured GDC embolization Rt terminal ICA >40 cigarettes/day/22 years Controlled on medication None
NB: Pt, patient; GDC, Guglielmi detachable coils; Lt, left; Rt, right; ICA, internal carotid artery.
the Department of Cardiovascular Science, University of Sheffield,
Sheffield, UK. A total of two (n=2) patients diagnosed with IAs
between January 2004 andMarch 2009, were identified retrospec-
tively and recruitedwith appropriate consent and ethical approval.
In order to avoid age and sex bias both patients were selected from
the same age group (45 years) with onemale and one female. Their
relevant demographic and clinical data are reported in Table 1.
2.1.2. 3DRA acquisitions
Medical images were obtained using rotational acquisition in a
Philips® IntegrisTM Alluramachine (Philips® Medical Systems, Best,
The Netherlands), producing 100 images in 6 s, with 5ms exposure
per image. Voxel size in the reconstructed 3D images was 121!m
with reconstruction matrix 512×512×512.
2.1.3. Numerical 3D model
@neuFuse, the computational tool-chain developed within the
EUproject@neurISTwasused to reconstruct vessel andaneurysmal
geometries. Vessel triangular surfaces were reconstructed using a
threshold iso-surface extraction tool, based on the marching cubes
algorithm developed by Lorensen and Cline [42]. The removal of
IAs was performed with the help of software @neuFuse. In order to
mark the location of the IA in the parent artery after its removal, the
image with IA in situ was superimposed over the image where the
IA was removed. This step was done during the post-processing of
data with the help of software ANSYS®-CFX PostprocessTM. A vir-
tualmarker (a sphere) was placed at the location of IA in the parent
vessel fromwhere the IAwas removed. Now the first image (image
with IA intact) was taken out and the location of IA (as localized by
thevirtualmarker)wasdisplayedby thearrows.Understanding the
importance of the issue authors have used exactly the same views
for comparing thehemodynamic indiceswithandwithout intracra-
nial aneurysms, so that the readers canmake out the location of IAs
easily in the view where there no IAs are present.
Volumetric meshes were generated using ANSYS® ICEMTM CFD
11.0 (Ansys®, Inc., Canonsburg, PA, USA) based on the octree
approach. The mesh was refined at the wall (using prismatic
elements) for more accurate computation of WSS and OSI. For
computational efficiency a progressively coarser mesh was used
towards the vessel axis. Tetrahedral elements were used for the
discretization of the domain core, with three layers of prismatic
elements adjacent to the wall, thus ensuring accurate computation
of WSS and OSI. Element size and number were set according to
the outcome of a mesh dependency study performed on similar
aneurysmal geometries [58]. In this study results were found to be
grid independent for meshes greater than 1700el/mm3. In order
to maintain consistency across the meshes used for all geome-
tries, similar element density and the same wall element size and
maximum core element size were used in the discretization of the
domains.
The 3D transient Navier–Stokes equations were solved using
the finite-control-volume software, ANSYS®-CFXTM. In view of the
recent findings of [44] we used the ‘plug-flow’ or ‘flat’ velocity
profile at inlet instead of Womersley flow profile. The default
second-order high-resolution advection differencing scheme was
used. Blood was assumed to be incompressible, with density
! =1060kg/m3 and Newtonian, with viscosity "typical =3.5mPa s.
The effects of hypertension and smokingweremodelled by increas-
ing BV values by 8.1% ("atypical =3.78mPa s) according to the
findings of de Simone et al. [17] and Price et al. [55]. Boundary con-
ditions (BCs) for the 3Dmodelswere provided in the formof typical
volumetric flow ratewaveforms at inlet and pressurewaveforms at
outlet. Thesewere computed using the 1D circulationmodel devel-
oped by Reymond et al. [60]. The authors validated their model
and found that the predictions of this 1D model have good agree-
mentwith themeasurementsperformed in the real patient/healthy
volunteers.
3. Results
Values ofWSS andOSIwere time-averaged for one cardiac cycle
and a qualitative and quantitative comparison made for the two
BVs. WSS contours reported in Figs. 1 and 2, and the data reported
in Table 2, show that, in the case of both patients, the aneurysm
formed at a location where WSS was higher than the mean value
in the parent vessel. At physiological BV, the maximum WSS at
the site of IA initiation for patient-1 (21.3 Pa) was approximately
5 times higher than the mean value in the parent vessel (4.5 Pa).
Similarly, for patient-2, the maximum WSS at the initiation site
(56.5 Pa) was approximately 5 times higher than in the parent ves-
sel (12.1 Pa).OSI also followed the same trendwith relativelyhigher
values at the sites of aneurysmal development for both patients,
compared to that in the respective parent vessel (Figs. 1 and 2
and Table 2). However, it must be noted that areas of relatively
high WSS and OSI were not exclusively limited to the sites of IA
formation.
The threshold value of 15Pa for WSS used in the study was
chosen as an arbitrary limit to highlight the areas of relatively
Table 2
Quantitative comparison of values of WSS and OSI obtained using two BVs; "typical and "atypical .
Patient-1 Patient-2
"typical "atypical %Change "typical "atypical %Change
Area of WSS >15Pa at aneurysm location (mm2) 1.24 1.42 +14.5 0.67 0.68 +1.5
Area of WSS >15Pa in parent vessel (mm2) 7.01 8.24 +17.5 148.8 160.0 +7.5
MaximumWSS at aneurysm location (Pa) 21.3 22.2 +4.2 56.54 58.73 +3.9
Average WSS in parent vessel (Pa) 4.5 4.7 +4.4 12.12 12.68 +4.6
Area of OSI >0.01 at location (mm2) 0.83 0.79 −5.3 0.21 0.22 +5.1
Maximum OSI at location (mm2) 0.018 0.019 +2.1 0.21 0.20 −2.8
NB: "typical , typical blood viscosity; "atypical , blood viscosity in smokers and hypertensive patients.
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Fig. 1. Reconstructed geometry of the IA and surrounding vasculature for patient-1 (A). Contours of WSS (B and C) and OSI (D and E) for "typical (B and D) and "atypical (C and
E) are displayed. Arrows indicate the site of IA along the parent vessel before removal.
Table 3
The literature-based evidence on the importance of WSS and OSI in the etiopathogenesis of IAs.
Hemodynamic factors Intracranial aneurysm Proposed mechanism(s) References
Initiation Growth Rupture
Wall shear stress (WSS) High Low Low Increased WSS increases the
production of MMP-13 which in turn
leads to vessel wall damage
Boussel et al. [8], Fukuda et al. [22],
Gao et al. [24], Jou et al. [37], Malek et
al. [46], Meng et al. [47], Ujiie et al. [79]
Decreased WSS increases iNOS
synthesis NO induced damage to vessel
wall
LowWSS increases endothelial
proliferation and apoptosis
Oscillatory shear index (OSI) High High High Degenerative changes in endothelium Glor et al. [25,26], Goubergrits et al.
[28], Mantha et al. [45]
NB: MMP-13, matrix metalloproteinases-13; NO, nitric oxide; iNOS, inducible-NO synthase.
Author's personal copy
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Fig. 2. Reconstructed geometry of the IA and surrounding vasculature for patient-2 (A). Contours of WSS (B and C) and OSI (D and E) for "typical (B and D) and "atypical (C and
E) are displayed. Arrows indicate the site of IA along the parent vessel before removal.
higherWSSwhere the IAswere initiated and to appreciate/quantify
the effects of changes in BV in smokers and hypertensives on
WSS. Whereas it was possible to identify a threshold for infra-
physiological WSS (<0.4 Pa) [46], no such values could be find
in the literature for supra-physiological WSS. An increase in
BV, to represent the effects of smoking and hypertension, is
reflected in the values of WSS and OSI, reported in Table 2.
For patient-1 the area of high WSS (>15Pa) increased by 17.5%,
whereas for patient-2 the increment was 7.5%. The maximum val-
ues of WSS at initiation sites followed a similar trend, but the
increment was around 4% for both patients. Interestingly, the
increase in the value of WSS does not correlate linearly with
the increment in BV. Furthermore, from the data in Table 2, it
can be seen that changes in BV do not have a significant or
consistent effect on the value of OSI at the site of aneurysmal
development.
4. Discussion
The exact etiopathogenesis of IA formation is poorly understood
[69].Whilst there is some indicationof a congenital link [19], IAs are
believed primarily to be acquired lesions [14,73]. Recent evidence
suggests a strong correlation between different hemodynamic fac-
tors and the etiopathogenesis of IAs [9,11,24,49]. In particular, a
number of studies suggest a link between aneurysmal initiation,
growth and rupture and the magnitude and distribution of WSS
and OSI (Table 3).
4.1. Wall shear stress (WSS)
WSS is a tangential frictional force exerted by flowing blood on
the arterial endothelium, and is proportional to the blood viscosity
and the velocity gradients. Mean arterial WSS has been suggested
Author's personal copy
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byMalek et al. to lie within the range of 1.5–2.0 Pa [46]. There is an
increasing body of literature suggesting that high WSS plays a role
in the initiation of IAs [9,11,24,27,49,63]. This is further supported
by the observation that IAs most frequently occur at bifurcations
and arterial bends. These are regions which are exposed to con-
stantly high WSS [21,62].
A number of different mechanisms have been proposed to
explain how WSS influences the natural history of an IA. It has
been established that the normal behaviour of arterial endothe-
lial cells (ECs) is regulated by hemodynamic shear stress. Sho et al.
[71] observed that increasedWSS stimulates ECs to producematrix
metalloproteinase (MMP-13) which, in turn, leads to degeneration
of the internal elastic lamina. In 1993 Luscher and Tanner [43]
found that the release of EC-derived growth and relaxation factor
(EDRF—later recognised as nitric oxide) is shear stress dependent
and is responsible for vascular remodelling. It has been demon-
strated by a number of workers [13,22,54] that WSS increases the
production of NO by the ECs by inducing an enzyme responsible
for its synthesis (iNOS, inducible nitric oxide synthase). Fukuda et
al. [22] found a high localization of iNOS at the site of IA formation,
in both rat and human arteries. They also demonstrated that iNOS
inhibitors such as Aminoguanidine and Batroxobin (DF-521) atten-
uate the early degenerative changes associated with IA formation.
The preventive effects of these drugs are thought to be mediated
by lowering BV and hence WSS [22]. They concluded that iNOS is
a prerequisite for de novo development of IAs in cerebral vessels.
In 1995, Wang and Tarbell [81] showed that smooth muscle cells
(SMCs) in arterial wall can also respond toWSS in intact arteries by
virtue of interstitial flow generated by transmural flow gradients,
further accentuating the vessel wall damage.
A number of authors have attempted to explain the mecha-
nisms linkingWSSwith EDRF/NOproduction. Experimental studies
conducted by Busse and Mulsch [10] revealed that WSS activates
calcium ion-dependent endothelial iNOS leading to its increased
production. Furthermore, WSS augments the release of adenosine
tri-phosphate (ATP) and substance-P from EC [48]. Increased con-
centrations of these two mediators are believed to enhance NO
production in a paracrine manner [54]. More directly, increased
WSS leads tohyperpolarizationof theECsbymobilizing the calcium
ions fromintracellular stores in culturedECs [3]probablyvia activa-
tionofphospholipase-C [4] and/orK+ channels [52]. Several authors
have attempted to explain the mechanism of WSS transduction
by the endothelium [7,54,58]. Born and Palinski [7] identified 3D
mechanoreceptors anchored to the endothelial membrane. They
hypothesized thatWSS acts on these mechanoreceptors, mechani-
cally enhancing the interaction between regulatory proteins and
their targets [7]. Resnick and colleagues [59] located a WSS-
responsive element for iNOS on endothelial genes in 1993.
Table 4 gives an overview of the important mechanisms pro-
posed on the role of WSS in vascular remodelling.
The findings of the current study support the correlation
between high WSS and initiation of IA. Maximum values of WSS
at the site of aneurysm formation were approximately 5 times
higher than themean values observed in the parent vessels, in both
patients (Table 2).
Table 4
WSS-induced vascular remodelling: an overview of some important mechanisms proposed.
Author/journal/year Proposed mechanism(s)/observations Implications
Rossitti (Acta Radiol, 1998) [62],
Foutrakis et al. (Neurol Res, 1997)
[21]
IAs mostly occur at arterial bends and bifurcations exposed
constantly to high WSS
High WSS can be a possible culprit in the development of
IAs
Sho et al. (Exp Mol Pathol, 2002) [71] Increased WSS stimulates endothelial cells to produce
matrix metalloproteinases (MMP-13)
Degeneration of the arterial internal elastic lamina by
MMP-13
Luscher and Tanner (Am J Hypertens,
1993) [43]
Release of endothelium derived EDRF is shear stress
dependent
Vascular remodelling by WSS
Cooke et al. (Am J Physiol, 1990) [13],
Pohl et al. (Am J Physiol, 1991) [54],
Fukuda et al. (Circulation, 2000) [22]
WSS induces iNOS, an enzyme responsible for NO synthesis Increased production of NO in the endothelium, EC injury
Fukuda et al. (Circulation, 2000) [22] Found high concentrations of iNOS at the site of IA
formation, both in rat and human arteries
Levels of iNOS correlate with IA initiation
Fukuda et al. (Circulation, 2000) [22] iNOS inhibitors; Aminoguanidine and Batroxobin (DF-521)
attenuate the early degenerative changes associated with
IA formation
Aminoguanidine and Batroxobin (DF-521) have preventive
effects on IA formation by lowering WSS
Wang and Tarbell (J Biomech Eng,
1995) [81]
SMCs in arterial walls also respond to shear stress WSS induced vessel wall damage can extend to SMCs
Busse and Mulsch (FEBS Lett, 1990)
[10]
WSS activate the calcium ion-dependent endothelial iNOS WSS increases the synthesis of iNOS
Milner et al. (Proc Biol Sci, 1990) [48],
Pohl et al. (Am J Physiol, 1991) [54]
WSS also augments the release of adenosine tri-phosphate
(ATP) and substance-P from ECs
These two mediators increase EDRF production in a
paracrine manner
Ando et al. (In Vitro Cell Dev Biol,
1988) [3]
High WSS leads to the hyperpolarization of the ECs by
mobilizing the calcium ions from intracellular stores
EC damage
Bhagyalakshmi and Frangos (Biochem
Biophys Res Commun, 1989) [4]
Hyperpolarization of ECs and mobilization of intracellular
calcium is via activation of phospholipase-C
EC damage
Olesen et al. (Nature, 1988) [52] Hyperpolarization of the ECs and mobilization of
intracellular calcium is via activation of K+ channels
EC damage
Born and Palinski (Br J Exp Pathol,
1985) [7]
Identified presence of 3D mechanoreceptors anchored to
the EC membrane, WSS acts on these mechanoreceptors,
mechanically enhancing the interaction between
regulatory proteins and their targets
Link is established on howWSS transduces signals to ECs
Resnick et al. (Proc Natl Acad Sci USA,
1993) [59]
Located a WSS-responsive element for iNOS on EC genes Role of WSS in EC damage
Fukuda et al. (Circulation, 2000) [22] Both, the magnitude of WSS as well as the duration of
exposure for the endothelium remain important
determinants for the induction of iNOS
Duration and magnitude of WSS play important role in IA
formation
Wagner et al. (J Clin Invest, 1997) [80] Demonstrated that no iNOS was induced when the SMCs
were exposed lower WSS (1.1–2.5 Pa) for shorter durations
(<24h)
Chronic and significant exposure of WSS are required for
the initiation of IAs
NB: MMP-13, matrix metalloproteinases-13; NO, nitric oxide; iNOS, inducible-NO synthase; EC, endothelial cells.
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4.2. Oscillatory shear index (OSI)
The OSI is a measure of the oscillatory nature of shear forces
[25,26,28,44]. This index, which has a range of between 0 and 0.5,
represents the fraction of the cardiac cycle over which the instan-
taneous shear force vector forms an angle greater than 90◦ to the
time-average direction of the same force. Consistently high values
of OSI have been associated with EC dysfunction [33] and changes
in cell structure secondary to cyclic mechanical stress have been
demonstrated byWang and Tarbell [81] reporting disruption of the
actin cytoskeleton of ECs.
Glor et al. propose that anOSI of 0.2 represents a threshold value
abovewhich endothelial damage is initiated [25,26]. Damage to ECs
produced by high OSI may contribute in IA formation. Areas of rel-
atively high OSI predicted at the site of aneurysm formation for
patient-2 in our CFD simulations support such theories; the maxi-
mum values observed approached the threshold value of OSI (0.2)
identified in the literature. In contrast, for patient-1, the OSI at the
site of IA initiation fell well below the threshold. This may indicate
a less significant role for OSI in IA formation, at least in the case of
this particular patient.
Whilst, for bothpatients, areas of highWSSandOSIwere located
primarily at the bifurcations where the two IAs were observed,
areas of high value for these indices were also predicted at other
sites in the parent vessels. This raises a further question; why are
these other critical areas unaffected? One explanation is that, in
addition to the key hemodynamic triggers, IA initiation is gov-
erned by many other factors including amongst others; smoking,
hypertension, genetics, polycystic kidney disease, Ehlers–Danlos
syndrome,Marfans’s syndrome, etc. In addition, thepossibility ofde
novo IA formation in these patients in other locations in the future
cannot be excluded without a long-term follow-up.
4.3. Role of smoking and hypertension in the IA formation
Smoking and hypertension are two well-established risk fac-
tors for IA formation. A number of clinical studies have highlighted
the strong association between smoking [2,6,57,63,67] and hyper-
tension [35,65,72,76,77] and de novo IA formation. Indeed, both
risk factors also correlate with the presence of multiple IAs
[18,38,53,57,61]. Experimental studies, where IA has been induced
by hypertension, confirm these findings [30–32,39,40,50,56,75].
Furthermore, autopsy studies conducted to assess the relation-
ship between the IA formation and hypertension demonstrate even
stronger correlations [12,15,16,66,78].
Whilst being well-established risk factors for IA formation,
the exact mechanisms by which smoking and hypertension lead
to increased IA formation remain controversial [35]. A num-
ber of explanations have been offered including; endothelial cell
injury, occlusion of vasa vasorum and disturbances in the syn-
thesis of elastin and collagen [35]. It has been proposed that
protease/protease-inhibitor factor imbalance is a factor in smok-
ers and a quantitative deficiency of alpha-1-antitrypsin has been
reported both in patients with SAH and in smokers [23,68,74].
Alpha-1-antitrypsin is an inhibitor of elastase, a proteolytic enzyme
which enhances collagen catabolism. This link is not supporteduni-
versally; Sakai et al. [64] attribute the increased plasma protease
levels found in patients with IAs to leucocytosis after SAH thus
disputing the significance of plasma protease/protease-inhibitor
imbalance as a marker for IA formation. Another hypothesis sug-
gests that IA formation is a part of a vascular degenerative process
similar to atherosclerosis and that smoking leads to IA initiation by
facilitating this process [1,29].
Onewidely recognised effect of smoking and hypertension is an
increase in BV [17,55]. We propose that the missing link between
these risk factors and increased IA formation is via high WSS sec-
ondary to an increase in BV. This hypothesis is supported by our
findings which show an increase in the area of vessel wall subject
to highWSS and elevatedmaximumvalues ofWSS coincidentwith
the IA initiation site for the two patients studied. For patient-1 both
qualitative (Fig. 1) and quantitative (Table 2) comparisons show
that increased BV results in a substantial increase in the maximum
WSS of 4.2%. The area ofwall affected by very highWSS (>15Pa), up
by 14.5% and 17.5% for the site of the IA and parent vessel respec-
tively. Similar trends were observed for patient-2 but the relative
differences were lower (Fig. 2 and Table 2).
There is strong evidence to indicate that induction of iNOS in ECs
is dependent on both the magnitude and duration of exposure to
WSS [22]. In an experimental study, Wagner et al. [80], found that
iNOS was not induced when the vessel walls were exposed to low
WSS (1.1–2.5 Pa) for short durations (<24h). The study suggests
that the chances of IA development are increased if an artery is
exposed to high WSS on chronic basis. Both patients included in
our study were exposed to these two risk factors chronically for an
extended period (20–25 years). Long-term exposure to high WSS,
and the increase in the area of vessel wall affected, may have led to
EC damage in these patients and contributed to an increased risk
of IA development.
Changes in OSI at the sites of IAswere lessmarked than changes
in WSS, and had no consistent trend. Whilst OSI is not directly
dependent on BV, changes in hemodynamics resulting fromaltered
rheology may be reflected in the OSI. However the results indicate
its less significant dependency from the hemodynamic changes
secondary to altered BV.
It is important to note that our findings differ in some respects
from those reported for previous studies, based on similarmethod-
ology [44,70]. These sought to develop novel indices in an attempt
to link initiationwith a hemodynamic triggerwhilst indicating that
WSS was relatively low at the site of IA initiation. Shimogonya et
al. [70] reported a significant correlation between IA formation and
a self-proposed hemodynamic index which they termed the ‘gra-
dient oscillatory number’ (GON) and Mantha et al. [45] showed a
correlation between IA initiation and their newly proposed hemo-
dynamic index; aneurysm formation indicator (AFI). In considering
these results in the light of the current work, it is important to note
that Shimogonya et al. used a simplified geometry whichmay have
influenced their results. Furthermore, as there are bodies of liter-
ature associating low [8,11,37,46] and high [9,11,22,24,27,49,62]
WSS with endothelial dysfunction and the etiopathogenesis of
IA, it could be argued that both supra-physiological and infra-
physiologicalWSS lead to perturbance of normal EC behaviour. Our
findings agree with the majority of studies [9,11,22,24,27,49,62]
which support the role of high WSS in IA formation.
It is evident that the IA formation is likely to have a multi-
factorial etiologywith hemodynamic factors acting as an important
cog in this process. Many factors are likely to act in parallel ren-
dering the vessel wall more susceptible to the effects of increased
pressure and WSS.
4.4. Limitations of the study
Before drawing any conclusions it is important to emphasise
that our study, in common with other CFD analyses, carries inher-
ent limitations associatedwith the assumptionsnecessary to create
themodels. First,whilst very high quality images (3DRA)were used
to reconstruct the vessel geometries, these represent the volume of
the vessel occupied by contrast agent. If vessel filling with contrast
is incomplete thismay generate errors in surface prediction. Unfor-
tunately, due to the limitations of current technology this remains
an unresolved problem. Second, the BCs used in the analyses were
obtained fromageneric 1D circulationmodel andwere not patient-
specific [60]. Here it is important to note that recent validation of
Author's personal copy
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thismodel against flowwaveformsmeasured for young volunteers
justify its use [60]. Third, despite being non-Newtonian, blood was
considered as a Newtonian fluid for the purposes of these analyses.
This assumptionwas based on the observations that, blood behaves
as a Newtonian fluid at the high shear-rates which apply at most
sites in the cerebral circulation (>100 s−1) [5], in particular in areas
coinciding with sites of IA formation. Fourth, the arterial wall was
considered rigid, neglecting wall motion, as this has been shown
to have a negligible effect on CFD predictions [20,36]. Finally, the
study was performed on a small cohort of two IAs. The work must
be considered as a preliminary study; analyses will be required for
a significantly larger number of IAs before firm conclusions can be
drawn.
5. Conclusions
The current study suggests that long-termexposure tohighWSS
may affect the behaviour of ECs leading, in turn, to an increased risk
of IA development. IA formation is likely to have a multi-factorial
etiology with hemodynamics acting as an important component
in the process. Increase in BV and hence WSS may be one of the
important underlying mechanisms responsible for the increased
incidence of IA formation in smokers and hypertensive patients.
Trends in OSI patterns were less significant, with no consistent
trend, anda less significant interdependencywithBV. Interestingly,
the relationship between BV and the area of increasedWSSwas not
linear, reflecting the need for patient-specific CFD analysis.
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1
CORRESPONDENCE
2 Effects of heparin on the hemodynamic charac-1
teristics of intracranial aneurysms2
A 58-year-old woman presented with a history of sudden3
onset of severe headache and loss of consciousness. She had4
a past medical history of deep vein thrombosis and was tak-5
ing long-term warfarin for that. Her Glasgow Coma Scale6
score at the time of admission was 13. An urgent CT scan7
of the head revealed the presence of subarachnoid hemor-8
rhage. The patient was recruited to the @neurIST project9
(www.aneurist.org) after obtaining the proper consent.10
Four-vessel cerebral angiography demonstrated the pres-11
ence of two intracranial aneurysms (Fig. 1). The ﬁrst12
aneurysm (Aneu-1) was a tiny ‘bleb’-type aneurysm located13
on the ophthalmic segment of the right internal carotid14
artery. It was considered a pre-aneurysm lesion. The second15
aneurysm (Aneu-2), which ruptured, was located at the ori-16
gin of the right posterior communicating artery (PCommA)17
and was coiled with GDC® (Guglielmi Detachable Coils).18
Throughout her hospital stay, the patient received low-19
molecular weight (LMW) heparin (enoxaparin, Clexane®).20
However, as the tiny ‘bleb’ aneurysm was unsuitable for21
coiling, it was followed by magnetic resonance angiography22
(MRA).23
Three-dimensional computer models of the intracra-24
nial aneurysms were created from 3D angiograms (Fig. 1).25
Boundary conditions were applied proximally at a distance26
of at least 10 vessel diameters and distally at 2—3 ves-27
sel diameters. Hemodynamic factors were computed with28
the help of @neuFuse software, using physiological values29
(untreated = 0.0045 Pa s) of blood viscosity (BV). The analyses30
were then repeated, using the values of BVs speciﬁc to hep-31
arin (heparin = 0.0025 Pa s), as reported in the literature. The32
latter simulates the effect of heparin at an average ther-33
apeutic concentration of 0.0075mg/mL. The 3D unsteady34
Navier—Stokes equations were solved with the use of ﬁnite35
control volume ANSYS®-CFXTM software. Qualitative (Fig. 2)36
and quantitative (Table 1) comparisons were made between37
the hemodynamic parameters computed in both settings.38
Findings showed that heparin administration decreased39
the maximum values of time-averaged wall shear stress (t-40
av-WSS) in both aneurysms, with a dramatic increase in41
the area affected by infraphysiological wall shear stress42
(< 0.4 Pa) in both lesions. The values for the oscillatory43
shear index (OSI) and pressure were decreased in the pre-44
aneurysm lesion, whereas an increase was observed in the45
ruptured lesion (Table 1).46
Ruptured aneurysms remain a major cause of morbid- 47
ity and mortality [1], and recent evidence indicates that 48
hemodynamics are an important underlying factor in their 49
etiopathogenesis [2]. As conﬁrmed by others [3], the hemo- 50
dynamics of the intracranial vasculature is dependent upon 51
the rheological properties of blood, including BV. It is then 52
logical to speculate that the factors affecting BV can also 53
inﬂuence the hemodynamic environment of intracranial 54
aneurysms, thereby affecting their initiation, growth and 55
rupture. 56
In the present study, we investigated the effects of hep- 57
arin on the hemodynamic characteristics of aneurysms. High 58
wall shear stress (WSS) values have been associated with 59
heparin initiation by increasing the production of MMP- 60
13, while low values are thought to be responsible for 61
aneurysm growth and rupture [4] by increasing inducible 62
nitric-oxide (iNOS) synthesis, resulting in vessel wall dam- 63
age. Heparin (and its derivative enoxaparin) is a widely used 64
injectable anticoagulant for preventing venous thrombosis 65
and pulmonary embolism. It inhibits the factors involved 66
in blood-clotting (factor Xa), causing instantaneous inacti- 67
vation of thrombin, thereby reducing BV [5] and, in turn, 68
Figure 1 Reconstructed geometry showing the intracranial
aneurysms and connecting vessels reconstructed with software
from @neuFUSE. Labels indicate the openings where boundary
conditions were applied.
0150-9861/$ – see front matter © 2010 Published by Elsevier Masson SAS.
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2 Correspondence
Table 1 Quantitative comparison of the effects of heparin on hemodynamic indices.
Aneu-1 Aneu-2
untreated heparin Change (%) untreated heparin Change (%)
t-av-WSSmin (Pa) 1.066 1.086 +1.8 0.055 0.048 −12.7
t-av-WSSmax (Pa) 35.9 28.08 −21.8 67.75 45.11 −33.4
Area of infraphysiological WSS (< 0.4 Pa) 0.009% 0.07% +677.8 0.8% 1.2 % +50.0
Area of supraphysiological WSS (> 1.5 Pa) 99.9% 99.6% −0.3 91.2% 88.7% −2.7
OSImax 0.21 0.17 −19.0 0.43 0.46 +7.0
Area of elevated OSI (> 0.2) 0.1% 00% −100.0 2.6% 4.1% +57.7
Area of elevated pressure (%) 2.1% 2.5% −19.0 3.5% 4.0% +14.3
Area values were computed as a percentage of the overall aneurysm surface; Aneu-1: pre-aneurysm lesion; Aneu-2: ruptured aneurysm;
untreated: untreated viscosity values used = 0.0045 Pa s; heparin: heparinized viscosity values used = 0.0025 Pa s; WSS: wall shear stress;
OSI: oscillatory shear index; t-av-WSSmin: minimum time-averaged wall shear stress; t-av-WSSmax: maximum time-averaged wall shear
stress.
altering the hemodynamics of the blood circulation. Hito-69
sugi and co-workers demonstrated a decrease in BV by 55.6%70
with the use of heparin at a therapeutic concentration of71
0.75 IU/L.72
However, heparin may also induce signiﬁcant derange-73
ments of the hemodynamics of intracranial aneurysms and74
may even facilitate the rupture of existing aneurysms, albeit75
while perhaps inhibiting the formation of new aneurysms.76
In addition, similar effects might be achieved with other77
pharmacological agents, thus warranting further investiga-78
tions. However, so far, it is difﬁcult to draw any deﬁnitive79
conclusions based on only two aneurysms in one patient.80
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Figure 2 Qualitative differences in the patterns of time-
averaged wall shear stress (t-av-WSS) and the oscillatory shear
index (OSI) in pre- (a, c) and post-heparinized (b, d) blood. The
upper two rows are contour plots for t-av-WSS, and the lower
two rows are contour plots for OSI. (a, b) Anterior views; (c, d)
posterior views; (rows 1, 3) Aneu-1; (rows 2, 4) Aneu-2.
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Abstract—Modeling of ﬂow in intracranial aneurysms (IAs)
requires ﬂow information at the model boundaries. In absence
of patient-speciﬁc measurements, typical or modeled bound-
ary conditions (BCs) are often used. This study investigates
the effects of modeled versus patient-speciﬁc BCs on modeled
hemodynamics within IAs. Computational ﬂuid dynamics
(CFD) models of ﬁve IAs were reconstructed from three-
dimensional rotational angiography (3DRA). BCs were
applied using in turn patient-speciﬁc phase-contrast-MR
(pc-MR) measurements, a 1D-circulation model, and a
physiologically coherent method based on local WSS at
inlets. The Navier–Stokes equations were solved using the
Ansys-CFXTM software. Wall shear stress (WSS), oscilla-
tory shear index (OSI), and other hemodynamic indices were
computed. Differences in the values obtained with the three
methods were analyzed using boxplot diagrams. Qualitative
similarities were observed in the ﬂow ﬁelds obtained with the
three approaches. The quantitative comparison showed
smaller discrepancies between pc-MR and 1D-model data,
than those observed between pc-MR and WSS-scaled data.
Discrepancies were reduced when indices were normalized to
mean hemodynamic aneurysmal data. The strong similarities
observed for the three BCs models suggest that vessel and
aneurysm geometry have the strongest inﬂuence on aneurys-
mal hemodynamics. In absence of patient-speciﬁc BCs, a
distributed circulation model may represent the best option
when CFD is used for large cohort studies.
Keywords—Computational ﬂuid dynamics, Phase-contrast
MRI, 1D circulation model.
INTRODUCTION
An aneurysm is a localized dilation in a blood ves-
sel, which carries an inherent risk of rupture and
consequent hemorrhage; for cerebral aneurysms rup-
ture results in a subarachnoid hemorrhage (SAH).
Despite improvements in surgical and medical man-
agement, SAH is still a major cause of morbidity and
mortality.20
Although the etiology of the disease remains
unclear, there is a growing consensus that hemody-
namics plays an important role in the growth, rupture,
and initiation of intracranial aneurysms (IAs).6,38,40
In this respect, a reliable prediction of stress or
strain of the aneurysm wall would possibly oﬀer a
greater diagnostic capacity in the context of imminent
rupture (it is likely that the event of rupture occurs
when the tissue stress or strain exceeds some sustain-
able level). The stress and strain in the aneurysm can
be calculated if the geometry, material characteristics,
and boundary (support) conditions are known:
unfortunately this will never be true for an individual
and approximations would be required for all of them,
thus compromising accuracy. The hemodynamic
characterization returns parameters that might drive
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biological processes that are important in the evolution
of an aneurysm toward a state in which it will rupture.
This, despite a smaller diagnostic capacity might pro-
vide more accurate predictions, which might prove
important with respect to correlation to rupture. Sev-
eral hemodynamic indices and many biological pat-
terns have been proposed that link hemodynamics to
aneurysm formation, and evolution. These are well
summarized by Singh et al.42 Two hemodynamic
indices, wall shear stress (WSS) and oscillatory shear
index (OSI), have received particular attention due to
their inﬂuence on endothelial cell behavior.6,40
Although studies from Rayz et al.,36 Boussel et al.,1
and Isoda et al.22 showed that in vivo measurement of
these quantities is possible using magnetic resonance,
inherent limitations in the current technology impede
its use, especially for smaller aneurysms, in large
cohort studies.
In this context, computational ﬂuid dynamics
(CFD) can provide detailed predictions of hemody-
namics using input parameters derived from medical
imaging, blood sampling, and other patient informa-
tion. CFD has been used by many groups to investi-
gate possible correlations between hemodynamics and
risk of rupture or growth of IAs. For convenience, the
spatial extent of the computational domain is often
limited to a restricted area around the aneurysm and
speciﬁcation of boundary conditions (BCs) at the
interfaces with the rest of the cardiovascular network
remains a pre-requisite to ﬁnd a numerical solution.
This issue is approached in diﬀerent ways by diﬀerent
authors.
Some studies use patient-speciﬁc BCs based on
measurements obtained using phase-contrast-MR
(pc-MR) or transcranial Doppler (TCD) ultrasound,
to record blood velocity, and applanation tonometry,
to infer pressure. More recently Ferns and colleagues13
have used a dual-sensor wire to measure in vivo pres-
sure and blood ﬂow velocity within intracranial vessels.
These measurements are costly to perform, are cur-
rently rarely justiﬁable as part of the clinical routine
and are inherently difﬁcult to obtain for the small,
intricate vessels of the cerebral vasculature hence, such
studies often involve small cohorts and the results lack
statistical signiﬁcance.1,19,24
Larger cohort studies, in contrast, rely on inﬂow
BCs based on measurements taken from healthy indi-
viduals, that are, in some cases8,23,29,35,44 scaled in an
attempt to achieve a more realistic mean WSS, and
outﬂow BCs that arbitrarily assume the same pressure
at all openings (zero pressure BCs). The assumptions
associated with this approach may also lead to unre-
alistic results.
As detailed comparison with in vivomeasurements is
currently difﬁcult, the validity of CFD tools in the
context of IA rupture-risk assessment relies upon the
extent to which the correlations between hemody-
namic predictions and rupture are statistically mat-
ched for a large cohort study. One of the important
aims of @neurIST (www.aneurist.org), a multidisci-
plinary EU project of which this study forms a part,
is to establish these correlations by processing a large
number of cases. The lack of patient-speciﬁc data for
use at computational boundaries remains an impor-
tant limiting factor in the project. This issue has been
addressed by deriving a complete set of BCs for 3D
CFD analysis from a 1D model of the circulatory
system.37
This article analyses and compares the sensitivity of
modeled hemodynamics within typical IAs to BCs
derived using the 1D model, patient-speciﬁc pc-MR
measurements, and other approaches described in the
literature.
MATERIALS AND METHODS
Study Design, Demographics, and Clinical Details
The study was conducted as a co-operation between
the Departments of Neurosurgery and Neuroradiol-
ogy, Royal Hallamshire Hospital, and the Department
of Cardiovascular Science, University of Sheﬃeld,
Sheﬃeld, UK. A total of ﬁve patients diagnosed with
IAs between Dec. 2006 and Jan. 2009, were iden-
tiﬁed retrospectively and followed prospectively upon
appropriate ethical approval and patient consent.
Table 1 shows the demographic constitution of the
population along with the relevant aneurysm details.
All IAs were side-wall saccular aneurysms with loca-
tions shown in Figs. 1 and 2.
X-ray Angiography Image Acquisition
The medical images used for surface reconstruction
were obtained using 3D rotational acquisition (3DRA)
in a Philips IntegrisTM Allura machine (Philips
Medical Systems, Best, The Netherlands), producing
TABLE 1. Patient demographics and aneurysm radiological
features.
Aneurysm Sex Age Side Location Rupture
Size (diam/neck)
(mm)
1 M 44 Left ICA No 5/4.3
2 M 52 Left MCA No 11.1/4.3
3 F 50 Left ICA No 3.4/3.1
4 F 41 Right MCA Yes 4.4/3
5 F 51 Left ICA No 2.9/3.1
ICA, internal carotid artery; MCA, middle cerebral artery bifurcation.
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100 images in 6 s, with 5 ms exposure per image. Voxel
size in the reconstructed 3D images was 121 microns
with reconstruction matrix of 512 9 512 9 512.
pc-MR Protocol
All MR imaging was performed at high ﬁeld
strength (AchievaTM 3.0T, Philips Medical Systems,
Best, The Netherlands) using a standard eight-chan-
nel, radiofrequency receive-only head coil. The same
radiographer imaged all patients to maximize the
reproducibility of the overall acquisition technique.17
A pre-designed protocol guided the radiographer
through the desired measurement locations for sub-
sequent application of CFD BCs. As afferent vascu-
lature has an important inﬂuence on intra-aneurysmal
hemodynamics,2,30,32,33 proximal measurements were
taken at a distance of approximately 10 parent vessel
diameters from the aneurysm. Measurements in distal
arteries were taken four diameters away from the IAs.
To minimize patient discomfort, table-occupancy time
was no greater than 1 h. Within this period it was
difﬁcult to ensure that all measurements were
obtained for all patients. The tortuous nature of the
vasculature also made slice selection perpendicular to
the artery difﬁcult to achieve. To maintain integrity in
the ﬁnal measurement data set, data was rejected if
there was doubt about the placement of the mea-
surement plane.
Locations of pc-MR measurements are reported
Table 2. The manufacturer’s proprietary post-data-
acquisition software (Q-FlowTM, Philips Medical
Systems, Best, The Netherlands) was used to estimate
volumetric ﬂow rate (VFR) waveforms at each
location.
1D Circulation Model
The model developed by Reymond et al.37 was used
to compute pressure and VFR waveforms at the
desired interfaces with the 3D domains. The model
solves the 1D form of the Navier–Stokes equation in a
distributed model of the main human systemic arteries
including the main arteries of the circle of Willis. It
accounts for ventricular–vascular interaction and wall
viscoelasticity, and it was recently validated through a
comparison with in vivo ﬂow measurements. Although
the model could be personalized tuning input param-
eters such as heart rate, cardiac contractility, vessel
elasticity, vessel geometry, and blood properties, in this
study the model was used with the properties of a
typical young individual as patient-speciﬁc data was
not available for all patients. A typical analysis is
solved in approximately 8 min.
3D Models
The @neurIST computational tool chain was used
to reconstruct vessel and aneurysmal geometries, as
described in Marzo et al.30 The 3D transient Navier–
Stokes equations were solved by using the ﬁnite-
control-volume software, ANSYS-CFXTM. Blood
was assumed to be incompressible, with density
q = 1060 kg m23, and Newtonian, with viscosity
l = 0.0035 Pa s. BCs were applied using three dif-
ferent approaches, as reported in Table 2. Method I
used pc-MR VFR measurements at the openings for
which these could be measured, and 1D model pres-
sure waveforms at every remaining interface. For
aneurysm 1 and 5, measurements were available at all
but one vessel opening. Method II used VFR and
pressure waveforms from the 1D circulation model.
Method III used the typical waveforms derived using
the 1D model, where VFR curves were scaled to
obtain a mean WSS of 1.5 Pa at inlets. For all
velocity-based BCs a ﬂat velocity proﬁle was applied,
in line with our recent ﬁnding.30 Arterial walls were
assumed to be rigid. The validity of this assumption
has been tested in the context of IAs.11 Tetrahedral
elements were used to discretise the core of the
computational domain, with three layers of prismatic
elements at the wall to ensure accurate computation
of the velocity gradients. Grid sizes with an average
density of 2000 el/mm3 were used following a mesh
dependency study in which WSS, pressure and
velocity values, were monitored at several points
within the aneurysm and parent vessel.35 Figure 2
shows the meshes and BC types used in the analyses.
To be independent of the initial numerical conditions
hemodynamic data were extracted from the last car-
diac cycle of a three-cycle analysis. Analyses were run
FIGURE 1. Locations of aneurysms 1–5 in typical cerebral
vasculature (illustration generated using the @neurIST soft-
ware).
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in parallel using 30 cluster nodes (Xeon 2.8 GHz,
2 GB RAM). The average time required to solve a
complete three-cycle analysis was 5 h.
Statistical Analysis
Quantitative agreement between data obtained with
the diﬀerent BC methodologies was analyzed using
boxplot diagrams.
RESULTS
Hemodynamic variables were compared qualita-
tively and quantitatively for the BC methods analyzed.
Qualitative Comparison
Figure 3 shows contour distributions of WSS time-
averaged along the cardiac cycle (tavWSS) at the wall
of the IAs. For all methods, in aneurysms 1, 2, areas of
FIGURE 2. Mesh particulars and BC types used. QMRI is the velocity-based boundary condition from MRI patient-specific
measurements, Q1D is the velocity-based boundary condition from 1D model, Q1D-S is the WSS-scaled velocity-based boundary
condition from 1D model, and P1D is the pressure boundary condition from 1D model.
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relatively high WSS were concentrated around the
aneurysmal neck and apex, while in aneurysm 5, an
area of relatively high WSS is also present in the body.
In aneurysms 3 and 4 only the neck is affected by high
WSS, with the remainder of the aneurysmal wall
exposed to lower WSS. For all aneurysms, areas of
relatively low WSS were found in their bodies.
From a visual comparison of the contour plots,
the most pronounced diﬀerences between method I
(pc-MR) and method II (1D model) are in the distri-
bution of tavWSS for aneurysms 1, 3, and 5, whereas
aneurysms 2 and 4 showed closer agreement. In terms
of qualitative diﬀerences between patient-speciﬁc
and 1D model waveforms tavWSS values were
underestimated when 1D-model BCs were applied, for
all IAs except IA2.
Qualitative comparison of method I (pc-MR) and
method III (WSS scaled) revealed larger diﬀerences
than those observed when comparing methods I and
II, except for aneurysm 1 where contour values of
tavWSS are closer to the predictions of method I. For
all IAs, the values of tavWSS obtained with method III
are lower than those observed for method I.
Figure 4 shows contours of normalized values of
tavWSS (ntavWSS). Normalization was achieved by
dividing the absolute values of tavWSS by the spatial
average of tavWSS at the aneurysmal wall. Interest-
ingly, for all methods, there is similarity in the over-
all distribution of areas of proportionally higher, or
lower, WSS.
Figure 5 shows contour distributions of OSI on
the aneurysmal surface. Although small differences
can be observed, the OSI patterns are very similar.
As expected, areas of elevated OSI tend to be associ-
ated with low tavWSS. OSI values obtained with
method II look closer to the pc-MR-based values, than
those obtained using method III.
Quantitative Comparison
Figure 6 shows the boxplots diagrams of the per-
centage differences between method I and method II
(top boxplot) and method I and method III (bottom
boxplot) for selected indices computed within the
aneurysmal sac, namely; maximum OSI (mOSI), nor-
malized maximum value of time-average WSS
(nmtavWSS), maximum time-average WSS (mtavWSS),
maximum time-average velocity (mtavU) and spatial
and time-average velocity (stavU). The percentage
error was calculated from (index_valuemethod I 2
index_valuemethod X)100/index_valuemethod I. As previ-
ously observed qualitatively, comparisons show that the
smallest discrepancies are observed in the values of
mOSI and nmtavWSS (median value 17.5–23.5% for
mOSI and 11–20.5% for nmtavWSS). The hemody-
namic index showing highest discrepancies is mtavWSS
with median values of 46% for method I versus II and
69% for method I versus III.
When considering the cross-comparison of methods
II (1D model) and III (WSS scaled) with method I
(pc-MR) (which is assumed to be the gold standard),
the largest discrepancies are observed for the com-
parison between methods I and III. If we consider
only the median values of each index we observe that,
for method I, all indices perform better than their
counterpart in method III.
TABLE 2. Boundary conditions location, type, and method.
Aneurysm BC location Type Method I Method II Method III
1 ICA proximal Inlet pc-MR/velocity 1D/velocity 1D/velocity scaled
ICA distal Outlet pc-MR/velocity 1D/pressure 1D/pressure
OphthA Outlet 1D/pressure 1D/pressure 1D/pressure
2 MCA M1 Inlet pc-MR/velocity 1D/velocity 1D/velocity scaled
MCA M2 supr Outlet 1D/pressure 1D/pressure 1D/pressure
MCA M2 infr Outlet 1D/pressure 1D/pressure 1D/pressure
3 ICA proximal Inlet pc-MR/velocity 1D/velocity 1D/velocity scaled
ICA distal Outlet 1D/pressure 1D/pressure 1D/pressure
OphthA Outlet 1D/pressure 1D/pressure 1D/pressure
4 MCA M1 Inlet pc-MR/velocity 1D/velocity 1D/velocity scaled
TempA Outlet 1D/pressure 1D/pressure 1D/pressure
MCA M2 supr Outlet 1D/pressure 1D/pressure 1D/pressure
MCA M2 infr Outlet 1D/pressure 1D/pressure 1D/pressure
5 ICA proximal Inlet pc-MR/velocity 1D/velocity 1D/velocity scaled
ICA distal Outlet pc-MR/velocity 1D/pressure 1D/pressure
OphthA Outlet 1D/pressure 1D/pressure 1D/pressure
ICA, internal carotid artery; OphthA, ophthalmic artery; MCA M1, middle cerebral artery; MCA M2 supr/infr, superior/inferior
division of the middle cerebral artery; TempA, temporal artery.
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DISCUSSION
In creating a computational model to predict the
hemodynamics in an IA, assumptions are often made
that can adversely aﬀect the numerical results. One of
the most important areas where assumptions are
required is the application of BCs. Several authors
have demonstrated the signiﬁcant inﬂuence of BCs on
computed hemodynamic indices.9,19,44
Depending on the method of derivation, BCs can be
broadly divided into two categories; those that are
patient-speciﬁc and those that are non-patient-speciﬁc.
FIGURE 3. Contour plots of tavWSS for method I (pc-MR), method II (1D model), and method III (WSS scaled).
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Patient-Speciﬁc BC’s
Patient-speciﬁc BCs are understandably considered
the ‘‘gold standard.’’9,19,44 Unfortunately, these are
rarely available. Of 24 articles reviewed for this study
(Table 3), only 6 (25%) used patient-speciﬁc BCs.1,19,24
pc-MR was the most common modality (5 out of 6)
used to obtain patient-speciﬁc measurements, with
TCD used by one author.19 Most authors (5 out of 6),
applied these measurements only at inlets. Only one
group, Jou and colleagues,25 used patient-speciﬁc
pc-MR measurements at both inlets and outlet when
analyzing a basilar artery fusiform aneurysm. Thus,
FIGURE 4. Contour plots of normalized values of tavWSS (ntavWSS) for method I (pc-MR), method II (1D model), and method III
(WSS scaled).
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even when patient-speciﬁc measurements can be justi-
ﬁed in a busy clinical setting, technical difﬁculties may
compromise their application at all openings, further
limiting their use in establishing statistical correla-
tions with rupture. In fact, a major constraint when
adopting patient-speciﬁc BCs is that due to current
restrictions in obtaining these measurements, they have
not been applied in large cohort studies, thus com-
promising the possibility of using CFD to ﬁnd signif-
icant statistical correlations between hemodynamics
and aneurysmal evolution (initiation, growth, and
rupture). In the current review, the mean cohort size
FIGURE 5. Contour plots of OSI for method I (pc-MR), method II (1D model), and method III (WSS scaled).
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for the patient-speciﬁc BC group was signiﬁcantly
smaller, i.e. 3 (range 1–7) compared to 9.5 (range 1–62)
when non-patient-speciﬁc BCs were used. Another
important aspect one has to consider: there may be
signiﬁcant diurnal variation in values for an individual
associated with stress or anxiety,12,27 physical exer-
tion,16,21 and other day-to-day activities.18 It can be
argued that patient-speciﬁc BCs, invariably measured
with a patient lying quietly in a scanner surrounded by
an artiﬁcial environment or stressed by the overall
clinical experience (e.g., white-coat hypertension),
might not represent the normal day-to-day physiology
for that individual, and thus might not represent
exactly the type of BCs needed for statistical associa-
tions. Gonzalez-Alonso et al.16 recorded a population-
average ﬂow rate variation as high as 1 mL/s at the
level of middle cerebral artery level between rest and
exercise.
Another important aspect is the error associated
with blood ﬂow measurement. For quantitative
MR angiography average measurement errors have
been reported to be as high as 7.6% for pulsatile
ﬂow.45
Non-Patient-Speciﬁc BC
In absence of patient-speciﬁc BCs many investiga-
tors use typical or modeled BCs. Out of 24 papers, 18
(75%) used this approach. Waveforms are usually
obtained from population-averaged measurements
taken on healthy volunteers.14,43 While the use of such
waveforms remains the most popular method of BC
application (17 out of 18 non-patient-speciﬁc BCs in
our review), the method carries important limitations.
First, as these measurements are taken in a healthy
population, they may not be representative of patient
waveforms. This is illustrated in Fig. 7, where wave-
forms from a healthy volunteer show differences both
in shape and values, when compared with those for
patients 1, 3, and 5.
Second, these waveforms represent average values
of pressure and velocity across the population, and
lack adaptability in terms of location and vessel geo-
metrical properties. In an attempt to address these
issues and make these typical waveforms more patient-
speciﬁc, Cebral and colleagues7 suggested ‘‘scaling’’ the
inﬂow rates to the inﬂow boundary area to keep the
WSS within a ‘‘physiological’’ range (around 1.5 Pa).
The same approach has been adopted by other scien-
tists.23,31,35 Although Cebral and co-workers found an
important ﬂow-area correlation based on experimental
evidence at some speciﬁc vessel locations, their
approach can be very sensitive to the boundary loca-
tion along the vessel, due to diameter variations along
the vessel, and to segmentation error and image
modality. This approach may be appropriate for a
typical healthy individual but, as reported by many
authors in the ﬁeld, it is predominantly atypical vari-
ations in hemodynamics (e.g., WSS) that are believed
to inﬂuence the etiopathogenesis of IAs.38,40 Cheng
et al.10 challenged this hypothesis in their recent
review, which showed large variations of average WSS
(range 0.2–1.6 Pa). Atypical values of WSS have been
associated with other conditions such as maladaptive
growth, congenital malformations, patent ductus
arteriosus, and atherosclerosis.
Quarteroni and collaborators pioneered the concept
of using lumped and 1D-circulation models in an
attempt to provide realistic BCs to 3D models.15,28,34
More recently in 2009, we30 introduced the use of a
1D-circulation model to derive BCs while studying
hemodynamics within IAs. This model is used in the
current study. The parameters of the 1D model used
are relative to a healthy typical individual, an
approach exposed to the limitations mentioned above
for typical ‘‘healthy’’ waveforms. Indeed, this might
FIGURE 6. Boxplots showing the distribution percentage
differences between method I and II (top) and method I and III
(bottom). Asterisks denote outliers above or below 1.5 times
the inter-quartile range.
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explain, in part, the quantitative discrepancies
observed. The use of a 1D model, however, has the
advantage of allowing ﬂexibility in the location of the
model boundaries and, more importantly, has the
potential for adaptation to patient-speciﬁc parameters,
when available, to obtain more representative values at
the boundaries. The comparison in Fig. 6 (top) shows
important differences between 1D model and pc-MR
data ranging from a minimum median value of 11%
(OSI) to a maximum of 46% (mtavWSS).
TABLE 3. A comprehensive review showing the methods adapted by different authors while applying BCs.
No. Author/references
Cohort
size (IAs) IA location (s) BC type/location BC source (method)
1 Steinman et al.43 1 Terminal ICA Inlet/ICA Healthy subjects (pc-MR)
Outlets/MCA, ACA Traction free
2 Chatziprodromou et al.9 2 Supraclinoid ICA Inlets/ICA Idealized
Outlets/ICA Traction free
3 Jou et al.24 1 BA (fusiform) Inlets/VA Patient-specific (pc-MR)
Outlet/BA Patient-specific (pc-MR)
4 Hassan et al.19 1 Vertebro-basilar Inlet/VA Patient-specific (TCD)
Outlet/BA Traction free
5 Shojima et al.40 20 MCA Inlets/MCA-M1 Healthy subjects (TCD)
Outlets/MCA-M2 Traction free
6 Cebral et al.6 62 ICA (22), MCA (14), Pcom (13),
ACA (1), Post (9), (3 NA)
Inlets/ICA, MCA, ACA, BA Healthy subjects (pc-MR)
Outlets/NA NA
7 Jou et al.25 2 BA (fusiform) Inlets/VA Patient-specific (pc-MR)
Outlets/PCA NA
8 Shojima et al.41 29 ICA (14), MCA (14), ACA (1) Inlets/ICA Healthy subjects (TCD)
Outlets/ICA, MCA Traction free
9 Cebral et al.5 4 ICA (2), SCA (1), Pcom (1) Inlets/NA Healthy subjects (pc-MR)
Outlets/NA Traction free
10 Karmonik et al.26 3 BA (top) Inlets/BA, VA Healthy subjects (pc-MR)
Outlet NA
11 Castro et al.2 4 Pcom (1), Acom (1), MCA (2) Inlets/NA Healthy subjects (pc-MR)
Outlets/NA Traction free
12 Castro et al.4 7 Acom (1), BA (1), ICA (2),
MCA (1), SCA (1),
PCA (1)
Inlets/NA Healthy subjects (pc-MR)
Outlets/NA Traction free
13 Castro et al.3 2 Acom Inlets/ICA Healthy subjects (pc-MR)
Outlets/NA Traction free
14 Mantha et al.29 3 ICA Inlets/NA Healthy subjects (scaled)
Outlets/NA NA
15 Venugopal et al.44 1 Acom Inlets/A1 Healthy subjects (scaled)
Outlets/A2 Zero pressure
16 Boussel et al.1 7 BA (3), ICA (3), MCA (3) Inlets/NA Patient-specific (pc-MR)
Outlets/NA NA
17 Mitsos et al.31 1 Acom Inlet/NA Healthy subjects (LDV)
Outlet/NA Traction free
18 Rayz et al.36 4 BA Inlets/VA Patient specific (pc-MR)
Outlets/PCA Traction free
19 Radaelli et al.35 1 ICA Inlet/ICA-proximal Healthy subjects (scaled)
Outlet/ICA-distal Traction free
20 Rayz et al.36 3 BA Inlet/VA Patient-specific (pc-MR)
Outlet/PCA Likely traction free
21 Shimogonya et al.39 1 ICA Inlet/ICA-proximal Healthy subjects waveforms
Outlet/ICA-distal Traction free
22 Jou et al.23 26 ICA-clinoidal Inlets/ICA Healthy subjects (scaled)
Outlet/NA NA
23 Marzo et al.30 3 BA, ICA Inlet/BA, ICA-proximal Computed (1-D model)
Outlet/BA, ICA-distal Traction free
24 Cebral et al.8 1 BA (top) Inlet/mid-BA Healthy subjects (scaled)
Outlets/PCA Traction free
BCs, boundary conditions; PC-MR, phase contrast magnetic resonance angiography; TCD, trans-cranial Doppler’s ultrasound; LDV, laser
Doppler velocimetry; ICA, internal carotid artery; ACA, anterior cerebral artery; Acom, anterior communicating artery; MCA, middle cerebral
artery; Pcom, posterior communicating artery; SCA, superior cerebeller artery; BA, basilar artery; VA, vertebral artery; Post, posterior
circulation.
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These discrepancies, however, are determined by
diﬀerences in ﬂow rates between the 1D model and
patient-speciﬁc waveforms, which are of the same
order of magnitude to physiological variations
reported by Gonzalez-Alonso et al.16, see Table 4.
While there are quantitative differences in hemody-
namic indices obtained by the different methods,
comparisons using normalized data showed that the
distribution of WSS remains unchanged. This conﬁrms
once again the signiﬁcance of geometry in determining
the hemodynamic development within the aneu-
rysm,5,30 but also some degree of linearity of the results
with respect to the ﬂow within the aneurysm. Table 5
shows information on geometry and ﬂow immediately
proximal to the aneurysm sac for all three methods
considered. Re values show a certain degree of linearity
with respect to the absolute values reported in Fig. 3.
Comparisons of OSI values showed good agree-
ment between the three methods. This is to be expected
as OSI, in its deﬁnition, uses the normalization of
local WSS.
Although blood is a non-Newtonian ﬂuid, in this
study we made the assumption of constant viscosity.
This is a valid assumption in the context of a study
whose aim is to evaluate the inﬂuence of BCs on intra-
aneurysmal ﬂow. In this respect, the use of a non-
Newtonian model would have negligible inﬂuence on
our ﬁndings as the same rheology model would be
consistently used to study the inﬂuence of BCs. Also,
Cebral et al.5 showed that the sensitivity of hemody-
namic predictions to different rheology models is
negligible in the context of aneurysmal hemodynamics.
The current study would beneﬁt from a larger
aneurysm cohort (although this would, of course, be
subject to clinical limitations), and from a wider range
of aneurysm locations (for example, aneurysm of the
anterior communicating artery (ACommA) or basilar
artery), which were not available in this study.
Summary
Whereas we can easily extract information about
aneurysm and vessel geometry, measurements of blood
ﬂow to be used as BCs in numerical predictions are
more diﬃcult to determine. As hemodynamic factors
are believed to be important in the aneurysm natural
history, we investigated the variability of certain
hemodynamic parameters with BCs. In this pre-
liminary study diﬀerences were found between results
obtained with patient-speciﬁc and modeled BCs. These
are attributable to underlying diﬀerences in the Re of
the ﬂow approaching the aneurysms. In fact, discrep-
ancies were signiﬁcantly reduced when considering
normalized indices, suggesting a certain degree of lin-
earity in the results and the important role played by
geometry in intraneurismal hemodynamics. It is likely
that in the future patient-speciﬁc BCs will be provided
as a part of routine clinical procedure. Until then,
afﬁrmation of CFD will be based on ﬁnding statistical
correlations using non-patient-speciﬁc BCs. The results
FIGURE 7. VFR waveforms for a typical healthy individual
and aneurysm patients included in this study, measured using
pc-MR at internal carotid level. Typical waveform was taken
from Radaelli et al.35
TABLE 4. Time-average volumetric flow rates and inlet radii
for the five aneurysms.
Qav-MR
(mL/s)
Qav-1D
(mL/s)
Qav-wss
(mL/s)
rpt
(mm)
r1D
(mm)a
Aneu-1 7.53 3.95 4.31 2.3 2.1–2.6
Aneu-2 1.46 1.90 0.74 1.3 1.4–1.5
Aneu-3 6.36 3.94 3.11 2.1 2.1–2.6
Aneu-4 2.00 1.91 0.42 1.1 1.4–1.5
Aneu-5 5.44 3.95 2.21 1.9 2.1–2.6
Aneu, aneurysm; Pt, patient; Qav-MR, average flow measured
using pc-MR; Qav-1D, average flow predicted by 1D-model;
Qav-WSS, average flow predicted by 1D-model scaled to obtain
wss = 1.5 Pa at boundary; rpt, radius of the vessel as measured in
the patient; r1D, average radius of the vessel used in 1D-model.
aMin and max radii in 1D model vessel where BCs was originated.
TABLE 5. Reynolds numbers of flow approaching aneurysm,
aneurysm aspect ratios, and vessel radii.
Aneurysm Re I Re II Re III Surface ratio rprox (mm)
1 551 285 311 4.7 1.8
2 140 228 89 20.1 1.3
3 343 223 176 5.6 2.1
4 155 184 138 15.5 0.9
5 434 298 152 2.5 1.9
Re I–II–III, Reynolds numbers of flow approaching aneurysm for
pc-MRI (I), 1D model (II), and WSS-scaled (III) boundary conditions
methods measured at end diastole; Surface ratio, aneurysm sur-
face area over neck surface area; rprox, vessel radius proximal to
aneurysm.
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of this study show that modeled BCs allow realistic
predictions of IA hemodynamics and offer a viable
means for ﬁnding correlations with rupture in large
cohort studies.
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Haemodynamics is believed to play an important role in the initiation, growth and rupture of intracranial aneurysms. In this
context, computational haemodynamics has been extensively used in an effort to establish correlations between flow
variables and clinical outcome. It is common practice in the application of Dirichlet boundary conditions at domain inlets to
specify transient velocities as either a flat (plug) profile or a spatially developed profile based on Womersley’s analytical
solution. This paper provides comparative haemodynamics measures for three typical cerebral aneurysms.
Three dimentional rotational angiography images of aneurysms at three common locations, viz. basilar artery tip, internal
carotid artery and middle cerebral artery were obtained. The computational tools being developed in the European project
@neurIST were used to reconstruct the fluid domains and solve the unsteady Navier–Stokes equations, using in turn
Womersley and plug-flow inlet velocity profiles. The effects of these assumptions were analysed and compared in terms of
relevant haemodynamic variables within the aneurismal sac. For the aneurysm at the basilar tip geometries with different
extensions of the afferent vasculature were considered to study the plausibility of a fully-developed axial flow at the inlet
boundaries.
The study shows that assumptions made on the velocity profile while specifying inlet boundary conditions have little
influence on the local haemodynamics in the aneurysm, provided that a sufficient extension of the afferent vasculature is
considered and that geometry is the primary determinant of the flow field within the aneurismal sac. For real geometries the
Womersley profile is at best an unnecessary over-complication, and may even be worse than the plug profile in some
anatomical locations (e.g. basilar confluence).
Keywords: boundary conditions; haemodynamics; blood flow; Womersley; plug-flow; intracranial aneurysm
1. Introduction
An aneurysm is a localised dilation in a blood vessel,
which carries an inherent risk of rupture and haemorrhage.
Aneurysmal subarachnoid haemorrhage, despite improve-
ment in surgical and medical management, remains a
major cause of morbidity and mortality with high rates of
case fatality (40–50%, Numminen et al. 1996; Inagawa
2001). Among different etiologies proposed so far
(genetic, traumatic and inflammatory), haemodynamics
is believed to play an important role in the initiation and
the development of the disease (Sekhar and Heros 1981;
Kayembe et al. 1984; Byrne and Guglielmi 1998; Shojima
et al. 2004; Cebral et al. 2005b).
Detailed in vivo measurements of all relevant flow
variables in the regions affected by the disease are currently
impossible. Computational fluid dynamics (CFD) might
represent a valuable tool to extract additional non-
observable information from patient-specific data.
Advances in image processing and vessel reconstruction
techniques, together with the wider availability of
significant computing power, have made possible the
realisation of characterisation of the haemodynamics
of patient-specific geometries. Steinman (2004) has made
the important observation that patient-specific CFD
analyses are possible and that the onus is now on researchers
to bring these technologies into a clinical setting. There are
two steps in this process: the first is to establish a consistent
analysis protocol and to undertake characterisation of large
numbers of aneurysms to provide confidence in the
association of haemodynamic measures with the event of
rupture. The second is to deliver an effective and robust
simulation workflow into the clinical environment.
Both of these steps are addressed in the @neurIST
project (www.aneurist.org), which seeks to develop a
robust, clinically-usable tool chain for the computation of
relevant haemodynamic data associated with the initiation,
growth and rupture of intracranial aneurysms.
The specification of an analysis protocol that can be
applied at all sites, both within and without the @neurIST
project, that are interested in contribution to an extensive
database of haemodynamic characterisations of patient-
specific aneurysms is an important goal.
The computational technologies currently available
limit the extension of the computational domain
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to a restricted area around the aneurysm. The specification
of boundary conditions at the interfaces with the rest of the
cardiovascular network thus remains a pre-requisite for the
solution of the governing equations.
Flow rate waveforms (describing area-integrated
velocity at each instant in time) in the region of the
aneurysm or in the afferent vessels might sometimes be
available from Doppler ultrasound in the carotid, from
transcranial Doppler ultrasound or from magnetic
resonance imaging, but none of these is currently
measured in routine clinical practice in the management
of cerebral aneurysm. Invasive pressure measurements
are even rarer. A viable alternative for description of
flow and pressure waveforms might be 1D circulation
models (Westerhof et al. 1969; Stergiopulos et al. 1992;
Vignon-Clementel 2006; Balossino et al. 2008; Bove
et al. 2008). From whatever source flow or pressure
measurements are available, it is unlikely or impossible
that they include spatial resolution of the profiles.
The solution of the 3D Navier–Stokes equations, on the
other hand, requires these quantities to be specified as
pointwise values at each node of the 3D boundary mesh.
Assumptions made while completing such deficient data
at boundaries is not trivial and can strongly perturb the
numerical results.
Many authors rely on the theory of Womersley (1955)
for the specification of the velocity profile of flowrate-
based boundary conditions, assuming that flow is spatially
developed to that associated with periodic flow in a
circular pipe. This might be appropriate but it is known
that geometry of the proximal vasculature remains the
most important factor in describing the flow presented to
the aneurysm (Cebral et al. 2005a; Oshima et al. 2005;
Castro et al. 2006; Moyle et al. 2006). The over-
complication of applying a Womersley velocity profiles
might be unnecessary and in some circumstances
unrealistic in the determination of the haemodynamics
within the aneurismal sac.
Myers et al. (2001) and Moyle et al. (2006) have
assessed the effect of these assumptions on arterial
haemodynamics and have shown that geometry takes over
within a relatively short distance from the location of the
inlet boundaries, thus nullifying the effects of careful
specification of inlet velocity profiles.
However, there is relatively little data in the context of
saccular cerebral aneurysms (Oshima et al. 2005), which
often presents more complex haemodynamic patterns
(Cebral et al. 2005a) when compared to the simpler
geometries of the studies reported so far (Myers et al.
2001; Moyle et al. 2006).
The current study investigates the effects of inlet
velocity profiles on the haemodynamics of intracranial
aneurysms and demonstrates their secondary role when
compared to anatomical geometry and extension of
afferent vasculature in three typical anatomical locations.
2. Materials and methods
Three typical intracranial aneurysms found in the circle of
Willis were considered in this study: an aneurysm at the tip
of the basilar artery (herein called geom.1), an aneurysm
of the right ophthalmic segment of the internal carotid
artery (geom.2), and an aneurysm of the terminal
bifurcation of the right middle cerebral artery (geom.3).
Locations are illustrated in Figure 1. In order to study the
flow development at the confluence of the vertebral
arteries, an additional geometry for the basilar artery
aneurysm was reconstructed (geom.1b), which contains
the junction of the two vertebral arteries.
Some of the case studies had additional minor
aneurysms. These are highlighted by black arrows in
Figure 2, but were excluded from the study.
The aneurysm in each of geom.1 and 3 was saccular
bilobular. The aneurysm in geom.2 was saccular with a
single lobe. These geometries present a progressively
higher level of tortuosity of the aneurysmal afferent loop
from geom.1, where the basilar artery is only slightly
curved, to geom.3, where the feeding vasculature presents
several bends, changes in the lumen diameter and
bifurcations, before reaching the aneurysm of interest.
More details of the geometries of interest are reported in
Table 1.
Rotational acquisitions were obtained using a Philipsw
Integrise BV 5000 machine (Philipsw Medical Systems,
Eindhoven, The Nederlands), producing 100 images in 4 s,
with 5 ms exposure per image. A built-in X-ray image
Figure 1. Representation in one of @neurIST application suites
of a typical cerebral arterial tree, with locations of geom.1, 1b, 2
and 3 indicated by white spheres and black arrows.
A. Marzo et al.2
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Table 1. Geometrical properties of geom.1–3.
Aneurysm size (mm)
Depth Max diameter
Neck
(max width)
Length of afferent vessel
(normalised with inlet diameter) Complexity of afferent loop
Geom.1 5.5–6.5a 4.6–5.8a 5.5 10 Low
Geom.1b 5.5–6.5a 4.6–5.8a 5.5 12b Low
Geom.2 5.5 4.6 4.3 8.2 Medium
Geom.3 4.4–3.8a 3.3–2.3a 3.1 12 High
a Values for the two lobes.
b Values for both inlet afferent vessels of geom.1b, i.e. vertebral arteries.
Figure 2. Reconstructed geometries: geom.1, basilar artery aneurysm; geom.1b, basilar artery aneurysm including vertebral arteries;
geom.2, internal carotid artery aneurysm, geom.3, middle cerebral artery aneurysm. Black arrows show secondary smaller aneurysms,
excluded from the study. Labels indicate the openings where boundary conditions were applied.
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intensifier was used, with a close-circuit-digital camera
and software to correct for geometrical deformation.
Voxel size in the reconstructed 3D images was 303mm
with reconstruction matrix 512 £ 512 £ 512. Images
were anonymised, respecting the ethical approval for
@neurIST’s for use of patient data.
The @neurIST computational tool-chain was used
to segment, extract and repair the vessel surfaces.
In particular, vessel triangular surfaces were created
using a threshold isosurface extraction tool, based on the
marching cubes algorithm developed by Lorensen and
Cline (1987). Artefacts and unnecessary vasculature were
removed and surface repaired using tools based on the
Visualisation Toolkit (www.vtk.org), first developed
within the Multimod Application Framework (Viceconti
et al. 2004) and further improved within the project
@neurIST. All inlet openings were extruded and morphed
into circular edges for the appropriate application of
Womersley-based boundary conditions. Extrusion of some
outlets was necessary to ensure that spatially constant
pressure represented an appropriate boundary condition at
the termination of the 3D domain. The results of the
geometry reconstruction process are shown in Figure 2.
During vessel reconstruction, the neck of the
aneurysms was manually identified and marked to define
the aneurysmal sac that was used for the haemodynamic
characterisation of each aneurysm.
Volumetric meshes were generated using ANSYSw
ICEM CFD 11.0e and based on the octree approach.
Grids were made finer at the walls and progressively
coarser towards the vessel axis. Tetrahedral elements were
used for the discretisation of the domain core, with three
layers of prismatic elements adjacent to the wall, thus
ensuring accurate computation of wall shear stresses
(WSS) and oscillatory shear indices (OSI). Element size
and number were set accordingly to the outcome of a mesh
dependency study performed on similar aneurysmal
geometries (Radaelli et al. 2008, private communications).
In this study, results were found to be grid independent for
meshes greater than 1700 el/mm3. In order to maintain
consistency across the meshes used for all geometries,
similar element density and the same wall element size and
maximum core element size were used in the discretisation
of the domains. Mesh details are reported in Table 2
below.
The 3D unsteady Navier–Stokes equations were
solved by using the finite-control-volume software,
ANSYSw-CFXe. The default second-order high-resol-
ution advection differencing scheme was used. The solution
algorithm is an implicit coupled solution scheme, based on
an algebraic multigrid method for the coupled linear
equations. Blood was assumed to be incompressible, with
density r ¼ 1050 kg/m3 and Newtonian, with viscosity
m ¼ 0.0035 Pa s. All analyses were run in parallel, using
the communication mode MPICH on two Itanium2
900MHz 64-bit processors of a Tiger-2 Linux cluster
node with 4GB of registered DDR-SDRAM PC1600. The
average time required to solve one cardiac cycle with the
meshes considered was approximately 8.6 h.
2.1 Boundary conditions
Patient-specific flow measurements at boundaries were not
available for the data sets under consideration, thus
boundary conditions were derived from the flow-rate and
pressure waveforms computed by using the 1D circulation
model developed by Reymond et al. (2008), which is part
of the @neurIST computational tool-chain. This is a
distributed model of the entire systemic arterial tree,
coupled to a heart model and including a detailed
description of the cerebral arteries. The 1D form of the
fluid equations are applied over each arterial segment and
intimal WSS is modelled using the Womersley theory.
Arterial wall was modelled with a non-linear viscoelastic
constitutive law and arterial tree dimensions and proper-
ties were taken from literature and extended to include a
description of the cerebral arterial tree obtained from real
patient scans. In some more detail, the pressure
dependency of compliance in thoracic and abdominal
aortas, measured ex vivo and described by Langewouters
(1982), was applied to the whole arterial tree. The elastic
component of the compliance, which is function of the
mean arterial lumen diameter, compliance, was described
as a function of pulse wave velocity (Reymond et al.
2008). The viscoelastic behaviour of the arterial wall was
described by the model developed by Holenstein et al.
(1980). Geometrical properties of the arterial tree,
including the circle of Willis, were taken from
Noordergraaf (1956), Gabrielsen and Greitz (1970),
Fox et al. (1973), Krayenbuehl and Yasargil (1982),
Table 2. Grid properties for geom.1–3.
Volume
(mm3) Elements Nodes
Average
density (el/mm3)
Max el.
size (mm)
Max wall el.
size (mm)
Geom.1 433.9 1321449 411331 3046 0.4 0.12
Geom.1b 540.4 1678606 527615 3106 0.4 0.12
Geom.2 1375.5 3173174 912842 2307 0.4 0.12
Geom.3 848.2 2292777 694172 2703 0.4 0.12
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Hillen et al. (1986), Dodge et al. (1992), Stergiopulos et al.
(1992), Krabbe-Hartkamp et al. (1998) and Holdsworth
et al. (1999), and completed by interpolated real patient
scans (3D rotational angiography and MRA).
Flow-rate waveforms were used for all primary inlets
and pressure waveforms for all primary outlets. All
pressure and flow rate waveforms used for the analyses are
reported in Figure 3. Flow-rate waveforms were used to
specify, in turn, plug-flow (i.e. flat velocity profile) and
Womersley velocity profiles at the inlet boundaries.
The waveforms were decomposed into Fourier series as
indicated in Equation (1):
QðtÞ ¼
XN
n¼0
Qne
invt; ð1Þ
where N is the number of harmonics, and v is the angular
frequency derived from the period of the cardiac cycle
T ¼ 0.8 s. The Womersley velocity profile was expressed
in terms of the Fourier representation of the flow rate
waveforms as indicated in Equation (2):
n ðr; tÞ ¼ 2Q0
pR2
12
r
R
 
2
h i
þ
XN
n¼1
Qn
pR2
12
J0 bn·ðr=RÞð Þ
J0ðbnÞ
12 2J1ðbnÞbn·JoðbnÞ
2
4
3
5·e invt;
ð2Þ
where R is the radius of the inlet boundary, Q0 is the first
harmonic coefficient responsible for the parabolic profile
of a steady flow (i.e. Poiseuille flow), J0 and J1 are Bessel
functions of order zero and one, respectively, and
bn ¼ i 3=2·an; ð3Þ
an ¼ R·
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n·4·r
m
r
; ð4Þ
where an is the Womersley number of the nth harmonic.
A Fortran subroutine was created and interfaced to the
ANSYSw-CFXe solver for the computation of the
velocity inlet profiles within each time loop.
Analyses were run for four cardiac cycles to nullify
the transient artefacts generated by the initial conditions,
and only data from the 4th cycle were used in the
post-processing phase.
3. Results
Relevant haemodynamic variables were compared quali-
tatively and quantitatively for the two velocity profile
assumptions both at two time-points along the cardiac cycle
(corresponding to the lowest and highest Reynolds numbers
achieved during diastole and systole, respectively), and
as time-averaged quantities across the cardiac cycle.
The haemodynamic variables chosen for these comparisons
have been associated with aneurysmal initiation, growth
and rupture in the literature (Shojima et al. 2004; Cebral
et al. 2005b).
3.1 Qualitative comparison using instantaneous
velocity contours
Figure 4 shows the comparison between Womersley and
plug-flow boundary conditions during diastole and systole,
using velocity contours at specific cross sections.
The cross-sections were selected as those, which
subjectively, best illustrated the complexity of the flow
within the three domains. Results for geom.1 show that for
both flow regimes; the Womersley and plug-flow flow
patterns are essentially the same with some minor
discrepancy in the magnitude of the velocity field, as
shown by the arrows in Figure. Results for geom.2 are
consistent with geom.1 except that discrepancies in
velocity magnitudes are more pronounced in the lower
part of the cross section, representing the velocity patterns
within the parent vessel. Finally, results for geom.3 show
good agreement in the patterns as well as the magnitude of
the velocity field. Contours in geom.2 and 3 show the
presence of a jet of fluid entering the aneurysm and
impinging onto the distal side of the aneurysmal wall.
Moreover, results for all geometries show that flow is
rather stable (according to the definition of Cebral et al.
2005b), exhibiting the same characteristics during diastole
and systole.
3.2 Qualitative comparison using instantaneous WSS
contours
Figure 5 shows the comparison between Womersley and
plug-flow boundary conditions during diastole and
systole, using contours of WSS on the wall of the
aneurysmal sac. Results for geom.1 show that Womersley
and plug-flow boundary conditions at inlet develop
essentially the same WSS distribution in the aneurysm in
both flow regimes. It was noticed that the bigger lobule of
geom.1 is one, which is subjected to comparatively low
WSS at both reported time-points in the cardiac cycle,
whereas in the smaller lobule WSS values reach their
highest values. Results for geom.2 and 3 show essentially
the same WSS patterns for both inflow assumptions and
for both flow regimes, with some minor variations for
geom.2 during diastole near the aneurysmal neck, and
for geom.3 during systole as shown by the arrows in
Figure 5.
As for velocity distributions, WSS present similar
patterns during diastole and systole, showing stability of
the flow.
Computer Methods in Biomechanics and Biomedical Engineering 5
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Figure 3. (a) Flow-rate (left) and pressure waveforms (right) applied in geom.1. (b) Flow-rate (left) and pressure waveforms (right)
applied in geom.1b. (c) Flow-rate (left) and pressure waveforms (right) applied in geom.2 and (d) Flow-rate (left) and pressure waveforms
(right) applied in geom.3.
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3.3 Qualitative comparison using time-averaged WSS
and OSI contours
Time-averaged haemodynamic quantities can be used to
assess the agreement between results over the whole
cardiac cycle, and not solely at specific snap-shots in time.
Time-averaged WSS are reported, together with OSI for
further comparison. OSI is defined in Equations (5) and (6),
and was used to quantify the oscillatory shears experienced
by the cells of the inner part of the arterial vessel and
aneurysm (endothelial layer).
OSI ¼ 1
2
12
tmean
tabs
 
; ð5Þ
tmean ¼ 1
T
ðT
0
ts·dt

; ð6Þ
where ts represents the surface traction vector. Figures 6
and 7 show the time-averaged WSS and OSI contours,
respectively, on the aneurysmal wall of all three
geometries and for both inlet boundary conditions.
The results are consistent with those of the instantaneous
measures, i.e. very little differences are observed between
WSS and OSI patterns, and only minor differences in
magnitudes, from Womersley and plug-flow boundary
conditions. For these aneurysms, exhibiting stable flow
patterns over the cardiac cycle, it is noted that the
time-averaged WSS pattern is qualitatively very similar to
that of its instantaneous counterparts.
3.4 Qualitative comparison on flow development
Figure 8(a),(b) shows the development of the flow for
Womersley and plug-flow boundary conditions for
geom.1. Although the two flows start from different
assumptions at the inlet opening, both develop into a very
similar velocity pattern before reaching the aneurysmal
sac. Figure 8(c), illustrating the results for the extended
domain of geom.1b, shows that the two converging vessels
produce a ring-like velocity profile that is significantly
different from both the Womersley and flat profiles, but
Figure 4. Velocity contours across the aneurysmal sac for (a) Womersley boundary conditions at lowest Re during diastole; (b) plug-flow
boundary conditions at lowest Re during diastole; (c) Womersley boundary conditions at highest Re during systole and (d) plug-flow
boundary conditions at highest Re during systole. From top to bottom: geom.1–3. Grey arrows indicate areas of discrepancies. Units for
velocity are expressed in m/s.
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in fact closer to the latter. This indicates clearly that there
are some geometries (of course those that are least like a
straight tube) for which the Womersley profile is actually a
worse choice than the flat profile. Nevertheless, once again
the flow close to the aneurysm is relatively similar for all
boundary conditions considered.
3.5 Quantitative comparison
For a more accurate and direct evaluation of the effects
that different boundary conditions may have on local
haemodynamics, several haemodynamic indices were
extracted from the flow field of the three aneurysmal
sacs, for both inflow boundary conditions. These are
reported in Table 3 with the percentage discrepancy
between Womersley and plug-flow results. In geom.1, the
maximum discrepancy was observed in the spatial-average
speed in the aneurysmal sac (4.3%) and in the area of
elevated pressure in the aneurysmal wall (also 4.3%).
Relatively high discrepancies were also observed in the
values predicted for the maximum speed within the
aneurysm at systole (2.3%) and the location of maximum
OSI (2.8%). In geom.2, the maximum discrepancy was
observed in the predictions of area of elevated pressure
(4.1%) and for geom.3 in the values of max OSI (3.7%)
and its location (4.1%).
The root mean square of the errors of the different
indices was also computed and is reported in the last row
of Table 3.
Overall the maximum discrepancy between Womersley
and plug-flow results was observed in geom.3, where the
RMS is 2%. Lower RMS values were calculated for geom.1,
RMS ¼ 1.9% and geom.2, RMS ¼ 1.2%.
4. Discussion
The purpose of this paper is to compare the results from
two common methods of application of proximal velocity
boundary conditions for haemodynamic analysis of
cerebral aneurysms. The context is that of specification
of a robust protocol for routine haemodynamic analysis as
part of a clinical workflow.
The isolation of the vessel of interest from the rest of
the cardiovascular tree and its surroundings (e.g. tissues
Figure 5. WSS contours for (a) Womersley boundary conditions at lowest Re during diastole; (b) plug-flow boundary conditions at
lowest Re during diastole; (c) Womersley boundary conditions at highest Re during systole and (d) plug-flow boundary conditions at
highest Re during systole. From top to bottom: geom.1–3. Units for WSS are expressed in Pa.
A. Marzo et al.8
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and bones) implies that wall and flow conditions will have
to be specified at the boundaries of the vessel. Patient-
specific assessment of the properties of the vessel walls
and its surroundings are difficult. There is some evidence
that pulsatility of the vessel wall might have negligible
effect on haemodynamics even when the wall motion is of
the order of the radius of a vessel (Jeays et al. 2007) and
even less so in the context of cerebral aneurysms in the
confined compartment of the skull (Dempere-Marco et al.
2006). For the purposes of the current study (and probably
for a routine clinical analysis protocol) the walls of the
vessel are considered fixed.
Patient-specific flow measurements are in principle
attainable from MRI or Doppler ultrasound but the
intricacy of the cerebral vasculature, the small size of its
vessels, and the fact that these are not part of the clinical
procedure make them rarely available. Even when they
are, it is unusual to rely on the spatial distribution of
velocity (due to resolution of MRI and difficulties of
location of Doppler ultrasound measures). To overcome
Figure 6. Time-averaged WSS contours for (a) Womersley boundary conditions; (b) plug-flow boundary conditions. From top to
bottom: geom.1–3. Units for WSS are expressed in Pa.
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these difficulties several authors use lumped-parameters or
1D models for the description of the remaining vascular
systems (Formaggia et al. 1999; Quarteroni et al. 2001).
Flow boundary conditions, whether from patient-specific
ultrasound or MRI measures, or computed using simple
models of the cardiovascular system, are available as
cross-sectional average values of velocity or pressure
along the cardiac cycle. Thus assumptions on their 3D
development across the same boundaries are to be made to
match the level of details required by 3D modelling. While
imposing inflow boundary conditions from the flow-rate
waveforms computed by a 1D distributed model, for
instance, one assumption often imposed at the inlet
boundary is that of axisymmetric flow with a velocity
distribution determined by the Womersley theory.
The results of the comparative analyses with Womersley
and flat velocity profiles indicate that there is no change in
qualitative flow patterns, and detailed examination of the
flow fields yields maximum differences of less than 5%, and
RMS differences between 1 and 2%. It is suggested that
these differences are unimportant in the context of
interpretability against known thresholds, and particularly
Figure 7. OSI contours for (a) Womersley boundary conditions; (b) plug-flow boundary conditions. From top to bottom: geom.1–3.
A. Marzo et al.10
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in the context of other uncertainties in the analysis (patient
blood pressure, beat-to-beat variations, alternative physio-
logical states including exercise, patient haematocrit and
viscosity models). Certainly, the errors are small compared
with those that might arise from inaccurate segmentation of
the patient specific geometry, when variabilities up to 48%
have been reported (Moyle et al. 2006). Whilst the true
significance and relevance of discrepancies between
Womersley and plug-flow results can only be assessed
once associations are found between haemodynamic indices
and aneurysmal evolution, it is probably safe to assume that
the uncertainties of any thresholds and the safety factors that
will be built into any clinical interpretation and recommen-
dations will always remain greater than that associated with
analysis errors from the inlet velocity profile provided the
inlet development domain is of adequate length.
The computational savings associated with a recommen-
dation of the simplest inlet velocity boundary condition, that
of a flat profile, are not significant. More important is that the
simpler the analysis protocol adopted, the more likely it is
that other centres will contribute to the growth of an
established database of haemodynamic characterisations,
ultimately reflecting on its power to provide meaningful,
peer-reviewed and clinically implementable associations of
the characteristic haemodynamic measures with observed
clinical outcome. Until such associations are established, the
impact of CFD on the management of cerebral aneurysms
will be minimal.
A limitation of the current study is that results are
reported for only three aneurysms, with one further
variation. Nevertheless, these aneurysms have been
selected as typical of those that arise most commonly in
the cerebral vasculature and given the consistency of the
results, and their resonance with expectations based on the
physics of the problem, it is suggested that it provides
strong evidence that haemodynamic characterisations are
indeed likely to be insensitive to details of the inlet
velocity distribution.
Although specific analysis and comment on the
haemodynamic results for any one aneurysm is not the
focus of the current study, the analysis of geom.1 revealed
some interesting haemodynamic characteristics that are
worthy of mention. Primary haemodynamic activity is
clearly confined to one of the lobules, whilst the other is
subject to very low WSS. In fact, it is the smaller lobule
that exhibits strong haemodynamic activity and the larger
that is relatively stagnant. It is noted that the larger lobe
has a more irregular shape. No follow-up data is available
and so it is impossible to determine which, if either, lobe is
growing or which might rupture. Nevertheless, it is
noteworthy that the haemodynamic environment in the
smaller of the lobes is more similar to that in the parent
vasculature than that in the larger lobe, and that the mean
shear stress in the larger lobe is below that threshold
that has been associated with negative outcome and
the onset of disease in other vascular applications
(Malek et al. 1999).
5. Conclusions
Our final conclusions are as follows:
(1) The haemodynamic characterisation of a cerebral
aneurysm under given proximal flow conditions is
relatively insensitive to the details of the velocity
profile on inlet boundaries that are sufficiently far
from the aneurysm.
(2) Wider adoption of a given analysis protocol is more
likely if it is simple to implement and the
specification of a flat velocity profile at the inlet to
a 3D domain provides an adequate and justifiable
description for the purposes of haemodynamic
characterisation.
Figure 8. Velocity vectors on cross-sections along the afferent vessel at peak systole for geom.1 with plug-flow boundary conditions (a);
geom.1 with Womersley boundary conditions (b) and geom.1b (c) with Womersley boundary conditions. The distance between the cross-
sections is approximately 1.5D, where D is the diameter of the inlet boundary in geom.1. Units for velocity are expressed in m/s.
Computer Methods in Biomechanics and Biomedical Engineering 11
D
o
w
n
lo
ad
ed
 B
y:
 [
Wa
rr
en
, 
Gr
eg
g]
 A
t:
 1
1:
24
 2
 F
eb
ru
ar
y 
20
09
Table 3. Haemodynamic indices extracted for geom.1–3 and percentage error between Womersley and plug-flow results.
Geom.1 Geom.2 Geom.3
Wom Plug Err% Wom Plug Err% Wom Plug Err%
Max speed within aneurysm
at systole (m/s)
1.774 1.733 22.3 1.154 1.155 0.1 1.555 1.544 20.7
Spatial mean speed in aneurysm
at systole (m/s)
0.331 0.317 24.3 0.557 0.557 0.0 0.619 0.619 0.0
Peak static wall pressure
at systole (Pa)
16,131 15,950 21.1 15,770 15,750 20.1 14560 14,550 20.1
Location X of max pressure (m) 3.51 £ 1022 3.51 £ 1022 0.0 4.20 £ 1022 4.20 £ 1022 0.0 1.73 £ 1022 1.73 £ 1022 0.0
Location Y of max pressure (m) 1.64 £ 1022 1.64 £ 1022 0.0 2.33 £ 1022 2.33 £ 1022 0.0 3.11 £ 1022 3.11 £ 1022 0.0
Location Z of max pressure (m) 23.67 £ 1022 23.67 £ 1022 0.0 23.48 £ 1022 23.48 £ 1022 0.0 23.65 £ 1022 23.65 £ 1022 0.0
Spatial mean static pressure
in aneurysm at systole (Pa)
15,260 15,130 20.9 15,140 15,120 20.1 13,770 13,770 0.0
Area of elevated pressurea (m2) 0.123 £ 1026 0.118 £ 1025 24.3 4.18 £ 1026 4.01 £ 1026 24.1 7.06 £ 1026 7.13 £ 1026 1.1
Max time-averaged WSS (Pa) 25.79 25.52 21.1 16.44 16.87 2.6 49.07 50.52 2.95
Location X of max time-averaged
WSS (m)
3.604 £ 1022 3.604 £ 1022 0.0 4.18 £ 1022 4.18 £ 1022 0.0 1.79 £ 1022 1.79 £ 1022 0.0
Location Y of max time-averaged
WSS (m)
0.196 £ 1023 0.196 £ 1023 0.0 0.232 £ 1023 0.232 £ 1023 0.0 0.291 £ 1023 0.291 £ 1023 0.0
Location Z of max time-averaged
WSS (m)
23.48 £ 1022 23.48 £ 1022 0.0 23.49 £ 1022 23.49 £ 1022 0.0 23.36 £ 1022 23.36 £ 1022 0.0
Area of elevated time-averaged
WSSb (m2)
1.83 £ 1026 1.82 £ 1026 20.9 6.39 £ 1027 6.39 £ 1027 0.0 2.60 £ 1027 2.56 £ 1027 21.4
Max OSI in aneurysmal wall 0.491 0.487 20.8 0.471 0.472 0.2 0.494 0.475 23.7
Location X of max OSI (m) 3.21 £ 1022 3.12 £ 1022 22.8 4.13 £ 1022 4.13 £ 1022 0.0 1.95 £ 1022 1.97 £ 1022 1.2
Location Y of max OSI (m) 1.80 £ 1022 1.79 £ 1022 20.9 2.34 £ 1022 2.34 £ 1022 0.0 3.12 £ 1022 2.99 £ 1022 24.1
Location Z of max OSI (m) 23.20 £ 1022 23.12 £ 1022 22.7 23.75 £ 1022 23.75 £ 1022 0.0 23.67 £ 1022 23.68 £ 1022 0.3
Area of elevated OSI (m2) 6.44 £ 1025 6.37 £ 1025 21.0 3.39 £ 1027 3.35 £ 1027 21.2 7.30 £ 1027 7.70 £ 1027 5.4
RMS error (%) 1.9 1.2 1.98
a Elevation defined as 50% of peak pressure minus average pressure in the aneurysm at systole.
b Elevation defined as 50% of maximum time-averaged WSS.
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Cerebral aneurysms are a multi-factorial disease with severe consequences. A core part of the
European project @neurIST was the physical characterization of aneurysms to ﬁnd candidate
risk factors associated with aneurysm rupture. The project investigated measures based on
morphological, haemodynamic and aneurysm wall structure analyses for more than 300
cases of ruptured and unruptured aneurysms, extracting descriptors suitable for statistical
studies. This paper deals with the unique challenges associated with this task, and the
implemented solutions. The consistency of results required by the subsequent statistical
analyses, given the heterogeneous image data sources and multiple human operators, was
met by a highly automated toolchain combined with training. A testimonial of the success-
ful automation is the positive evaluation of the toolchain by over 260 clinicians during
various hands-on workshops. The speciﬁcation of the analyses required thorough investi-
gations of modelling and processing choices, discussed in a detailed analysis protocol.
Finally, an abstract data model governing the management of the simulation-related data
provides a framework for data provenance and supports future use of data and toolchain.
This is achieved by enabling the easy modiﬁcation of the modelling approaches and solution
details through abstract problem descriptions, removing the need of repetition of manual
processing work.
Keywords: cerebral aneurysms; computational imaging and modelling;
computational physiology; virtual physiological human
1. INTRODUCTION
Cerebral aneurysms are local pathological dilatations of
arteries in the brain causing signiﬁcant morbidity and
mortality rates [1]. A large proportion (1–5%) of the
population has unruptured aneurysms. Once an aneur-
ysm ruptures, subarachnoid haemorrhage (SAH) usually
occurs, and the impact is devastating. After SAH,
patients have a 45 per cent 30 day mortality rate, and
an estimated 30 per cent of survivors present moderate-
to-severe disability. As a consequence, SAH induces a
serious burden for patients, their relatives and society.
A considerable debate regarding the optimal treat-
ment of patients harbouring unruptured intracranial
aneurysms has developed in recent years, stemming lar-
gely from the inﬂuence of several factors. Among them
stand out the impact of recent technological improve-
ments on diagnostic and interventional imaging, the
appearance of a new generation of therapeutic devices,
and the increase in the number of large-scale, random-
ized, multi-institutional studies centred in the outcome
evaluation of existing treatments [2] as well as the
evolution of unruptured aneurysms [3]. The combination
of these factors and the sometimes contradictory
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conclusions introduced by these studies have led to con-
siderable uncertainty about the optimal treatment for
patients harbouring unruptured intracranial aneurysms.
These efforts from the clinical community have
caused an increasing interest in modelling the complex
multi-factorial mechanisms thought to be involved in
aneurysm genesis, growth and rupture, which include
genetic, physical and environmental factors. This
global approach to the disease links with the wide inter-
national interest in the construction of an integrated in
silico human. The ‘IUPS Physiome’ [4,5] provides the
framework for a hierarchy of models spanning the
length scales from the molecule to the individual. Other
activities exploring the development of multi-scale and
multi-disciplinary physiological models up to speciﬁc
organ level have resulted in the development of the vir-
tual physiological human (VPH) [6–8], in the context
of which we could frame this work.
1.1. The @neurIST project
This work was developed as part of the European project
‘Integrated Biomedical Informatics for the Management
of Cerebral Aneurysms’ (@neurIST; http://www.aneuri
st.org) [9,10]. @neurIST was a 4 year project started in
2006 with a 17 million euro budget, gathering 28 public
and private institutions of 12 European countries,
including industrial, medical and academic institutions.
Several organizations from the USA, New Zealand and
Japan participated as external collaborators. The
mission statement of the project was the following:
@neurIST will transform the management of
cerebral aneurysms by providing new insights,
personalized risk assessment, and methods for the
design of improved medical devices and treatment
protocols.
To fulﬁl this mission, four software suites (@neuRisk,
@neuLink, @neuFuse and @neuEndo) and two infra-
structure components (@neuCompute and @neuInfo)
were developed to collaborate with each other [11–13].
@neuRisk provides personalized risk assessment and
treatment guidelines to practitioners based on the ana-
lyses performed by the other three suites. @neuLink
enables not only the study of the existing links between
genetics and disease, but also provides links to the
biomechanical indices extracted from @neuFuse. @neu-
Fuse addresses the patient data fusion from different
modalities and the extraction of such biomechanical
indices. @neuEndo works closely to the other three
suites facilitating the optimization and customization
of medical devices used for patient treatment. The
two infrastructure components allowing the intero-
perability and collaboration of the suites are
@neuCompute, by providing high-performance-distrib-
uted computing capabilities, and @neuInfo, by
enabling a homogeneous data access and storage to
the heterogeneous data types handled in the suites. A
more detailed description of the @neurIST system
architecture is provided in Benkner et al. [14], where
the authors introduce the developed service-oriented
IT infrastructure supporting the seamless access to
distributed medical data and computational resources
in an easy and secure manner.
From the previous, one can understand the role that
@neurIST has in tackling a disease in a global manner,
a concept which directly links to the VPH. The
developed multi-scale paradigm could be extended to
other diseases.
1.2. Finding biomechanical risk factors:
approach and challenges
This paper describes the @neurIST complex infor-
mation processing toolchain approach to provide
physical models of cerebral aneurysms and derive
representative descriptors that could be associated
with their rupture.
To create a comprehensive basis for investigating
potential physical risk factors, the project aimed to
compute for a large number of cases many different
characterizations based on the analysis of shape,
blood ﬂow (haemodynamics) and wall mechanics. To
enable statistical analyses, the typically continuous
output of these analyses had to be reduced to a ﬁnite
number of descriptors suitable for ﬁnding statistical
associations that would help understanding the natural
history and the risks of available treatments.
To this end, @neurIST collected extremely hetero-
geneous data that included patient’s clinical history,
images and blood samples, for more than a total of
1400 patients with ruptured and unruptured aneur-
ysms. Our goal was then to compute the whole set of
physical characterizations mentioned before for the
nearly 500 patients having associated medical images.
To reach these goals, we had to face three major chal-
lenges. First, to determine the details of the most
representative biomechanical analyses to be performed
and select the most meaningful physical descriptors
that could be derived (§2). Second, to enable perform-
ing multi-case, multi-operator and multi-site analyses
guaranteeing consistency and repeatability among
users and processing sites, and to reduce the manual
work needed (§3). And third, to preserve the prove-
nance of the derived descriptors, to link back to the
clinical data, and to permit revisions of the modelling
decisions, allowing for future variations and extensions
of the analysis (§4).
Section 5 gives an account on our practical experi-
ence with using the toolchain. Among others, the
work needed to synchronize between different proces-
sing teams and feedback collected from exposure to
clinicians, i.e. non-experts with respect to the tools.
Finally, we discuss how relevant these results are for
clinical practice and VPH research in general.
2. CHALLENGE 1: BIOMECHANICAL
MODELLING AND DESCRIPTORS
The ﬁrst challenge faced while designing the @neurIST
toolchain was to identify the set of most representative
biomechanical descriptors suitable for performing
risk assessment and association studies, and to identify
the most appropriate computational model of the
underlying physical problem. Along the lines set by
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Ma et al. [15] and Ma [16], three general analyses were
chosen to be performed: morphological, haemodynamic
and structural. These analyses have been linked in the
literature to aneurysm genesis, growth and rupture
[17–19]. Evidence indicating differences in morphology
[20–23] and ﬂow [18,24] between ruptured and unrup-
tured aneurysms have been shown for reduced patient
cohorts. Structural wall mechanics [25–28] has been
used to justify the growth and remodelling happening
at the aneurysm level.
The balance between merits and demerits of each
analysis is sketched in ﬁgure 1. The theoretical level
of conﬁdence in the physical measures on which each
of the analyses are based and the direct diagnostic capa-
bility derived from them varies inversely depending on
the analysis. As an example, morphological characteriz-
ations have the least requirements in terms of the
physical measures, only depending on the anatomical
information extracted from the medical image. This is
opposed to the difﬁculties in obtaining the physical
measures needed to perform haemodynamic and struc-
tural analyses in this order of complexity. In the case
of haemodynamics, the exact boundary conditions
(inlet, outlet and wall movement) are usually unknown.
For structural analysis, the situation is worse, as lack
of information on the aneurysm wall (thickness, indivi-
dual material properties) limits the analysis to provide
qualitative results only. In contrast, the theoretical
diagnostic capability would certainly be highest for a
quantitatively correct wall mechanics analysis, as stres-
ses exceeding the strength of the wall could be more
directly associated with the mechanical processes indu-
cing growth and remodelling phenomena and, therefore,
linked to the event of rupture. Nevertheless, practically,
morphological characterizations might currently have
the highest predictive capabilities with respect to the
other analyses.
Once these analyses were chosen, based on prior evi-
dences found in the literature, and especially in the case
of the haemodynamic and structural analyses, the
immediate need was to decide what to simulate and
how to perform such simulations. Unfortunately, there
is not a clear answer to this problem. Each of the
modelling choices presented trade-offs [30] and needed
to be judged in the light of the available input data
and intended purpose of the output.
To address these issues, an analysis protocol was
developed in two stages. During the ﬁrst stage, an initial
version of the protocol was created and where the funda-
mental alternatives were identiﬁed, the core processing
steps and data entities were speciﬁed and the topics
that needed further exploration were highlighted. As an
example of the last, the need for performing sensitivity
studies was discussed. An external scientiﬁc advisory
board of experts reviewed the protocol and raised several
questions, including the need of performing linear versus
nonlinear wall mechanics studies, using moving versus
ﬁxed wall boundary conditions for haemodynamics,
employing coupled or isolated models (ﬂuid structure
interaction being an option) and using a personalized
versus generic systemic model.
As a result, a second version of the protocol was
written [29] providing a high-level tool-independent
description of the processing chain, clearly describing
each major operation with the speciﬁcation of inputs
and outputs. In addition, it included references to several
of the studies carried out by the project to evaluate
aspects such as the sensitivity of ﬂow simulations to the
imaging modality [31] and inlet boundary conditions set-
ting [32], and the relationship between patient-speciﬁc
and generic boundary conditions [33].
3. CHALLENGE 2: IMPLEMENTATION OF
THE TOOLCHAIN
The second challenge was to enable multi-case,
multi-user and multi-site analyses, which guaranteed
medical images
+
+
–
–
morphological
characterization
morphological descriptors
(size, aspect ratio)
haemodynamic
analysis
haemodynamic
descriptors
(wall shear stress, flow,
pressure...)
structural descriptors
(deformation, strain,
stress...)
structural
analysis
boundary conditions
constitutive equations
boundary conditions
constitutive equations
confidence in
physical measures
direct diagnostic
capability from
derived descriptors
Figure 1. The theoretical diagnostic power (right) versus the practical reliability of physical measures (left) of the different
analysis modes are inversely related [29].
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consistency and repeatability among operators and geo-
graphically disperse processing sites, while minimizing
the amount of required user manual intervention. How-
ever, some steps had to remain under user control and
considerable efforts had to be devoted to synchronize
the different operators in the various processing
teams. In the current section, the actual implemen-
tation of the toolchain is discussed, highlighting the
efforts made to automate or semi-automate it. The tool-
chain encompassed the whole process from reading a
medical image to the extraction of the morphological,
structural and haemodynamic descriptors selected in
the analysis protocol. These were combined with
information available from the patient record and
stored within a structured data repository, as described
in §4.
3.1. Vascular geometry creation
All three analyses speciﬁed in the analysis protocol get
as an input a surface mesh. Therefore, the ﬁrst stage in
the toolchain proceeds to create a vascular geometry
from a three-dimensional rotational angiographic
image (3DRA). This imaging modality is currently
considered the gold standard [34,35] for aneurysm
detection owing to its superior spatial and contrast res-
olution. A three-dimensional triangulated surface mesh
is obtained using an automatic segmentation method
based on geodesic active regions (GAR) in combination
with an image standardization technique [36,37],
recently presented and validated by Bogunovic et al.
[38]. The method eliminates most of the dependency
on the operator, and on the speciﬁc imaging protocols
and equipment used. The only possible choice for the
operator is the selection of the region of interest to be
segmented as opposed to other methods such as the
manual iso-intensity surface extraction (ISE), where in
addition the selection of a threshold is left to the oper-
ator. While the impact of the selection of the region of
interest for both methods has shown to be negligible,
GAR outperformed ISE qualitatively and quantitat-
ively for 3DRA and time of ﬂight magnetic resonance
angiographic images obtained from clinical routine
when compared with manual measurements performed
by clinicians. The dependency on the equipment used
to image the patient is removed, thanks to the use of
a training set and standardized images. The impact of
the selection of images to build a training set has also
shown to be minimal when compared with the
inter-observer variability among clinicians when per-
forming manual measurements. In terms of execution
time, it was able to segment a region of interest with
a size of 2563 voxels in 17+ 4 min (average+ standard
deviation) on a standard personal computer with
an Intel quad-core 2.4 GHz processor and 4GB
of memory.
Once the segmented surface mesh is available, it is
manually manipulated to remove some of the artefacts
not belonging to the cerebral vasculature or not relevant
for the subsequent analyses (ﬁgure 2). A skeletonization
algorithm [39] is used to extract the skeleton (medial
axis) of this geometry. The skeleton acts as a reference
to perform the perpendicular cuts where the ﬂow bound-
ary conditions need to be set, and as the linking point to
the three-dimensional model of the human systemic cir-
culation [40]. This ﬁrst step in the toolchain is critical
because the resulting vascular geometry is used as the
basis for all further analyses. The impact of the chosen
imaging modality and the quality of the image might
have a strong inﬂuence in quantitative parameters
extracted from ﬂow simulations [31]. Therefore, the
role of the operator in accepting or rejecting the images
based on their quality before they are processed is funda-
mental for the accuracy of subsequent analyses. In our
experience in @neurIST, the approximate discard rate
of 3DRA images for all clinical centres involved in the
data collection was between 30 and 40 per cent.
3.2. Morphological characterization chain
A collection of morphological descriptors of various
complexity was selected among the wide variety avail-
able in the literature [21,22]. Basic size indices such as
aspect ratio [20], non-sphericity index [22], aneurysm
volume and surface area are calculated for the aneurysm
sac. Aspect ratio relates the aneurysm depth and neck
width, while non-sphericity index relates the aneurysm
volume and surface area. To isolate the aneurysm sac,
(a) (b)
Figure 2. Examples of typical topological problems introduced during the segmentation because of low image quality: (a) touching
vessels and (b) missing vessels.
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the aneurysm neck is manually delineated as shown in
ﬁgure 3. A set of more sophisticated descriptors called
three-dimensional Zernike moment invariants [23,41]
are also used to characterize the aneurysm shape and
a portion of the surrounding feeding vessels using a
ﬁxed cutting protocol at every inlet and outlet. Three-
dimensional Zernike moments provide a complete
three-dimensional morphological characterization of
objects, and their invariants remove scale and orien-
tation dependency. These have shown for a small
heterogeneous population promising rupture prediction
rates [42]. Finally, inlet and outlet vessel diameters are
also calculated at the cut planes used to isolate the geo-
metry for which the Zernike moment invariants are
computed. All of these descriptors are automatically
computed in real time from the isolated geometries of
the sac and aneurysm plus a portion of the surrounding
feeding vessels.
3.3. Haemodynamics analysis chain
Two complementary haemodynamic analyses are car-
ried out as part of this chain: a global one and a local
one, with an optional uni-directional coupling between
them. The global one is based on a one-dimensional
model of the human systemic circulation [40], including
the main arteries of a complete circle of Willis, and pre-
dicts ﬂow rate and pressure waveforms at predeﬁned
points (ﬁgure 4). The local analysis uses the full
three-dimensional geometry near the region of interest,
obtained by clipping the three-dimensional geometry at
appropriate places [29,32].
As no patient-speciﬁc measurements of ﬂow properties
at the openings deﬁned by the clipping are generally avail-
able, the results of the one-dimensional global analysis can
be used to obtain boundary conditions for the local three-
dimensional analysis. Using the skeletonized represen-
tation of the three-dimensional vasculature in the region
of interest calculated during the vascular geometry extrac-
tion stage, the operator manually deﬁnes perpendicular
clipping planes and links the appropriate nodes of the
one-dimensional circulation model to the corresponding
points of the three-dimensional inlet and outlet boundaries,
thus deﬁning the boundary conditions for the three-dimen-
sional model (ﬁgure 4).
The set of qualitative and quantitative descriptors (can-
didate risk factors) deﬁned by the analysis protocol were
extracted from the ﬂow solution automatically, except a
few qualitative ones such as ﬂow stability and intra-aneur-
ysmal ﬂow type (ﬁgure 5) requiring expert judgement.
Quantitative volumetric measures were performed within
the aneurysm and at the neck. These included the maxi-
mum and mean velocities deﬁned at peak systole and
averaged over the cardiac cycle. Similarly, other measures
were computed on the model surface, including areas of
elevated pressure, impingement jet location, maximum
static pressure on the wall at peak systole and the wall
shear stress and derivates such as the oscillatory shear
index. Some of these measures are highly dependent on
the location of the aneurysm neck, which unfortunately
had to be manually deﬁned as already mentioned in the
morphological analysis. There have been several efforts
in the literature aimed to solve this problem in an
automated way, but to date none has been able
to extract the aneurysm neck reliably in the general case
[43–46].
The analysis protocol chose to model the transient
blood ﬂow by the Navier–Stokes equations under the
assumption of rigid walls and a simple Newtonian rheo-
logy model with blood density of 1060 kg m23 and
viscosity of 0.0035 Pa s.
The production runs were performed using a com-
mercial three-dimensional ﬂow solver ANSYS CFX
(Ansys Inc., Canonsburg, PA, USA), which is a ﬁnite-
volume computational ﬂuid dyamics (CFD) code
solving for the Navier–Stokes ﬂow equations across an
unstructured three-dimensional discretization (known
as mesh) of the vasculature volume. Such mesh was gen-
erated by the ANSYS ICEM 3D (Ansys Inc.) mesh
generator that labelled the aneurysmal interior in a
completely automatic manner.
3.4. Structural analysis chain
Of all types of analyses in ﬁgure 1, an ‘accurate’ structural
analysis would have the largest predictive capabilities.
Nevertheless, in practice it also is the analysis requiring
the most assumptions and simpliﬁcations. Still it can be
hoped to gain information about risk factors [28]. In@neur-
IST, and owing to the lack of patient-speciﬁc data, the
assumptions being made included averaged material prop-
erties and aneurysmal wall thickness and spatially and
temporally constant pressure, for simplicity assumed at
diastole. However, the membrane code FEANOR [47],
developed speciﬁcally for @neurIST, computes the zero-
load state of the aneurysm under the above assumptions,
which is a ﬁrst step towards more realistic wall mechanics
simulation.
The thickness of the aneurysm wall was set to a con-
stant value of 86 mm, the thickness of the vessel wall to
500 mm, and was linearly interpolated in a transition
region (ﬁgure 6a). Owing to this thin wall, computing
the zero-load state is a numerically delicate process
Figure 3. Example of the manual delineation of the aneurysm
neck implemented in the @neurIST toolchain.
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(ﬁgure 6) and great effort was required to make this
numerically stable and hence automatic.
Two different protocols are supported. The ﬁrst one
uses a nonlinear material model and computation of a
zero-load state, and the second uses a linear material
model assuming zero stresses at diastole. Given the
essential uncertainties in quantitatively estimating the
model parameters, the characteristic measures include
only relative measures like ratio of areas exceeding
certain thresholds of maximum stress and strain, as
these are expected to be less sensitive to variations of
the unknown patient-speciﬁc values of aneurysm wall
thickness and material properties.
4. CHALLENGE 3: A MODEL FOR
@NEURIST SIMULATION DATA
4.1. Motivation and overview
The third challenge was to preserve the provenance of
the derived descriptors, to be able to link back to the
clinical data and to permit future revisions of the mod-
elling decisions, allowing for future variations and
extensions of the analysis. This concern was partially
originated by the huge amount of manual work going
into the toolchain and into the data processing, despite
the level of automation and semi-automation achieved
during the implementation of the toolchain. Moreover,
feeding the results into the sophisticated data mining
machinery of @neuLink [11] meant that various subsets
and combinations of the result data were possibly
needed, in order to select statistically meaningful
groups of cases and to provide the greatest ﬂexibility
in the search for patterns.
The answer was to design a systematic model of the
different data entities involved to facilitate meeting
these requirements. Relationships, mutual dependencies
and history (provenance) needed to be clearly captured.
In contrast to the general approaches for provenance
recording described in Simmhan et al. [48], our
approach is geared towards the speciﬁc needs of the
@neurIST project. According to the taxonomy of
Figure 4. A view of the @neurIST one-dimensional model.
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Figure 5. Example of unstable ﬂow from (a) end diastole and (b) peak systole.
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Simmhan et al. [48], we use a coarse-grained and some-
what abstracted replication recipe (see also below §4c on
abstract problem descriptions (APDs)). At the same
time, to maximize opportunities for future use, the enti-
ties in this model had to be represented in a sufﬁciently
general way in order to distinguish from details speciﬁc
to concrete tools and applications. That is, to abstract
from information which will become obsolete sooner
or later. This application-neutrality was already
required within the @neurIST complex information
toolchain, as it was designed to support different solvers
for the same computational problem (e.g. ANSYS CFX
and a Lattice–Boltzmann code for haemodynamics).
Our solution thus consisted of the following
ingredients:
— A relational data model (using structured query
language (SQL) as data deﬁnition language) linking
the important classes of simulation (or ‘derived’)
data to the clinical data, hence ‘derived data
model’ (DDM).
— A set of tools automatically translating the abstract,
application-neutral description of the DDM into
complete input speciﬁcations for concrete simulation
applications.
— A strategy for storing and retrieving bulk data, like
raw simulation results, images, etc. While most of
the bulk data is application-speciﬁc and can be
reproduced using the high-level data and the two
tools just mentioned, it may be worthwhile to keep
it for a certain period of time, e.g. for visualization
and review purposes.
4.2. A relational data model for derived data
The DDM forms the core of these developments. A
high-level overview in the form of an entity-relationship
(ER) diagram is shown in ﬁgure 7. The DDM covered
the following major entities.
— Aneurysm. The anatomical structure in the focus of
interest.
— Image (split in imagingStudy and imagingSeries). A
medical image of the region of interest.
— Processed geometry. A valid geometric representation
of one or more aneurysms with anatomically correct
topology.
— Analysis. A high-level description of a computational
model, e.g. blood ﬂow through the vasculature sur-
rounding an aneurysm.
— Run. An actual computation of an analysis with a
simulation programme.
— Index. A discrete1 characterization of an aneurysm,
e.g. aspect ratio, collection of three-dimensional
Zernike moment invariants or maximal wall shear
stress inside the aneurysm.
— Experiment. A group of similar analyses suitable for
ﬁnding statistical correlations.
Some of these entities (namely aneurysm and image)
contained references to their counterparts in clinical
databases that may be enhanced with additional infor-
mation, such as image quality. The clinical databases
containing the anonymized patient’s clinical record
use their own data model developed in the project,
the @neurIST clinical reference information model
(CRIM). The DDM was kept deliberately separate
from the CRIM to minimize dependencies.
The central use case of the DDM in our context
of ﬁnding risk indicators is the ability to retrieve ans-
wers to questions (known as queries) like ‘for a set of
aneurysms, retrieve rupture status and values of bio-
mechanical characterizations A, B, and C’. This query
could easily be reﬁned by restriction to aneurysms in
certain locations, or by excluding cases with certain
irregularities (like bad image quality), and so on.
An important means to form meaningful groups of
comparable analyses is the experiment entity. For
instance, we used two different experiments for the wall
mechanics analyses, one using a linear material model,
and one using a non-linear model with computation of
a zero-load state. Another example of use of experiments
is for different conventions for geometry clipping in shape
analysis. Clearly, it does not make sense to mix analy-
ses pertaining to different experiments in a statistical
evaluation.
4.3. Handling bulk data
The storage of the actual bulk data (meshes, pictures
and full simulation results) can be handled in a quite
ﬂexible way, as the data model provides a placeholder
(a) (b)
Figure 6. Computing the zero-load state leads to considerable wrinkling and is numerically delicate. (a) Computed zero-load
conﬁguration (with assumed thickness) and (b) stresses at 120 mmHg computed by using the nonlinear material model.
1I.e. a small, ﬁnite set of values, as opposed to a continuum like a
pressure ﬁeld, which is not usable in a statistical clustering analysis.
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for each such data entities, with the necessary meta-
data as to where and how it is stored. Smaller data
like surface meshes can even be stored directly in a
data base management system (DBMS) as binary
large object (BLOB). Data stored outside the DBMS
can be referenced by URLs, or most generally, by end-
point references (EPR), containing the details for
addressing a service delivering the data.
An important criterion to support decisions about
whether to store a particular piece of data, such as
raw simulation results or processed geometries, is the
cost associated to (re-)generate them. This can be com-
putational costly as well as, and more importantly, the
amount of manual work needed to create them. For the
case of the @neurIST toolchain, this differentiates pro-
cessed geometries, possibly requiring a lot of manual
work, see §3a, from simulation results, which can be
generated automatically from their APDs, a concept
we will discuss in more detail next.
4.4. An important concept: abstract problem
descriptions
An APD is a high-level deﬁnition of a computational
biomechanical problem, like a blood ﬂow analysis
through an aneurysm and surrounding vasculature.
Despite their high-level nature, they contain or refer-
ence all information needed to generate input for any
concrete simulation application run computing the
analysis. There could be different runs using different
applications for the same analysis, which should yield
the ‘same’ results (up to some limit of accuracy). Sets
of different runs could be used for veriﬁcation of the
solver-independence of results.
The conversion of an APD into a concrete simulation
input and the subsequent run is, in principle, a comple-
tely automatic task, as the APD contained all relevant
information; all necessary pieces of data needing human
intervention are generated and stored before creating
the APD. In practice, the feasibility of automation is
certainly dependent on the application; in the case of
@neurIST, we fully automated this step for the sup-
ported simulation packages. An exception to this rule
are some qualitative characterizations that inevitably
required human intervention.
The precise but application-neutral representation of
biomechanical problems in the APDs enables their
long-term storage, making them insensitive to the rise
and fall of simulation applications, or just incompatibil-
ities between versions. For instance, we integrated two
fundamentally different types of CFD solvers. First,
ANSYS CFX based on a ﬁnite volume scheme on
unstructured meshes, and, second, a Lattice–Boltz-
mann solver, based on regular structured grids (the
latter was not used for production runs). Basically,
this meant implementing speciﬁc preprocessors
examed in imagingStudy
P. has aneurysm
G coversderived from P
S covers
G. based on
A. based on
R. based onI. based on
A. based on
A. part of
processedGeometry
systemic_model
I describes
index_XYZ_ABC
experiment_XYZ
run_XYZ analysis_XYZ
imagingSeriesconsists ofpatient
1 0..N
0..N1
1 1
1
1
1
1 1
1
1
1
0..N
0..N
0..N 0..N
0..N
1..N
0..M
0..N
0..N 0..N
1 1..N
Figure 7. An entity-relationship diagram of the @neurIST derived data model [29]. Grey entities link to their counterparts in the
clinical reference information model (CRIM) developed in the project, white ones to derived (i.e. computed) data. The diamond-
shaped boxes describe the relationship of two entities, and the numbers give their multiplicities. For example, a processed geo-
metry is based on exactly one imaging series, and each imaging series is the basis for 0 up to N processed geometries. The sufﬁx
XYZ is a placeholder for the different types of analysis.
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translating the APD into either ANSYS CFX or Lat-
tice–Boltzmann input. The abstractness of the
representation also facilitates automatic transformation
of analyses to yield variants implementing different
experiments. For instance, it would be easy to
implement features like changing the generation of
boundary conditions or using a different material
model. Such automatic transformations pave the way
to practical future uses of the results, like doing para-
metric studies or setting up completely new modelling
approaches.
5. PRACTICAL EXPERIENCE
Even if the degree of automation accomplished in the
implementation of the complex information toolchain
is beyond the state of the art, it was not sufﬁcient to
achieve consistent results across the different processing
teams. To achieve this, training was fundamental, and
veriﬁcation of the level of understanding of the case pro-
cessing rules was mandatory. To evaluate the overall
impact of the operator decisions on the ﬁnal-derived
descriptors, six patient images were chosen as demonstra-
tors and were fully processed by eight representatives of
the processing teams. The objective was to synchronize
the results of the operators for the shape, structural and
haemodynamic analyses.
Several rounds of this synchronization were needed
before a common agreement was reached and a set of
accurate guidelines could be distilled. This process was
simpler in the case of the morphological analysis and
only two rounds were needed. As an example of the
importance of this process, see in ﬁgure 8 the surprising
variability in the results for some operators after the ﬁrst
synchronization iteration. In the case of the haemo-
dynamic analysis, the synchronization took longer
because of the elevated complexity of this chain as well
as the impact that operator decisions could have on the
ﬁnal simulation results. Still, agreement was reached in
the end and the @neurIST case processing was started.
In total, 15 operators from four case processing
centres were involved and fully processed images from
ﬁve hospitals producing descriptors for more than 300
aneurysms. The essential data items created during
this process were stored using the mechanism described
in §4 and are thus available for future work. Statistical
associations are currently being analysed between
these descriptors and the aneurysm rupture status
information, among others.
In addition, we also wanted to evaluate the suit-
ability of our toolchain for clinical practice. In this
spirit, and to gain useful feedback, the toolchain has
been ofﬁcially exposed to more than 260 neurointerven-
tionists, neurosurgeons and neurologists for their
evaluation through hands-on workshops at different
public events, where the participants worked under gui-
dance through a simple case, from medical image to a
three-dimensional blood ﬂow simulation. They achieved
results comparable to those obtained by experts users,
with similar performance.
The main venues have been the 1st and 2nd Euro-
pean Society for Minimally Invasive Neurovascular
Treatment (ESMINT) Teaching Courses, respectively,
held in Lisbon, Portugal (7–12 September 2008) and
Barcelona, Spain (13–18 December 2009), the 4th
International Conference on Computational Bioengi-
neering, Bertinoro, Italy (16–18 September 2009), the
XIV World Congress of Neurological Surgery, Boston,
USA (30 August–4 September 2009) and the Simposio
Internacional de Neuroradiologı´a Intervencional,
Santiago de Chile, Chile (26–27 November 2009).
The collected feedback was used to further improve
the subsequent releases of the toolchain. Some of the
conclusions reached during the 1st ESMINT Teaching
Course were reported and described in Singh et al.
[49]. In general, clinicians recognized shortcomings in
current management of cerebral aneurysms and the
need for better understanding of the disease and the
identiﬁcation of novel and more efﬁcient risk descrip-
tors. Although most clinicians believe that physical
characterization (mainly haemodynamics at that work-
shop) may offer better diagnostic value, there is a clear
lack of awareness concerning the role of haemodynamics
in the aetiopathogenesis of cerebral aneurysms and the
use of CFD in this context.
6. DISCUSSION
A number of unique challenges were associated with the
large-scale multi-case, multi-operator and multi-site
biomechanical processing undertaken by @neurIST.
The solutions we have developed to meet these chal-
lenges are, we believe, of interest not only for the ﬁeld
of aneurysm research, but also beyond that for the
larger VPH community studying other diseases.2
The toolchain itself was developed and automated to
a degree which proved sufﬁcient to process more than
300 aneurysms minimizing and quantifying the impact
of human operators, either by ensuring synchronization
among operators through training or by performing
operator 1 operator 2 operator 3
operator 4 operator 5 operator 6
Figure 8. Results for the ﬁrst synchronization round showing
the differences among six of the eight operators during the
manual isolation of the region of interest. Operators 1, 2 and
4 showed signiﬁcant discrepancies with the correct geometries
isolated by operators 3, 5 and 6.
2Parts of the toolchain are available through the @neurIST web site
http://www.aneurist.org/, as well as the data model SQL deﬁnition
and the ﬁnal analysis protocol document. Currently, there are
efforts in the direction of making derived data available through the
European Society of Minimally Invasive Neurological Therapy
(ESMINT) society http://www.esmint.eu/.
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several sensitivity studies. Also, more than 260 clini-
cians ran full blood ﬂow simulations starting from
medical images, using our toolchain during internation-
ally renowned hands-on events. Their feedback
convinced us that these kinds of tools will ﬁnd their
way into clinical practice. All together, the amount of
practical usage, testing and continual improvement
based on user feedback of this toolchain certainly sur-
passes that of most similar research-oriented efforts.
There is, however, still room for improvements.
Our analysis protocol [29], with its detailed speciﬁca-
tions and ample discussion of limitations versus
modelling alternatives, is an ideal starting point for con-
tinuing and extending our efforts. It can also serve as a
blueprint for transferring the approach to other dis-
eases, which should be straightforward for vascular
diseases.
The analysis of the biomechanical characterizations
with respect to their diagnostic value is still ongoing.
Some preliminary works [42,50–53] have already used
the toolchain on a reduced number of cases. However,
it can be expected that the larger the number of
cases, the statistically more reliable conclusions will be
achieved compared with similar prior works [53], but
always under the strong and arguable assumption
that aneurysms do not change over time.
Using the toolchain to simulate ﬂow in the presence of
virtual endovascular devices such as stents [54] currently
allows evaluating the performance of endovascular
devices from a haemodynamic point of view [55,56], ben-
eﬁtting from the ability of setting boundary conditions
based on a one-dimensional model of the systemic circu-
lation [32,33,40]. The inclusion in the project of genetics
data has rendered already relevant results [57] to the
scientiﬁc community in identifying three new risk loci,
which still need to be linked to biomechanical factors
through @neuLink [12].
The results of our processing are organized using the
DDM and are available for future extensions of the our
work, both by adding new cases or by varying the model-
ling approach. In this case, it might be interesting to
enable the toolchain to investigate effects of certain
drugs on blood viscosity and hence on the computed
ﬂow characterizations. The prospect of being able to run
large-scale computational experiments with these many
cases without having to invest a lot of human effort into
manual case-by-case model adaptation is exciting.
We believe that our approach has the potential to
serve as a model for organizing large-scale multi-case
simulation in the VPH context in general, as it supports
looking both into the past, by providing provenance
information, and into the future, by providing a
means to modify toolchain details (like replacing
speciﬁc solvers) and to transform problem descriptions
to support alternative modelling choices. Currently,
the model only supports the coupling between the sys-
temic and the local three-dimensional haemodynamics
analyses; a particularly promising path for future evol-
ution is to add explicit support for coupling between
different analyses on different scales.
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1The management of patients with unruptured cerebral aneu-rysms (UA) remains controversial because of their uncer-
tain natural history. Although estimates of the prevalence of 
intracranial aneurysms range from 0.5% to 6% on radiologi-
cal and autopsy studies, the incidence of aneurismal subarach-
noid hemorrhage (SAH) is 10/100.000 per year in the United 
States, leading to the conclusion that the majority of UAs do 
not rupture.1,2 The average risk of rupture of a UA is estimated 
to be between 1% and 2% per year.3,4 The International Study 
of Unruptured Intracranial Aneurysms (ISUIA) reported on a 
retrospective and prospective multicenter study in 1998 and 
2003.5,6 In the latter, they observed that aneurysm location, 
size, and previous SAH were risk factors for rupture, with pos-
terior circulation (PC) aneuryms collectively (including poste-
rior communicating artery [PcoA] aneurysms) and aneurysms 
>7 mm located in the anterior circulation (AC) rupturing with 
at rates high enough to justify intervention. This observation 
seems to contradict the clinical perception that patients com-
monly present with ruptured small aneurysms. Moreover, 
aneurysm locations were segregated only as being either AC 
or PC for risk assessment, raising concerns that the effects of 
pathophysiological mechanisms specific to individual arteries 
were combined reducing sensitivity to location as a risk factor. 
Work has since been published demonstrating the importance 
of aneurysm location, along with criteria such as patients’ age, 
sex, ethnicity, and aneurysm morphology (size and shape) as 
risk factors for rupture. Recently, the Unruptured Cerebral 
Aneurysm Study of Japan (UCAS Japan) reported an annual 
rupture rate for UAs of 0.95%.7 It also found that aneurysms 
>7 mm in general, smaller aneurysms of the anterior com-
municating artery (AcoA) or internal carotid-PcoA, and aneu-
rysms having a daughter sac were associated with increased 
rupture risk.
The aim of the present study was to assess whether AcoA 
aneurysms behave differently from other AC aneurysms. 
Furthermore, we provide a detailed comparison with previous 
studies of the risk factors for aneurysm rupture, and in doing 
so examine whether simply dividing UAs into anterior or PC 
locations along with aneurysm size, as proposed by ISUIA, 
remains adequate for rupture risk analysis.
Background and Purpose—According to the International Study of Unruptured Intracranial Aneurysms (ISUIA), anterior 
circulation (AC) aneurysms of <7 mm in diameter have a minimal risk of rupture. It is general experience, however, that 
anterior communicating artery (AcoA) aneurysms are frequent and mostly rupture at <7 mm. The aim of the study was 
to assess whether AcoA aneurysms behave differently from other AC aneurysms.
Methods—Information about 932 patients newly diagnosed with intracranial aneurysms between November 1, 2006, and 
March 31, 2012, including aneurysm status at diagnosis, its location, size, and risk factors, was collected during the 
multicenter @neurIST project. For each location or location and size subgroup, the odds ratio (OR) of aneurysms being 
ruptured at diagnosis was calculated.
Results—The OR for aneurysms to be discovered ruptured was significantly higher for AcoA (OR, 3.5 [95% confidence 
interval, 2.6–4.5]) and posterior circulation (OR, 2.6 [95% confidence interval, 2.1–3.3]) than for AC excluding AcoA 
(OR, 0.5 [95% confidence interval, 0.4–0.6]). Although a threshold of 7 mm has been suggested by ISUIA as a threshold 
for aggressive treatment, AcoA aneurysms <7 mm were more frequently found ruptured (OR, 2.0 [95% confidence 
interval, 1.3–3.0]) than AC aneurysms of 7 to 12 mm diameter as defined in ISUIA.
Conclusions—We found that AC aneurysms are not a homogenous group. Aneurysms between 4 and 7 mm located in AcoA 
or distal anterior cerebral artery present similar rupture odds to posterior circulation aneurysms. Intervention should be 
recommended for this high-risk lesion group.   (Stroke. 2013;44:00-00.)
Key Words: intracranial aneurysm ◼ registries ◼ risk factors ◼ SAH ◼ subarachnoid hemorrhage
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Methods
As part of the European Union’s Sixth Framework Program 
Information Society Technologies priority, an information platform 
was designed, developed, and implemented by a group of clinical 
centers, universities, and companies from across Europe. Its purpose 
was to integrate complete biomedical information for the manage-
ment of cerebral aneurysms. The system was used in the collection 
of the clinical data on aneurysm patients from multiple centers as 
described below.
Patients
Between November 1, 2006, and March 31, 2012, a total of 932 
patients diagnosed with intracranial aneurysms were enrolled at 7 
European clinical centers (Royal Hallamshire Hospital, Sheffield, 
United Kingdom; John Radcliffe Hospital, Oxford, United Kingdom; 
Erasmus Medical Center Rotterdam, The Netherlands; University 
Hospital of Geneva, Switzerland; University Hospital of Barcelona, 
Spain; General Hospital of Catalonia, Spain; University Hospital of 
Pecs, Hungary) using the platform. The data collection protocol was 
approved by individual local ethics committees, and written consent 
obtained from patients or where appropriate, next of kin, in all cases.
All clinical centers were made aware of the importance of consecu-
tive recruitment from an identifiable catchment area but only 1 was 
able to verify and guarantee consecutive recruitment from a stable 
population. The University Hospital of Geneva embedded the data 
collection tool (@neuQuest) in the hospital’s electronic information 
system and trained neurosurgical medical staff to use the platform as 
the basis of the electronic medical record. Regular checks were per-
formed to ensure consistency between the administrative and medi-
cal databases. Thus, prospective and consecutive recruitment of all 
patients with a newly diagnosed intracranial aneurysm and known to 
be resident within this referral area was ensured, and the referral area 
did not vary during the course of data collection.
For analysis, the data were separated into 2 groups:
1. The Total @neurIST Cohort (TC), including all the cases of 
diagnosed intracranial aneurysm recruited prospectively or 
retrospectively by the 7 participating clinical centers. In the 
TC, 651 (70%) patients were recruited prospectively, and 281 
(30%) patients were recruited retrospectively, for a total of 932 
patients, of which 343 (36.8%) patients had no history of SAH 
and 589 (63.2%) patients had a SAH.
2. The Consecutive Cohort (CC), a subset of the TC, including 
cases prospectively and consecutively diagnosed with ≥1 sac-
cular intracranial aneurysm, living within the hospital’s recruit-
ment area. Two patients were excluded from the analysis be-
cause they refused to give consent to participate (0.6%). The 
CC consisted of 404 patients; 194 (48%) patients without his-
tory of SAH and 210 (52%) patients recruited after SAH. Of the 
patients without SAH, 174 (89.7%) patients had incidentally 
discovered aneurysm(s) and 20 (10.3%) patients had symp-
tomatic aneurysms causing cranial nerve palsy or focal strokes 
from upstream thrombosis.
Aneurysms and Clinical Information
For all recruited patients, data were collected relating to aneurysm 
location, characteristics, clinical history, and risk factors, some par-
ticulars of which are as follows.
Neurovascular Nomenclature
Adapted from the ISUIA study, aneurysm locations were defined as 
follows. The internal carotid artery (ICA), anterior cerebral artery 
(ACA), AcoA, middle cerebral artery (MCA), vertebral artery, basilar 
artery, and posterior cerebral artery were considered as parent vessels. 
In accordance with most neurovascular publications, we defined each 
parent artery segment as starting proximal to the origin of a branch 
and finishing proximal to the next branch artery. Each parent artery 
segment was then given the name of the branch that departs from 
that segment. The following branches were taken into consideration: 
ophthalmic artery, PcoA anterior choroidal artery, pericallosal artery, 
posterior inferior cerebellar artery, and anterior inferior cerebellar ar-
tery, and superior cerebellar artery (Figure 1A).
For bifurcations, the segments were defined as per Rhoton,8 start-
ing where the walls diverge and finishing at the cross-sections perpen-
dicular to the flow within the daughter vessels where the projection of 
the parent vessel wall crosses the medial wall of the daughter vessel 
(see Figure 1B).
Risk Factors of Aneurysm Rupture and SAH
Risk factors considered in the study were those previously described 
for aneurysm rupture, including presence of an unruptured symp-
tomatic aneurysms (relative risk [RR], 8.2 [95% confidence interval 
{CI}, 3.9–17.0]), aneurysms >10 mm (RR, 5.5 [95% CI, 3.3–9.5]), 
location in the PC (RR, 4.1 [95% CI, 1.5–11.0]), and female sex (RR, 
2.1 [95% CI, 1.1–3.9]).9–15
We also included those additional factors identified by a system-
atic Cochrane literature review of reviews16 as having significant RR 
associated with SAH in the general population, including positive 
family history (RR, 4.0 [95% CI, 2.7–6]), smoking (RR, 2.4 [95% 
CI, 1.8–3.4]), alcohol consumption of >150 g/wk (RR, 2.1 [95% CI, 
1.5–2.8]), hypertension (RR, 2 [95% CI, 1.5–2.7]).
The @neurIST system was designed to serve the clinical manage-
ment of patients with aneurysms. The data collected therefore includ-
ed the above parameters as well as the patient’s presenting history, 
symptoms, and signs, and details of any treatments and their follow-
up. These records, coupled with angiographic imaging (eg, computed 
tomography angiogram, magnetic resonance angiogram, digital sub-
traction angiogram, digital rotational angiogram) and neurovascular 
morphological measurements and characterizations, were collated 
using elements (@neuQuest, @neuFuse, @neuInfo) of the purpose 
built information platform, developed during the course of the proj-
ect. Prospective and retrospective clinical data were collected and the 
subject’s residency could be determined from within the database.
Statistical Analysis
It has been postulated that the process leading to an aneurysmal SAH 
depends first on the formation of ≥1 aneurysm and, subsequently, the 
rupture of the aneurysm wall; our study is designed to estimate the 
latter risk.
The above data collection allowed us to count and compare the 
occurrence of newly diagnosed ruptured and unruptured aneurysms 
in each vessel segment. To evaluate the risk of rupture of an aneurysm 
located in a particular vessel segment, the odds of aneurysms being 
discovered ruptured versus being discovered unruptured was calcu-
lated for each vessel segment.
The role of size in AcoA aneurysm rupture was further compared 
with MCA aneurysms using groups composed of aneurysms with 
maximum dome sizes in the following ranges: 0 to 4, 4 to 7, 7 to 
12, 12 to 25, and >25 mm. Again, the odds of aneurysms being dis-
covered ruptured were calculated for comparison between AcoA and 
MCA locations.
To compare our observations with those reported in ISUIA, the TC 
data were analyzed for size and location effects, as per the categori-
zations used in the ISUIA report. This involved dividing the aneu-
rysms by size into 2 groups: aneurysms of <7 mm in diameter and 
those between 7 and 12 mm, and then subdividing both groups by 
location. Observations on larger aneurysms groups are not reported 
because the rupture risk is known to be high and statistical robust-
ness is low because of their relative rarity and limited population 
studied. In keeping with the ISUIA categorization, the PC group was 
composed of aneurysms located in the vertebrobasilar system, basilar 
tip, posterior cerebral artery, and PcoA segment of the ICA. The AC 
was formed by pooling all aneurysms located on the ICA (exclud-
ing PcoA), ACA (including AcoA), and MCA (ACA+ICA+MCA). 
To assess the place of AcoA aneurysms relative to this categorization 
system, subcomponents of the AC (namely the MCA-ICA, the ACA, 
and AcoA) were also considered separately. The 5-year cumulative 
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rupture risk of 2.6%, calculated by ISUIA for AC aneurysms between 
7 and 12 mm, was taken as point of reference. The latter group was 
used as reference to calculated odds ratios (ORs).
To verify that the TC and CC were consistent, the risk factors and 
clinical characteristics of the cohorts were compared with each other 
and, to the extent possible, the same comparisons were made to the 
results in a 2002 report by Weir et al.14 Limited to UA patients with 
no previous history of SAH, similar comparisons were made between 
the @neurIST TC, Weir et al14 2002, the ISUIA cohorts, and the 2012 
UCAS report. For this, frequencies were calculated on a per patient 
basis and, for completeness, we also calculated per aneurysm statis-
tics. The purpose of these comparisons was to identify differences 
between the cohorts that could affect the conclusions drawn from the 
observations either attributable to selection bias or to general changes 
in the population over time.
Case categorization and information extraction were performed 
using the @neuBrowser tool developed in the course of the @neu-
rIST project. Statistics were produced using SPSS version 15.0 
software (SPSS: IBM, NY) or MedCalc software (MedCalc soft-
ware, Belgium), whichever was considered to be the most practical. 
Results for continuous variables are reported as mean±SD. The test 
of significance for mean differences was assessed using Student t test 
(significance level P<0.05). Odd ratios are reported with a 95% CI. 
Significance of differences in proportions was assessed by means of 
Fisher exact tests.
Results
Summaries of patient demographics, clinical histories, and risk 
factors obtained for the 2 @neurIST cohorts and their com-
parisons are given in the Table. In both the TC and CC, there 
was a ratio of ≈3 females for every male (Table). The aver-
age maximal unruptured aneurysm diameter was significantly 
higher in the TC than in the CC (6.35±4.8 versus 5.51±4.23 
mm; P<0.05). However, there was a higher proportion of 
small (2–7 mm) aneurysms (63.9% versus 52.8%; P<0.05) 
and a significantly lower proportion of large (13–24 mm) 
aneurysms (6.3% versus 12.2%; P<0.05) reported in the CC 
(Table I in the online-only Data Supplement). The proportion 
of symptomatic patients was significantly smaller in the CC 
(9% versus 16.9%; P<0.05). Both cohort populations were, 
however, comparable for all other variables studied (Table; 
Table I in the online-only Data Supplement).
Location and Size Dependence of Aneurysms  
and Rupture
AcoA was the vessel segment most commonly bearing a rup-
tured aneurysm (n=162), followed by the PcoA (n=121) and 
MCA bifurcation (n=72). The occurrence of SAH secondary 
to the rupture of aneurysms was more frequent in the AcoA 
and in the PcoA than in the MCA bifurcation (RR, 2.25 [95% 
CI, 1.7–3.0] and RR, 1.7 [95% CI, 1.2–2.25], respectively).
Figure 2 shows a forest plot reporting the ORs of aneurysms 
discovered ruptured or unruptured at each anatomic location 
(regardless of aneurysm size) in the TC. ORs to the right of the 
reference line (OR=1) reflect a higher than average proportion 
of aneurysms being ruptured at discovery. AcoA aneurysms 
had the highest OR (TC: 4.3 [95% CI, 2.8–6.5]; CC: 2.1 [95% 
CI, 1.4–3.2]) for rupture followed in order by basilar tip, A2 
and pericallosal, and PcoA and posterior inferior cerebellar 
artery aneurysms. In contrast, aneurysms located in the oph-
thalmic segment of the ICA had the lowest OR for rupture. 
Observations were similar when analyzing the CC (Figure I in 
the online-only Data Supplement).
For different size subgroups, the odds of discovering rup-
tured AcoA aneurysms relative to that of similarly sized 
MCA aneurysms are compared in Figure 3. The OR for rup-
tured AcoA aneurysms was the highest in the size group 4 
to 7 mm (OR, 8.3 [95% CI, 4.4–16]; P<0.001). At larger 
diameters, the differences decreased as the corresponding 
proportion of ruptured MCA aneurysms increased; at >12 
mm diameter, no conclusions were drawn in light of the 
small sample size.
Figure 1. Left, Basis for attributing aneu-
rysm locations according to the Interna-
tional Study of Unruptured Intracranial 
Aneurysms (ISUIA). Aneurysms of the 
internal carotid artery (ICA), middle cere-
bral artery (MCA), and anterior cerebral 
artery (ACA; excluding posterior com-
municating artery [PcoA]) belong to the 
anterior circulation (orange), whereas 
aneurysms of the vertebrobasilar system, 
PcoA, and PcoA segment of the ICA 
belong to the posterior circulation (red). 
Note that there is no subdivision in ISUIA 
between ACA and anterior communicat-
ing artery (AcoA). Right, Refined subdivi-
sion of neurovasculature as applied in 
this study: each parent vessel segment 
starts proximal to the origin of the branch 
and finishes proximal to the next branch 
and takes the name of the branch depart-
ing from the segment. Inset, As defined 
by Rhoton,8 a bifurcation begins where 
the walls diverge (dotted line) and ends 
on the cross-sections perpendicular to 
the flow (lines B1 and B2) located in the 
daughter vessels where the projection of 
the parent vessel wall (lines A1 and A2) 
cross the medial wall of the daughter vessel. AC indicates anterior circulation; AchIC, anterior choroidal artery segment of the ICA; 
and PC, posterior circulation.
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Reflecting the ISUIA classification of aneurysms by location 
(AC or PC) and size (<7 mm, 7–12 mm, or >12 mm in diam-
eter), the incidences and ORs for ruptures of the subgroups 
are compared in Figure 4 (aneurysms >12 mm excluded). Also 
shown are the behaviors of separable AC components, bro-
ken down as AcoA, ACA (including A1, AcoA, A2, PerA, and 
Distal ACA aneurysms), or MCA+ICA aneurysms. The OR 
of ruptured AC aneurysms of <7 mm in size showed fewer 
ruptured aneurysms than the reference group, suggesting their 
rupture risk could be ≤2.6% per 5 years. In contrast, aneu-
rysms located in the PC showed a trend to higher ORs (1.29 
[95% CI, 0.9–1.9]). These observations are in accordance with 
the ISUIA observations. We found however, that aneurysms of 
<7 mm in size in ACA locations in general, and AcoA aneu-
rysms in particular, were more likely to be ruptured at presen-
tation than other AC aneurysms, and that they showed ORs 
similar to PC lesions (ACA: 1.58 [95% CI, 1.10–2.30]; AcoA: 
2.0 [95% CI, 1.31–3.03]). Interestingly, the OR for ruptured 
aneurysms <4 mm in the AcoA was smaller, although not sig-
nificantly so, than the reference group (OR, 0.547 [95% CI, 
0.279–1.073]). When separated from the AC aneurysms, a low 
OR for rupture of ICA+MCA became apparent even at diam-
eters up to 12 mm (0.26 [95% CI, 0.18–0.37] for aneurysms 
<7 mm and 0.61 [95% CI, 0.39–0.95] for aneurysms between 
7 and 12 mm; Figure 4).
Comparison With Previous Studies
Included in the Table, along with the details of the @neurIST 
cohorts, are summary data from Weir et al14 2002. A simi-
lar summary and analysis, limited to patients with UA at the 
time of recruitment, is given in Table I in the online-only Data 
Supplement. Because our interest here is in possible differ-
ences in bias between studies, or changes in the patient popula-
tions over time, below, we focus primarily on describing the 
Table.  Baseline Characteristics of Patients and Aneurysms for Cohorts
Weir et al14  
(n=507)
Consecutive Cohort 
(n=404)
Total @neurist Cohort 
(n=932) P Value* P Value†
Period of recruitment 1967–1987 2007–2012 2007–2012
Baseline characteristics of patients
  Age, mean (SD) 47 (NA) 55.3 (14.11) 55.02 (13.24) NA NS
  Sex ratio (% of female) 318/189 (62.7) 298/106 (74) 663/269 (71) <0.005 NS
  Ratio of multiple aneurysms  
(% of cases with multiple lesions)
111/396 (21.9) 134/270 (33) 278/654 (30) <0.005 NS
  Percentage of patients with SAH 86 53 63 <0.001 <0.001
  Number of aneurysms 621 1347
  Max aneurysm diameter, mm; 
mean (SD)
9.7 (0.3 se) 6.2 (7.35) 6.76 (11.39) <0.001 NS
Baseline characteristics of 
aneurysms
  Size of aneurysm,  
number of patients (%)
   0–1.9 mm 8 (2.0) 13 (1.4) NS
   2–6.9 mm 155 (38.5) 239 (59.2) 490 (52.6) <0.001 <0.05
   7–12 mm 144 (36.0) 117 (29.0) 316 (33.9) NS NS
   13–24 mm 73 (18.0) 33 (8.2) 95 (10.2) <0.001 NS
   >24 mm 30 (7.5) 7 (1.7) 18 (1.9) <0.001 NS
  Location of aneurysm,  
number of patients (%)
   Cavernous part of carotid 
artery
18 (3.5) 26 (6) 50 (5) NS NS
   Internal carotid artery 53 (10.4) 109 (27) 218 (23) <0.001 NS
   Anterior communicating  
or anterior cerebral artery
158 (31.2) 141 (35) 308 (33) NS NS
   Middle cerebral artery 158 (31.2) 137 (34) 386 (31) NS NS
   Posterior communicating 
artery
88 (17.4) 65 (16) 186 (20) NS NS
   Vertebrobasilar system  
(other than basilar tip)
10 (2) 33 (8) 74 (8) <0.001 NS
   Tip of basilar artery 22 (4.3) 30 (7) 79 (8) <0.005 NS
NA indicates not applicable; NS, not significant; SAH, subarachnoid hemorrhage; and se, standard error.
*P value comparing @neurIST Total Cohort (TC) with Weir et al.14
†P value between @neurIST cohorts.
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points where significant differences were observed. Care has 
been taken to compare population of patients recruited accord-
ing to the same criteria between studies. @neurIST cohorts 
are compared with Weir et al,14 whereas population of patients 
recruited with unruptured aneurysms and no history of SAH 
are compared with ISUIA and UCAS, and the subpopulation 
of patients recruited with unruptured aneurysms in Weir et al.14
Demographics, Signs, and Symptoms
The TC was populated with older patients, more females, 
more patients with multiple aneurysms, and fewer patients 
that had SAH than reported in Weir et al14 (Table).
The patients with unruptured aneurysms in the TC and 
ISUIA populations were similar in age (56±13.1 versus 
55±13.1 years), whereas those in UCAS were older (65±10.4 
years) and those in Weir et al14 were younger (46 years). Fewer 
of the @neurIST patients with unruptured aneurysms had mul-
tiple aneurysms or a family history of aneurysms than those 
in ISUIA. @neurIST patients had lower levels of alcohol and 
tobacco consumption and a trend toward fewer patients using 
stimulants as compared with ISUIA (Table I in the online-only 
Data Supplement).
Relative to ISUIA, the comparable patient group in UCAS 
was older, and contained more males, whereas fewer patients 
were smokers, had multiple aneurysms, were symptomatic, or 
had a family history of SAH (Table IV in the online-only Data 
Supplement).
Ruptured Versus Unruptured
The population of patients with unruptured intracranial aneu-
rysms (UA) corresponded to 37% of all cases recruited to the 
@neurIST (47% in the CC). This clearly contrasts with the 
observation made between 1967 and 1987 reported by Weir in 
2002 wherein only 14% of patients were found to have UAs.
Location
@neurIST contained significantly more patients with internal 
carotid aneurysms than reported by Weir et al14 (CC: 27%, TC: 
23%, Weir: 10.4%; P<0.001). Patients with PC aneurysms 
(vertebrobasilar and basilar tip) were also more frequent in 
@neurIST than in Weir et al (16% versus 6.3%; P<0.01; Table).
Figure 2. Odds ratios of aneurysms dis-
covered ruptured vs unruptured for each 
location compared with all other aneurysms 
included in the cohort. N is the number 
of aneurysms observed for each location 
or location cluster. AC indicates anterior 
circulation; AchIC, anterior choroidal artery 
segment of the ICA; AcoA, anterior com-
municating artery; CI, confidence interval; 
IC bif, ICA bifurcation; MCA, middle cerebral 
artery; Oph IC, ophtalmic segment of the 
ICA; OR, odds ratio; PcoA, posterior com-
municating artery; Per ACA, pericallosal 
segment of the ACA; PICA, posterior inferior 
cerebellar artery; and VB other, other loca-
tion within the vertebrobasilar system.
Figure 3. Odds ratios of anterior communicating artery (AcoA) aneurysms being discovered ruptured vs unruptured relative to those of 
the middle cerebral artery (MCA) stratified by size. CI indicates confidence interval; and OR, odds ratio.
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Limited to patients with UAs, internal carotid aneurysms 
were significantly more represented in the @neurIST cohorts 
than in ISUIA and Weir et al14 (patient-based counting, respec-
tively 35% versus 22.9% and 13.9%; P<0.01; Table I in the 
online-only Data Supplement). Comparing the distribution of 
aneurysms by location, aneurysms located in the ICA were 
significantly more frequent in @neurIST than in UCAS (aneu-
rysm-based counting: 29% versus 19%; P<0.001); in contrast, 
aneurysms located in PcoA were significantly less frequent 
in @neurIST (11.9% versus 16.5%; P<0.05; Table III in the 
online-only Data Supplement). This latter observation may be 
attributable to differences in classifying aneurysms between 
the PcoA and the anterior choroidal artery segment of the ICA.
Unruptured AcoA aneurysms also formed a much greater 
fraction of the observed patients with aneurysms in the @neu-
rIST cohort than those in Weir et al14 and ISUIA (24% versus 
13.9% and 10.3%, respectively; P<0.001; Table I in the online-
only Data Supplement). Comparing @neurIST and UCAS 
cohorts, a similar representation of unruptured AcoA aneurysm 
was observed (Table III in the online-only Data Supplement).
The pattern of aneurysm distribution varied slightly between 
@neurIST centers. Centers where neurosurgeons were less 
involved in the project reported fewer MCA and pericallosal 
segment of the ACA aneurysms (P<0.001) and proportionally 
more PcoA, basilar artery, and M1 aneurysms (P<0.001).
Size
The average aneurysm size was similar between UCAS and 
@neurIST CC (Table I in the online-only Data Supplement), 
with progressively larger average aneurysm sizes being seen 
in the @neurIST TC, ISUIA, and Weir et al14 studies.
However, concerning the distribution of aneurysm sizes, 
the @neurIST TC was close to that of Weir et al,14 whereas 
the distribution for the @neurIST CC was closer to that of 
ISUIA, with the former pairing having slightly fewer small 
and more midsized aneurysms relative to the latter pairing. 
UCAS was populated with significantly more patients with 
aneurysms <7 mm than ISUIA, TC, and CC (78.4% versus 
62%, 53.4%, 65.2% respectively; P<0.01; Table II in the 
online-only Data Supplement).
Discussion
This study was designed to evaluate AcoA aneurysm rupture 
risk relative to the anterior and PC location and size groupings 
used in ISUIA. Our motivation was the common perception 
that the behavior of AcoA aneurysms is not that suggested 
by the ISUIA results. Consistent with ISUIA, we found that 
aneurysms <7 mm in size and located in the AC (as defined in 
ISUIA) were less likely to be discovered ruptured than aneu-
rysms in other locations or of larger size. More importantly, 
however, our results also provide statistical evidence that 
AcoA aneurysms rupture with smaller diameters than MCA 
aneurysms and, that generally, AcoA aneurysms rupture at 
least as frequently as those of the PC, in contrast to those in 
other AC locations. Furthermore, our data indicate that risk of 
rupture of aneurysms of <7 mm located in the internal carotid 
or MCA is low relative to the PC and AcoA, but not negli-
gible. Thus, the AC as defined by ISUIA should not be consid-
ered homogeneous for aneurysm rupture, and we suggest that 
because of unknown factors (ie, embryogenesis or blood flow 
coherence), both AcoA and PcoA be considered with the PC 
for risk stratification.
The distinct rupture risk of AcoA aneurysms seen in the 
present study has important implications for our understanding 
of the ISUIA and UCAS studies. As mentioned by the authors 
of ISUIA, “the potential limitations of the study include the 
nonrandomised nature of the unoperated, surgical and endo-
vascular cohorts, which led to asymmetries within groups;…” 
We think that the implications of this possible recruitment bias 
have not been fully appreciated by the medical community. The 
assignment of patients to one of the 2 ISUIA cohorts (treated 
Figure 4. Odds of aneurysms discovered ruptured vs unruptured for groups clustered according to location and size compared with a refer-
ence group defined as aneurysms between 7 and 12 mm located in the anterior circulation aneurysm as defined by the International Study of 
Unruptured Intracranial Aneurysms, and for subsets of the anterior circulation. ACA indicates anterior cerebral artery; AcoA, anterior commu-
nicating artery; CI, confidence interval; ICA, internal carotid artery; MCA, middle cerebral artery; OR, odds ratio; and PC, posterior circulation.
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or not treated) was “based on whether surgical or endovascular 
treatment of ≥1 unruptured intracranial aneurysm was planned 
on clinical grounds at the time the patient was first seen at the 
ISUIA center.” Although the study coordinators took steps to 
minimize bias, there is no description or discussion of how 
consecutive the recruitment was. It may have been for various 
unstated reasons, for example, a reputation to rupture at small 
diameters or surgical accessibility, that more patients with 
unruptured AcoA aneurysms were treated and not observed in 
ISUIA. This may explain why patients with AcoA aneurysms 
represented only 13.5% of patients enrolled, as opposed to 
24% in @neurIST, and why 10.3% were followed up without 
surgery. Other possible reasons for this difference include the 
following: (1) increased opportunities and improved quality 
of cerebral imaging, leading to more patients being diagnosed 
with incidental aneurysms, (2) a decrease in the incidence of 
rupture of existing aneurysms, resulting in an increase of the 
prevalence of unruptured lesions, (3) an aging population that 
may increase the prevalence of aneurysms, and (4) changes 
in an environmental risk factor such as increased prohibition 
of smoking in public areas. These factors apart, patients in 
ISUIA with ICA and AcoA aneurysms were significantly more 
frequently assigned to treatment than those with PcoA aneu-
rysms. All together, our observations suggest that the AcoA 
location was under-represented in the ISUIA study, and that 
the particular behavior of lesions in that location could not be 
distinguished from lesions in other AC sites. This conclusion 
is supported by our finding that when all AC aneurysms are 
included in 1 single group, the increased rupture risk associ-
ated of AcoA aneurysms is masked (Figure 4).
Based on these considerations, we emphasize that the 
observation in ISUIA of a negligible rupture risk for AC aneu-
rysms <7 mm in size is only applicable in the situation where 
expert clinicians had considered observation as an acceptable 
alternative to treatment.
In order that our data be valid as a basis for the above com-
parison of our patient group with ISUIA, we sought to reduce 
case-selection bias as much as possible through a multicenter, 
population-based study (transversal study). Patients were 
recruited prospectively and consecutively in one of the clini-
cal centers, and an audit was performed to verify that cases 
were not missed. All the other centers attempted to achieve 
these aims but were not able to provide checks that all cases 
were captured, and hence completeness in these sites is not 
guaranteed. To estimate and identify potential biases, a num-
ber of characteristics of patients and aneurysms reported when 
the lesion was initially discovered were examined between the 
@neurIST cohorts. We observed that the proportion of inci-
dentally discovered aneurysms in @neurIST was significantly 
higher than in historical reports but also that this trend was 
more pronounced in the CC where all aneurysms identified 
within the clinical center were captured. However, the pro-
portion of patients with known risk factors (familial history, 
symptomatic, multiple aneurysms) was lower. These observa-
tions suggest that selection biases are progressively attenuated 
because of the increased use and quality of head imaging. 
Despite differences in recruited populations, similar results 
were obtained in the 2 @neurIST cohorts and when analyzing 
separately cohorts recruited in each center.
All the studies of intracranial aneuryms, including the 
present, are affected by ≥2 limitations. First, the recruitment 
population can be naturally defined by the established, stable 
activity of the centers involved, but this is a difficult quantity 
to determine accurately. Furthermore, costs and ethical issues 
preclude screening for intracranial aneurysms in a randomly 
selected population. In consequence, we are not able to report 
absolute incidence, but rather must consider the odd ratios of 
aneurysm rupture associated with a condition in the fraction of 
the recruited population affected or not by the studied risk fac-
tor. Therefore, it can be assumed that the OR for rupture was 
overestimated because of undiagnosed unruptured aneurysms 
mentioned above. In counterpoint, the loss of information 
on patients with lethal hemorrhage and dying before being 
brought to medical attention and the impact on natural history 
in treated cases would lead to an underestimation of the OR. 
The validity of our observation may therefore be affected by 
the selection of a population where the distribution of unrup-
tured aneurysms according to location and size does not match 
the distribution in the overall population.
When analyzing the odds of aneurysm rupture by location, 
the AcoA location was the most frequent site of aneurysm 
rupture followed by PcoA and MCA bifurcation in both the 
consecutive and TC. To determine whether the observed high 
frequency of ruptured aneurysms is associated with a higher 
prevalence of aneurysm or a higher risk of aneurysm rup-
ture, the prevalence of aneurysm by location and size groups 
was estimated from the population of patients diagnosed 
with unruptured aneurysms We could not identify factors 
that could explain why unruptured aneurysms in the AcoA 
should be underdiagnosed as compared with other locations. 
As for aneurysms located in the IC (close to bone structures), 
the incidence of unruptured aneurysms diagnosed increased 
between older and more recent studies.
Concerning risk associated with size, we made the assump-
tion that if aneurysm rupture modifies the size or the mor-
phology, it would happen regardless of location. Therefore, 
we decided to highlight the risk of rupture associated with 
aneurysm size by comparing AcoA with MCA, both loca-
tions sharing high anatomic similarities. Aneurysms between 
4 and 7 mm in the AcoA were significantly more frequently 
observed ruptured than similar size aneurysms in the MCA 
location. This observation also held when the AcoA location 
was compared with other AC locations.
It has been debated whether the risk of rupture of an UA can 
or cannot be extrapolated from size or morphology observa-
tions of ruptured aneurysms as these features may be modified 
by the rupture itself.17,18 The Small Unruptured Intracranial 
Aneurysm Verification (SUAVe) study has demonstrated the 
different characteristics of aneuryms relative to their growth 
and rupture. Different types of aneurysm evolution have been 
described, from rapid aneurysm development and rupture at 
small sizes within days or months, to slower growing aneu-
rysms with rupture occurring after years or remaining rupture 
free for decades. Based on a single evaluation at the time of 
diagnosis, our work is unsuited to answering questions of how 
aneurysms grow and what rupture rate to expect. Recently, 
the UCAS Japan reported results of a longitudinal follow-up 
study of patients enrolled from January 2001 through April 
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2004 and follow-up until April 2010. A total of 5720 patients 
with 6697 aneurysms were studied; of which, 3050 aneurysms 
were treated during follow-up, and 3647 aneurysms were 
left for observation. A total of 11 660 aneurysm-years were 
recorded with 111 aneurysm ruptures. The overall annual 
rupture rate in the untreated population of patients in Japan 
was estimated at 0.95% (95% CI, 0.79–1.15). The authors 
report that compared with MCA aneurysms, lesions located 
in the AcoA or in the PcoA are more likely to rupture with 
hazard ratio of 1.90 (95% CI, 1.12–3.21) and 2.02 (95% CI, 
1.13–3.58), respectively. As stated by the UCAS authors, 
however, this type of study can never be entirely free of case-
selection bias. A significant proportion of small aneurysms 
were treated, and the characteristics of these aneurysms were 
different from the studied group. Therefore, it is difficult to 
extrapolate the observed rupture rate to the general population 
of incidentally discovered aneurysms. It would be extremely 
interesting to compare the OR and the rate of rupture for aneu-
rysms stratified in identical location and size groups for both 
@neurIST and UCAS. @neurIST continues to record rupture 
or treatment of unruptured aneurysms in the CC cohort to 
provide longitudinal data on top of the transversal informa-
tion reported herein. We may then extrapolate rupture rates 
in the clinically pertinent population by comparing ORs with 
homogenous aneurysm groups with known rupture rates and 
be able to propose estimates.
Currently, most studies apply multiple univariate analy-
ses in evaluating rupture risk but these may be inadequate 
because, as illustrated by our results, location, size, and many 
other factors may influence aneurysm behavior, such as sex, 
smoking, alcohol consumption, and hypertension. New tools 
are being developed to assess the risk of rupture using genet-
ics, transcriptomics, morphodynamic evaluation, and simula-
tions, and new treatments are being explored. This progress 
puts ever greater demands on the scale of aneurysm studies 
required for adequate and appropriate statistical analyses to 
be performed. The only way to achieve this is through wider 
multicentric collaboration and rigorous patient documentation 
practices. Further projects need to be launched to integrate all 
this information and help clinicians provide individualized 
recommendations to patients and the general population.
Conclusions
AcoA aneurysms with a size between 4 and 7 mm have a higher 
risk of rupture than was inferred from the ISUIA observations. 
We recommend that in the absence of complicating comorbidi-
ties, unruptured AcoA aneurysms >4 mm should be treated. 
Small aneurysms of <7 mm located in the internal carotid or 
middle cerebral arteries were seen to present lower risk of rup-
ture. We recommend following these aneurysms with regular 
imaging.
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Supplementary Table I
Cohort
ISUIA                   
no surgery 
(n=1692) ref
Weir et al 
unruptured 
(n=170) p
UCAS                
Not Surg      
(n=3647) p p p p*
Period of recruitment 1991-1998 1967-1987 2001-2004 2007-2012 2007-2012
Baseline characteristics of patients
Age (mean [SD]) 55.2 [13.1] 46[NA] NA 65.0 [10.4] <0.0001 57.35 [14.09] 0.03 56.67 [13.09] NS NS
Gender ratio (% of female) 1261/431 (74.5%) 124/46 (72.9%) NS 2480/1167 (68%) <0.0001 148/43 (77%) NS 262/81 (76%) NS NS
ratio of multiple aneurysms (% cases with multiple lesions) 679/1013 (40.3%) NA NA 1003/2641 (27.5%) <0.0001 59/132 (31%) <0.05 96/247 (28%) <0.001 NS
symptomatic patients 186/1506 [11%] 9% NA 171/5720 [3%] <0.0001 18/173 [9.4%] NS 58/285 [16.9%] <0.01 <0.05
number of aneurysms 2686 NA 6697 291 493
Max aneurysm diameter (mm) (mean [SD]) 7.4 [6.9] 7.76 [0.68"se"] NS 5.3[3.3] <0.0001 5.51 [4.23] <0.001 6.35 [4.8] <0.005 <0.05
Baseline characteristics of aneurysms
Size of aneurysm (number of patients [%])
0-1.9mm 4     [  2.1%] NA 4     [  1.2%] NA NS
2-6.9mm 1049 [62%] 79 [55%] NS 122 [63.9%] NS 181 [52.8%] <0.005 <0.05
7-12mm 390   [23%] 40 [28%] NS 50   [26.2%] NS 108 [31.5%] <0.005 NS
13-24 198   [12%] 15 [11%] NS 12   [  6.3%] <0.05 42   [12.2%] NS <0.05
>24mm 55     [  3%] 9   [  6%] NS 3     [  1.6%] NS 8     [  2.3%] NS NS
Location of aneurysm (number of patients [%] number of aneurysms [%])
Cavernous part of carotid artery 210 [12.4%] 18 [10.6%] NS 22 [12%] 25[ 3%] NS 37   [11%] 42[ 3%] NS NS
Internal carotid artery 387 [22.9%] 22 [13.9%] <0.01 68 [36%] 81[28%] <0.0005 121 [35%] 144[29%] <0.0001 NS
Anterior communicating or anterior cerebral artery 175 [10.3%] 22 [13.9%] NS 58 [30%] 61[21%] <0.0001 82   [24%]  87[18%] <0.0001 NS
Middle cerebral artery 475 [28.1%] 61 [35.9%] <0.05 65 [34%] 82[28%] NS 114 [33%] 139[28%] NS NS
Posterior communicating artery 246 [14.5%] 37 [21.8%] <0.05 18 [  9%] 19[ 6%] NS 39   [11%]  41[ 8%] NS NS
Vertebrobasilar system (other than basilar tip) 87   [  5.1%] 5   [  2.9%] NS 15 [  8%] 15[ 5%] NS 21   [  6%]  21[ 4%] NS NS
Tip of basilar artery 112 [  6.6%] 5   [  2.9%] NS 8   [  4%]  8[ 3%] NS 19   [  6%]  19[ 4%] NS NS
NS: non significant
NA: not available
p: p-value compared to ISUIA
p*: p-value comparing both @neurIST cohorts
Consecutive  C.          
noSAH                      
(N=191)
Total @neurist C.                 
no SAH                               
(N=343)
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Supplementary Table II
Cohort Total UCAS cohort Not Surgically Surgically Consecutive cohort Total  cohort
Treated before Treated before No SAH No SAH
Rupture Rupture
(N = 6697) (N = 3647) (N = 3050) (N=187) p p* (N=339) p p*
maximal aneurysm size
≥7 mm 1711 [25.5] 786 [21.6] 925 [30.3] 65 [34.8] <0.01 <0.0001 158 [46.6] <0.0001 <0.0001
3-4 mm 3132 [46.8] 2000 [54.8] 1132 [37.1]
5-6 mm 1854 [27.7] 861 [23.6] 993 [32.6]
p = compared to Total UCAS cohort
p*= compared to Not Surgically Treated before Rupture group from UCAS
<0.0001
UCAS @neurIST
4986 [74.5] 2861 [78.4] 2125 [69.7] 122 [65.2] <0.01 <0.0001 181 [53.4] <0.0001
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Supplementary Table III
Total
% % % % p p* % p p*
Middle cerebral artery 2425 36.2 1210 33.2 1215 39.8 82 31 NS NS 139 31 <0.05 NS
Anterior communicating artery 1037 15.5 530 14.5 507 16.6 47 18 NS NS 63 14 NS NS
Internal carotid artery 1245 18.6 696 19.1 549 18 77 29 <0.001 <0.001 131 29 <0.001 <0.001
Internal carotid–posterior communicating artery 1037 15.5 602 16.5 435 14.3 23 9 <0.005 <0.001 54 12 <0.05 <0.05
Basilar tip and basilar–superior cerebellar artery 445 6.6 327 9 118 3.9 13 5 NS <0.05 25 6 NS <0.05
Vertebral artery–posterior inferior cerebellar artery and vertebrobasilar junction 123 1.8 80 2.2 43 1.4 8 3 NS NS 13 3 NS NS
Other 385 5.7 202 5.5 183 6 16 6 NS NS 27 6 NS NS
Total 6697 3647 3050 266 452
p = probability their is a difference compared to UCAS total
p*= probability their is a difference compared to UCAS Not surgical group
UCAS @neurIST
Not surgically 
treated before 
rupture
Surgically 
treated before 
rupture
Consecutive 
cohort                  
no SAH
Total 
@neurIST  C.                           
no SAH
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Supplementary Table IV
Cohort
ISUIA                
no surgery 
(n=1692) ref
UCAS                  
Not Surg 
(n=3647) p
Consecutive C.  
noSAH            
(N=191) p
Total @neurist C.      
no SAH           
(N=343) p p*
Consecutive         
cohort           
(N=404) p
Total @neurist           
cohort                  
(N=932) p p*
Medical History
Hypertension 732 (43·6%) 1665 (45.6%) NS 68 (35.6%) <0.05 144(42.0%) NS NS 110 (27.2 %) <0.001 320  (34.3 %) <0.001 <0.01
Hypertension therapy 637 (37·8%) 60 (31.4%) NS 126(36.7%) NS NS 88 (21.7 %) <0.001 258 (27.7 %) <0.001 <0.001
Valvular disease 37 (2·2%) 3/158 (1.9%) NS 4/305(1.3 %) NS NS 3 (1 %) NS 8  (1 %) <0.05 NS
Family History
Aneurysms 276 (18·4%) 416 (11.4%) <0.0001 15  (7.9%) <0.005 45 (13.1%) NS NS 22 (5.4%) <0.001 88  (9.4 %) <0.001 NS
Behavioural history
Alcohol (>5 drinks per week) 502 (30·2%) 29 (15.2%) <0.0001 54 (15.7%) <0.0001 NS 58 (14.4 %) <0.001 175 (18.7 %) <0.001 NS
Current smoker 693 (41·1%) 54 (28.3%) <0.001 92 (26.8%) <0.0001 NS 98 (24.2 %) <0.001 258 (28 %) <0.001 NS
551 (15%) <0.0001
Former smoker 602 (35·7%) 30 (15.7%) <0.0001 78 (22.7%) <0.0001 NS 57 (14.1 %) <0.001 204 (22 %) <0.001 <0.001
Use of stimulants 79 (4·7%) 5 (2.6%) NS 10 (2.9%) NS NS 6 [1.5%] <0.005 12 (1.3 %) <0.0001 NS
Associated disorders
Coarctation of aorta 9 (0·5%) 2 (0.9%) NS 3 (0.9%) NS NS 3 (0.7%) NS 4 (0.4%) NS NS
Polycystic kidney disease 25 (1·6%) 11 (0.3%) <0.0001 7 (3.6%) NS 10 (3%) <0.05 NS 8 (1.8%) NS 12(1.3%) NS NS
Arteriovenous malformation 34 (2·0%) 2 (0.9%) NS 3 (0.9%) NS NS 3 (0.7%) <0.06 7 (0.7%) <0.01 NS
Ehlers-Danlos syndrome 0 (0%) 1 (0.5%) NS 1(0.3%) NS NS 1 (0%) NS 1(0.1%) NS NS
Neurofibromatosis 0 (0%) 0 (0%) NS 0 (0%) NS NS 0 (0%) NS 1 (0.1%) NS NS
Tuberous sclerosis 0 (0%) 0 (0%) NS 0 (0%) NS NS 0 (0%) NS 0 (0%) NS NS
Moyamoya disease 0 (0%) 0 (0%) NS 1 (0.3%) NS NS 1 (0.2%) NS 2 (0.2%) NS NS
Hypocoagulable state 6 (0·4%) 0 (0%) NS 2 (0.6%) NS NS 0 (0%) NS 3 (0.3%) NS NS
Fibromuscular disease 14 (0·9%) 0 (0%) NS 0 (0%) NS NS 0 (0%) NS 2 (0.2%) NS NS
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Supplementary Figure I
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Supplemantal Table and Figure Legends
Supplementary table I: 
Base line characteristics of patients and aneurysms for cohorts of cases with unruptured aneurysms. 
Supplementary table II:
Distribution of aneurysms by size in UCAS and @neurIST no SAH  cohorts.
Supplementary table III:
Distribution of aneurysms by location in UCAS and @neurIST no SAH cohorts.
Supplementary table IV: 
Medical, family and behavioural history and associated disorders characteristics for all cohorts.
Supplementary figure I: 
Odds of aneurysms discovered rupture versus unruptured for each location compared to the odds of all other aneurysms 
included in the consecutive cohort (CC). N is the number of aneurysms observed for each location or location cluster.
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Saccular intracranial aneurysms 


are balloon-like dilations
of the intracranial arterial wall; their hemorrhage 
commonly results in severe neurologic impairment and 
death. We report a second genome-wide association study 
with discovery and replication cohorts from Europe and 
Japan comprising 5,89 cases and 4,8 controls with 
~832,000 genotyped and imputed SNPs across discovery 
cohorts. We identified three new loci showing strong 
evidence for association with intracranial aneurysms in 
the combined dataset, including intervals near RBBP8 
on 8q.2 (odds ratio (OR) = .22, P = . × 0−2), 
STARD13-KL 


on 3q3. (OR = .20, P = 2.5 × 0−9)
and a gene-rich region on 0q24.32 (OR = .29, P = .2 × 
0−9). We also confirmed prior associations near SOX17 
(8q.23–q2.; OR = .28, P = .3 × 0−2) and CDKN2A-B 
(9p2.3; OR = .3, P = .5 × 0−22). It is noteworthy 
that several putative risk genes play a role in cell-cycle 
progression, potentially affecting the proliferation and 
senescence of progenitor-cell populations that are 
responsible for vascular formation and repair.
Intracranial aneurysms affect approximately 2% of the general popula-
tion and arise from the action of multiple genetic and environmental 
risk factors1. We previously reported the first genome-wide association 
study (GWAS) of intracranial aneurysms2 that identified three risk loci 
on chromosomes 8q11.23–q12.1, 9p21.3 and 2q33.1 with P < 5 × 10−8. 
This previous study had limited power to detect loci imparting geno-
typic relative risk (GRR) < 1.35 (Supplementary Table 1).
To increase the power to detect additional loci of similar or 
smaller effect, we ascertained and whole-genome sequenced 


two new 
European case cohorts (n = 1,616) and collected genotyping data 
from five additional European control cohorts (Supplementary Note, 
n = 11,955). We also increased the size of the original Japanese rep-
lication cohort and added a new Japanese replication cohort (2,282 
affected individuals (cases) and 905 controls) (Table 1). The new com-
bined cohort had nearly threefold more cases than the original cohort 
and increased our power to detect variants with modest effect sizes. 
For example, this study had 89% and 64% average power to detect 
common variants (minor allele frequencies (MAF) ≥ 10%) with GRR 
of 1.25 and 1.20, respectively (Supplementary Table 1).
All subjects were genotyped using the Illumina platform. The new 
as well as the previously analyzed genotyping data were subjected to 
well-established quality-control measures (Supplementary Table 2). 
We sought to eliminate potential confounding due to population 
stratification and gender1,3 by matching cases and controls of the 
same gender based on inferred genetic ancestry. As previous studies 
demonstrated that the Finnish population forms an ancestry cluster 
distinct from other European populations similar to 


those included in 
this study4,5, we analyzed our Finnish cohort independently from the 
others. To maximize opportunities for genetic matching and analytic 
power, we analyzed all subjects in the remaining European cohorts 
together. The resulting matched case-control data consisted of 808 
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cases and 4,393 controls in the Finnish cohort and 1,972 cases and 8,122 
controls in the rest of the combined European cohort (Supplementary 
Table 3). We used the genotype data that passed quality-control filters 


and phased chromosomes from the HapMap CEU sample to impute 
missing genotypes6. We based our further analyses on 831,534 SNPs 
that passed the quality-control filters both in the Finnish and European 
samples (Table 1 and Supplementary Table 2).
We tested for association of each quality control–passed SNP with 
intracranial aneurysms using conditional logistic regression, assum-
ing a log-additive effect of allele dosage. We corrected each cohort for 
residual overdispersion (Table 1) using genomic control7, and com-
bined the results from the Finnish and European cohorts to obtain 
P values, ORs and CIs for the discovery cohort of 2,780 cases and 
12,515 controls using a fixed-effects model.
To evaluate the strength of association, in addition to obtaining 


P values, we employed a Bayesian approach8. We used the Bayes fac-
tor that represents the fold-change of the odds of association before 
and after observing the data9 and the posterior probability of asso-
ciation (PPA), calculated through the Bayes factor, that provides a 
simple probabilistic measure of the evidence of association8,10. For 
every SNP, we assumed a uniform prior probability of association of 
1/10,000 and set the prior of the logarithm of the per-allele OR as a 
normal distribution with a 95% probability for the OR to be between 
0.67 and 1.5, with larger weights for smaller effect sizes9,11.
From the discovery results, we eliminated two imputed SNPs 
that showed PPAs of 0.97 and 0.94 because their association signals 
were not supported by surrounding geno-
typed SNPs and because their genotypes 
were not confirmed by direct genotyping 
results (data not shown


). This resulted in 
831,532 SNPs that passed quality control 
(Supplementary Table 2).
We observed three regions that showed very 
high PPA (>0.995; Fig. 1a) and also a substan-
tial excess of SNPs with P < 1 × 10−3 (1,295 
SNPs versus 831 SNPs expected by chance) 
even after excluding those within previ-
ously identified associated regions2 (Fig. 1b). 
Moreover, we observed a strong correlation 
between the P values and Bayes factors for the 
upper tail of the distribution (Fig. 1c).
We focused on five genomic regions 
(Fig. 1a) that contained at least one SNP 
with PPA >0.5 for which the hypothesis of 
association with intracranial aneurysm was 
more likely than the null hypothesis of no 
association. The PPAs of the most highly associated SNPs in these 
intervals ranged from 0.6621 to >0.9999 and the P values ranged 
from 7.9 × 10−7 to 2.2 × 10−16 (Supplementary Table 4). The five 
chromosomal segments included three newly identified SNP clusters 
at 10q24.32, 13q13.1 and 18q11.2. The remaining two regions were 
previously identified loci at 8q11.23–q12.1 and 9p21.3 (Fig. 2; 
ref. 2). The third locus identified in our previous study, at 2q33, did 
not contain any SNPs with PPA >0.5. Furthermore, consistent with 
our previous results2, detailed analysis of the 8q11.23–q12.1 region 
detected two independent association signals within the <100-kb 
interval that spans the SOX17 locus (Fig. 2 and Supplementary 
Fig. 1); these two signals are hereafter referred to as 5′-SOX17 and 
3′-SOX17

. Thus, the five chromosomal segments comprised six 
independent association signals for follow-up.
We performed replication genotyping in two Japanese cohorts 
including 3,111 cases and 1,666 controls (JP1 and JP2, see Table 1). 
For each independent signal, we selected for replication the geno-
typed SNP with the highest PPA and added up to two additional SNPs 
per locus. For the 5′-SOX17 region, we selected two SNPs analyzed 
previously, as they tag the best 


SNP in the current study 
(Supplementary Fig. 1).
table 1 Overview of the study cohorts
Cohort Case (n) Control (n)
Quality control-passed  
SNPs (n) GIF
Discovery Finland (FI) 808 4,393 1,303,876 1.070
Combined European (CE) 1,972 8,122 905,906 1.090
Total discovery 2,780 12,515 831,532 1.007
CE sub-cohorts NL 708 3,954 905,906 1.110
DE 789 2,228 905,906 1.060
AN 475 1,940 905,906 1.060
Replication Japan 1 (JP1) 829 761 12
Japan 2 (JP2) 2,282 905 13
Total replication 3,111 1,666 12
Total 5,891 14,181 12
Combined 


European cohort consisted of all European subjects who were not ascertained in Finland. Sub-cohorts of 
the European cohort were defined on the basis of case series; NL, cases from The Netherlands with matched controls; 
DE, German cases with matched controls; AN, @neurIST cases with matched controls. NL, DE and AN were exclusive 
subsets of the European cohort 


(see also supplementary table 3). AN cases consisted of subjects from Germany, Great 
Britain, Hungary, The Netherlands, Switzerland and Spain. JP1 and JP2 were two independent Japanese case-control 
cohorts. Genomic inflation factors of the Finnish and European cohorts (as well as NL, DE and AN) were calculated for 
1,303,876 and 905,906 SNPs, respectively. The genomic inflation factor of the discovery cohort (total discovery) was 
based on the meta-analysis result for 831,532 SNPs after correcting each cohort for genomic control. The discovery 
data (combined Finnish and European cohorts) was not corrected for genomic control. GIF, genomic inflation factor.
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Figure 1 Genome-wide association analysis results in the discovery cohort. 
(a) The PPAs for 831,532 quality control–passed SNPs that were analyzed 
specifying a prior probability of association of 1/10,000 are plotted against 
genomic locations of SNPs. A gray horizontal line at PPA = 0.5 indicates 
the cutoff value for follow-up genotyping. (b) Quantile-quantile plots 
of P values (−log10 scale) are shown for all the SNPs analyzed (black; 
n = 831,532); SNPs after excluding those within previously identified 
regions (red; n = 830,907); and SNPs after excluding all within the final 
associated intervals (blue; n = 830,158). (c) A scatter plot of −log10 P 
versus log10 Bayes factors is shown with color for each point indicating the 
range of PPA values. There are very close relationships among the  
P values for association, the Bayes factor and the PPA value. Note that, 
given a uniform prior probability of association, the PPA increases as 
the Bayes factor increases. A vertical line indicates the minimum PPA 
threshold at 0.5 (Bayes factor = 1.0 × 104) for follow-up.
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All but one of the SNPs (rs12411886 on 
10q24.32 in JP1) were successfully genotyped 
and passed quality-control filters. We tested 
for association of each SNP with intracranial 
aneurysm using logistic regression stratified 
by gender, specifying the same model as 
for the discovery cohort (Supplementary 
Table 5). We combined results from JP1 and 
JP2 using a fixed-effects model (Table 2 and 
Supplementary Table 4). We considered an 
association to be replicated if the Bayes factor 
increased the odds of association more than 
tenfold after observing the replication data


.
Of the six candidate loci, all but the 5′-SOX17 interval were rep-
licated, with replication P values ranging from 0.0019 to 1.0 × 10−7, 
and the odds of association with intracranial aneurysm increasing by 
22.9-fold 


to 1.5 × 105-fold, yielding robust evidence for replication 
for each interval (Table 2).
We combined the discovery and replication results using a fixed-
effects model. All of the five loci that replicated in the Japanese cohort 
surpassed the conventional threshold for genome-wide significance 
(P < 5 × 10−8), with P values ranging from 2.5 × 10−9 to 1.5 × 10−22, 
and all also had PPAs ≥ 0.998 (Table 2).
In order to determine each cohort’s contribution to the observed 
association and to assess the consistency of the effect size across 
cohorts, we analyzed each ascertained cohort separately (Table 1 and 
Supplementary Table 5) and then combined the results from the 
six cohorts using a random-effects model. The association results 
remained highly significant (Fig. 3). For the five loci that were rep-
licated in the Japanese cohorts, we found no evidence of significant 
heterogeneity across cohorts (P > 0.1). Every cohort had the same 
risk allele and provided support for association with the exception 
of JP1 cohort for the 3-SOX17 locus, consistent with our previous 
study2 (Fig. 3).
The most significant association was detected in the previously 
reported2 9p21.3 region near CDKN2A and CDKN2B with P = 1.5 × 
10−22 (OR = 1.32, PPA > 0.9999). All of the newly studied cohorts 
strongly supported this association with intracranial aneurysm 
(Fig. 3). These same alleles are also associated with coronary artery dis-
ease, but not with type 2 diabetes12. Similarly, the previously reported 
8q11.23–q12.1 region showed significant association. The 3′-SOX17 
interval (rs92986506) showed robust association with P = 1.3 × 10−12 
(OR = 1.28, PPA > 0.9999) and all new cohorts supported the associa-
tion of this SNP with intracranial aneurysm (Fig. 3). For the 5′-SOX17 
region (rs10958409), the new cohorts introduced a substantial hetero-
geneity across cohorts, lowering the PPA to 0.016 (Fig. 3).
Among the newly identified loci, the strongest association was 
found at rs11661542 on 18q11.2 (OR = 1.22, P = 1.1 × 10−12, PPA > 
0.9999). A cluster of SNPs that are associated with intracranial aneu-
rysm spans the interval between 18.400 Mb and 18.509 Mb and are 
strongly correlated with rs11661542 (Fig. 2). A single gene, RBBP8 
(encoding the 


retinoblastoma binding protein 8), is located within 
an extended linkage disequilibrium interval (Fig. 2).
The second strongest new association was at rs12413409 on 
10q24.32 (OR = 1.29, P = 1.2 × 10−9, PPA = 0.9990), which maps to 
intron 1 of CNNM2 (encoding cyclin M2) (Fig. 2). A cluster of SNPs 
strongly correlated with rs12413409 and located within a ~247-kb 
interval in the same linkage disequilibrium block supported the asso-
ciation (Fig. 2).
The third new locus is defined by rs9315204 at 13q13.1 (OR = 1.20, 
P = 2.5 × 10−9, PPA = 0.9981) in intron 7 of STARD13 (encoding 
the STAR


-related lipid transfer (START) domain containing 13) 
(Fig. 2). Two SNPs, rs1980781 and rs3742321, that are strongly cor-
related with rs9315204 (r2 > 0.9) also showed significant association 
with intracranial aneurysm (Fig. 2 and Supplementary Table 4). 
These two SNPs are missense (lysine to arginine) and synonymous 
coding variants of STARD13, respectively. Another gene that has been 
implicated in aging phenotypes, KL (also known as 


KLOTHO), is 
located nearby13.
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Figure 2 Regional plots for associated regions. 
For each chromosomal interval, −log10  
P values for association are plotted against the 
genomic coordinates (NCBI build 36) above; 
the recombination rates obtained from the 
HapMap database and the RefSeq genes (hg18) 
within the regions are shown below. Above, rs 
identifiers of SNPs listed in table 2 are shown 
and their positions are indicated by gray vertical 
lines. Gray dashed lines indicate locations 
of other SNPs genotyped in the replication 
cohorts. Dark blue and light blue dots represent 
results of genotyped and imputed SNPs for the 
discovery cohort, respectively; orange and light 
orange squares represent association results for 
the replication cohort using JP1 combined with 
JP2 and also JP2-only, respectively; combined 
results for SNPs genotyped both in the discovery 
and the replication cohort using JP1 plus JP2 
and JP2-only are shown by red and light red 
diamonds, respectively.
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A search of the gene-expression database (eQTL browser, see URLs) 
for all the intracranial aneurysm-risk loci did not reveal any consistent 
pattern of association of intracranial aneurysm SNPs with variation 
in gene expression levels.
In this second GWAS of intracranial aneurysm, which included 
nearly three times as many cases as the initial study, we detected three 
new risk loci and obtained strong independent evidence for asso-
ciation of two previously identified loci. The evidence that these are 
table 2 representative sNPs analyzed both in the discovery and replication cohorts
Locus SNP Position Genes
Risk  
allele Cohort P value log10 (Bayes) PPA
Per-allele OR  
(95% CI) Control RAF Case RAF
8q11.23 rs10958409 55,489,644 SOX17 A Discovery 4.2 × 10−7 4.64 0.8128 1.24 (1.14–1.35) 0.15, 0.19 0.18, 0.22
Replication 0.12 –0.11 1.08 (0.98–1.20) 0.28 0.29
Combined 9.0 × 10−7 4.30 0.6685 1.17 (1.10–1.25)
8q12.1 rs9298506 55,600,077 SOX17 A Discovery 1.2 × 10−10 7.94 0.9999 1.33 (1.22–1.45) 0.81, 0.76 0.85, 0.81
Replication 0.0012 1.56 1.21 (1.08–1.36) 0.79 0.81
Combined 1.3 × 10−12 9.85 1.0–1.4 × 10–6 1.28 (1.20–1.38)
9p21.3 rs1333040 22,073,404 CDKN2A, 
CDKN2B
T Discovery 2.5 × 10−16 13.41 1.0–3.9 × 10–10 1.32 (1.24–1.41) 0.56, 0.45 0.63, 0.53
Replication 1.0 × 10−7 5.18 1.31 (1.19–1.45) 0.66 0.72
Combined 1.5 × 10−22 19.48 1.0–3.3 × 10–16 1.32 (1.25–1.39)
10q24.32 rs12413409 104,709,086 CNNM2 G Discovery 7.9 × 10−7 4.29 0.6621 1.38 (1.22–1.57) 0.91, 0.91 0.94, 0.93
Replication 0.00014 2.34 1.23 (1.10–1.37) 0.74 0.77
Combined 1.2 × 10−9 7.00 0.9990 1.29 (1.19–1.40)
13q13.1 rs9315204 32,591,837 KL, STARD13 T Discovery 3.3 × 10−7 4.73 0.8443 1.21 (1.13–1.31) 0.21, 0.33 0.24, 0.39
Replication 0.0019 1.36 1.18 (1.06–1.31) 0.24 0.27
Combined 2.5 × 10−9 6.72 0.9981 1.20 (1.13–1.28)
18q11.2 rs11661542 18,477,693 RBBP8 C Discovery 5.6 × 10−9 6.39 0.9959 1.21 (1.14–1.30) 0.49, 0.44 0.54, 0.47
Replication 4.5 × 10−5 2.79 1.22 (1.11–1.34) 0.61 0.65
Combined 1.1 × 10−12 9.92 1.0–1.2 × 10–6 1.22 (1.15–1.28)
Genomic locations for SNPs are based on NCBI build 36, and risk alleles are aligned to the forward strand of the reference sequence. Control and case risk allele frequencies (RAFs) for the dis-
covery cohort are shown in the form: RAF of European cohort, RAF of Finnish cohort. Log10 (Bayes) indicates the logarithm of the Bayes factor in favor of association. PPA, posterior probability 
of association. Genes closest to the listed SNPs within the same LD regions are shown.
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Heterogeneity: τ2 = 0.00086, I 2 = 11.7, P = 0.34
8q:rs10958409 8q:rs9298506
10q:rs12413409
18q:rs1166154213q:rs9315204
9p:rs1333040
FI
FI
FI
FI
NL
NL
NL NL
DE
DE
DE DE
AN
AN
AN AN
JP1
JP1
JP1 JP1
JP2
JP2
JP2 JP2
Fixed-effects
Fixed-effects
Fixed-effects Fixed-effects
Random-effects
Random-effects
Random-effects
FI
FI
NL
NL
DE
DE
AN
AN
JP1
JP1
JP2
JP2
Fixed-effects
Fixed-effects
Random-effects
Random-effects
Random-effects
1.00
1.00
1.00
1.00
1.00
1.00
1.26 1.26
1.26
1.12
1.581.45
1.45 1.45
1.32
1.32 1.32
1.20
1.20 1.20
1.10
1.10 1.10
1.12
1.12
Odds ratio (log scale)
Odds ratio (log scale)
Odds ratio (log scale) Odds ratio (log scale)
Odds ratio (log scale)
Odds ratio (log scale)
1.41 1.41
1.41
1.58 1.58
1.58 1.78 2.00
1.23
1.39
1.20
1.20
1.20
1.16
1.15
1.13
1.25
1.27
1.32
1.32
1.26
1.41
1.25
1.31
1.30
1.39
1.27
1.22
1.22
1.20
1.24
1.19
1.30
1.23
1.14
1.29
1.29
1.21
1.27
1.44
1.66
1.23
1.43
1.34
1.15
1.14
1.25
1.28
1.28
0.0051
0.00040
0.0080
1.2E–22
1.2E–22
3.4E–05
5.4E–05
4.8E–05
5.3E–08
0.010
0.078
0.14
0.11
0.0026
0.00017
2.4E–09
2.4E–09
1.0E–05
4.6E–09
4.4E–05
9.1E–13
9.1E–13
0.0062
0.0073
0.021
0.096
0.042
0.00087
0.0023
0.0061
0.044
0.023
1.1E–09
4.9E–05
4.0E–05
1.8E–10
1.6E–12
0.0022
0.19
0.011
0.11
0.00011
0.30
0.013
0.061
0.60
1.03
19.59
19.59
1.94
2.76
0.88
2.66
2.72
5.29
6.74
6.74
0.79
0.15
0.02
0.04
1.26
2.25
2.66
7.79
9.76
1.33
–0.06
0.76
0.05
3.22
7.06
6.46
0.96
0.91
0.50
2.27
0.15
0.37
10.01
10.01
1.31
0.97
0.33
2.74
1.66
0.47
2.34
–0.22
–0.46
0.71
0.23
4.35
2.21
8.1E–07
0.00019
OR
OR
OR
OR
OR
OR
P
P
P
P
P
P
log10(BF)
log10(BF)
log10(BF)
log10(BF)
log10(BF)
log10(BF)
PPA
PPA
PPA
PPA
PPA
PPA
1.36
1.09
1.32
0.6914
> 0.9999
> 0.9999
0.9982
0.9982
0.9998
> 0.9999
0.9965
0.9991
> 0.9999
> 0.9999
0.0161
1.17
1.04
1.17
1.18
Figure 3 Consistency of association across cohorts. Forest plots are shown for meta-analysis of the SNPs listed in table 2. Squares and horizontal segments 
represent estimated per-allele ORs and 95% CIs for individual cohorts. Diamonds represent the summary OR estimates and 95% CIs for the meta-analyses of 
six cohorts (using 


fixed- and random-effects models). Log10 (Bayes factor) > 0 supports association with intracranial aneurysm, whereas log10 (Bayes factor) < 0
supports no association with intracranial aneurysm. Analyzing the results here as six distinct cohorts rather than four cohorts (as in the primary analysis) 
resulted in only minor differences due to different weights given to sub-cohorts of the combined European cohort associated with genomic control correction.
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bona fide risk loci for intracranial aneurysm is very strong from both 
Bayesian measures and conventional P values.
Given our power (~90%) to detect variants that confer risk of 
intracranial aneurysm with GRR = 1.25 and MAFs ≥ 10%, we expect 
that we have identified most of these variants, limited principally by 
potential gaps in SNP coverage. Indeed, across the rest of the genome, 
there was no locus with PPA >0.22 and MAF ≥10%, whereas there 
were 14 loci with PPAs between 0.1 and 0.22 and ORs between 1.16 
and 1.25 (data not shown). We expect that a fraction of these loci are 
genuine intracranial aneurysm risk loci, as suggested by the excess of 
SNPs with P < 1 × 10–3 (Fig. 1b); exploring this possibility will require 
analysis of larger intracranial aneurysm cohorts and/or genotyping 
of alleles with lower MAF.
Based on the results of the first GWAS of intracranial aneurysm 
and the role of the implicated gene products, encoded by SOX17 and 
in individuals with the genotype P15INK4b; P16INK4a, we previously 
hypothesized2 that the genes associated with intracranial aneurysm 
might play a role in determining cell cycle progression, and may affect 
the proliferation14 and senescence of progenitor-cell populations 
and/or the balance between production of progenitor cells versus 
cells committed to differentiation


. Genes located within the newly 
identified regions support this idea. The protein encoded by RBBP8, 
located within the 18q11.2 region, influences progression through 
the cell cycle by interacting with BRCA115. Similarly, of the two genes 
located within the 13q13.1 interval, STARD13 contains the Rho-GAP 
and C-terminal STAR-related lipid transfer (START) domains and 
its overexpression results in suppression of cell proliferation16. The 
other gene implicated here


, KL, encodes a transmembrane protein that 
modulates FGF receptor specificity17; mice lacking KL show acceler-
ated aging in diverse organ systems13.
On the assumption that there is a fourfold increase in the risk of 
intracranial aneurysm among siblings of cases18,19 and that the SNPs 
combine to increase log-odds of disease in an additive fashion, the 
five intracranial aneurysm risk loci explain 5.2% (within the Finnish 
cohort), 4.0% (in the European cohort) and 3.5% (in the combined 
JP1 and JP2 cohort) of the familial risk of intracranial aneurysm. 
Under this model, the odds of developing an intracranial aneurysm 
varies 4.99- to 7.63-fold across the top and bottom 1% of genetic 
risk profiles at these loci in the populations studied here and 3.61- 
to 4.64-fold across the 5% extremes (Supplementary Fig. 2). When 
combined with traditional risk factors such as gender, blood pressure 
and smoking, these findings form the basis of future work aimed at 
preclinical identification of individuals who are at high risk of intra-
cranial aneurysm formation and rupture.
URLs. eQTL browser, http://eqtl.uchicago.edu/.
MEthOdS
Methods and any associated references are available in the online version 
of the paper at http://www.nature.com/naturegenetics/.
Note: Supplementary information is available on the Nature Genetics website.
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Genotyping. Whole-genome genotyping for the discovery cohort was 
performed on the Illumina platform according to the manufacturer’s pro-
tocol (Illumina). Bead chips used for individual cohorts are presented in 
Supplementary Table 2. Replication genotyping in the JP1 cohort was 
performed using either Taqman (Applied Biosystems) or MassARRAY 
(Sequenom) assays. For the JP2 cohort, genotyping for cases was performed 
using the multiplex PCR-based Invader assay (Third Wave Technologies 
Inc.); genotyping for controls was performed on an Illumina platform as 
described previously20.
Ethics. The study protocol was approved by the Yale Human Investigation 
Committee (HIC protocol #7680). Institutional review board approval for 
genetic studies, along with written consent from all study participants, was 
obtained at all participating institutions.
Data storage and analysis tools. We used PLINK21 v1.06 and R statistical 
environment v2.9.0 (in particular, the snpMatrix package22) for storage of 
genotype data and data analysis.
Preprocessing. Prior to the analysis of genotyping data, we excluded SNPs 
that were located either on mitochondrial DNA or sex chromosomes, SNPs 
with A/T or C/G alleles, those for which all subjects were assigned as ‘no call’, 
and those that were assayed on Hap300v1 or 550v1 but were dropped from 
newer versions


.
Sample quality control. We excluded subjects in the discovery cohort who did 
not conform to our study design on the basis of genotyping and information 
quality, cryptic relatedness and population outliers. We summarize the sample 
exclusion steps in Supplementary Table 2. This filtering process resulted in the 
inclusion of 


835 cases and 6,529 controls in the Finnish cohort and 2,000 cases 
and 8,722 controls in the rest of the combined European cohort.
Imputation. We performed imputation analysis with the HapMap phase II 
CEU reference panel (release 24) using the IMPUTE v1 software6. The analysis 
was performed separately for the Finnish and European cohorts. We converted 
posterior probabilities of three possible genotypes to fractional allele dosage 
scores (between 0 and 2) and used these scores for association tests in order 
to take into account the imputation uncertainty23. For the quality assessment 
of imputed SNPs, we also converted the posterior probabilities to the most 
likely genotypes with the threshold at 0.9.
Case-control matching. Population stratification and independent genotyp-
ing of cases and controls are major causes of confounding in GWAS24. Because 
our study consisted of multiple independently ascertained cohorts that were 
genotyped separately, we performed a stringent analysis to control for these 
biases by inferring the genetic ancestries of subjects25,26. We used the Laplacian 
eigenmaps27 to infer population structure. Following the determination of the 
number of dimensions (K + 1) using the threshold given in Lee et al.28, we 
used the K-dimensional nontrivial generalized eigenvectors29 to calculate the 
Euclidean distance between any 


two subjects.
In the course of this analysis, we excluded ‘isolated’ subjects who were 
identified by using the nearest-neighbor distance distributions in any of the 
two-dimensional sections. After excluding these subjects, we observed 13 
dimensions in the Finnish cohort and 5 dimensions in the European cohort. 
The larger dimensions observed in the Finnish population could be attribut-
able to the presence of many isolated populations in Finland5.
Before matching, we stratified data into males and females because female 
gender is a known risk factor of intracranial aneurysm1,3. We also set the 
maximum distance between cases and controls to match to be less than 0.028 
in the Finnish cohort and 0.009 in the and European cohort. These values were 
determined by examining the distribution of the nearest-neighbor distances 
in K dimensions (data not shown). We matched cases and controls using the 
fullmatch function in the R-package optmatch30,31.
SNP quality control. For both genotyped and imputed SNPs in the discovery 
cohort, we applied quality-control filters to individual cohorts and to cases 
and controls separately on the basis of the missing rate, MAF and the P value 
of the exact test of Hardy-Weinberg equilibrium32. For imputed SNPs, we also 
assessed imputation quality using the average posterior probability, MAF and 
allelic R2 metric33. Finally, we assessed differential missingness between cases 
and controls (Supplementary Table 2).
Any genotyped SNP that passed the quality-control filters both in the 
European and Finnish cohorts was referred to as a ‘genotyped SNP’, and any 
one for which we used the quality control–passed imputation data either in 
one or both of the cohorts was classified as an ‘imputed SNP’.
For genotyping data of the replication cohorts, we excluded SNPs if any of 
the following three conditions were met in either cases or controls: (i) miss-
ing rate >0.05; (ii) P value of the exact test of Hardy-Weinberg equilibrium 
<0.001; or (iii) MAF <0.01.
Statistical analysis. Cohort-wise association analysis. We tested for association 
between each quality control–passed SNP and intracranial aneurysm using 
conditional and unconditional logistic regression for the discovery and repli-
cation cohorts, respectively34. For the discovery cohort, we used the matched 
strata to correct for potential confounding due to population stratification and 
gender and for the replication cohorts we adjusted for gender. We assumed the 
log-additive effect of allele dosage on disease risk. We obtained P values from 
the score test (two-sided) and estimated the logarithm of per-allele ORs with 
standard errors (s.e.m


.) by maximizing the conditional or unconditional likeli-
hood. Both the test statistic and the s.e.m. of the log of the OR 


were corrected 
using genomic control7. We performed the association analysis for the Finnish 
and European cohorts, as well as sub-cohorts of the European group that 
consisted of NL cases, DE cases or @neurIST cases and their matched controls 
(Table 1 and Supplementary Table 3). We used the following R functions to 
perform the association analysis: clogit, glm and snp.rhs.tests22.
Meta-analysis. We combined the cohort-wise per-allele ORs in the Finnish 
and European cohorts using a fixed-effects model of meta-analysis for 831,534 
quality control–passed SNPs to obtain the discovery results. For SNPs analyzed 
both in the discovery and replication cohorts, we combined JP1 and JP2 to 
obtain replication results and all four cohorts to obtain combined results. Our 
primary analysis was based on the fixed-effects model23. To assess the hetero-
geneity of the effect size between cohorts, we first divided the European cohort 
into three groups as described above, aiming to analyze the data without aver-
aging effect sizes over the combined European cohorts, and then combined 
our six cohorts using the random-effects model


. We employed the restricted 
maximum likelihood procedure to estimate the between-cohort heterogeneity 
variance (τ2) using the R function MiMa35 (see URLs). From this estimate, we 
calculated the Cochran′s Q statistic and the I2 statistic


36.
Bayesian evaluation of the strength of association. To evaluate the strength 
of association with intracranial aneurysm


, we used a Bayesian approach9,37. 
A limitation of the use of P values alone is that variability in factors such as 
effect size, MAF and sample size can result in identical statistics that might 
correspond to markedly different levels of evidence regarding the strength 
of association10. The Bayes factor provides an alternative that compares the 
probabilities of the data under the alternative hypothesis of association ver-
sus the null hypothesis of no association


. For computational simplicity, we 
approximated the Bayes factor as described by Wakefield8. For all SNPs, we 
assumed a single prior 


for the log-OR: a normal distribution with mean of 0 
and a standard deviation of log(1.5)/Φ−1(0.975), where Φ is the normal 
 distribution function9.
The PPA10 provides a simple probabilistic measure of evidence by intro-
ducing the prior probability of association, π1. We assumed a uniform prior, 
π1 = 1/10,000, for all the SNPs11. For Bayes factor >106, changing π1 to a more 
conservative value of 1/100,000 would result in little change in the PPA.
To combine the results from multiple cohorts, we extended the formula38 
to be applicable to multiple (>2) cohorts.
Conditional analysis. For each region that contained a SNP with PPA >0.5, 
we examined the number of independent association signals by testing for 
association of every genotyped SNP with intracranial aneurysm by adjusting 
for the effect of a specified SNP (Supplementary Fig. 1).
Two-locus interaction analysis. We tested for deviation from a linear model, 
which assumes that two SNPs combine to increase the log-odds of disease in 
an additive fashion, using conditional (in the Finnish and European cohorts) 
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or unconditional (in 


JP1 plus JP2, stratified by cohorts and gender) logistic 
regression. There was no significant deviation from the linear model (data 
not shown).
Cumulative effect. We evaluated potential clinical implications of the genetic 
profiles of the five intracranial aneurysm risk loci following the approach 
described by Clayton39. We fitted a five-locus conditional (Finnish and European 
cohorts) or unconditional (Japanese cohorts) logistic regression model including 
the additive and dominance-deviation terms for each locus


. Using the estimated 
effect sizes and each individual’s genotype, we calculated the risk scores for every 
individual. The receiver-operating characteristic curve for each ethnic cohort 
(Finnish, European and Japanese) was depicted using the risk score.
We also calculated the ratio of the exponential of the mean of the risk scores 
for control subjects within the top versus bottom 5% or 1


% of each cohort to 
obtain approximated odds ratios of disease between these classes.
The sibling recurrence risk was estimated by assuming the polygenic model 
that fits well to our data39. Fraction of the sibling recurrence risk attributable 
to all of the five loci was calculated by taking the ratio of the logarithm of this 
value and epidemiologically estimated value of 418,19.
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